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Abstract 
Outbreaks and sporadic cases of viral Infectious Intestinal Disease (IID) are a major 
public health issue resulting in significant morbidity and sometimes mortality each year.  The 
economic costs associated are substantial. 
Laboratory  diagnosis  of  viral  IID  is  important  as  the  many  infectious  and  non-
infectious  causes  cannot  be  reliably  differentiated  using  clinical  or  epidemiological 
characteristics alone. An accurate diagnosis can aid patient management, infection control 
procedures and reduce health care costs by preventing unnecessary treatments, testing for 
alternative causes and hospital stay. It also aids public health surveillance. 
At the start of the research described in this thesis the West of Scotland Specialist 
Virology  Centre  (WOSSVC)  used  Electron  Microscopy  (EM)  as  the  frontline  test  for 
outbreaks and sporadic cases of IID. However, although rapid on a small number of samples, 
this technique has been shown to be insensitive, laborious and is not suited to testing large 
numbers of samples.  
The research presented in this thesis sought to examine whether molecular diagnostic 
techniques such as conventional gel-based or real-time Polymerase Chain Reaction (PCR) 
assays could be a viable replacement for EM as the frontline test(s) for viral IID in a routine 
laboratory service of this type, and whether their implementation could bring benefits to the 
laboratory service in terms of improved rapidity, sensitivity and throughput. The aim was to 
adapt published PCR methods for use in routine diagnostic work rather than for research 
purposes, an approach that distinguishes this research from previous work in this area.  
In order to achieve this aim, the appropriate PCR techniques were first selected from 
the  literature,  based  on  a  combination  of  clinical  and  laboratory  requirements,  and  were 
adapted for use in the laboratory service. A series of laboratory experiments was then carried 
out in order to compare the sensitivity of the adapted methods to existing techniques such as 
EM and antigen detection assays (EIAs) and to other methods that emerged during the period 
of study including alternative PCR assays. Where found to be suitable, the selected PCR tests 
were implemented in the routine diagnostic service for viral IID. The effects of these changes 
on the laboratory service were then examined.  
The results show that since the introduction of molecular tests at WOSSVC for the  
detection of viral pathogens in cases of gastroenteritis the number of samples tested has risen 
steadily, as have the detection rates for each of the main viral causes of IID. Furthermore, this 
has been achieved at the same time as a substantial reduction in sample turn-around-times. 
Such improvements will have a positive impact in several areas of public health relating to 
viral IID and are discussed fully, including patient management, infection control and national 
surveillance.    iv 
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 Introduction 
1.1. Introduction 
The  thesis  expounded  in  this  research  is  that  the  implementation  of  the 
molecular method Polymerase Chain Reaction (PCR) for the diagnosis of the viral 
causes of outbreaks and sporadic cases of gastroenteritis can bring significant benefits 
to a routine laboratory service in terms of increased sample throughput, increased 
detection rates and rapidity of results. 
Outbreaks and sporadic cases of Infectious Intestinal Disease (IID) are a major 
public health issue, resulting in significant morbidity and sometimes mortality each 
year.  Outbreaks  affect  more  than  one  person,  whilst  sporadic  cases  are  individual 
cases that cannot be confirmed as belonging to an outbreak. The associated economic 
costs are substantial. A recent study estimated that IID costs the United Kingdom 
greater than £743 million each year (Roberts et al, 2003). This total was based on 
health-care  costs  alone,  including  the  cost  of  hospitalisation,  GP  consultation, 
treatments and laboratory investigations.  It did not include the cost to business in 
terms of lost workdays, the costs due to missed education or leisure time or the costs 
relating to public health interventions. Furthermore, the costs of outbreaks occurring 
in  closed  settings  such  as  hospitals,  residential  homes  and  the  food  and  leisure 
industry were not included. Few studies incorporate these factors, all of which are 
likely to increase the overall economic burden of IID significantly. 
Laboratory  diagnosis  of  IID  is  important,  as  its  agents  cannot  be  reliably 
differentiated  using  just  clinical  or  epidemiological  characteristics  alone.  Accurate 
diagnosis can aid patient management, infection control procedures and reduce health 
care costs by preventing unnecessary treatments, testing for alternative causes and 
hospital stay. Accurate diagnosis also aids public health surveillance. In the UK a 
number of NHS laboratories provide routine diagnostic services for IID. In general 
these laboratories offer testing for bacteria, parasites and viruses. The exact nature of 
the  types  of  tests  offered  and  the  pathogens  tested  for  tend  to  differ  between 
laboratories.  Specialist  centres  are  also  available  that  offer  a  more  comprehensive 
testing service for some pathogen types.  
Viral pathogens have been shown to be responsible for a significant proportion 
of the IID burden, particularly in sporadic cases in children and outbreaks in all age   5 
groups. From a clinical standpoint, the ideal diagnostic test for viral IID in a routine 
diagnostic setting is one that gives an accurate diagnosis in a timeframe rapid enough 
to be useful to clinicians and public health officials. Ideally the test should also be 
high throughput (i.e. able to process a large number of samples simultaneously) as this 
will contribute to the overall test rapidity and is also more likely to mean that the test 
is robust when faced with the fluctuations in sample submissions seen with seasonal 
infections such as viral IID. From a laboratory standpoint the test should also be cost 
effective and easy to use. 
Many methods exist for the diagnosis of viral causes of IID, which differ in 
sensitivity,  rapidity,  ease  of  use  and  throughput.  Electron  Microscopy  (EM),  for 
example,  is  a  commonly  used  method  in  many  diagnostic  virology  laboratories, 
mainly for historical reasons. However, although rapid on a small number of samples, 
it  is  limited  in  terms  of sensitivity,  is  laborious  and  is  not  suited  to  testing  large 
numbers of samples. Antigen detection methods such as enzyme immunoassays (EIA) 
and  Immunochromatography  (ICG)  offer  similar  sensitivity  to  EM  but  with  the 
potential for improved rapidity, ease of use and throughput. These methods however, 
are not available for all the main viral causes of IID.  
In recent years, the molecular method Polymerase Chain Reaction (PCR) has 
been increasingly used in research on the main causes of viral IID. PCR assays are not 
currently  offered  by  commercial  companies  but  can  often  be  more  sensitive  than 
either EM or antigen detection methods. Research studies utilising conventional gel-
based  PCR  have  determined  that  viral  pathogens  are  the  main  causes  of  IID  in 
children  and  contribute  significantly  to  IID  in  adults  and  immunocompromised 
patients.  Furthermore,  use  of  this  method  has  established  that  norovirus  is  the 
principle  cause  of  outbreaks  of  IID.  However,  early  versions  of  this  assay  were 
technically challenging to implement as they consisted of numerous steps, which in 
turn reduces the test rapidity, robustness and throughput. Furthermore, such assays 
require a strict laboratory set-up and as a result are expensive to implement. Thus, 
although it is now possible to reduce the number of steps involved in conventional 
PCR, the assay is rarely used as a frontline diagnostic test for IID in routine laboratory 
services and is still mainly used as a research tool. 
Real-time PCR has the potential to overcome many of the pitfalls associated 
with the early PCR methods. Using real-time PCR, all or the majority of the numerous 
steps associated with PCR can be carried out in a single step. Reducing the number of   6 
separate steps results in improved rapidity, ease of use and favours high throughput 
and  automation.  The  costs  of  implementation,  equipment  and  reagents  have  also 
reduced significantly in recent years as an increasing number of companies compete 
to sell to an increasing number of users. As a result, real-time PCR has characteristics 
that make it more likely to be of value in a routine diagnostic laboratory. 
The  West  of  Scotland  Specialist  Virology  Centre  (WOSSVC)  is  one  such 
diagnostic  laboratory.  The  WOSSVC  is  based  at  Gartnavel  General  Hospital  in 
Glasgow and it is one of only two specialist virology centres in Scotland. It provides a 
virology service for the whole of Glasgow. In addition, over 40% of its workload is 
from health boards outside Glasgow. The users include hospital-based users, users in 
primary  care  and  general  practice  and  private  industry.  Each  year  over  200  000, 
predominantly viral, investigations are performed.  
At the start of the research described in this thesis the WOSSVC used EM as 
the frontline test for outbreaks and sporadic cases of IID. Outbreak testing was carried 
out  on  samples  from  all  age  groups  whilst  for  sporadic  cases  testing  focused  on 
samples  from  children  less  than  10  years  of  age  and  immunocompromised 
individuals.  
The research presented in this thesis sought to examine whether conventional 
gel-based or real-time PCR tests could be a viable replacement for EM as the frontline 
test  for  viral  IID  in  a  routine  laboratory  service  of  this  type,  and  whether  their 
implementation could bring benefits to the laboratory service in terms of improved 
rapidity, sensitivity and throughput. The aim was to adapt published PCR methods for 
use in routine diagnostic work rather than for research purposes, an approach that 
distinguishes this research from previous work in this area.  
First, the laboratory methods to be used for each step of the molecular service 
were selected from published scientific data based on the combination of clinical and 
laboratory requirements described earlier and knowledge of the equipment available 
in the laboratory. Following this the chosen PCR assays were adapted for use in the 
routine  setting  and  evaluated  against  existing  assays  such  as  EM  and  commercial 
antigen detection methods. Since this is an evolving field of research, the assays were 
also compared to tests that emerged during the period of study including new EIA 
methods and alternative conventional and real-time PCR methods. Studies aimed at 
amending  each  assay,  in  order  to  reduce  the  turn-around-times  and  cost  of  each 
without affecting their sensitivity were also carried out. Based on this research several   7 
changes to the routine service were implemented. The outcomes of these changes on 
the laboratory service in terms of sample throughput, detection rate and turn-around-
times were then examined retrospectively.  
This work will have wide applicability, as it will influence other diagnostic 
laboratories  in  Scotland  and  in  other  countries.  It  will  also  influence  disease 
surveillance and patient management and form the basis for new services in future. 
1.2. Thesis Outline 
The structure of the thesis is as follows. 
Chapter 2 provides a background to the research carried out in this thesis. It 
begins with an overview of the burden of IID in developing and developed countries 
and discusses the economic costs of IID. This is followed by a discussion of the five 
main viral causes of IID: adenovirus, astrovirus, norovirus, rotavirus and sapovirus. 
Aspects of these pathogens discussed include their virology, classification, elicited 
immune response, epidemiology, the clinical illness in which they result, methods of 
preventing  this  illness,  infection  control  and  treatment.  The  contribution  of  viral 
pathogens to the overall burden of IID in sporadic cases of IID in adults and children, 
outbreaks and asymptomatic individuals is then outlined, which provides the rationale 
for decisions taken later in the work concerning the patient groups tested. 
The next section begins by outlining the importance of laboratory diagnosis in 
cases of IID and then discusses the ideal characteristics of a diagnostic test. Following 
this is a review of the available diagnostic assays such as EM, antigen detection, and 
conventional  and  real-time  PCR.  The  chapter  concludes  with  a  description  of  the 
diagnostic service used at the WOSSVC for viral IID at the start of the research and 
outlines the aim of replacing this EM-based service with a PCR-based service in two 
parts: a norovirus RT-PCR as the frontline test for outbreaks of IID and PCR tests for 
both norovirus and the other viruses as the frontline test for sporadic IID in children 
less than 10 years of age and immunocompromised patients. 
Chapter 3 discusses the PCR and associated methods that were selected for 
evaluation  as  the  proposed  replacements  for  the  EM-based  service,  including  the 
sample  preparation  methods  stool  extraction  and  nucleic  acid  extraction.  This  is 
followed  by  a  detailed  review  of  the  published  PCR  methods  for  adenovirus, 
astrovirus,  norovirus,  rotavirus  and  sapovirus.  This  chapter  then  concludes  by   8 
outlining  which  of  these  PCR  tests  were  adapted  for  routine  use  in  the  proposed 
molecular  service  and  explains  the  factors  that  influenced  their  choice  including 
published evaluation data, the clinical and laboratory characteristics of an ideal test 
and the equipment available in the laboratory at the time of development.  
Chapter 4 begins with an explanation of how the new PCR assays were then 
assessed.  The  assessments  are  split  into  two  parts:  those  that  focussed  on  the 
development of a molecular service for outbreaks of IID; and those carried out with 
the  development  of  a  molecular  service  for  sporadic  cases  of  IID  in  mind.  Each 
section contains a progressive series of controlled experiments comparing the adapted 
PCR  methods  (described  in  Chapter  3)  to  existing  diagnostic  methods  such  as 
Electron Microscopy (EM) and antigen detection methods, and to newer methods that 
emerged as the project progressed.  
The outbreak section begins by comparing the  selected norovirus real-time 
PCR method to EM for testing samples from outbreaks of IID. This PCR method is 
then  compared  to  two  EIA  methods  and  then  two  alternative  PCR  methods  for 
norovirus:  a  conventional  gel-based  method  recommended  by  a  European 
collaboration  in  2003,  and  a  real-time  PCR  method  using  dual-labelled  probes 
(published in 2003). The results of each comparison are discussed and the resultant 
changes to the WOSSVC diagnostic service are described.  
The section on the development of a routine sporadic service begins with an 
experiment attempting to multiplex gel-based methods for the remaining four viral 
pathogens into a smaller number of assays. The resultant assays are then compared to 
antigen detection methods for rotavirus and astrovirus before being compared to four 
different dual-labelled probe-based PCR methods. The results of each comparison and 
the  resultant  changes  to  the  diagnostic  service  are  then  discussed.  This  section 
concludes with the description of a number of experiments aimed at reducing the turn-
around-times and cost of the resulting service without affecting the sensitivity of the 
assays.  
Chapter 5 contains an analysis of the effects of these test developments on the 
WOSSVC diagnostic service. The chapter begins by summarising the changes made 
to the service between 1999-2006 as a result of the research described above. Various 
measures  are  then  used  to  examine  the  outcomes  of  the  service  developments, 
including the number of samples submitted for testing (examined by total, by health 
board of origin and by age group), the number of detections made, the number of   9 
outbreaks classified as either positive or negative, and the turn-around-times of the 
results. These data are examined for both the outbreak and sporadic service and are 
cross  referenced  with  the  service  changes  to  determine  whether  these  resulted  in 
improvements  in  sample  throughput,  test  sensitivity  and  rapidity  of  results. 
Contributing  to  this  analysis  are  the  results  of  a  questionnaire,  which  asked 
laboratories in Scotland to outline their testing protocols for outbreaks and sporadic 
cases of IID. This questionnaire examined how other laboratories use the WOSSVC 
service and examined whether the developments described have resulted in changes to 
their own services. 
Finally,  a  thorough  discussion  of  all  the  research  findings  is  presented  in 
Chapter 6. Included in this are the likely outcomes of the service developments on 
non-laboratory  aspects  such  as  patient  management,  infection  control  and  national 
surveillance.  A  discussion  of  the  potential  role  of  the  molecular  methods  in  new 
services for the prevention and investigation of outbreaks based on testing non-patient 
samples such as environmental samples is also included.  
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Background To The Research 
2.1. Overview 
This chapter outlines the importance of Infectious Intestinal Disease (IID) in 
public health. Its burden in terms of morbidity and mortality worldwide is discussed 
followed by an in-depth review of the economic cost of IID in developed countries. 
The  main  viral  causes  of  IID  are  then  reviewed  with  particular  focus  on  each 
pathogen’s  virology,  classification,  elicited  immune  response,  epidemiology,  the 
clinical  illness  in  which  they  result,  methods  of  preventing  this  illness,  infection 
control  and  treatment.  The  contribution  viral  pathogens  make  to  overall  IID  in 
children, adults and outbreaks is also discussed. The next section begins by describing 
the characteristics of an ideal diagnostic test for viral IID before outlining the different 
methods  available.  Electron  Microscopy  (EM),  antigen  detection  assays,  and 
Polymerase Chain Reaction (PCR) methods such as conventional gel-based and real-
time PCR are all described. The advantages and disadvantages of each test type are 
described, together with data on their relative performance. The chapter concludes 
with a description of the West of Scotland Specialist Virology Centre (WOSSVC) 
diagnostic service for viral IID at the start of the research followed by a description of 
the thesis aims for the improvement of this service using molecular methods. 
2.2. Importance Of Infectious Intestinal Disease (IID)  
2.2.1. Mortality And Morbidity Of IID Worldwide 
Infectious Intestinal Disease (IID) results in a substantial burden of morbidity 
and  mortality  worldwide.  It  is  responsible  for  approximately  4  billion  cases  of 
diarrhoea  and  3  to  4  million  deaths  each  year  (Farthing,  2000;  World  Health 
Organisation 1996; World Health Organisation 1994).  
In both the developing and the developed world the majority of illness and 
death is borne by infants and children, with the risk increasing as the weaning stage 
ends (Kosek, Bern and Guerrant, 2003). Children in developing countries experience 
most  of  the  total  annual  burden  of  IID  (Parashar  et  al,  2003).  In  economically 
deprived areas such as the Indian subcontinent, Africa and Latin America children can 
experience up to 10 episodes of IID per year. Repeated cases in children leads to 
malnutrition, which can result in impaired growth and development, and death. Most   12 
deaths are a result of excessive fluid and electrolyte loss leading to severe dehydration 
and acidosis (Farthing, 1998) although deaths can easily be avoided by the prompt 
administration  of  fluid  and  electrolytes.  The  economic  burden  of  treating  IID  in 
developing countries often takes up a substantial proportion of the nation’s health-care 
budget.  
The elderly are also at increased risk of severe IID. This is thought to be a 
result of decreasing immune and gastric acid protection. Others at risk of severe IID 
include  the  immunocompromised  (e.g.  HIV  positive  individuals,  solid  organ 
transplant  and  bone  marrow  transplant  recipients),  individuals  with  congenital 
abnormalities and travellers (Faruque et al, 2004; Mattila et al, 1992). 
2.2.2. Morbidity And Mortality Of IID In The Developed World 
In developed nations sporadic cases and outbreaks of IID result in significant 
morbidity and sometimes mortality. Sporadic cases are those that cannot be identified 
as belonging to a particular outbreak. In the US an estimated 79 million cases of 
sporadic IID occur each year resulting in approximately 325,000 hospitalisations and 
around  5000  deaths  (Frenzen,  2003;  Mead  et  al,  1999).  The  mortality  rate  is 
significant when compared to the mortality rates of other infection related deaths in 
the US. For example, cervical cancer, rheumatic fever and hepatitis B virus result in 
approximately 4400, 4800 and 4400 deaths per year respectively (American Cancer 
Society, 2001; American Heart Association, 2001; Kane, 1995). Studies carried out in 
other developed countries have also highlighted a substantial burden of sporadic IID. 
For  example,  each  year  Australia  experiences  an  estimated  15  million  cases  of 
sporadic  IID  resulting  in  more  than  1  million  GP  visits  and  more  than  1  million 
missed workdays (Hellard et al, 2003). In the Netherlands an estimated 4.5 million 
episodes of sporadic IID occur each year (Wit MAS et al, 2001). As a result of these, 
more  than  80,000  patients  require  hospitalisation  and  approximately  300,000 
workdays  are  missed.  A  study  of  sporadic  IID  in  England  estimated  there  to  be 
approximately  9.4  million  cases  each  year  resulting  in  1.5  million  GP  visitations 
(Wheeler et al, 1999). A telephone study in Ireland concluded that an estimated 3.2 
million cases of IID occurred in 2003 (Acute Gastroenteritis in Ireland, North and 
South - A Telephone Study, 2003). 
Outbreaks  of  IID  (where  multiple  individuals  are  affected)  are  also  an 
increasingly  recognised  problem  in  developed  countries  (Meakins  et  al,  2003;   13 
Fankhauser et al, 2002; Lopman et al, 2003). An assessment of outbreaks reported to 
the Heath Protection Agency (HPA) from 1991-2000 showed that there were  more 
than 5000 outbreaks in England and Wales during this time. This total is likely to be a 
huge underestimate of the total number of outbreaks  as many  are not  detected or 
reported  each  year.  Over  50%  of  the  outbreaks  that  were  reported  occurred  in 
hospitals and residential care homes. Due to the general poor health of many of the 
patients present in hospitals and care homes the risk of significant morbidity and death 
in these settings as a result of IID is increased (Goller et al, 2004). Outbreaks in the 
food and leisure industry are also common with large outbreaks reported in holiday 
camps, hotels, restaurants and cruise ships (Koopmans and Duizer, 2003; Lawrence, 
2004).  
Few studies to date have examined the short and long term sequalae in patients 
with clinically diagnosed IID. Cumberland et al followed up a large cohort of patients 
with sporadic IID and found that a significant proportion had symptoms that persisted 
for longer than previously described (Cumberland et al, 2003). For example, over 
25% of patients had persistent diarrhoea 3 weeks after onset, approximately 12% had 
persistent vomiting and around 33% of adults and children had continued abdominal 
pain. As a result patients were more likely to request a repeat consultation with their 
GP within 3 months of the initial episode. This was especially true in children (those 
aged under 5 years) and the elderly (aged over 60 years). There was also an increased 
rate  of  hospitalisation  and  subsequent  diagnosis  of  irritable  bowel  syndrome  in 
patients who had suffered IID. Other studies have also shown an increased risk of 
irritable bowel syndrome after IID (Parry et al, 2003). Helms and colleagues followed 
a  cohort  of  48,547  patients  in  Denmark  with  diagnosed  IID  (Helms  et  al,  2002). 
Patients with IID were shown to have an increased risk of mortality both in the short 
and long term. The increased risk was mainly as a result of complications such as 
invasive illness (septicaemia,
 endocarditis, vasculitis, septic arthritis, etc), intestinal 
perforation,
 abscesses, and complications of
 surgery. These complications occurred 
weeks or months after the initial IID episode. 
2.2.3. The Economic Cost Of IID In Developed Countries 
The  substantial  morbidity  caused  by  IID  in  developed  countries  has  a 
significant  economic  impact.  Many  studies  have  attempted  to  measure  the  overall 
economic burden of sporadic  IID. Most have based their estimates on the cost of   14 
medical treatment (hospitalisation, Accident & Emergency visitation, GP/physician 
visitations and prescriptions/treatments), missed workdays (due to illness or having to 
care for a relative), laboratory investigations, and transport (of the affected individual 
to the GP/hospital). Garthright et al estimated the cost of sporadic IID in the US to be 
greater than $23 billion per year (Garthright, Archer and Kvenberg, 1988). Similar 
high  totals  have  been  estimated  in  Australia  (more  than  $1000  million  Australian 
dollars per annum), Canada ($1.1 billion US dollars per annum), the Netherlands (345 
million euros per  year)  and England (£743 million) (Hellart et al, 2003; Van den 
Brandhof et al, 2004; Roberts et al, 2003; Todd, 1989). No study has yet measured the 
cost of sporadic IID in Scotland but it is likely to be substantial.  
Most of the published studies described above are likely to be underestimates 
as many do not include the costs to business, the costs of missed education (e.g. at 
school/university),  lost  leisure  time  (e.g.  interrupted  evenings,  weekends  and 
holidays),  and  public  health  interventions  (the  costs  of  which  are  likely  to  be 
substantial).  Furthermore  these  studies  do  not  include  costs  relating  to  post  IID 
complications such as repeat GP consultation or hospital admission (described above).  
The cost of outbreaks of IID moreover, has not been included in many of the 
aforementioned studies. Outbreaks of IID in hospitals are a substantial burden and can 
often affect multiple wards, resulting in ward closure, cancelled operations and even 
hospital closure. Few studies have attempted to measure these costs. A recent study by 
Lopman et al estimated the cost of health-care associated outbreaks of norovirus by 
monitoring 3 hospital sites in Avon, England during 2002 (Lopman et al, 2004). In 
total, outbreaks of IID caused by norovirus were found to have cost more than £115 
million-12.5% of the total Health care Associated Infection (HAI) budget or 1% of the 
total NHS expenditure on in-patient service.  
Zingg et al estimated the cost of a single nosocomial outbreak of norovirus 
(Zingg  et  al,  2005).  The  costs  were  estimated  based  on  various  factors  including 
nursing care, staff sick leave, laboratory testing and the infection control team costs. 
In total, this single outbreak was estimated to cost the US health care system over 
$40,000. A recent study in England estimated the cost of a single norovirus outbreak 
to be greater than £280,000 (Cooke, Goddard and Golland, 2002). 
The cost of outbreaks of IID to the food and leisure industry is also likely to be 
substantial.  Large  outbreaks  result  in  mass  cancellations,  emergency  treatment, 
refunds and compensation proceedings. Any accompanying bad publicity is likely to   15 
affect future bookings. However, no studies have so far attempted to measure these 
costs. 
2.3. Viral Causes Of IID 
There  are  at  least  5  viral  causes  of  IID:  rotavirus,  norovirus,  sapovirus, 
astrovirus  and  adenovirus.  Below  is  a  detailed  review  of  each  of  the  pathogens 
virology, their classification, their elicited immune response, their epidemiology, the 
clinical illness they cause and various methods aimed at preventing, controlling and 
treating these infections due to these causes. This review will show that each of these 
pathogens  is  genetically  complex  with  genomes  that  contain  areas  of  significant 
variability between the many types and subtypes. This is important when considering 
the design of molecular assays, which is a major part of the next chapter. The complex 
immune responses elicited are highlighted to show that repeat infections can occur 
with  each  virus  and  that  infections  can  occur  in  all  age  groups.  Their  numerous 
sources and transmission routes are also described in order to highlight how difficult 
these pathogens are to control and prevent. Together, these factors ensure that these 
viral pathogens contribute significantly to sporadic illness and outbreaks in all age 
groups. 
2.3.1. Rotavirus 
Rotaviruses  were  first  discovered  as  a  cause  of  human  illness  in  1973  by 
Bishop and colleagues using electron microscopy (EM) to examine duodenal biopsy 
specimens from children with gastroenteritis (Bishop et al, 1973). Rotaviruses are 
members of the Reoviridae family. They are icosahedral, non-enveloped viruses of 
70-75nm in diameter. The rotavirus capsid is composed of 3 concentric protein layers 
that  enclose  the  viral  genome.  Viewed  under  the  EM  rotavirus  particles  have  a 
characteristic “wheel-like” appearance (Figure 1) from which their name is derived 
(the latin for wheel is “rota”).    16 
Figure 1: Rotavirus as viewed under electron microscopy (Copyright 1994 Veterinary 
Sciences Division) 
 
2.3.1.1. Genome Organisation and Function  
Rotaviruses possess a genome made up of 11 segments of double stranded 
RNA of approximately 18,850 base pairs in length. Each segment codes for 1 protein 
except segment 11, which codes for 2. Of the 12 proteins, 6 are structural (VP1-4, 6 
and 7) and 6 are non-structural (NSP1-6) (Figure 2). At present the role of a number 
of these proteins are unclear.    17 
Figure 2: The genome segments and encoded proteins of rotavirus.   
 
Structural Proteins 
VP1 is coded for by gene segment 1. It is a minor component of the central 
core making up 2% of total virion mass. Comparisons of different rotaviruses have 
shown VP1 to be highly conserved both at amino acid and protein levels. It is the 
largest polypeptide and shares consensus sequences with several well-characterised 
RNA dependent RNA polymerases (Valenzuela et al, 1991). 
VP2 is encoded by gene segment 2 and alongside VP1 and VP3, makes up the 
inner core of the rotavirus. It is the most abundant protein of the inner core and it 
encloses the VP1, VP3 and genome (Jayaram et al, 2004). It is highly conserved and 
of the 3 proteins that make up the inner core it is the only one that has nucleic acid 
binding  activity.  VP2  interacts
  with  VP6  in  order  to  transport  metabolites
  in  and 
nascent RNA out during transcription (Prasad et al, 1988). VP2 is also thought to 
have a role in the assembly of the rotavirus particles and is necessary for replicase and 
transcription activity (Mansell and Patton, 1990). 
VP3 is encoded by gene segment 3. It is a minor component of the central 
core. It has sequence homology to other viral polymerases and is thought to have 
guanyltransferase and methyl transferase activity (Chen et al, 1999; Liu et al, 1992). 
The VP4 protein is 775 amino acids long and is the product of gene sequence 
4. Cyro-electron microscopy studies have shown that for every 780 copies of VP7   18 
present in the outer layer, there are 120 copes of VP4 (Jayaram et al, 2004). It appears 
as  spikes  on  the  capsid  surface  and  is  implicated  in  cell  entry,  attachment, 
haemagluttination, neutralisation and virulence (Ciarlet and Estes, 2001). The VP4 
region contains several variable regions that define the P serotype (Gorziglia et al, 
1990). 
The VP6 protein is encoded by gene segment 6. It is the major constituent of 
the intermediate layer which contains 260 trimers of VP6 arranged as hexamers on a 
T=13 icosahedral lattice (Mathieu et al, 2001; Jayaram et al, 2004). It is sandwiched 
between the outer T=13 later (VP4/7) and the inner T=1 (VP2) layer. The VP6 is 
essential for transcription of the genome. It also has a structural and immunological 
role and is responsible for the wheel-like appearance of the rotavirus (Greenberg et al, 
1983; Kohli et al, 1987). Although VP6 is more conserved than either VP7 or VP4, 
this region contains variable regions that are used to determine the group (A-G) and 
subgroup antigens (Sg1, Sg2, non Sg 1 or 2, and Sg1+2).  
VP7 is encoded by gene segment 9 and is the only structural glycoprotein. It 
forms  the  outer  layer  of the  viral  capsid  and  comprises  30%  of  total  virion  mass 
(Jayaram et al, 2004). Cryo-electron microscopy reconstructions have identified that 
the outer layer comprises of 780 copies of VP7 which are located at the local and 
strict  fold  axis  at  T=13 (Prasad  et  al,  1990;  Jayaram et  al,  2004).  The  VP7  may 
modulate the VP4 function during cell attachment and entry and may also interact 
with cell surface molecules after VP4 attachment (Beisner et al, 1998; Mendez et al, 
1996; Mendez et al, 1999). Comparative studies of various rotaviruses have identified 
at least 6 (A-F) or 9 discrete regions within the VP7 (VR1-9) that show significant 
amino acid divergence (Gouveau et al, 1990; Green et al, 1987). These areas are the 
target  of  type-specific  and  cross-reactive  neutralisation  antibodies  and  are  used  to 
determine the rotavirus serotype (G type). Genotypic classification based on the VP7 
region has been shown to match serotype (Goveau et al, 1990).  
Non-Structural Proteins 
NSP1 is coded for by gene segment 5. At present its role is unknown but it is 
thought to have a role in modulating the inate immune response by degrading IFN-3 
(Barrow  and  Patton,  2005).  Sequence  analysis  shows  that  this  region  contains 
extensive sequence variation, although there is a 88 amino acid region present that is 
conserved amongst all rotaviruses (Xu et al, 1994).    19 
NSP2  is  encoded  by  gene  segment  8.    As  with NSP1  its  role  is  currently 
unclear  although  it  is  proposed  to  have  a  role  in  RNA  replication  and  packaging 
(Gombold et al, 1985). Studies have also showed it to have nucleoside triphosphate 
activity. Sequence comparisons of mammalian rotaviruses have shown a high level of 
amino acid conservation of over 83% (Patton et al, 1993). The last 75 nucleotides at 
the 5’ end and 23 nucleotides of the 3’ end are nearly identical among rotaviruses. 
NSP3 is coded for by gene segment 7. It has shown to be an RNA binding 
protein and therefore it has been proposed that it may have a role in re-initialisation of 
translation protein synthesis (Boyle and Holmes, 1986). Others have suggested that it 
may have a role in viral replication in the gut and then subsequent spread to other 
tissues (Mossol and Ramig, 2002). Sequence analysis of the NSP3 shows that more 
that 75% is conserved amongst mammalian rotaviruses (Rao et al, 1995). However, 
using this method, rotaviruses can be split into 3 evolutionary groups: SaII, Wa and 
S2. Of particular interest are the eighty nucleotides in the 3UTR region, which are 
highly conserved (Pang et al, 2004).  
The  NSP4  is  coded  for  by  gene  segment  10.  It  is  the  most  studied  NSP. 
Studies have shown it to interact with both VP6 and VP4 and it has been suggested 
that it may be involved in outer capsid assembly (Lynn et al, 2005).  Several studies 
have suggested that NSP4 is also a viral enterotoxin (Parr et al, 2006; Ball et al, 
2005). The proposed mechanism of action is via the activation of a signal transduction 
pathway resulting in altered intestinal epithelial transport, membrane destabilisation 
and altered calcium levels in the endoplasmic reticulum (Tian et al, 1995; Ball et al, 
1996; Horie et al, 1999). Studies using fusion proteins, containing 86-175 aminoacids 
of the murine NSP4 (expressed in E-coli), were found to cause severe diarrhoea when 
given  to  CD1  mice.  Furthermore,  sequence  differences  in  the  NSP4  have  been 
observed between symptomatic and asymptomatic rotavirus infections (Kirkwood et 
al, 1996; Ward et al, 1997). However, others have failed to confirm either of these 
findings (Angel et al, 1998). Sequence analysis of the NSP4 shows there to be 2 hyper 
variable regions allowing rotaviruses to cluster into 2-5 groups (Cunliffe et al, 1997; 
Kirkwood et al, 1999). There are two main groups for human rotaviruses (A and B). 
These correlate with the VP6 subgroups-VP6 Sg1 matches with NSP4 A and VP6 Sg2 
matches with NSP4 B (Iturriza-Gomara et al, 2003). 
NSP5 is encoded by gene segment 11. It is the only segment with more than 
one Open Reading Frame (ORF) (Mitchell and Both, 1988). These are overlapping.   20 
The ORF1 is 198 amino acids in length and the ORF2 is 92 amino acids. ORF2 codes 
for NSP6. At present their roles are unclear. Transient expression of this protein in 
uninfected  cells  has  provided  evidence  for  its  participation  in  the  formation  of 
“viroplasms”, which are thought to be key structures for the replication of rotavirus 
(Lopez et al, 2005).  
2.3.1.2. Classification  
Serological cross reactivity of the inner capsid protein VP6 has determined 
there to be 7 groups of rotavirus (A-G) (Greenberg et al, 1983; Kapikian et al, 1981). 
Groups A-C are human and animal pathogens whereas the remainder are pathogens of 
animals  only  (Estes,  2001).  Group  A  rotaviruses  can  be  further  divided  into  four 
subgroups (subgroup 1, subgroup 2, subgroup 1+2, subgroup non 1 and non 2) based 
on reactivities with two VP6 specific monoclonal antibodies. Subgroup 1 includes 
mostly  animal  and  some  human  rotaviruses.  Subgroup  2  includes  mostly  human 
rotaviruses, whereas subgroup 1+2 and subgroup non 1 and non 2 are mostly animal 
pathogens and are rarely associated with infection in humans. 
Strains of rotavirus  are  classified by the analysis of VP4 and VP7 surface 
proteins using a similar method to the one that is used to classify influenza. Using this 
method rotaviruses are attributed G types (based on the VP7 Glycoprotein) and P 
types (based on the VP4 Protease sensitive protein). So far, at least 14 G types and 20 
P  types  have  been  recognised  (Rao,  Gowda,  and  Reddy,  2000).  This  enormous 
antigenic and genetic diversity is the result of a number of mechanisms. The principle 
method of generating rotavirus diversity is thought to be re-assortment (known as 
antigenic shift) (Iturriza-Gomara et al, 2001). VP4 and VP7 are coded for on different 
RNA segments. Dual infection of a host by different rotavirus strains can lead to re-
assortment and the subsequent emergence of new G and P type combinations. Dual 
rotavirus infections are common. A recent study in the UK found that 2% of rotavirus 
infections were of mixed type (Iturriza-Gomara et al, 2000). Rates of mixed infection 
in other countries are thought to be higher (Ahmed et al, 1991; Unicomb et al, 1999; 
Jain et al, 2001). Although intra-group re-assortment has been described on a number 
of  occasions  it  has  yet  to  be  documented  for  different  rotavirus  groups.  One 
hypothesis is that rotavirus groups differ in their genome end terminal RNAs and this 
may prevent inter group re-assortment.   21 
Other  methods  of  generating  rotavirus  diversity  are  thought  to  include  the 
accumulation  of  point  mutations  (known  as  antigenic  drift)  and  recombination 
(Blackhall et al, 1996; Desselberger, 1996; Ramig, 1997).   
The introduction of animal rotaviruses or animal/human strain re-assortments 
has also been raised as possible contributors to rotavirus diversity (Cook et al, 2004; 
van der Heide et al, 2005; Palombo, 2002).  Studies have demonstrated that animal 
rotaviruses can cause symptomatic infection in humans (Desselburger et al, 2001; 
Theil, 1990; Kojima et al 1996; El-Attar et al, 2001). For example, Nakagomi and 
Nakagomi found a feline G3 rotavirus infection in a child with a pet cat (Nakagomi 
and Nakagomi, 1989). Molecular studies on human rotavirus type G9 have shown it to 
share genetic similarities to porcine strains thus raising the possibility that it may have 
been recently introduced from pigs (Iturriza-Gomera et al, 2000; Hoshino et al, 2005; 
Teodoroff  et  al,  2005).  The  clinical  and  epidemiological  characteristics  of  G9 
infection compliment this view as it tends to occur in older age groups and cause more 
severe infection when compared to common rotavirus strains (Widdowson et al, 2000; 
Cubitt,  Steele  and  Iturriza,  2000;  Iturriza-Gomara,  Kang  and  Gray,  2004). 
Furthermore this type had not been detected in the UK prior to 1995. Dual rotavirus 
infection with animal and human types has also been demonstrated (Nakaomi et al, 
1994; Holmes et al, 1999).  
2.3.1.3. Immune Response 
After primary infection, the immune response to rotavirus is mainly humoral. 
This response is thought to be homotypic although there is partial protection against 
other serotypes (Gorrell and Bishop, 1999). This has been confirmed by volunteer 
transmission  and  vaccination  studies  that  have  shown  that  natural  infection  or 
vaccination protects from severe disease in subsequent infections (Davidson, Hogg 
and Kirubakaran, 1983; Bishop et al, 1983; Hjelt et al, 1985; Bhan et al, 1993; Ward 
and Bernstein, 1994). However, although partial protection is elicited after primary 
infection  subsequent  infections  occur  throughout  life.  Valazquez  and  colleagues 
examined 200 Mexican infants over a 5-year period (Velazquez et al, 1996). By 2 
years of age approximately 96% of infants had had a primary rotavirus infection. Over 
the same period approximately 70% had a second rotavirus infection and by 5 years of 
age over 10% had suffered greater than 5 episodes of rotavirus. Cases of rotavirus in 
adults  are  being  increasingly  recognised,  again  highlighting  partial  protection   22 
(Gonzalez-Losa et al, 2001; Wenman et al, 1979; Echeverria et al, 1983; Cubitt and 
Holzel, 1980; Holzen et al, 1980; Dupuis et al, 1995; Linhares et al, 1981). Some 
studies have shown that protection correlates with the formation serum IgA antibodies 
targeting VP4 and VP7 antigens and the VP6 capsid antigen (Ward, Bernstein and 
Shukla, 1989; Hjelt et al, 1987). Other studies have highlighted the importance of 
IgG, IgA and IgG or neutralising antibody (Clemens et al, 1992; O’Ryan et al, 1994; 
Velazquex  et  al,  2000).  Cytotoxic  T  Lymphocytes  (CTL)  responses  have  been 
detected but their exact role has yet to be determined (Chiba et al, 1986; Chiba et al, 
1993). 
2.3.1.4. Epidemiology 
Group A rotavirus has a worldwide distribution and is the predominant cause 
of  childhood  gastroenteritis  in  the  developed  and  developing  world.  In  temperate 
regions rotavirus infections occur predominantly during the winter months (Cook et al 
1990). However, a recent study highlighted that the seasonality of rotavirus infections 
in Japan has shifted from winter to early spring (Suzuki et al, 2005). The reason for 
this  is  unclear.  The  seasonality  is  less  defined  in  tropical  areas  with  infections 
occurring all year round (Iturriza-Gomarra et al, 2000; Kapikian et al, 1976).  
Sources  of  rotavirus  infection  include  individuals  with  asymptomatic 
infection. A recent case control study by de Wit et al detected rotavirus in 0.6% of 
control samples (de Wit et al, 2001). More recent studies using increasingly sensitive 
tests  have  detected  higher  rates  (Amar  et  al,  2007).  Individuals  with  long  term 
shedding (4-57 days) and severe illness (as they have been shown to have a higher 
viral load in faecal samples (Richardson et al, 1998; Kang et al, 2004)) are another 
source of illness. Recent evidence also suggests interspecies transmission of rotavirus 
as  numerous  animal  and  human  strains  have  been  shown  to  share  genetic  and 
antigenic features (see section 2.3.1.2).  
Group A rotavirus has a low infectious dose (Goldman, 1992; Bishop, 1996). 
As a result transmission is person to person and occurs mainly via the faecal oral route 
(Al Frayh et al, 1987; Dennehy, 2000; Vipond, 2001). Evidence also points towards 
spread via the respiratory route (Price et al, 1986; Goldwater, Chrystie and Banatvala, 
1979). Studies using aluminium surfaces have shown rotavirus to remain stable for up 
to  60  days,  suggesting  transmission  via  contaminated  fomites  (Sattar  et  al,  1986;   23 
Koopmans  and  Duizer,  2004;  Abad,  Pinto  and  Bosch,  1994).  Other  forms  of 
transmission include contaminated food and water.  
Most  rotavirus  infection  occurs  in  infants  greater  than  3  months  of  age 
(Sharma et al, 2002). Infants under 3 months can have symptomatic infection but 
most seem to be protected from severe infection, probably as a result of maternal 
antibody (Crawley et al, 1993).  
Adults are also at risk of rotavirus infection. However, although adults may 
obtain infection from the sources described above, the greatest risk is from rotavirus-
infected children (Zissis et al, 1976; Wenman et al, 1979; Grimwood et al, 1983; 
Anderson and Weber, 2004). Wenman et al showed child to parent transmission to be 
a common event, with 36 of 102 adults who had children with rotavirus infection also 
found to be positive for the virus. Infection has also regularly been documented in 
medical staff that are in frequent contact with rotavirus-infected infants (Samadi, Huq 
and Ahmed, 1983; Hjelt et al, 1985). As a result the seasonality of adult infection 
probably reflects that of children (Nakajima et al, 2001). However, Cox and Medley 
tested routine serum samples from hospitalised adults and detected IgM to rotavirus 
throughout the year thus suggesting a sporadic distribution similar to that in tropical 
areas (Cox and Medley, 2003).  
Other adults at risk of rotavirus infection include travellers (Keswick et al, 
1982; Vollet et al, 1979; Bolivar et al, 1979). A recent study of travellers returning 
from  Jamaica  with  diarrhoea  found  that  rotavirus  infection  was  second  only  to 
Enterotoxigenic E-coli (Steffen et al, 1999).  
Outbreaks of rotavirus have been documented but are rare (MMWR, 2000; 
Halvorsrud  and  Orstavik,  1980;  Abbas  and  Denton,  1987;  Friedman  et  al,  1988; 
Foster et al, 1980). Closed settings such as hospitals, care homes, and day care centres 
are at particular risk.  
Evidence from molecular epidemiological studies has shown that different G 
types co-circulate at any location at any given time. A study of UK strains detected 
between 1995-1999 found a total of 15 different strains circulating during this period. 
Over 95% were of types G1-4  (Iturriza-Gomara et al, 2001).  This epidemiological 
pattern has also been seen in other countries. Santos and Hishino examined 45,571 
strains from 124 studies (1989-2004) carried out in 52 countries from 5 continents 
(Santos and Hishino, 2005). They found that types G1-4 (in conjunction with either 
P6 or P8 types) accounted for 88% of all circulating types. The newly emerged G9   24 
was  the  fourth  most  important  rotavirus  type  (4.1%).  Different  types  were 
predominant in different geographical areas. For example, G1/P8 type accounted for 
more than 70% of strains in North America, Europe and Australia. However, this type 
accounted for only 30% of strains in South America and Asia. Another emerging G 
type (G5) has recently become common in South America. 
Group  B  rotaviruses  show  a  different  epidemiology  to  that  of  group  A 
rotaviruses (Sen et al, 2001; Kelkar and Zade, 2004). Group B rotaviruses were first 
discovered as a cause of human illness in 1982 when large outbreaks of severe cholera 
like-illness were described in adults in China (Yang et al, 2002). Since then several 
outbreaks have been reported in China and more recently in India and Bangladesh 
(Barman et al, 2004; Ahmed et al, 2004; Sanekata et al, 2003; Kobayashi et al, 2001). 
Group C rotaviruses cause illness similar to that of group A rotaviruses and 
can affect children and adults (Kuzuya et al, 2003; Nilsson et al, 2000; Gabbay et al, 
1999; Souza et al, 1998; Teixeira et al, 1998; Otsu, 1998).  Studies in numerous 
countries have shown high sero-positive rates suggesting that infection is common 
(James et al, 1997; Nilsson et al, 2000; Steele and James, 1999; Jiang et al, 1995; 
Iturriza-Gomara et al, 2004). Targeted studies using sensitive molecular tests have 
detected  group  C  rotavirus  in  approximately  1-10%  of  all  cases  of  infantile 
gastroenteritis  (Sanchex-Fauquier  et  al,  2003;  Yan  et  al,  2004;  Phan  et  al,  2004; 
Schnagl et al, 2004; Castello et al, 2002; Cunliffe et al, 2001). These studies have also 
highlighted that primary group C rotavirus infections may occur in children older than 
those that suffer group A rotaviruses. 
2.3.1.5. Clinical Illness 
Infantile  rotavirus  infection  has  an  incubation  period  of  approximately  1-2 
days  followed  by  a  sudden  onset  of  watery  diarrhoea  lasting  between  4-7  days. 
Diarrhoea is often accompanied by vomiting (Sharma et al, 2002; Bishop, 1996). The 
severity of the illness varies (Ruuska and Vesikari, 1990). For example, asymptomatic 
infection by so called “nursery strains” have been described (Crawley et al, 1993). 
More serious infections have also been described sometimes leading to neurological 
abnormalities  resulting  from  electrolyte  imbalances  (Hung  et  al,  2003;  Jones  and 
Blikslager, 2002; Lin et al, 1996).  A recent study by Blutt et al detected virus and 
antigen in the serum of both animals and children raising the possibility that rotavirus 
may also escape from the gastrointestinal tract and cause disease elsewhere in the   25 
body (Blutt et al, 2003; Blutt et al, 2007). Studies have demonstrated rotavirus in the 
Central Nervous System (CNS) of patients with neurological illness such as meningo-
encephalitis but whether this is a cause, bystander or contaminant is unclear (Lynch et 
al, 2003; Lynch et al, 2001; Pager et al, 2000). Rotavirus has also been demonstrated 
in the kidney, liver and lung (Nuovo et al, 2002; Gilger et al, 1992). Other reported 
complications  of  rotavirus  infection  include  necrotising  enterocolitis  (Rotbart  and 
Levin, 1983), infantile acute hemorrhagic edema, and possible intussusception (Bines 
et al, 2004; Robeinson et al, 2004; Nelson et al, 2002; Rennels et al, 1998; Mulcahy 
et al, 1982; Konno et al, 1978; Sharma et al, 2004; Boccia et al, 2001; Di lernia, 
Lombardi and Lo Scocco, 2004). 
In immunocompromised children, chronic and severe rotavirus infections have 
frequently been documented (Saulsbury, Winkelstein and Yolken, 1980; Troussard et 
al,  1993;  van  Kraaij  et  al,  2000).  In  1980  for  example,  2  children  with  primary 
immune  deficiencies  developed  chronic  diarrhoea  that  improved  after  the 
administration  of  human  breast  milk  containing  high  titres  of  rotavirus  antibody 
(Gilger  et  al,  1999).  Gilger  et  al  also  described  4  children  with  various  immune 
deficiencies  who  were  suffering  from  chronic  diarrhoea  and  were  found  to  have 
rotavirus present in the liver and kidney.  
The  clinical  illness  seen  in  adults  has  mainly  been  determined  through 
volunteer studies (Hardy, 1987; Jewkes et al, 1981; Kapikian et al, 1983; Ward et al, 
1990; Ward et al, 1986). The incubation period seems to be longer than in children (2-
6 days) and symptoms of diarrhoea, fever, headache, malaise, nausea and cramping 
last 1-4 days. Case reports have indicated a similar incubation period and symptoms 
to those ascertained through volunteer studies, although reports from elderly patients 
have shown more prolonged symptoms and shedding.  
Rotavirus  infection  has  also  been  described  in  adult  solid  organ  transplant 
patients, Bone Marrow Transplant (BMT) patients, patients with cancer and adults 
who are infected with HIV. Bolivar et al investigated 90 adult patients with solid 
tumours  or  leukaemia  (Bolivar  et  al,  1983).  Two  patients  developed  rotavirus 
infection with subsequent graft versus host disease. Yolken et al examined 78 adult 
BMT patients and found evidence of rotavirus infection in 9 (Yolken et al, 1982). 
Most  of  those  affected  suffered  abdominal  cramps  and  diarrhoea.  Six  developed 
respiratory illness (as proven by chest infiltrates on a chest radiograph) of whom five 
subsequently died.    26 
Other  reports  of  rotavirus  pneumonitis  have  included  a  patient  undergoing 
steroid  treatment  for  multiple  sclerosis  (Thomas,  Pollok  and  Gazzard,  1999). 
Stelzmueller and colleagues described rotavirus cases in 3 adult solid organ transplant 
patients. All developed enteritis and one developed toxic megacolon with ulcerative 
colitis (Stelzmueller et al, 2005). In each case the rotavirus infection was associated 
with secondary infections and prolonged hospitalisation.  
Albrecht et al followed 66 HIV positive patients from 1987-1991. Thirteen 
were  found  to  be  positive  for  rotavirus.  These  patients  had  evidence  of  chronic 
diarrhoea for up to 8 weeks duration (Albrecht et al, 1993). Other studies have also 
described chronic diarrhoea and shedding in HIV positive individuals (Liste et al, 
2000). 
2.3.1.6. Treatment  
Treatment of infantile rotavirus is unnecessary in most cases. However, when 
needed,  treatment  relies  upon  oral,  intramuscular  or  intravenous  re-hydration 
(Sachdev,  1996;  Mahalanabis  et  al,  1995).  The  use  of  probiotics  has  also  been 
examined with some studies showing reduced duration of diarrhoea (Szajewska and 
Mrukowicz,  2001).  As  mentioned  above,  breast  milk  containing  anti-rotavirus 
antibodies has also been used (Saulsbury, Winkelstein and Yolken, 1980; Schoub et 
al, 1978).  Recent studies using nitrazoxanide, a thiolzolide anti-infective agent, have 
shown it to reduce the duration of symptoms in paediatric patients (Rossignol and 
Gohary, 2006; Rossignol et al, 2006). 
Treatment in adults is similar to that advocated for children. Oral rehydration 
and (if needed) pain relief utilising codeine, loperamide and diphenoxylate have been 
used. The use of oral human immunoglobulin has also been found to be of benefit. For 
example,  Guarino  et  al  noted  a  reduction  in  diarrhoea  duration  (76  hours  vs  131 
hours)  following  this  treatment.  Such  formulations  have  also  been  used  in  the 
immunocompromised  (Guarino  et  al,  2002;  Guarino  et  al,  1997;  Guarino,  1996; 
Guarino et al, 1996; Guarino et al, 1994; Guarino et al, 1991). 
2.3.1.7. Control And Prevention  
Controlling  rotavirus  infections  is  difficult  due  to  its  low  infectious  dose, 
environmental stability and possible respiratory spread (Taylor and Greenough, 1989; 
Le Baron et al, 1990). Most measures are based on universal precautions (frequent   27 
hand washing is important for example) and are similar to those outlined for norovirus 
infection (Rao, 1995; Sattar et al, 1994).   
Rotavirus  vaccines,  however,  have  shown  promise  in  prevention.  The  first 
such vaccine was a bovine strain tested in Finnish children in the 1980s (Vesikari et 
al, 1983). This vaccine was found to be safe and resulted in protection against repeat 
challenge,  and  partial  cross-protection  from  other  rotavirus  types.  However, 
development was halted after further clinical trials in Rwanda and Gambia showed 
reduced  effectiveness  (Georges-Courbot  et  al,  1991;  Hanlon  et  al,  1987).  Similar 
inconsistent results were found with other animal mono-valent vaccines (Bernstein et 
al, 1995; Snodgrass et al, 1984). 
Multi-valent vaccines containing animal strains and mono-re-assortments of 
human outer capsid strains G1-4 were tested in the early 1990s (Kapikian et al, 1996). 
In one trial 1278 children aged between 5-25 weeks were given three doses (at 2, 4, 
and 6 months) of a multi-valent vaccine. The vaccine resulted in 50% protection from 
rotavirus infection. In those infected with rotavirus there was a 60-92% reduction in 
severe gastroenteritis and 100% protection from severe dehydration (Bernstien et al, 
1995; Rennels et al, 1996; Santosham et al, 1997; Joesuu et al, 1997). Rotashield™, 
as the vaccine was called, was approved by the FDA in the US in 1998. However, 
after the administration of more than 1.5 million doses in the first 10 months, an 
excess of intersussception in vaccinated children was detected by the vaccine adverse 
event  monitoring  system  (MMWR,  1999;  Murphy  et  al,  2001).  The  risk  of 
intersussception in vaccinated children was estimated to be 1 in 2500 and may have 
resulted in upwards of 1600 cases. This risk was deemed to be too great in a country 
where the actual risk of mortality due to rotavirus was 1 in 100,000. The vaccine was 
immediately removed from the childhood vaccination schedule. However, recent re-
appraisal of the data by scientists at the US National Institute of Health found no 
evidence of an overall increased risk of intersussception (Roberts, 2004). Since then 
other vaccines have been developed. A mono-valent (G1) vaccine has recently been 
licensed in Mexico (Perez-Schael et al, 2002). Another monovalent and a multi-valent 
(G1-4 and P1) vaccine has recently been trialled with promising results (Glass and 
Parashar, 2006). A hexa-valent vaccine (for types G1-4, 8 and 9) is also being trialled 
(Roberts, 2004; Bonn, 2004).   28 
2.3.2. The Caliciviruses: Norovirus And Sapovirus 
Norovirus and sapovirus are two of the four genera in the Caliciviridae family 
(Green et al, 2000; Thiel and Konig, 1999). The remaining two genera are vesivirus 
and lagovirus, which are animal viruses. Norovirus was first discovered in 1968 in the 
faecal samples of students and teachers from a school outbreak of gastroenteritis in 
Norwalk,  Ohio,  US  (Kapikian  et  al,  1972).  Sapovirus  was  detected  in  1976  by 
Madeley and Cosgrove and later during a sequence of outbreaks at a home for infants 
in Sapporo, Japan (Madeley and Cosgrove, 1976; Chiba et al, 1977). Caliciviruses are 
non-enveloped with a diameter of 27-35nm. Under electron microscopy the surface of 
the viral particles have “cup-like” depressions (Figure 3 and Figure 4) from which 
these  viruses  get  their  name  (“Calici”  is  latin  for  goblet/cup).  Caliciviruses  are 
positive sense, single stranded RNA viruses with a genome of approximately 7.7kb in 
length. 
Figure 3: Norovirus as viewed under electron microscopy. 
Figure provided by David Brown, Health Protection Agency, Colindale. 
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Figure 4: Sapovirus as viewed under electron microscopy.                                               
Figure provided by David Brown, Health Protection Agency, Colindale. 
 
2.3.2.1. Genome Organisation And Function 
Norovirus Genome Structure 
Most understanding of the norovirus genome organisation and function has 
come from expression studies with cDNA clones and recombinant expression systems 
(Hardy, 2005). These studies have shown that noroviruses are genome protein linked 
at the 5’ end and polyadenylated at the 3’ end (Jiang et al, 1993; Lambden et al, 
1993). Noroviruses have 3 ORF. ORF1 codes for the non-structural proteins (p48, 
NTPase, p22, VPg, 3C like protease and the RdRp). ORF2 codes for the major capsid 
protein VP1 whereas ORF3 codes for the minor structural protein VP2 (Figure 5).   30 
Figure 5: The genomic structure of the caliciviruses.                                                        
Figure taken from: Atmar and Estes, 2001. 
 
 
 
Norovirus Non-Structural Proteins 
The  ORF1  is  more  conserved  than  either  the  ORF2  or  ORF3.  However, 
significant variation can still be found. The non-structural protein p48 is located at the 
N  terminal  protein  of  the  ORF1  and  varies  in  both  length  and  sequence  between 
different norovirus genogroups (Hardy, 2005). Its role is currently unknown but it is 
thought to play a role in the regulation of cell proliferation. The p41 NTPase is similar 
in sequence to the 2C in picornaviruses. Experiments suggest it is an NTPase without   31 
helicase activity with similar activity to the polio 2C (Pfister and Wimmer, 2001). 
Sequence analysis of different noroviruses suggests that nucleotide homology can be 
as low as 36% in this region (Atmar and Estes, 2001; Katayama et al, 2002). The p22 
protein is also of unknown function.  It holds a similar position to that of the 3A in the 
poliovirus  genome.  As  a  result  it  has  been  suggested  that  it  may  have  a  role  in 
membrane  localisation  of  replication  complexes  (Belliot  et  al,  2003).  Sequence 
analysis of this region has highlighted areas of significant variation with similarities 
of approximately 50% (Katayama et al, 2002).  VPg is a protein of 15kDa in length 
and is found covalently linked to genomic and subgenomic mRNA (Burroughs and 
Brown, 1978). Experiments using caliciviruses devoid of VPg have found them to be 
non-infectious  and  FCV  devoid  of  VPg  has  reduced  viral  protein  synthesis 
(Daughenbaugh et al, 2003). Therefore it has been suggested that VPg is involved in 
ribosome recruitment to viral RNA. 3Clpro is similar in sequence to the picornavirus 
3C and is thought to be the viral protease. The RNA dependent RNA polymerase has 
similar structural and catalytic elements to the RdRp of other RNA viruses (Ng et al, 
2002; Ng et al, 2004). Sequence analysis of the VPg, 3Clpro and the RNA polymerase 
show that these regions are reasonably conserved amongst norovirus genogroups with 
similarities of approximately 70% (Katayama et al, 2002). 
Norovirus Structural Proteins 
The structural proteins VP1 and VP2 make up the norovirus capsid. X-ray 
crystallography has shown the capsid to be composed of 90 dimers of VP1 with a 
small  number  of  VP2  copies  (Prasad  et  al,  1994).  These  are  together  in  a  T=3 
icosahedral virion (Prasad et al, 1996; Prasad et al, 1999).  
Studies of VP1 have shown that it folds into 2 domains linked together by a
 
flexible hinge region: S (shell) and P (protrusion). S is essential for the icosahedral 
virion whereas the P domain forms the arch-like structures extending from the shell. 
The P domain has 2 sub-domains (P1 and P2). P1 and P2 correspond to the leg and 
the top of the arch-like capsomere and contain substantial variation structurally. This 
is of two types: the orientation with respect to the S domain and the size of the P2 
region. On an amino acid and nucleotide level, P1 is moderately conserved. However, 
sequence analysis of the P2 region shows it to be highly variable (Chen et al, 2004). 
Changes in the amino acid sequence are likely to result in structural variations in the 
size and shape of the determinants of cell binding, antigenicity and host specificity   32 
(Chen  et  al,  2004).  This  region  is  also  thought  to  determine  the  ABO  histo 
susceptibility discussed below (see section 2.3.2.3)(Tan et al, 2003). The P2 region is 
under immune pressure and thus accumulation of amino acid changes occurs rapidly. 
For  example,  analysis  of  the  P2  region  in  an  immunocompromised  patient  with 
chronic norovirus infection detected up to 32 amino acid changes in one year (Nilsson 
et al, 2003).  
The  VP2  is  a  protein  of  208-268  amino  acids.  in  length  with  a  molecular 
weight of 22-29kDa. The nucleotide sequence of the VP2 region varies significantly 
between strains (Seah et al, 1999; Katayama et al, 2002). It is a basic protein, which 
suggests it may bind RNA and be involved in RNA packaging. 
Sapovirus Genome Structure 
Sapoviruses have two or three open reading frames depending on genotype 
(Figure  5).  Of  the  five  genotypes  currently  recognised.  GI  and  GIV  and  GV  are 
predicted to have a third ORF (Schuffenecker et al, 2001).  
The 2C-like NTPase (NTPase), VPg, 3C-like protease, RNA-dependent RNA 
polymerase, and capsid protein (VP1) are encoded in the ORF1 polyprotein, which is 
afterwards cleaved into the nonstructural and structural proteins (Oka et al, 2005). 
The roles and genetic variability of each of the non-structural proteins are likely to be 
similar to those of the norovirus genome discussed above. The ORF2 codes for minor 
structural proteins of unknown function (Vinje et al, 2000).  
Like  norovirus,  the  capsid  region  of  the  sapovirus  contains  most  of  the 
nucleotide variation. Analysis of the amino acid sequence of the sapovirus genome 
shows that the capsid region can be separated into 3-4 regions (Okada et al, 2006). 
Two of these regions contain significant variation: the N terminal variable and the 
central variable region contain significant variation. The other two regions, known as 
the N terminal region and the C terminal region show more conservation between 
genogroups and strains. Chen et al suggested that the CVR region is homologous to 
the P2 region of the noroviruses in that it is located on the viral surface and may 
confer strain/antigen specificity (Chen et al, 2004). 
2.3.2.2. Classification 
Historically, noroviruses have been classified using cross-challenge studies in 
volunteers  and  cross-reactivity  by  Immune  EM.  However,  this  method  has  poor 
accuracy and reproducibility. Serotyping with neutralisation is not possible as there is   33 
no  cell  culture  system  available  (Duizer  et  al,  2004).  As  a  result,  nucleotide 
sequencing has played a major role in norovirus characterisation. Four regions have 
been  used  for  classification  (Ando  et  al,  2000;  Vinje  et  al,  2004):  region  A  (the 
RdRp), region B (the 3’ end of the ORF1), region C (short stretch near to the 5’ end of 
ORF2) and region D (located at the 3’ end of the ORF2). Nucleotide sequencing has 
tentatively suggested that there are 5 assigned genogroups, each containing a number 
of clusters and strains (Fankhauser et al, 2002). Zheng et al aligned the capsid protein 
sequences of 164 noroviruses and found genogroups, clusters and strains to differ by 
41-61%,  15-45%  and  0-14%  respectively  (Zheng  et  al,  2006).  Using  sequencing, 
genogroup 1 and 2 were found to contain the largest number of norovirus clusters. 
There are at least 8 in genogroup 1 and 17 in genogroup 2. The genogroups 1, 2 and 4 
are  known  to  cause  human  infections.  Genogroups  3  and  5  contain  animal 
noroviruses.  
Classification of sapoviruses is also an evolving process and because of the 
issues  highlighted  with  norovirus  above  has  thus  far  relied  upon  nucleotide 
sequencing methods. Various classification schemes have been proposed. Vinje et al 
proposed 3 genogroups based on the sequence analysis of the capsid region (Vinje et 
al,  2000).  However,  more  recent  studies  have  suggested  that  there  are  5  or  6 
genogroups,  each  containing  clusters  and  strains.  For  example,  Gallimore  et  al 
examined the sapovirus capid sequence and described 5 genogroups.  Genogroups 
were  found  to  differ  by  49-55%,  clusters  by  19-25%  and  strains  by  1-5%.  The 
sapoviruses  known  to  cause  human  infections  were  shown  to  be  members  of 
genogroups 1, 2, 4 and 5, whereas animal strains fell into group 3 (Gallimore et al, 
2006). Okada et al, analysed the capsid region of 15 sapoviruses. In their study these 
divided into 6 genogroups, 2 of which represented animal sapoviruses (Okada et al, 
2006). Based on the capsid region the animal strains were shown to differ from the 
human strains by 40-44%. 
The large amount of diversity observed in norovirus and sapovirus strains is a 
result of the accumulation of point mutations due to error prone RNA replication and 
recombination events (Matson and Szucs, 2003; Nilsson et al, 2003; Dingle, 2004). 
Nilsson  et  al  examined  sequential  samples  taken  from  an  immunocompromised 
patient with chronic norovirus infection and identified a section in the capsid region 
(called the P2 domain) where mutations frequently accumulated, eventually leading to 
the formation of new phenotype (under immune pressure). Jiang et al identified the   34 
first norovirus recombinant in 1999 and since this discovery several more have been 
reported (Jiang et al, 1999; Katayama et al, 2002; Lochridge and Hardy, 2003; Vinje 
et al, 2000). Evidence from these reports suggests that recombination occurs at the 
junction between ORF1 and ORF2. Other potential recombination sites include the P2 
region (Rohayem et al, 2005).  
Recently a sapovirus recombinant has also been described (Katayama et al, 
2004). As with norovirus, the recombination event is thought to have occurred at the 
RdRp-Capsid  junction.  Recombination  seems  to  be  restricted  to  intragroup  strains 
since intergroup and intergenus recombination has yet to be described (Katayama et 
al, 2004). 
2.3.2.3. Immune Response 
The immune response to norovirus is not yet fully understood (Matsui and 
Greenberg, 2000). Early transmission studies showed that the majority of adults are 
susceptible to norovirus infection suggesting that childhood norovirus infection fails 
to elicit long-term protection (Parrino et al, 1977; Wyatt et al, 1974). Parrino et al 
examined  the  formation  of  short  and  long-term  immunity  by  challenging  12 
volunteers with norovirus. Of these, 6 became ill. The 6 volunteers who became ill 
were then re-challenged with the same virus 27-42 months later. All became ill thus 
demonstrating an absence of long-term immunity. However, the same 6 patients were 
then re-challenged 6-14 weeks later and this time all failed to become ill suggesting 
the formation of short-term immunity. 
Long-term immunity has been described in a number of studies and may be a 
result of repeated exposure (Ewald et al, 2000; Black et al, 1982; Ryder et al, 1985). 
For  example,  in  1998  a  foodborne  outbreak  of  norovirus  occurred  in  a  group  of 
tourists  who  were  staying  with  an  aboriginal  community  (Matsui  and  Greenberg, 
2000). Although the aborigines ate the same meal as the tourists none became ill. 
Similar reports have been published in Bangladesh and Panama (Ryder et al, 1985). 
The relationship between the different norovirus strains is also complicated by 
some  evidence  of  cross-protection  (Wyatt  et  al,  1974).  Wyatt  et  al  examined  the 
immune relationship between the norovirus strains Norwalk, Hawaii and Montgomery 
County virus. Volunteers were challenged first with one of the three noroviruses. The 
results showed that those who became ill were then re-challenged with the same virus 
or another. Those initially challenged with Norwalk virus became ill when challenged   35 
with Hawaii virus. However if re-challenged with Montgomery County virus some 
cross protection was observed. Other studies have found similar results (Madore et al, 
1990; Noel et al, 1997). 
A confusing relationship exists between the presence of pre-existing antibody 
to  norovirus  and  susceptibility.  Sero-prevalence  studies  have  shown  that  antibody 
production to norovirus is lowest in the 0-5 years age group and increases with age, 
which is consistent with the theory that antibody production aids resistance, since 
children are more susceptible to norovirus than adults (Jing et al, 2000). However, 
antibody is also often found to be significantly higher in susceptible adults than those 
able to resist infection.  
Recent  evidence  has  pointed  towards  genetic  factors  as  determinants  of 
norovirus susceptibility (Hutson, Atmar and Estes, 2004; Rockx et al, 2005; Hutson et 
al, 2002). Studies utilising Virus Like Particles (VLPs), which are structurally and 
antigenically similar to norovirus, have shown that noroviruses will only attach to and 
infect  host  cells  in  the  gut  if  they  express  specific,  genetically  determined 
carbohydrates (Lindesmith et al, 2003; Hutson et al, 2003; White et al, 1996). These 
carbohydrates  are  thought  to  include  H,  Lewis  and  histo-blood  group  antigens 
(Harrington et al, 2002; Harrington et al, 2004; Marionneau et al, 2002; Huang et al, 
2003; Green et al, 1988). These carbohydrates have a wide tissue distribution and are 
thought to be present on saliva, red blood cells, and gastro duodenal epithelial cells. 
Evidence from serological and volunteer studies supports this theory. For example, it 
has  been  found  that  convalescent  sera  and  human  breast  milk  block  VLPs  from 
binding to the aforementioned carbohydrates (Jiang et al, 2004). Individuals unable to 
produce  H  antigen  do  not  become  infected  when  challenged  with  norovirus 
(Lindesmith et al, 2003; Hutson et al, 2002; Harrington et al, 2002; Meyer et al, 
2004). Rockx et al found that individuals with type B histo-blood group antigen are 
protected  against  norovirus  G1  strains  but  not  G2  strains  thus  highlighting  that 
different noroviruses may bind preferentially to different carbohydrates (Rockx et al, 
2005; Huang et al, 2005). This may explain the worldwide predominance of G2.4 
norovirus types (see section 2.3.2.4). Unlike some norovirus types, these viruses have 
been shown to be able to bind to a broad range of carbohydrate targets. As a result 
they have a large susceptible target population. These findings may also explain the 
confusing  relationship  between  pre-existing  antibody  and  risk  of  infection  as 
described  above.  Pre-existing  antibodies  to  a  particular  norovirus  may  be  an   36 
indication that the individual is particularly susceptible to that virus and has suffered 
repeated infections in the past. 
These  genetic  characteristics  have  also  been  shown  to  be  important  pre-
determinates of other gastrointestinal infections. For example, B histo-blood group 
antigen was shown to be less common in patients with haemolytic uraemic syndrome 
after an E-coli 0157 outbreak in Sakai, Japan (Hutson, Atmar and Estes, 2004).  
The immune response to sapovirus is less well defined. Studies in adults have 
shown  a  low  incidence  of  infection  thus  suggesting  that  primary  infection  in 
childhood results in long-term immunity (Chiba et al, 2000). 
2.3.2.4. Epidemiology 
Since  long-term  immunity  to  norovirus  is  rare,  humans  of  all  ages  are 
susceptible to repeat infections throughout life. As a result norovirus is frequently 
implicated in sporadic cases of IID and is now thought to be the predominant cause of 
outbreaks of IID, especially in closed settings such as hospitals, residential homes, 
hotels, schools and cruise ships etc (Matson, 2005; Thornton et al, 2005; Isakbaeva et 
al, 2005).  
Sapovirus is predominantly a pathogen of children with infections limited to 
mainly the very young (de Wit, Koopmans and van Duynhoven, 2003). As a result its 
burden is likely to be less than that of the other viral causes of IID. Outbreaks due to 
sapovirus have been documented but are rare (Johansson et al, 2005). 
Limited  data  exist  on  the  epidemiology  of  sapoviruses.  As  a  result  the 
remainder of this section mainly focuses on the epidemiology of norovirus infections. 
Sporadic  cases  and  outbreaks  show  winter  predominance  although  cases  and 
outbreaks can occur all year round (Zahorsky, 1929; Adler and Zickl, 1969; Mounts et 
al, 2000; Lopman et al, 2003; Hale et al, 2000). Norovirus has a low infectious dose 
with fewer than 10 viral copies capable of causing illness in a human adult volunteer 
(Levett et al, 1996; Moe et al, 1999). The vast majority of norovirus cases are a result 
of  faecal-oral  spread  but  there  is  also  evidence  of  airborne  spread  (via  droplets 
produced during vomiting) and spread by contaminated fomites (Widdowson et al, 
2005; Fretz et al, 2005; Caul, 1994).  Environmental studies using surrogate virus 
feline calicivirus (FeCv) have estimated that (at 20
oC) the virus may remain infectious 
on surfaces for between 21-30 days  (Sattar, 2004; Barker, Vipond and Bloomfield,   37 
2004; Steinmann, 2004; Doultree et al, 1999; Hota, 2004; Gehrke, Steinmann and 
Goroncy-Bermes, 2004) 
Potential  sources  of  infection  include  those  with  asymptomatic  infection 
(Duizer et al, 2004; Marshall et al, 2001; Vinje et al, 1997; de Wit et al, 2001). 
Asymptomatic infections have been detected have been measured in a few studies. 
For  example,  in  the  Netherlands  asymptomatic  norovirus  infections  have  been 
detected in between 1-5% of the general population but have been detected in up to 
19% of individuals in outbreak settings. Asymptomatic sapovirus infections have also 
been  detected  in  young children  (range  1-13%).  Other  sources  include  those  with 
symptomatic infection who have prolonged viral shedding after their symptoms have 
resolved.  There  is  evidence  of  norovirus  shedding  up  to  7  weeks  or  more  after 
resolution of symptoms in immunocompetent individuals (Ball et al, 2005; Rockx et 
al, 2002; Cliver, 1997). Longer durations of shedding have also been observed in 
immunocompromised patients (Nilsson et al, 2003). There is also evidence of pre-
symptomatic shedding (Lo et al, 1994).  
The remainder of cases are likely to be a result of contaminated food or water 
(Hirakata et al, 2005; Paez Jimenez et al, 2004; Parshionikar et al, 2003; Boccia et al, 
2002). Data suggests that most foodborne infections are caused by norovirus. A recent 
study in the US estimated that 67% of all foodborne infections were due to norovirus 
(Mead,  1999).  Food  can  become  contaminated  in  numerous  ways.  Infected  food 
handlers are a common source (Lo Sv et al, 1994; White et al, 1986; Gaulin et al, 
1999). At-risk foods include those with prolonged hands-on preparation such as salads 
and sandwiches (Holtby et al, 2001; Kilgore et al, 1996).  
A number of large outbreaks have been linked to the consumption of bivalve 
shellfish such as oysters, which have been shown to filter sewage from sea water and 
concentrate virus in their flesh (Chalmers and McMillan, 1995; Ang, 1998; Stafford et 
al, 1997; Kohn et al, 1995)  
Several  outbreaks  have  been  linked  to  the  consumption  of  sewage-
contaminated drinking water (van den Berg et al, 2005; Kukkula et al, 1999; Brown et 
al, 2001; Lodder et al, 1999; Hafliger, Hubner and Luthy, 2000). Such water has also 
been used in the preparation and storage of particular foods.  
Noroviruses  have  been  shown  to  be  resistant  to  freezing  and  have  been 
implicated in a number of outbreaks relating to frozen foods. Noroviruses have also 
been detected in bottled mineral water, although the significance of these findings has   38 
been  questioned  (Sanchez,  Joosten  and  Meyer,  2005;  Beuret  et  al,  2002;  Beuret, 
Kohler and Luthi, 2000; Lomothe et al, 2003).  
Several studies have suggested a possible animal source, since noroviruses 
have been detected in cattle and other animals (Van der Poel et al, 2003; Van der Poel 
et al, 2000; Smiley, 2002; Smiley et al, 2003). These strains have yet to be associated 
with human illness. A recent study by Widdowson et al found significant levels of 
antibodies  to  bovine  norovirus  strains  in  vets  and  others  in  frequent  contact  with 
cattle. These data suggest that infection with these animal strains is possible and may 
contribute to the diversity of noroviruses (Widdowson et al, 2005).  
Recent studies have suggested that norovirus may also be an important travel 
associated infection. Chapin et al found norovirus in 65% of travellers returning to the 
US from Mexico and Guatemala with travel-associated diarrhoea (Chapin et al, 2005).  
Molecular  epidemiological  studies  have  shown  that  a  number  of  norovirus 
strains and serotypes circulate at any one time, with one type predominant worldwide 
(Gallimore et al, 2004; Hale et al, 2000; Kageyama et al, 2004). Since 1996 type G2.4 
strains  have  dominated  worldwide  (Lopman  et  al,  2004;  Noel  et  al,  1999). 
Occasionally a new strain may supersede previous strains to become predominant. 
This was the case in 2002 when a new G2.4 variant emerged worldwide (Lopman et 
al,  2004).  This  emergence  was  accompanied  by  several  alterations  in  the 
epidemiology of norovirus infection.  For example, although there still appeared to be 
a peak of activity over the winter months particularly in closed settings, there was also 
an increase in outbreak reports during the summer months (Lopman et al, 2003). This 
new  variant  norovirus  contained  a  mutation  at  position  4820  (from  AACTTG  to 
AATCTG). It is unclear, however, how this change led to such an increase in activity. 
It has been suggested that this variant is more stable in the environment or more 
virulent.  However,  some  researchers  have  suggested  that  the  sudden  increase  in 
norovirus  infection  may  instead  be  the  result  of  a  large,  as  yet,  unidentified 
introduction of this new variant.  
A similar increase in activity was observed in 2005 and again in 2006 (CDR 
weekly, 2005; HPS weekly report, 2005; Bull et al, 2006; Gallimore et al, 2007). 
These  have  also  been  associated  with  the  emergence  of  a  new  norovirus  G2.4 
norovirus  variant.  Recent  data  also  suggests  that  sapovirus  may  act  in  a  similar 
fashion (Gallimore et al, 2006). Gallimore and colleagues sequenced the sapoviruses   39 
detected in the UK between 1989 and 2004 and found a change in the predominant 
strain in 2004 (from G1.1 to G2.1). 
2.3.2.5. Clinical Illness 
Classically, the clinical symptoms of norovirus and sapovirus were derived 
from transmission studies (Dolin et al, 1971; Gotz et al, 2001; Kaplan et al, 1982; 
Graham et al, 1994). These studies reported that after an incubation period of 24-48 
hours the illness is of sudden onset with nausea, headache,  cramps, vomiting and 
diarrhoea. Symptoms resolve after 24-48 hours. The studies also showed that children 
with norovirus infection are more likely to have episodes of vomiting whereas adults 
have a predominance of diarrhoea. However more recent work has suggested that 
these findings may be inaccurate (Rockx et al, 2002). A recent community cohort 
study in the Netherlands found that vomiting was less common in children under 1 
year  of  age  than  in  older  patients.  This  study  also  showed  that  the  symptoms  of 
norovirus and sapovirus lasted longer than previously thought (5 days and 6 days 
respectively).  
Clinically, most infections caused by norovirus and sapovirus are thought to 
be mild. However, it is increasingly recognised that norovirus is responsible for a 
significant proportion of childhood hospitalisation due to IID (see 2.3.6). Studies of 
norovirus hospital outbreaks have shown that infection lasts longer in this setting, and 
can  often  be  severe,  with  an  increased  risk  of  mortality-probably  as  a  result  of 
underlying illness (Lopman et al, 2004; Meakins et al, 2003, Mattner et al, 2006).  
Unusual presentations of norovirus have been observed in some individuals, 
usually as a result of physical stress or immunocompromise. For example, an outbreak 
of  norovirus  at  a  military  field  hospital  in  Afghanistan  resulted  in  neck  stiffness, 
confusion and photophobia, and in one case disseminated intravascular coagulation 
(MMWR, 2002). These symptoms were probably a result of electrolyte imbalance 
similar to that seen in severe rotavirus infections. Studies of norovirus infection in the 
elderly have also highlighted the occurrence of post infection complications (Goller et 
al,  2004;  Oliver  et  al,  1985).  For  example,  in  one  elderly  care  home  outbreak  a 
“residual malaise” was present in 42% of those affected 1-4 weeks after onset.  
Other studies have highlighted the presence of anorexia, lethargy and vertigo 
in the weeks after symptoms. In some elderly patients these non-specific symptoms 
and even the original acute symptoms can recur (Goller et al, 2004).   40 
Chronic  diarrhoea  and  shedding  have  been  observed  in  both  solid  organ 
transplant  patients  and  bone  marrow  transplant  patients  (Kaufman  et  al,  2003; 
Gallimore et al, 2004). In some cases shedding for up to 2 years has been observed 
(Nilsson et al, 2003). The importance of caliciviruses in HIV positive individuals is 
uncertain. A recent study by Rodriguez-Guillen et al suggested that caliciviruses are 
not implicated in HIV  associated diarrhoea in  adults. However, caliciviruses were 
found to be more frequent in HIV positive children (Rodriguez-Guillen et al, 2005). 
2.3.2.6. Control   
Controlling an outbreak of norovirus is difficult due to its low infectious dose 
and numerous modes of transmission.  
Most  of  the  current  guidelines  concern  norovirus  outbreaks  in  the  hospital 
setting (Chadwick et al, 2000)
1. Controlling an outbreak on a ward or other closed 
setting requires rapid implementation of infection control procedures. Lopman et al 
estimated that control procedures must be implemented within 3 days of an outbreak 
onset if they are to be successful. However, detecting an outbreak at such an early 
stage is difficult due to the high frequency of non-infectious gastrointestinal disease 
such as incontinence and anti-microbial associated diarrhoea (Lopman et al, 2003).  
Recommended control procedures include the wearing of gloves and aprons 
when in contact with infected patients or contaminated areas (see Table 1 and Table 
2). Hand washing is advocated at all times. Studies using FeCv have shown ethanol 
based hand rubs with a 70-95% concentration of ethanol to be best (Kampf, Grotheer 
and  Steinmann,  2005).  However,  other  studies  have  questioned  this  finding  and 
suggested  that  these  protocols  need  to  be  compared  to  standard  hand  washing 
procedures  before  such  conclusions  can  be  drawn  (Duizer  and  Koopmans,  2006). 
Guidelines  suggest  that  affected  staff  should  be  excluded  for  48-72  hours  after 
suffering their last symptoms (this should also be applied to infected food handlers). 
Wards  should  also  be  closed  to  further  admissions.  Staff  and  patients  from  the 
affected areas should be prevented from entering other unaffected areas. There is also 
evidence  that  patient  cohorting  is  effective  in  containing  affected  patients  and 
contaminated areas.  
                                                 
1 http://www.hps.scot.nhs.uk/enviro/guidelinedetail.aspx?id=18578   41 
Cleaning  norovirus  from  the  environment  is  essential  but  difficult,  and  re-
infections  have  been  documented  following  the  re-introduction  of  individuals  into 
previously contaminated areas. Since there is no culture method for measuring the 
viability  of  norovirus  or  sapovirus  many  cleaning  and  disinfection  studies  have 
utilised  animal  caliciviruses  known  to  be  related  to  norovirus  in  an  attempt  to 
establish  efficient  methods.  Studies  using  FeCv  have  shown  conflicting  results 
(Duizer et al, 2004; Sattar, 2004; Barker, Vipond and Bloomfield, 2004; Steinmann, 
2004; Doultree et al, 1999; Hota, 2004; Gehrke, Steinmann and Goroncy-Bermes, 
2004). For example, Steinmann demonstrated that ethanol was effective in cleansing 
FeCV  from  the  environment  whereas  Duizer  et  al  found  that  ethanol  was  not 
effective.  Doultree  et  al  showed  that  glutaraldehyde,  iodine  and  hypochlorite  at 
1000ppm were effective. Other studies have suggested the use of sodium bicarbonate 
(Malik and Goyal, 2006). For soft furnishing a steam clean of at least 70
oC is thought 
to be effective (Doultree et al, 1999). 
Although these procedures have proved successful in containing some ward 
outbreaks, spread to other wards is a common occurrence. The reasons for this are 
unclear.  It  has  been  suggested  that  large  multi-ward  outbreaks  are  a  result  of  a 
breakdown in the infection control procedures, which can often be difficult to achieve 
in practice (Christie, 2002; Cowden, 2002). For example, closing wards is difficult 
when faced with acute bed shortages due to other winter pressures. The failure to 
close a ward may prevent extensive cleaning, which is needed to remove virus from 
the environment. Restricting staff and patient movement is also difficult. Many staff 
may be asked to work in a number of wards and patients will be frequently moved 
between different wards. The duration of exclusion (48-72 hours) may also be too 
short, as many studies have indicated that virus can be excreted for longer periods. 
This  raises  the  possibility  that  a  staff  member  may  return  to  work  before  viral 
shedding has ceased and spread further infection. Furthermore, agency nursing staff 
may not be entitled to sick pay and will therefore be tempted to return to work before 
their illness has resolved. However, it may also be possible that large multi-ward/area 
outbreaks may be a result of the multiple introductions of different noroviruses.    42 
Table 1: Recommended infection control guidelines within wards (Chadwick et al, 
2000).     
 
Table 2: Recommended infection control guidelines between wards (Chadwick et al, 
2000).     
 
2.3.2.7. Prevention  
At present there is no vaccine for norovirus or sapovirus infection. Since the 
immune response to norovirus infection is not yet understood, developing a vaccine 
may prove difficult. Most of the vaccine studies pre-date the discovery of the genetic 
determinants of norovirus immunity (as discussed earlier). Most have utilised VLPs. 
VLPs  are  morphologically  and  antigenically  similar  to  noroviruses,  are  stable, 
immunogenic, can be produced in large amounts, and can be stored in lyphophilised 
form  (Estes  et  al,  2000).  Initial  studies  in  mice  have  shown  them  to  be  highly 
immunogenic after oral administration and to result in serum and mucosal immunity 
(Guerrero, Ball and Estes, 1997). Phase 1 trials in humans have shown them to be safe   43 
but  the  immune  response  elicited  was  significantly  less  than  that  observed  after 
natural infection (Ball et al, 1999). Further trials are to be carried out (Tacket, 2005). 
2.3.3. Astrovirus 
Astrovirus  was  first  discovered  in  1975  by  Appleton  and  Higgens  in 
hospitalised children with gastroenteritis (Appleton and Higgens, 1975). Astroviruses 
are members of the Astroviridae family. Under electron microscopy the astrovirus 
capsids are 28-30nm in diameter and have a characteristic 5-6 pointed star appearance 
(Figure 6).  
2.3.3.1. Genome Organisation and Function 
Astroviruses  are  positive  sense,  ssRNA  viruses  with  a  genome  of 
approximately 6.8 kb in length (Figure 7). The genomic organisation is as follows: a 
5NCR region followed by three ORF (1a, 1b and 2), a 80 nucleotide NCR and a poly 
A tail of 30 nucleotides (Belliot et al, 1997; Jiang et al, 1993; Lewis et al, 1994).  
The ORF1a is 2700 nucleotides in length whereas ORF1b is 1550 nucleotides 
in length. ORF1a and 1b code for the non-structural proteins such as the protease and 
the RNA dependent RNA polymerase. ORF1a also encodes other motifs including 
transmembrane  helices,  a  nuclear  localisation  signal  and  immunogenic  epitopes. 
ORF1a length can also vary amongst strains although the significance of this is at 
present uncertain.  
The ORF2 codes for the viral capsid. The viral capsid precursor is 86-90kDa 
in size and after protease processing forms 2-5 major proteins (Herring et al, 1981; 
Monroe et al, 1991; Belliot et al, 1997; Wang et al, 2001). ORF2 is less conserved 
than ORF1a and 1b and varies significantly between astrovirus types (Wang et al, 
2001).  Analysis of the ORF2 regions has detected 4 main areas: the N region, the 
central upper, central lower regions and C region. The N and C regions were shown to 
be  relatively  conserved  between  different  astroviruses.  The  two  regions  between 
these,  the  central  upper  and  central  lower,  are  the  regions  that  show  the  most 
variation. The central upper region can vary in sequence length between serotypes. It 
is not thought to be present on the virion surface. The central lower region contains 
several stem loops. These genes are thought to contain the regions that determine 
immune response, cell attachment and entry. As a result these regions differ between 
serotypes.   44 
 The  3’  NCR  is  highly  conserved  between  the  8  astrovirus  types  and  it  is 
thought it may play a role in the initiation of RNA synthesis (Monceyron et al, 1997). 
In  addition,  it  has  been  postulated  that  it  may  also  play  a  role  in  RNA  stability, 
translation initiation and intracellular localisation. 
2.3.3.2. Classification 
Astroviruses are serotyped using neutralisation antibodies. Various methods 
exist including immunoflourscence, neutralisation assays or IEM. Sequence analysis 
of a 348bp region of the ORF2 has been shown to correlate with serotype. 
Overall  there  are  8  recognised  types  of  astrovirus  (Monroe,  Holmes  and 
Belliot, 2001). Types 1-7 were distinguished by 1995 whereas type 8 was recognised 
more recently (Taylor et al, 2001). Types 1-7 cluster into 2 groups. Group A contains 
types 1-5 whereas group B contains types 6 and 7. Type 8 can cluster with either 
group  depending  on  the  area  sequenced  (Taylor  et  al,  2001;  Walter  et  al,  2001; 
Belliot, Laveran and Monroe, 1997). This has led some researchers to speculate that 
type  8  is  a  recombinant  virus.  The  area  most  studies  suggest  as  the  potential 
recombination site is the ORF1b/ORF2 junction. 
2.3.3.3. Immune Response 
At present the immune response to astrovirus is not well understood. The fact 
that cases are mainly restricted to the young or elderly suggests that primary infection 
results  in  long-term  protection,  which  then  wanes  in  old  age  (Glass  et  al,  1996). 
Koopmans  et  al  showed  that  immunity  was  homotypic  (Koopmans  et  al,  1998). 
Infections in adolescence and adulthood are therefore likely to be caused by rarer 
types of the virus.   45 
Figure 6: Astrovirus as viewed under the electron microscope.                                                                                                                                  
Figure taken from: http://www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/05000000.htm 
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Figure 7: The genomic structure of astrovirus (Walter and Mitchell, 2003). 
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2.3.3.4. Epidemiology 
Astroviruses have a worldwide distribution (Walter and Mitchell, 2003) and 
are  found  in  humans,  lambs,  calves,  deer,  piglets,  mice,  dogs  and  ducks.  Human 
infections are mainly seen in infants and the elderly (Noel et al, 1996). Reports of the 
age of initial infection vary in different studies. A hospital study in France showed 
acquisition  to  be  in  those  aged  less  than  7  months  (Marie-Cardine  et  al,  2002). 
However, a community-based study in France and a hospital study in Spain showed 
the age of acquisition to be between 2-4 years (Chikhi-Brachet et al, 2002; Guix et al, 
2002). Interestingly the age of acquisition may vary according to type, with astrovirus 
types 1-3 acquired in children under 3 years whereas types 4 and 8 occur at an older 
age (Guix et al, 2002). This is no doubt related to the predominance of the various 
types (see below). 
The seasonality of astrovirus varies in different regions (Walter and Mitchell, 
2003). In Egypt, Brazil and Eastern USA a spring/summer peak of activity has been 
reported. However, in Korea, Argentina and Western USA a winter predominance 
occurring  alongside  rotavirus  infections  has  been  observed  (Giordano  et  al,  2001; 
Kang et al, 2002; Rodriguez-Baez et al, 2002).  
Astroviruses  have  been  shown  to  cause  endemic  illness  and  outbreaks  in 
closed  settings  such  as  hospitals,  schools  and  care  settings  (Cubitt  et  al,  1999; 
Mitchell et al, 1995; Oishi et al, 1994). Transmission is mainly fecal-oral but may 
also  involve  contaminated  fomites  (Abad  et  al,  2001).  Other  sources  include 
contaminated food (including oysters and mussels) and sewage-contaminated water 
(Pinto et al, 2001; Le Guyader et al, 2000; Taylor et al, 2001). 
Numerous studies have shown that, like other viral causes of IID, multiple 
serotypes co-circulate at any one time (Lee and Kurtz, 1994; Mustafa, Palombo and 
Bishop,  2000;  Palombo and  Bishop,  1996).  Overall,  type  1  astrovirus  is  the  most 
common. Types 2-4 are of medium frequency whereas types 5-7 are rare. Type 8 has 
had an increasing incidence in some countries including Egypt, Spain, France and 
Australia. This raises the possibility that type 8 is an emerging genotype.  
2.3.3.5. Clinical Illness And Treatment 
The clinical illness caused by astrovirus is similar to rotavirus but is milder 
(Dennehy et al, 2001; Pang and Vesikari, 1999; Guerrero et al, 1998; Kurtz et al,   48 
1979). Studies show that after an incubation period of 1-4 days there is a sudden onset 
of watery diarrhoea. Illness is mainly seen in infants over 6 months of age.  
Immunocompetent individuals can shed virus for up to 2 weeks post resolution 
of symptoms. Some studies have suggested that persistence may be linked to infection 
with certain astrovirus types. Cabellero et al found higher levels of persistence and 
viral shedding in faecal samples showing infection with astrovirus type 3 (Caballero 
et al, 2003). 
Severe infections have been observed especially in the immunocompromised, 
those  with  malnutrition  and  those  co-infected  with  another  viral  enteric  pathogen 
(Walter and Mitchell, 2000; Grohmann et al, 1993; Roman et al, 2003). There have 
been  several  reports  of  prolonged  and  recurrent  illness  in  immunocompromised 
individuals.  
However, the illness caused by astrovirus is usually mild and self-limiting and 
therefore no specific therapy is needed. For severe infection replacement of fluids and 
electrolytes may be necessary. 
2.3.3.6. Control And Prevention 
Control  of  astrovirus  infection  relies  upon  the  application  of  universal 
hygienic and disinfection practices especially in hospitals and other closed settings. 
Food  handlers  are  advised  to  follow  guidelines  excluding  them  from  work  until 
several days after symptoms subside (Table 1 and Table 2). At present there is no 
vaccine available for the prevention of astrovirus. 
2.3.4. Adenovirus  
Adenoviruses are non-enveloped icosahedral viruses of 70-80nm in diameter 
(Figure 8). Adenoviruses were first isolated in 1953 from tissue cultures of human 
adenoidal  tissue  (Cocchi,  1960).  They  belong  to  Adenoviridae  family,  genus 
Mastadenovirus.  Adenoviruses  have  an  icosahedral  capsid  with  icosahedral 
symmetry.  The  protein  capsid  is  made  up  of  252  capsomers:  240  hexons  and  12 
pentons. Each penton has a protruding fiber.   
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Figure 8: Adenovirus as viewed under the electron microscope.                              
Figure taken from: http://www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/em_adeno.gif 
 
 
2.3.4.1. Genome Organisation and Function 
Adenoviruses are dsDNA viruses with a genome of approximately 335kb in 
length (Brown et al, 1996; Horwitz, 1996).  The genome contains several inverted 
terminal  repeats  that  vary  in  length  between  different  adenoviruses  (Wold  and 
Gooding,  1991).  As  a  result  the  adenovirus  genome  differs  between  genera  and 
species.  All  adenoviruses  produce  early  (E1-4),  intermediate  and  late  RNA  (1-5) 
transcripts and virus-associated RNA gene transcripts. 
The Early RNA Transcripts 
The E1 is a transcription unit with 2 regions, E1A and 1B (Shenk and Flint, 
1991; Shenk, 2001). The E1A is a transcription activator of virus (of other early and 
late proteins) and some cellular promoters, whereas E1B contributes to evading the 
immune response by blocking host mRNA transport to the cytoplasm and inhibiting 
p52-mediated apoptosis (Wold and Gooding, 1991). High levels of sequence identity   50 
in the E1/A region have been observed between members of the same subgroup. For 
example,  Avvakumov  et  al,  found  four  region  which  were  relatively  conserved 
between  adenoviruses  (similarity  scores  of  between  50-60%)  (Avvakumov  et  al, 
2002).  However,  between  these  regions  significant  sequence  variation  is  observed 
(similarity scores of <30%). 
The  E2  transcript  codes  for  the  viral  proteins  that  are  directly  involved  in 
adenovirus replication. It contains 2 regions (E2A and 2B), which code for a number 
of proteins. These include E2A-DBP (a single stranded DNA binding protein), E2B-
pTP (a terminal precursor protein functioning as a protein primer for initiation of viral 
DNA replication) and E2B-ad pol (DNA polymerase).  
The E3 transcript has at least 8 recognised ORFs, which vary according to 
adenovirus serotype. The E3 transcripts are mainly used to counteract host antiviral 
defences. Modes of action include the inhibition of CTL responses and TNF alpha 
mediated cell lysis.  
The E4 transcript has numerous ORF that, like that of E3, vary according to 
adenovirus serotype. For example adenovirus type 5 has six recognised ORFs whereas 
adenovirus  11  has  five.  The  E4  transcript  is  thought  to  encode  for  proteins  that 
regulate  viral  and  cellular  gene  expression  at  the  transcriptional  and  post 
transcriptional level. 
The Intermediate Region 
The adenovirus intermediate region produces 2 proteins: pIX and pIVa2. The 
pIX is a structural component of the virus and is a transcriptional activator of the 
major late promoter (Lutz et al, 1997; van Oostrum and Burnett, 1985). The pIVa2 is 
also a transcriptional activator of the major late promoter, but is also thought to be 
involved in genome packaging. 
Late Proteins. 
The  late  proteins  are  organised  into  one  primary  transcript  unit  that  is 
processed  using  different  poly  A  sites  to  produce  distinct  mRNAs.  These  are 
recognised as late proteins L1-5. 
The  L1  late  protein  facilitates  capsid  assembly  and  enables  genome 
encapsidation via interaction with pIVa2 (Shenk, 2001). 
The L2 late protein contains 3 ORFs coding for the Penton, pVII and pV. The 
penton,  alongside  the  fiber,  plays  an  important  role  in  host  cell  binding  and   51 
penetration. pVII is the major component of the adenovirus core whereas pV acts as 
the bridge between the core and the penton base. It should be noted that pV contains a 
second ORF of unknown function (Shenk, 2001). 
The L3 late protein contains 3 ORFs, which code for the pVI, pII (hexon) and 
L3-23  (Shenk,  2001).  The  pVI  is  a  capsid  component  that  is  associated  with  the 
hexon.  It possibly  acts as a bridge between  capsid and core components. The pII 
(hexon) trimerises with itself to form the major capsid. It contains at least 7 hyper 
variable regions but there are regions outside these areas that are conserved between 
adenovirus serotypes (Crawford-Miksza and Schnurr, 1996). These areas are thought 
to  determine  the  adenovirus  serotype.  The  L3-23K  is  the  adenovirus  protease.  It 
cleaves viral precursor proteins during viral maturation. 
The L4 has 4 ORFs (Andrade et al, 2001). Three proteins have thus far been 
identified.  The  L4-100K  is  a  non-structural  protein  that  is  required  for  hexon 
assembly, late protein synthesis and inhibition of granzyme B mediated lysis. The L4-
33k is a protein of unknown function. The pVIII is associated with hexons and is 
possibly a link between hexon capsomere and core capsids. 
The L5 late protein is a single ORF. It codes for the adenovirus fibre. Analysis 
of the nucleotide sequence shows that the fibre contains areas of significant variation. 
It forms a structure consisting of a tail, shaft and knob. The knob determines the 
adenovirus tissue tropism via cell surface receptors. 
2.3.4.2. Classification 
Adenovirus serotypes are classified according to the ability to induce specific 
neutralising  antibodies.  The  serotype  specific  antigens  are  located  on  the  virion 
surface (possibly via the hyper variable regions on the hexon region). The results of 
analysis of the HVR regions of the hexon region match their serotypic classification. 
The  adenovirus  genera  (A-F)  are  determined  by  numerous  factors  including  the 
haemagluttination of rat and monkey cells or the oncogenicity in hamsters. 
2.3.4.3. Epidemiology 
Adenovirus IID is mainly endemic but outbreaks have also been reported in 
closed settings (Richmond et al, 1979; Retter et al, 1979; Yolken et al, 1982; Murphy, 
1981; Albert, 1986). Adenovirus IID has no specific seasonal pattern and spread is 
mainly via the fecal-oral route. Most infections occur in childhood and studies have   52 
shown that by 3 years of age 30-100% of children are seropositive for adenovirus 
(type 40 and 41).  
2.3.4.4. Clinical Illness And Treatment 
Clinical illness due to adenovirus is similar to that of other viral causes of 
illness (Bhan et al, 1988; Whitelaw, Davies and Parry, 1977; Richmond et al, 1979; 
Vesikari  et  al,  1981;  Johansson  et  al,  1980;  Blaskovic,  Freitag  and  McLaughlin, 
1982).  Symptoms  include  watery,  non-bloody  faecal  samples  and  vomiting.  The 
duration of symptoms (3-11 days) is possibly longer than that produced by other viral 
causes of IID (Dowling and Wynne, 1981) and it is thought that type 41 causes a 
longer illness than type 40. In general, adenovirus IID results in shedding for between 
1-14 days.  
Although  fatal  cases  have  been  described,  the  illness  is  usually  mild  and 
treatment is not needed (Whitelaw, Davies and Parry, 1977). Disseminated adenovirus 
type 40 or 41 infection has rarely been described in immunocompromised patients, 
although a recent case report by Slatter et al described a paediatric BMT patient who 
died of disseminated adenovirus 41 infection (Slatter et al, 2005). 
2.3.4.5. Control And Prevention 
Control  of  infection  relies  upon  universal  precautions  and  strict 
decontamination procedures as described for norovirus (Table 1 and Table 2).  No 
vaccine is available for adenoviruses that cause IID.  
2.3.5. Other Possible Viral Causes Of IID 
There are many other possible causes of viral IID mentioned in the literature. 
In most cases a causative role has yet to be proven.  
It has been suggested, for example, that the enteroviruses (members of the 
Picornaviridae family) are a rare cause of gastroenteritis in humans. Echoviruses (4, 
11,  14,  18,  19  and  22)  and  coxsackie  A1  have  been  implicated  in  outbreaks  of 
diarrhoea in immunocompetent and immunocompromised humans (Townsend et al, 
1982;  Patel  et  al,  1985;  Melnick,  1996).  Another  member  of  the  Picornaviridae 
family, aichivirus, has been associated with both sporadic and outbreaks of IID in 
Japan and south East Asia (Yamashita et al, 1993; Yamashita et al, 1995). However, a 
role for this virus in IID in other countries has yet to be determined.   53 
Reoviruses (members of the Reoviridae family) have regularly been found in 
faecal samples and most children have antibodies to all 3 serotypes (Tyler and Fields, 
1996). However, although a role in childhood IID has been suggested, firm evidence 
has yet to be established (Giordano et al, 2005). 
Toroviruses  and  coronaviruses  are  members  of  the  virus  family 
Coronaviridae.  Toroviruses  have  been  established  as  a  cause  of  IID  in  cattle  and 
horses,  and  recent  studies  have  suggested  a  role  in  sporadic  IID  in  children 
(Koopmans et al, 1997; Waters et al, 2000). Coronaviruses are recognised as causes 
of the common cold in humans. Like toroviruses, they have been shown to be a cause 
of IID in animals. Coronavirus particles have been found in the faecal samples of 
cases of IID but have also been found in healthy volunteers (Holmes, 2001). 
Like the coronaviridae family, parvovirus is associated with IID in animals. In 
addition,  parvovirus-like  particles  have  frequently  been  found  by  EM  in  faecal 
samples. However, a causative role has yet to be established. Picobirnaviruses are 
members  of  the  Birnaviridae  family  and  have  been  found  to  be  significantly 
associated with IID in Aids patients (Grohmann et al, 1993). They have also been 
found to be associated with IID in various animals (Leong et al, 2000). 
2.3.6. The Contribution of Viral Pathogens To The Burden Of IID 
The significant morbidity and economic burden of IID in the developed world 
has already been outlined (section 2.2). But what proportion of the total number of 
cases is due to viruses?  
The contribution of each of the five main viral pathogens to overall IID in 
children,  adults  and  outbreaks  has  only  recently  been  ascertained  using  sensitive 
detection  techniques  such  as  PCR  (see  section  2.4.3.3)  and  is  discussed  in  the 
following section.   
2.3.6.1. Burden Of Viral IID In Children 
Recent studies using sensitive techniques have established that viral pathogens 
are the major cause of sporadic IID in children, both those requiring hospitalisation 
and those presenting to GPs. For example, Simpson et al detected viral pathogens in 
60.3% of children hospitalised for IID in Addenbrookes hospital, England (Simpson 
et al, 2003). de Wit et al detected viral pathogens in over 44% of community managed 
cases of IID in children presenting to GPs in the Netherlands (de Wit et al, 2001).   54 
Pang et al investigated 832 samples from community cases of IID in children (aged 
under 2 years) in Finland and found a viral pathogen in approximately 60% of cases 
(Pang  et  al,  2000).  Similar  detection  rates  (48-75%)  have  been  shown  in  other 
countries (Phan et al, 2005; Bon et al, 1999; Bereciartu, Bok and Gomez, 2002; Qiao 
et al, 1999; Oh, Gaedicke and Schreier, 2003). 
Rotavirus is the predominant cause of childhood IID in both the community 
and hospital setting (Brandt et al, 1983; McIver et al, 2001; Fruhwith et al, 2001). For 
example, Barnes et al examined 4,637 samples from children admitted to hospital 
with IID between 1980-93 and found rotavirus in 39.6% of cases (Barnes et al, 1998). 
Bon et al examined 414 children who consulted their GP for IID in France between 
1995-99 (Bon et al, 1999). Overall, 61% of all cases were attributed to rotavirus. 
Similar findings have been found in numerous other studies (Giordano et al, 2001; 
Fischer, 2001; Donelli et al, 1993; Sethi, Khuffash and al-Nakib, 1989; Waters et al, 
2000; Boga et al, 2004; Oh, Gaedicke and Schreier, 2003; Subekti et al, 2002; Qiao et 
al, 1999; de Wit et al, 2001; Pang et al, 2000; Froggatt et al, 2004; Chikhi-Brachet et 
al, 2002).  
An increasing number of studies have shown that norovirus is second only to 
rotavirus as a cause of community or hospital managed IID in children. For example, 
Oh et al examined the burden of norovirus in children hospitalised in Germany (Oh, 
Gaedicke and Schreier, 2003). Between February 2001 and January 2002, 20.7% of 
cases  were  attributed  to  norovirus.  Chikhi-Brachet  and  colleagues  examined  161 
patients with community managed IID in France in 1998-99. Norovirus was detected 
in 19% of cases (Chikhi-Brachet et al, 2002). Similar findings (7.6-29.9%) have been 
reported in numerous other studies (Kirkwood and Bishop, 2001; Simpson et al, 2003; 
McIver et al, 2001; Subekti et al, 2002; Qiao et al, 1999; Phan et al, 2004; Bereciartu, 
Bok and Gomez, 2002; Sakai et al, 2001; Boga et al, 2004; Rodriguez-Baez et al, 
2002; Phan et al, 2005; Buesa et al, 2002; de Wit et al, 2001; Bonn et al, 1999; Farkas 
et  al,  2000;  Pang  et  al,  2000;  Froggatt  et  al,  2004;  Chikhi-Brachet  et  al,  2002; 
Simpson et al, 2003; Fretz et al, 2005). 
The burden of adenovirus in children with community and hospital managed 
IID is less than that of rotavirus and norovirus. Studies have demonstrated detection 
rates between 2-7.9% of children hospitalised with IID or managed in the community 
(Wood et al, 1988; Barnes et al, 1998; Giordano et al, 2001; Donelli et al, 1993; 
Sethi,  Khuffash  and  al-Nakib,  1989;  Simpson  et  al,  2003;  Bereciartu,  Bok  and   55 
Gomez, 2002; Waters et al, 2000; de Wit et al, 2001; Pang et al, 2000; Froggatt et al, 
2004; Chikhi-Brachet et al, 2002; Simpson et al, 2003; Basu et al, 2003).  
The burden of astrovirus in hospital or community managed IID is similar to 
the  proportion  attributable  to  adenovirus  with  detection  rates  ranging  between  0-
16.2%  (Phan  et  al,  2004;  Qiao  et  al,  1999;  McIver  et  al,  2001;  Liu  et  al,  2004; 
Dennehy et al, 2001; de Wit et al, 2001; Bonn et al, 1999; Pang et al, 2000; Froggatt 
et al, 2004; Chikhi-Brachet et al, 2002; Simpson et al, 2003; De Grazia et al, 2004; 
Espul et al, 2004).  
Sapovirus is predominantly a pathogen of very young children. As a result, 
sapovirus is the least common of the viral causes of IID. Studies have demonstrated 
detection rates of 0-9.2% (Froggatt et al, 2004; Phan et al, 2005; Pang et al, 2000; 
Pang, 2001; Farkas et al, 2000; Simpson et al, 2003). In general, studies reporting 
higher  rates  of  sapovirus  infections  have  usually  investigated  only  younger  study 
populations (those under 2 years).  
2.3.6.2. Burden Of Viral IID In Adults 
Viral pathogens contribute significantly to IID in adults. de Wit et al examined 
the incidence and cause of IID in two studies; one of patients attending GPs between 
1996-99 and the second a general population-based cohort study in the Netherlands 
(de Wit et al, 2001 (i); de Wit et al, 2001 (ii)). The GP study (which examined 34 
sites) covered all age groups and took place between 1996-99. Faecal samples were 
taken  from  857  patients and  tested  for  viral  and  other  microbiological  pathogens. 
Overall, 37.5% of cases of IID tested positive for at least one pathogen (15.4% of 
cases  were  positive  for  a  virus,  16.5%  were  positive  for  bacteria,  and  8.3%  were 
positive for parasites). The burden of viral pathogens was greatest in the 0-4 years age 
group (44.7%). It was less in the older age groups (15.4% in the 5-14 years age group, 
14.1% in those aged 15-29 years, 7.3% in 30-59 year olds, and 7.8% in those aged 
over 60 years). In comparison the bacterial pathogens, in particular Campylobacter 
spp, were restricted mainly to the older age groups (2.6% in the 0-4 age group, 15.6% 
in the 5-14 age group, 14.7% in those aged 15-29 years, 10.5% in 30-59 year olds and 
7.8% in patients aged over 60 years). From this study it can be seen that although 
viruses are not the most common cause of IID in adults presenting to GPs the disease 
burden is still substantial. In the population-based cohort viruses were detected in 
33.5% of community managed cases of IID (bacteria were detected in 2.4% of cases   56 
and parasites 6.8%). Viral pathogens were found to be responsible for most cases of 
IID in all age groups with the majority of viral diagnoses attributable to norovirus.  
The norovirus burden was thus higher in the community setting, possibly because it 
results in milder infections that do not necessarily require GP or hospital attention. 
2.3.6.3. Burden Of Viral IID In Outbreaks 
It has recently been established that the majority of IID outbreaks are caused 
by norovirus. Fankhauser et al examined 284 outbreaks submitted to the Centre for 
Disease Control (CDC) from 1992-2000 (Fankhauser et al, 2002). Of these, 93% were 
found  to  be  caused  by  norovirus.  Similar  findings  have  been  reported  elsewhere 
(Chatterjee et al, 2004; Inouye et al, 2000; van Duynhoven et al, 2005). For example, 
Lopman et al reviewed the causes of outbreaks reported in a number of European 
studies occurring between 1995-2000 (Lopman et al, 2003). Noroviruses were shown 
to cause most cases of outbreaks in England and Wales (96%), Germany (100%), 
Sweden (97%), the Netherlands (84%), Slovenia (43%) and Spain (57%). The other 
viruses discussed are also known to cause outbreaks of IID, however outbreaks of this 
type are much less common than those caused by norovirus. 
2.4. Laboratory Methods For The Diagnosis Of Viral Causes Of IID 
Laboratory diagnosis of viral IID is important, as the aetiological causes of IID 
(bacteria,  parasites  or  viruses)  cannot  be  differentiated  based  on  clinical  or 
epidemiological data alone. There are many tests available for the detection of viral 
causes of IID. Some are predominantly used in the research setting whereas others are 
commonly used in routine diagnostic services.  
The requirements of a diagnostic test are quite different to an assay that is to 
be used in the research setting. Both settings require tests that have high sensitivity 
and specificity, however in the diagnostic setting speed, throughput and ease of use 
are also essential. Ideally, for a diagnostic test to be clinically useful it should be 
sensitive, specific, rapid and high throughput. A test with these characteristics will 
bring several advantages. First, the high sensitivity and specificity will increase the 
likelihood of the clinician receiving an accurate etiological diagnosis. Providing an 
etiological  cause rather  than a “syndromic” diagnosis allows  clinicians and public 
health officials to make informed management decisions regarding patient care based 
on knowledge of the prognosis, length of infectiousness and possible transmission   57 
routes. A rapid diagnosis may also prevent unnecessary tests for other potential causes 
or empirical treatment. Although not generally recommended for treating IID, a recent 
study in Ireland found that approximately 7.5% of patients who consulted a GP for 
symptoms  of  IID  received  antibiotics,  which  represented  15%  of  all  treatments 
prescribed  (Acute  Gastroenteritis  in  Ireland,  North  and  South-A  Telephone  Study, 
2003). A rapid and accurate diagnosis may also help reduce unnecessary or prolonged 
hospitalisations whilst other tests are carried out. Taken together, all these factors will 
also help reduce health care costs. Rapidity is particularly important in the outbreak 
setting as it may influence decisions on infection control measures such as patient 
isolation or cohort nursing. A high throughput test will contribute to rapidity and will 
increase  the  robustness  of  the  assay  when  faced  with  seasonal  peaks  in  sample 
submissions and sudden increases resulting from the emergence of a new virus type. 
From the laboratory standpoint, an ideal test should not be expensive to implement 
and maintain. In addition, it should also be easy to use and robust since the tests may 
be operated by less specialised staff. 
Accurate  and  rapid  diagnosis  will  also  inform  public  health  surveillance 
systems. Rapidity ensures surveillance data is timely whereas the ability to provide an 
accurate  result  allows  the  morbidity,  mortality  and  economic  cost  of  particular 
infections to be measured and prevention measures to be planned or evaluated.  
Since  the  initial  discovery  of  viral  causes  of  IID  by  EM  in  1972  several 
techniques for the detection of viral causes of IID have been developed. These include 
the  direct  detection  techniques  culture  and  EM,  antigen  detection  assays  and  the 
nucleic  acid  detection  technologies  such  as  PAGE,  hybridisation  and  PCR.  The 
advantages and disadvantages of each of are described in the following sections 
2.4.1. Direct Detection Of Viral IID. 
2.4.1.1. Culture Methods 
One of the shared characteristics of the different viral causes of IID is their 
fastidious nature. There have been few reports of the successful use of culture systems 
to grow these viruses. Those that have been successful have often used specialist cell 
lines that are not commonly used in laboratories. For example, a permissive cell line 
for rotavirus is the monkey kidney epithelial cell line MA104 (Brydon et al, 1977; 
Purdham et al, 1975; Babiuk et al, 1977; Urasawa, Urasawa and Taniguchi, 1981).   58 
Group B rotavirus has also been successfully cultured and is distinguished from group 
A rotavirus by forming multinucleated syncitia. Norovirus and sapovirus have proved 
impossible,  thus  far,  to  culture  in  either  cell  lines  or  organ  cultures.  Duizer  et  al 
attempted  to  culture  norovirus  in  24  different  cell  lines  with  and  without  various 
supplements (Duizer et al, 2004). No successful growth was reported. Wobus et al 
successfully  cultured  a  murine  norovirus  in  dendritic  and  macrophage  cell  lines 
(Wobus et al, 2005). However, whether or not this cell line can be used in human 
norovirus strains remains to be seen. Astrovirus has been frequently isolated using the 
cell line Ca-Co-2 (Grimm et al, 2004; Brinker et al, 2000; Pinto, Diez and Bosch, 
1994). Rohayem et al compared Ca-Co-2 to Reverse Transcriptase Polymerase Chain 
Reaction (RT-PCR) for the diagnosis of astrovirus. In 287 samples Ca-Co-2 detected 
8 as positive whereas 19 were detected by RT-PCR. Other cell lines that can be used 
for  astrovirus  include  MA104  and  T84.  Adenovirus  types  40  and  41  have  been 
successfully cultured in the cell line Graham 293 (Szucs and Uj, 1998).  
In general most of the methods described above are prolonged and laborious 
and not suited for high throughput work. As a result viral culture is rarely used for 
diagnosis, as other methods are more sensitive, rapid and are easier to use. However, a 
culture  system  is  still  desirable  in  order  to  carry  out  viability  studies  to  assess 
detergents and future antivirals. 
2.4.1.2. Electron Microscopy 
EM was instrumental in the discovery of the viral causes of IID and as a result 
has been the diagnostic gold standard for many years. It is an open technique allowing 
the detection of a number of pathogens if present in the sample (Biel and Madeley, 
2001). This characteristic is also useful in the search for new pathogens (Curry, 2003). 
Of all the viral causes of IID rotavirus is probably the most easily identified using this 
method as the virus can be excreted in large quantities for prolonged periods (over 
10
10  viral  particles/ml  has  been  described).  Furthermore,  rotavirus  can  be  readily 
identified by its “wheel like” appearance under EM. However, other viral pathogens 
are more difficult to detect using EM. The “star like” appearance of astrovirus is often 
only  present  in  around  10%  of  the  viral  particles.  The  “cup  like”  depressions  of 
norovirus are often indistinct although they tend to be more distinct in sapovirus. As a 
result astrovirus and norovirus pathogens can often be mistaken for each other.    59 
The overall detection limit of EM is approximately 10
6 viral particles/ml of 
faecal  sample.  However,  viruses  causing  IID  are  often  shed  at  levels  below  this 
detection limit, especially a few days after the onset of symptoms. As a result EM is 
reliant on collecting samples early on in the illness, when viral shedding is at its 
greatest.  Furthermore,  if samples  are  not  refrigerated  before  examination  the  viral 
particles  can  break  down  reducing  the  sensitivity  of  the  assay  still  further 
(McCaughey et al, 2000).  
Samples that contain no virus or levels of virus below the detection limit can 
take time to examine, since the whole sample has to be scanned in detail to check for 
the presence of the virus, thus prolonging turn-around-times and lowering throughput. 
The  use  of  Immune  Electron  Microscopy  (IEM)  can  increase  the  sensitivity, 
specificity and rapidity of EM. IEM utilises convalescent serum or immune serum and 
mixes this with faecal sample. The viral particles, if present, should then form large 
antibody-antigen complexes, which are easier to detect by EM. The adaptation of this 
method to include a grid coated in antibody (called Solid Phase IEM or SPIEM) is 
also useful (Kjeldsberg, 1994; Wood et al, 1989; Svensson, Grandien and Pettersson, 
1983;  Svensson  and  von  Bonsdorff,  1982).  Both  methods  have  also  been  used  to 
serotype viral pathogens and measure immune responses.  
Overall, however, EM is laborious since each sample requires detailed manual 
examination,  which  predisposes  it  to  low  throughput.  It  is  also  insensitive  in 
comparison to other techniques (Buesa et al, 1996; Pang et al, 1999; Simpson et al, 
2003).  It  requires  highly  trained  personnel  and  expensive  equipment.  Automated 
systems  have  been  described  which  reduce  the  need  for  specialised  personnel 
(Utagawa et al, 2002), however these are often very expensive. The large initial cost 
of EM (in terms of both equipment and building costs) and continued maintenance 
costs has resulted in EM being restricted to specialised virology testing centres.  
2.4.2. Antigen Detection Methods 
Since the 1980s an increasing number of in-house and commercial antigen 
detection methods have been described for the detection of viral IID. These methods 
have many advantages over EM. They are easy to use, high throughput and have a 
rapid turn-around-time (less than 4 hours from sample arrival to result). They are also 
less expensive than EM as they do not need specialised equipment or large laboratory 
space.  As a result these assays tend to be used by a wider range of laboratories for the   60 
detection of viral causes of IID. Commercial assays have proved particularly useful, 
as the reagents are already provided, they have good standardisation, Quality Control 
(QC) and technical support. These assays are available in numerous formats including 
Enzyme  ImmunoAssay  (EIA),  Latex  Agglutinations  assays  (LA),  and 
ImmunoChromatoGraphy methods (ICG). 
Most of the commercial antigen detection assays available are for the detection 
of rotavirus and adenovirus. Methods are also available for the simultaneous detection 
of both viruses (Giordano et al, 2005; Rabenau et al, 1998).  
For rotavirus, most assays utilise monoclonal or polyclonal based assays that 
target the conserved VP6 antigen (Anand et al, 2001; Eing et al, 2001; Kelkar et al, 
2004). Monoclonal-based EIA assays (developed in the 1990s)  are more sensitive 
than polyclonal based assays, whilst both tend to be more sensitive than LA methods 
(Dennehy,  Gauntlett  and  Tente,  1988;  Thomas  et  al,  1988;  Altindis  et  al,  2004). 
However LA is more rapid than EIA (Thomas et al, 1994; Kohno et al, 2000). ICGs 
are now regarded to be as sensitive as EIA and as rapid as LA for rotavirus diagnosis 
(Wilhelmi et al, 2001; Bon et al, 2005).  
All of the above antigen detection methods are considered at least as sensitive 
for rotavirus, if not more so, than EM. Detection limits tend to be between 10
4-10
7 
viral  particles/ml.  However,  their  reduced  specificity  can  result  in  false  positive 
results. This is especially true during non-peak times of the year (Moore, Steele and 
Alexander, 2000; Banyai et al, 2003; Sanekata et al, 1990). Other problems include 
their  reduced  sensitivity  in  adult  patients  and  in  others  who  shed  low  levels  of 
rotavirus (Anderson and Weber, 2004). They are also, at present, unable to detect non 
group A rotavirus strains (James et al, 1998). 
There are a number of commercial antigen detection methods available for 
adenovirus including EIA, LA and ICG (Moore, Steele and Alexander, 2000; Banyai 
et al, 2003; Sanekata et al, 1990). Most of the assays target the hexon antigen and are 
either in monoclonal or polyclonal format (Vizzi et al, 1996; Wood et al, 1989; Wood 
et al, 1989; Nishio et al, 1990). Monoclonal-based EIAs tend to be superior to LA and 
ICG. In comparison to EM, the assays show comparable or slightly greater sensitivity. 
As  with  rotavirus  however,  antigen  based  methods  for  adenovirus  detection  have 
reduced  specificity  and  can  result  in  false  positive  reactions  (Moore,  Steele  and 
Alexander, 2000; Banyai et al, 2003; Sanekata et al, 1990).    61 
The  development  of  an  antigen  detection  assay  for  noroviruses  has  been 
hampered by their variability and complicated immune reactions (described earlier). 
Early  antigen  detection  methods  were  in-house  and  targeted  viral  capsid  proteins 
using hyper immune sera from mice, guinea pigs and rabbits, targeting viral capsid 
proteins. These assays often failed to detect all of the different types of norovirus and 
thus were restricted to research laboratories only (Nakata, Estes and Chiba, 1988). 
Some in-house  assays  were specifically devised to detect the predominant strains, 
allowing other methods to be used on a smaller subset of samples (Vipond et al, 2000; 
Matson  et  al,  1989).  The  ability  to  express  norovirus  capsid  proteins  in  a 
baculoexpression system allowed the generation of VLPs. VLPs have been used to 
immunise animals, producing both monoclonal and polyclonal antibodies. This led to 
the discovery of genotype and genogroup specific antibodies, which in turn led to the 
development of a small number of commercial EIAs for the detection of norovirus. 
Studies  have  shown  these  assays  to  be  more  sensitive  than  EM.  Richards  et  al 
compared a commercial polyclonal EIA (IDEIA, Dako Cytomation) with EM on a 
panel of outbreak specimens (Richards et al, 2003). Overall the sensitivity of the EIA 
was greater than that of EM (55.5% vs 23.9%). It was concluded that this EIA would 
prove useful in laboratories without access to EM or molecular methods such as PCR. 
However, this assay was later withdrawn and replaced with a monoclonal-based EIA. 
Burton-Macleod et al compared the monoclonal EIA (IDEIA, Dako Cytomation, Ely, 
UK) to another  commercial EIA called the Denka EIA (Seiken Co.  LTD, Tokyo, 
Japan) on 103 samples containing G1 and G2 norovirus, and representatives of other 
enteric viral pathogens (Burton-Macleod et al, 2004). Although the Denka kit was 
more sensitive than the Dako assay (70% vs 30%) the specificity was significantly 
reduced (69% vs 100%). The Denka assay also detected sapovirus. However, neither 
EIA was recommended for routine diagnosis. Recent assessments of other commercial 
EIAs for norovirus have also proved disappointing (Dimitradis and Marshall, 2006).  
There are relatively few antigen detection methods available for the detection 
of astrovirus. A number of in-house EIAs have been described in the literature with 
varying levels of sensitivity (Herrmann et al, 1990; Komoriya et al, 2003; Kohno et 
al, 2000). Recently commercial assays have become available. Putzker et al compared 
a commercial EIA assay (IDEIA, Dako Diagnostika, Hamburg, Germany) with EM 
on 213 faecal samples  (Putzker et al, 2000). Overall the EIA was able to detect all of 
the sample positives as EM from all 8 astrovirus groups. A recent study by Liu et al   62 
compared the same commercial EIA with RT-PCR (using primers mon 269 and 270). 
They found that the EIA had comparable sensitivity to the RT-PCR assay (Liu et al, 
2005).  
At  present  there  is  no  commercial  assay  available  for  the  detection  of 
sapovirus.  Several  in-house  assays  have  been  described.  Most  use  polyclonal 
antibodies but these have tended to be insensitive (Hansman et al, 2005; Hansman et 
al, 2006). The use of VLPs for sapovirus may in future lead to the development of 
commercial assays for its detection. 
Overall, antigen detection methods are a useful laboratory diagnostic method. 
Studies have shown them to be at least as sensitive as EM with the advantage that 
they  are  rapid,  easy  to  use,  and  high  throughput.  They  are  also  inexpensive  to 
implement  in  a  laboratory,  as  they  require  little  extra  equipment  or  specialised 
training.  However,  despite  these  advantages,  question  marks  remain  over  their 
specificity, especially for norovirus detection. They also have stringent requirements 
concerning the time from sample collection to testing taking place, which must be 
between 3-7 days depending on the pathogen under test. Furthermore, no commercial 
assay is currently available for sapovirus.  
2.4.3. Nucleic Acid Detection Assays  
2.4.3.1. Poly-Acrylomide Gel Electrophoresis (PAGE) 
An  inexpensive  and  effective  alternative  to  either  EM  or  antigen  detection 
methods for the diagnosis of rotavirus is polyacrylomide gel electrophoresis (PAGE). 
To carry out this technique the segmented dsRNA is extracted directly from faecal 
samples, electrophoretically separated on polyacrylomide gels and then detected by 
silver staining (Steele et al, 1993; Johnson and McCrae, 1988). The sensitivity is as 
good  as  EIA  and  can  be  improved  using  nucleic  acid  extraction  techniques.  This 
method detects all rotavirus types and allows group A rotavirus to be differentiated 
from other rotaviruses as it has a distinctive banding pattern to that of group B and C. 
However, the steps described above mean that this method is laborious and therefore 
not routinely used in laboratories. 
2.4.3.2. Hybridisation 
A number of hybridisation assays have been described that use complementary 
labelled probes such as radio labelled dioxygenin (Willcocks et al, 1991; Moe et al,   63 
1991). Some of these assays have been shown to be as sensitive and specific as EIAs 
for rotavirus (Ali et al, 1993; Flores et al, 1983). However, hybridisation assays for 
variable  RNA  viruses  such  as  norovirus  and  sapovirus  have  shown  reduced 
sensitivity, mainly because of the difficulty in targeting conserved areas. As a result 
these  assays  quickly  became  redundant,  as  laboratories  preferred  the  increased 
sensitivity of other molecular techniques such as PCR (described in the following 
section). 
2.4.3.3. Polymerase Chain Reaction (PCR) Assay 
PCR (shown in Figure 9) is a very sensitive technique allowing the detection 
of minute quantities of virus (Mullis and Faloona, 1987; Holland et al, 1991). PCR 
utilises  a  pair  (or  more)  of  synthetic  oligonucleotides  called  primers,  which  are 
specific to a conserved region (of defined length) of the genome of the virus to be 
detected. These primers are then added to a mixture containing dNTPs (nucleotides), 
various buffers, and an  enzyme called Taq DNA polymerase. To this mixture the 
nucleic acid from a clinical sample is added. This PCR mixture then undergoes a 
cycle of temperature changes consisting of: a denaturation step that causes the DNA 
strands to separate; an annealing step during which the primers bind to the target 
sequence; and an extension step where the Taq DNA polymerase uses the primers as a 
substrate to create a complimentary strand, by adding dNTPs to the primers. At the 
end of one PCR cycle the number of starting target sequences doubles. After 30-50 
cycles millions of copies of the original template can be made.  
Although principally a DNA detection technique the detection of RNA can be 
achieved by the addition of a Reverse Transcriptase (RT) step, which converts RNA 
to cDNA that can then be used in PCR reactions.  
Successful PCR relies upon numerous factors. Efficient nucleic acid extraction 
is needed to purify the nucleic acid from the clinical sample and remove substances 
that may inhibit the PCR (Rasool, Monroe and Glass, 2002). There are many different 
methods available for this (Hale, Green and Brown, 1996; Kok et al, 2000; Santos and 
Gouvea, 1994). Many are in a commercial kit format thus improving the reliability 
and ease of use of the  extraction process. Many of these kits also work using an 
automated robot format allowing multiple samples to be extracted reliably and within 
a short time period, which is useful in a high throughput (i.e. diagnostic) laboratory 
and helps improve the rapidity of PCR.    64 
Another important factor for successful PCR is the choice of primers. Primers 
should  be  designed  to  detect  and  amplify  conserved  regions  of  the  target  virus. 
Targeting variable regions may prevent primers from binding and can result in false 
negative PCR results. 
Figure 9: The Polymerase Chain Reaction assay. 
 
The use of multiple primers (known as multiplex PCR) allows the detection of 
multiple pathogens within a single PCR reaction (O’Neil et al, 2002). Multiplexing a 
number of PCR methods into a single tube can improve test rapidity by allowing a 
number of tests to be carried out in one step and can also reduce tests costs by using 
less reagent.  
Carrying out a nested PCR can increase the sensitivity of a PCR test. Nested 
PCR consists of a second PCR reaction that uses the PCR product as a template and 
primers that target an area within the first PCR target region. However, although this   65 
increases the sensitivity of the PCR, it also raises the risk of false positive results due 
to contamination. 
Currently, two forms of PCR assay exist - conventional methods and the more 
recent real-time PCR techniques. Both are based on the above chemical reaction and 
differ only in how the result is analysed. In conventional PCR, which was the first 
kind to be developed, the product from the PCR reaction is detected by adding a 
volume of the PCR mixture to an agarose gel once the reaction is complete. After 
electrophoresis the gel is examined under ultraviolet light. If the target was present in 
the original sample a band of defined length (corresponding to the target sequence) is 
observed. Other methods of confirmation include micro-titre plate hybridisation and 
southern hybridisation (van der Vliet, Hermans and Klatser, 1993; Keller et al, 1990). 
This form of PCR therefore provides end point analysis, which means that the result is 
only available at the end of the test.  
Real-time  PCR,  in  contrast,  allows  visualisation  of  the  PCR  process  as  it 
occurs. This technique first began to appear in the late 1990s. Instead of a band on a 
gel a positive reaction is shown by an increase in flourescence above background 
levels. The PCR cycle point at which the sample becomes positive is called the cycle 
threshold (Ct). The Ct is directly related to the starting target copy number. The lower 
the Ct (i.e. the nearer it is to zero) the greater the starting target copy number (Figure 
10), which means that real-time PCR is a semi-quantitative assay and with the use of 
known standards can be made fully quantitative (Kang et al, 2004). 
There are a number of chemistries available for real-time PCR including dual-
labelled probes (formally known as TaqMan™ probes), molecular beacons, Minor 
Groove Binding probes (MGB), fluorescent-labelled primers and DNA chelating dyes 
(Figures 11-14). The advantages and disadvantages of these chemistries are discussed 
in Table 3. Most published assays use dual-labelled probes or molecular beacons. This 
is probably due to the fact that the addition of a probe or beacon improves specificity, 
since this and the primers have to bind to the PCR to provide a positive result.   66 
Figure 10: Real-time PCR fluorescent curve. 
 
The figure shows a representative amplification plot (fluorescence signal versus cycle number) for real time PCR. In the initial cycles of 
PCR, there is little change in fluorescence signal (This is the baseline for the amplification plot). An increase in fluorescence above the 
baseline indicates the detection of accumulated PCR product. The parameter Ct (threshold cycle) is defined as the cycle number at which 
the fluorescence passes the fixed threshold. So the higher the initial amount of the target in the sample, the sooner accumulated product 
is detected in the PCR process as a significant increase in fluorescence, and the lower the Ct value.    67 
Figure 11: Dual-Labelled Probes. 
 
 
 
 
Dual-labelled probes (also known as Taqman™ probes) are oligonucleotides that contain a fluorescent dye on the 5' base, and a 
quenching dye located on the 3' base. When excited the fluorescent dye transfers energy to the nearby quenching dye molecule rather 
than fluorescing, resulting in a nonfluorescent probe. Dual labelled probes are designed to hybridise to an internal region of a PCR 
product. During PCR,  when the polymerase replicates a template on  which the probe is bound, the 5' exonuclease  activity of the 
polymerase cleaves the probe. This separates the fluorescent and quenching dyes, allowing detection of the signal from the reporter dye. 
Fluorescence increases in each cycle, proportional to the rate of probe cleavage (http://probes.invitrogen.com).   68 
Figure 12: Molecular Beacons. 
 
 
Here the primer binding site is within the loop. Molecular beacons contain fluorescent and quenching dyes and are designed to adopt a 
hairpin structure while free in solution, bringing the fluorescent dye and quencher into close proximity. When a molecular beacon 
hybridises to a target, the fluorescent dye and quencher are separated and the fluorescent dye emits light upon irradiation. Unlike dual 
labelled probes, molecular beacons are designed to remain intact during the amplification reaction. (http://probes.invitrogen.com)   69 
Figure 13: Scorpion primers. 
 
 
Schematic representation of real-time PCR with Scorpion primers. In the hairpin loop structure, the quencher (black circle) forms a 
nonfluorescent complex with the fluorophore (green circle). Upon extension of the amplicon, the Scorpion probe hybridises to the newly 
formed  complementary  sequence,  separating  the  fluorophore  from  the  quencher  and  restoring  the  fluorescence 
(http://probes.invitrogen.com).   70 
Figure 14: Uniprimers. 
 
 
 
Schematic representation of real-time PCR with UniPrimers. In the first round of amplification, the reverse primer, containing a special 
sequence tag, primes synthesis along the template. In the second round, the forward primer primes synthesis that extends through the 
special sequence tag, forming a complementary sequence to the tag. In the third round, the UniPrimer hybridizes to this complementary 
sequence via the special sequence tag. The hairpin structure of the UniPrimer ensures that the quencher (black circle) suppresses the 
fluorescence of the fluorophore (green circle). Finally, in the fourth round, synthesis extends through the hairpin loop, relieving the 
quenching of the fluorophore (http://probes.invitrogen.com).   71 
Table 3: Comparisons of the various technologies available for real-time PCR. 
Chemistry  Advantages  Disadvantages 
Molecular beacons  Specific 
Sensitive 
Susceptible to probe mis-match 
Expensive 
Low fluorescence 
Less available 
Dual-labelled probes  Specific 
Many publications available 
Increased fluorescence 
Less susceptible to probe mis-match 
Many manufacturers 
False negative results can still 
occur 
Minor groove binders  Specific 
Increased fluorescence produced 
Can be used in small conserved areas 
Susceptible to probe mis-match 
Few suppliers 
Expensive 
Labelled primers 
(e.g. sunrise, 
scorpion, and lux) 
Cheap (no probe needed) 
As sensitive as probe-based technology 
Less homology needed (no probe region) 
Primer-dimer formation 
Strict design criteria 
Chelating dyes  Cheap 
Used on large regions 
Primer-dimer formation 
Less specific than other methods 
 
Since both conventional and real-time PCR methods detect nucleic acid rather 
than  viral  particles  or  antigen,  these  tests  involve  less  stringent  requirements  than 
either EM or EIA concerning the time taken between sample collection and testing. 
Both methods have also been shown to offer significantly improved sensitivity in 
comparison to other diagnostic methods (for a full review of each of the PCR methods 
available  see  Chapter  3),  although  more  data  is  available  on  the  performance  of 
conventional  PCR  due to  the  relatively  recent  nature  of  real-time technology.  For 
example, for rotavirus detection, Buesa et al carried out a comparison of conventional 
RT-PCR,  PAGE  and  EM  on  200  samples.  The  PCR  assay  detected  66  positive 
samples, whereas PAGE and EM detected 59 and 56 positive samples respectively 
(Buesa  et  al,  1996).  Similar  results  were  found  by  Pang  et  al,  who  compared  a 
different gel-based RT-PCR with a commercial EIA (Rotaclone) on a total of 2398 
infants. In Pang et al’s study, 256 cases of rotavirus-associated gastroenteritis were 
detected  by  EIA  whereas  with  RT-PCR,  84  (33%)  more  cases  of  rotavirus 
gastroenteritis were diagnosed (Pang et al, 1999). Similarly, Simpson et al compared 
a real-time RT-PCR assay with EM on 305 samples collected from children under five 
years of age with acute gastroenteritis (Simpson et al, 2003). The RT-PCR method 
detected  86  rotavirus-positive  samples,  compared  to  70  using  EM  (an  increase  in 
detection rate of 22.9%). Similar increases in  detection have been observed  when 
comparing  PCR  to  EM  for  adenovirus.  For  example,  Simpson  et  al  detected  40   72 
adenovirus-positive samples using real-time PCR compared to 12 detected by EM (an 
increase of 233%). 
Similar, if not greater, increases in detection rate have been observed when 
using PCR for the detection of norovirus, astrovirus and sapovirus. Early studies using 
EM and EIA often failed to detect these viruses. For example, Waters and colleagues 
used EM and EIA to examine 1386 samples from children admitted to hospital in 
Canada with IID. Although the detection rate for rotavirus and adenovirus was in line 
with other studies, the detection rates for norovirus, astrovirus and sapovirus were 
found to be 2%, less than 1% and less than 1% respectively (Waters et al, 2000). An 
Italian  study  examining  417  children  hospitalised  with  IID  found,  using  EM, 
astrovirus in less than 1% of cases. No cases of norovirus or sapovirus were reported 
(Donelli et al, 1993). The use of PCR has significantly increased the detection rate of 
these pathogens. For example, Frogatt et al examined 3,172 samples from children 
(aged under 7 years) in Bristol, UK (Froggatt et al, 2004). Using EM, 0.9% of cases 
tested positive for norovirus. The use of EIA and a gel-based RT-PCR increased the 
detection rate to 4.2% and 10.3% respectively. In the study carried out by Simpson et 
al norovirus was detected using real-time RT-PCR in 46 samples compared to 6 using 
EM.  This  study  also  showed  an  increase  of  astrovirus  positives  (7  vs  3)  and 
sapoviruses (8 vs 1) using the real-time PCR assay.  
This increased sensitivity of PCR in comparison to other techniques has in 
recent years helped establish that viral pathogens are the major cause of sporadic IID 
in  children  both  requiring  hospitalisation  and  presenting  to  GPs,  and  that  these 
pathogens also contribute significantly to sporadic IID in adults  (Simpson et al, 2003; 
de Wit et al, 2001 (i); de Wit et al, 2001 (ii)) 
The greatest impact, however, has been in the diagnosis and investigation of 
outbreaks of IID. Before the application of RT-PCR in the late 1990s the aetiology of 
most outbreaks of IID was undetermined. This was highlighted by Bean and Griffin 
who examined 7500 outbreaks of IID reported to the CDC between 1973-87 (Bean 
and Griffin, 1990). Of these, only 38% had a diagnosed aetiological cause (1.8% were 
attributed to viruses). In contrast, the utilisation of PCR methods has now established 
that the majority of IID outbreaks are caused by norovirus. Fanklauser et al examined 
284 outbreaks submitted to the CDC from 1992-2000 using a conventional gel-based 
PCR (Fankhauser et al, 2002). Of these, 93% were found to be caused by norovirus. 
Similar findings have been reported elsewhere based on the use of PCR techniques   73 
(Chatterjee et al, 2004; Inouye et al, 2000; van Duynhoven et al, 2005). For example, 
Lopman et al reviewed the causes of outbreaks reported in a number of European 
studies occurring between 1995-2000 (Lopman et al, 2003). Noroviruses were shown 
to cause most cases of outbreaks in England and Wales (96%), Germany (100%), 
Sweden (97%), the Netherlands (84%), Slovenia (43%) and Spain (57%). The other 
four viruses discussed are also known to cause outbreaks of IID, however outbreaks 
of this type are much less common than those caused by norovirus. 
There  is  some  concern  that  PCR  techniques  may  in  fact  be  over-sensitive, 
detecting low levels of virus that may be due either to prolonged shedding after the 
resolution of symptoms or to asymptomatic infection in patients with illness due to 
other causes. 
Prolonged viral shedding after the resolution of symptoms has been detected in 
a number of cases (Richardson et al, 1998; Ball et al, 2005; Rockx et al, 2002; Cliver, 
1997). Moreover, the fact that in such cases the more sensitive PCR techniques have 
detected virus for the longest periods suggests that it is shed at low levels. Richardson 
et al, for example, followed up 37 children with acute rotavirus infection. Using EIA 
rotavirus was detected up to 21 days (with a mean of 7 days) after infection whereas 
RT-PCR detected rotavirus up to 57 days post-infection. Here, the mean was 10 days 
(Richardson et al, 1998). The extended duration of shedding could not be linked to 
disease severity or age. Norovirus shedding, also, has been detected up to 7 weeks or 
more  post-infection  (Ball  et  al,  2005;  Rockx  et  al,  2002)  whereas  sapovirus  and 
astrovirus have been detected up to 2 weeks post-infection using RT-PCR (Rockx et 
al, 2002; Cliver, 1997). However, the percentage of infections that result in prolonged 
shedding has yet to be established and may be in the minority (Rockx et al, 2002; de 
Wit et al, 2001).  
True asymptomatic infections have also been observed in a small number of 
studies and are likely to be the result of a complicated relationship between various 
viral and host factors (Graham et al, 1994). For example, Graham et al inoculated 50 
volunteers  with  norovirus  and  of  these  32%  showed  seroconversion  and  viral 
shedding  in  the  absence  of  clinical  symptoms.  Recent  studies  have  attempted  to 
demonstrate that a link exists between the severity of the illness and the level of virus 
shed, with the suggestion that less severe or asymptomatic infections result in low 
levels  of  shedding.  Kang  et  al,  for  example,  used  a  real-time  PCR  to  quantitate 
rotavirus  shedding  and  compared  it  to  Vesikari  severity  scores  in  66  children   74 
presenting to hospital with IID (Kang et al, 2004). Those with mild to asymptomatic 
infection were found to have very low viral loads (i.e. Ct values close to 40 cycles) 
compared to those with more severe infection. Similarly, Pang et al compared RT-
PCR to EIA on children with IID (Pang et al, 1999). The RT-PCR detected more 
cases of rotavirus in comparison to the EIA, but these were more often from those 
with  mild/asymptomatic  infection.  These  findings  have  not  been  restricted  to 
rotavirus.  Richards  et  al  used  real-time  PCR  to  quantitate  norovirus  shedding  in 
volunteers with symptomatic and asymptomatic infection (Richards et al, 2004). Two 
of the 3 volunteers with asymptomatic infection (note a very small sample size) were 
found to have a low level of viral shedding. Gallimore et al tested asymptomatic staff 
and patients after an outbreak of norovirus in a hospital ward (Gallimore et al, 2004). 
In  total,  87  asymptomatic  staff  were  tested  and  of  these  26%  were  positive  for 
norovirus. Since these were detected by a nested method but not by a less sensitive 
single round PCR it was suggested that the virus in the asymptomatic cases was being 
shed at low levels.  
However, others studies have failed to find a link between viral shedding and 
disease  severity.  In  the  study  mentioned  above  by  Richards  et  al  one  of  the 
asymptomatic patients was found to have a high viral load in the stool. Conversely, 
low  levels  were  also  detected  in  a  number  of  symptomatic  volunteers  with  more 
severe infection. Zhang et al also used real-time PCR to correlate astrovirus viral load 
and severity in 54 patients presenting at hospital with gastroenteritis (Zhang et al, 
2006). Here, no link between viral load and severity was observed. Consequently, the 
link  between  low  level  viral  shedding  and  asymptomatic  infection  has  yet  to  be 
confirmed.  
Furthermore, the rate of asymptomatic infection in different patient groups and 
the population at large has also yet to be determined. Much of what is known about 
the rate of asymptomatic IID infections has come from a small number of case-control 
studies. Some of these studies have suggested that asymptomatic shedding is very 
common, whereas other studies have found it to be rare or have failed to detect such 
cases at all. Many of these differences are likely to be a result of the tests used, the 
cohort examined and the country the study was carried out in. For example, Tompkins 
et al examined the detection rate of various pathogens in cases of IID and controls in 
both a general population and a GP cohort (Tompkins et al, 1999). This study used 
EM and EIA to test for viral pathogens. Detection rates were found to be low (1.1%-  75 
1.2%) in both control groups, with rotavirus and norovirus most common in both 
populations. Recently, the same samples were  re-tested using more sensitive PCR 
methods for norovirus, rotavirus and sapovirus (Amar et al, 2007). The detection rate 
for norovirus, rotavirus and sapovirus in the control groups increased significantly 
from the previous study to means of 16% (range 5-31%), 14% (range 4-29%) and 2% 
(range 0-13%) respectively. Examining the detection rate by age group showed that 
the highest values were detected in the young. It is important to note, however, that 
children under 5 yrs of age may have been over-represented in the study resulting in 
an inflated mean detection rate. Moreover, information on whether the control cases 
had had a recent gastrointestinal illness was not known, which is a serious flaw as the 
detections  may  not  have  been  due  to  true  asymptomatic  cases  but  examples  of 
prolonged  shedding  following  infection.  Other  case  control  studies  have  used 
molecular methods for the detection of viral pathogens. For example, de Wit et al 
used  RT-PCR  to  test  for  norovirus  and  sapovirus  and  EIA  methods  to  test  for 
adenovirus, astrovirus and rotavirus. They detected viruses in approximately 9.1% of 
controls taking part in a community cohort study (de Wit et al, 2001). Of this total, 
norovirus was detected in 5.2% of the control samples. Again, however, this value 
may  have  been  an  over-estimate  as  children  were  over-represented  in  the  study 
(Marshall et al, 2004). However, similar rates for norovirus asymptomatic infection 
have been found in studies in Japan and Mexico (Garcia et al, 2006; Akihara et al, 
2005). High levels of asymptomatic infection have also been found in the outbreak 
setting (Vinje et al, 1997) and in countries with low socioeconomic conditions (Garcia 
et al, 2006). On the other hand other studies have failed to detect norovirus at all in 
asymptomatic control groups (Marshall et al, 2004). Marshall et al tested samples 
from  399  asymptomatic  individuals  with  a  nested  RT-PCR  and  failed  to  detect  a 
single norovirus case. Meanwhile, few studies have applied molecular techniques to 
investigate the detection rate of adenovirus and astrovirus in asymptomatic patients.  
In  summary,  therefore,  the  concern  that  PCR  techniques  may  be  over-
sensitive, detecting asymptomatic cases of IID or cases following resolution of the 
symptoms, is based on several assumptions that have yet to be fully proven. Although 
there  is  evidence  that  prolonged  shedding  post-infection  does  take  place,  the 
proportion of infections that this applies to has yet to be established and may be in the 
minority. Meanwhile, data on whether asymptomatic infection is associated with viral 
shedding (at low levels) is more contradictory, as is the evidence on the rate of such   76 
infections in patient groups and the population at large. While it is possible, therefore, 
that the use of PCR may result in some cases of unnecessary detection of IID these are 
likely to be in the minority.  
Whilst similar levels of sensitivity are achievable using both types of PCR, in 
practical  terms  there  are  some  differences  between  them  that  mean  real-time 
techniques  are  more  likely  to  be  of  use  in  a  routine  diagnostic  setting.  Despite 
conventional  gel-based  PCR  having  been  available  for  some  time,  its  use  is  still 
mainly restricted to specialist testing centres and research facilities. This is a result of 
many factors. Firstly, in order to reduce the risk of contamination the laboratory needs 
to be set up with a particular structure or flow through to prevent amplified product 
being  reintroduced  into  subsequent  PCR  reactions.  Conventional  PCR  is  also 
technically  demanding  and  requires  specially  trained  staff  in  order  to  develop, 
implement and “trouble shoot” assays. The need for a post-amplification step such as 
agarose gel electrophoresis reduces the likelihood of automation and thus the potential 
for high throughput. As a result, although sensitive, the assay is not rapid or capable 
of processing a large number of samples at one time. The combination of these factors 
means  that  little  use  of  conventional  PCR  is  made  in  non-specialist  and  routine 
diagnosis laboratories. Despite this adaptations can be used to improve conventional 
PCR  and  increase  its  usefulness  in  the  routine  setting.  For  example,  multiplexing 
more than one PCR test into a single test can reduce test costs and improve rapidity.    
Real-time  PCR  offers  the  potential  to  overcome  many  of  the  problems 
encountered  with  traditional  gel-based  PCR  (Mackay,  Arden  and  Nitsche,  2002; 
Lomeli et al, 1989; Heid et al, 1996; Pfaffl, 2001). In contrast to traditional gel-based 
PCR, for example, real-time PCR is a closed technique, which means all of the PCR 
steps  take  place  in  one  tube  (reverse  transcriptase,  PCR  and  detection).  This 
characteristic is likely to improve reproducibility and robustness, and reduces the risk 
of contamination thus favouring automation and high throughput. As a result, real-
time PCR has the potential to be more rapid. The closed system also reduces the need 
for a strict laboratory set-up and as a result reduces implementation costs. The cost of 
reagents and equipment are also starting to reduce, as companies compete to provide 
to an increasing numbers of users. As a result, of all the methods discussed in this 
section, this thesis takes the view that it is real-time PCR that is most near to the ideal 
test outlined in the introduction.   77 
2.5. The WOSSVC Diagnostic Service For Viral IID. 
The  West  of  Scotland  Specialist  Virology  Centre  (WOSSVC)  is  based  at 
Gartnavel  General  Hospital  (GGH)  in  Glasgow.  It  is  one  of  only  two  specialist 
virology  centres  in  Scotland  and  provides  a  virology  service  for  the  whole  of 
Glasgow. In addition, a significant proportion of its workload (over 40%) is from 
health  boards  outside  Glasgow.  The  users  include  hospital-based  users,  users  in 
primary  care  and  general  practice  and  private  industry.  Each  year  over  200,000 
investigations are performed. Since the late 1990s, as part of an ongoing programme 
of  innovative  service  development  the  number  of  in-house  molecular  tests  has 
increased significantly and these are now used in routine services for detecting viral 
and bacterial pathogens in Cerebrospinal Fluid (CSF) samples, respiratory samples, 
blood, urine, vesicle fluids and genial swabs.  
At the start of the research documented in this thesis, although the process of 
implementing molecular methods had begun in other areas, the WOSSVC diagnostic 
service  for  viral  gastroenteritis  was  based  solely  upon  electron  microscopy.  The 
laboratory offered this service for samples from outbreaks of IID, and samples from 
sporadic cases of IID in children less than 10 years of age and immunocompromised 
patients. However, as made clear in previous sections, EM is laborious and not suited 
to  testing  large  numbers  of  samples.  Furthermore  recent  research  has  clearly 
highlighted the insensitivity of EM in comparison to emerging techniques, particularly 
PCR.  In  the  interests  of  continuing  to  improve  the  diagnostic  service  offered 
therefore, a need was identified to replace EM in the laboratory with an improved test 
for the detection of viral IID. Based on the literature PCR was identified as the most 
suitable candidate. However, although highly sensitive and able to test a number of 
samples  at  any  one  time,  PCR  has  been  found  to  be  technically  demanding  to 
implement, maintain and troubleshoot. To date these factors have resulted in its use 
being largely restricted to a research setting. However, the view taken in this thesis is 
that  such  tests  have  the  potential  to  be  adapted  for  use  in  the  routine  setting, 
particularly real-time versions of this technique.  
Consequently,  the  overall  aim  of  this  work  was  to  improve  the  routine 
diagnostic service for IID offered at the WOSSVC, by replacing EM as the frontline 
test with PCR methods adapted from the literature. This was broken down into several 
smaller  objectives.  The  initial  objective  was  to  select  and  adapt  appropriate  PCR   78 
techniques  from  the  literature.  The  second  was  to  compare  these  techniques  to 
possible alternatives such as EIA and EM through a series of laboratory experiments 
to ensure their suitability. The final aim was to implement the new techniques in the 
routine service and examine their impact on the quality of the service offered. 
2.6. Summary 
This chapter has provided the background to the research presented in this 
thesis and through this the motivation for its existence. The chapter began with an 
overview  of  the  public  health  importance  of  IID  in  developing  and  developed 
countries. Particular focus was then given to the cost of IID in developed countries in 
order  to  show  that  IID  is  a  significant  cause  of  morbidity  in  such  countries  and 
although mortality is low, the economic cost is substantial.  
This section was followed by a description of the five main viral causes of IID. 
For  each  pathogen  a  number  of  characteristics  were  described  including:  their 
virology, classification, elicited immune response, epidemiology, the clinical illness in 
which they result, methods of preventing this illness, infection control and treatment. 
This section was designed to show that these genetically complex pathogens are a 
cause of world wide sporadic illness and outbreaks in all age groups, and can cause 
severe  and  chronic  illness  in  numerous  patient  groups.  The  multiple  types  and 
subtypes and the complex immune responses were highlighted to show that repeat 
infections can occur with each virus. The virology of each virus was also described in 
order to highlight the variable nature of some  parts of the viral  genomes. This is 
important when considering the design of molecular assays to test for these pathogens, 
which is a major part of the next chapter. Their numerous sources and transmission 
routes were also described in order to highlight how difficult these pathogens are to 
control and prevent.  
Following this, a review of the different laboratory methods available for the 
detection  of  viral  IID  was  presented.  This  began  with  a  description  of  the 
characteristics of an ideal diagnostic test in order to highlight that a routine diagnostic 
test has different requirements to an assay that is to be used as a research tool. The 
advantages and disadvantages of each diagnostic method were then described in this 
context. This section outlined the increased sensitivity offered by PCR techniques, 
which have helped to establish that viral pathogens are the most common cause of IID   79 
in children and outbreaks of IID and contribute significantly to such illness in adults. 
As such, services for their diagnosis are particularly important. It was then highlighted 
that conventional and in particular real-time PCR methods have the potential to be 
adapted for use in the routine diagnostic laboratory and the aims of the research were 
described.  
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Selection And Development Of The PCR 
Protocols For Investigation 
3.1. Overview  
This chapter describes in detail the selection and development of the PCR tests 
to be investigated as a potential replacement for the existing EM-based diagnostic 
service for viral gastroenteritis. The chapter begins by describing key decisions taken 
with regard to the structure of the proposed new service, based on a review of the 
literature (described in Chapter 2). These include the decision to split the service in 
two, with samples from outbreaks treated separately to those from sporadic cases of 
IID, and the decision on which pathogens to test for in each case. This is followed by 
a summary of the steps involved in a generic PCR assay. For each key stage (i.e. the 
sample preparation followed by the PCR method itself) the available protocols are 
then reviewed, and the factors affecting the eventual choices made for each of the 
outbreak and sporadic services are discussed. The methods selected in each case are 
described in detail, together with any adaptations necessary for use in the routine 
laboratory setting. The chapter ends with a full technical description of the sample 
preparation and PCR methods assessed in the research described in Chapter 4. 
3.2. Introduction 
It  was  established  in  Chapter  2  that  norovirus  is  the  principle  cause  of 
outbreaks of gastroenteritis, whilst for sporadic cases of IID there are five main viral 
causes:  adenovirus,  astrovirus,  norovirus,  rotavirus  and  sapovirus.  Based  on  this 
information, the decision was taken to divide the new diagnostic service into two 
parts: a separate service for samples from outbreaks of IID and one for those from 
sporadic cases, with the distinction between the two types made via the clinical details 
provided on the specimen request form. This division of the service allows the tests in 
each case to be tailored to best match the known characteristics of the two types of 
viral IID. For the outbreak service, for example, the decision was taken to adopt a 
norovirus assay as the frontline test for sample investigation, based on an increasing 
number of reports showing norovirus to be the principle cause of outbreaks of IID 
(see Chapter 2). For the sporadic service, the decision was taken to employ this same 
norovirus  assay  together  with  PCR  tests  for  adenovirus,  astrovirus,  rotavirus  and   82 
sapovirus to investigate sporadic cases of gastroenteritis in children under 10 years of 
age and immunocompromised patients (the patient groups already tested using the 
EM-based  service).  As  shown  in  Chapter  2,  these  viral  pathogens  contribute 
significantly  to  IID  in  children  and  can  cause  severe  and  chronic  infection  in 
immunocompromised  individuals  of  all  age  groups.  In  the  case  of  the  outbreak 
service, moreover, it was decided that samples which tested negative for norovirus 
should be examined further using the tests for  the other non-norovirus pathogens. 
Testing for other possible causes of IID was rejected (in both services) since this 
would mean additional cost when the clinical significance of many of these pathogens 
is unclear.  
A PCR test for viral IID is made up of numerous individual stages including 
the sample preparation steps (stool extraction followed by nucleic acid extraction), 
and the PCR-related steps such as reverse transcription (if the target is RNA), the PCR 
step itself (or two PCR steps if using a nested protocol) and, if using a conventional 
PCR method, agarose gel analysis for the interpretation of results. Numerous methods 
are available for each of these steps that each differ in their sensitivity, specificity, 
ease of use, cost and rapidity. Furthermore, some of these steps can be bought from 
commercial companies whereas others must be carried out using in-house methods. 
As a result each method must be chosen carefully in order to develop a PCR test that 
is both effective and applicable for use in the routine diagnostic setting.  
This  chapter  motivates  the  choice  of  laboratory  protocols  for  use  in  the 
proposed new molecular service for IID and describes each of the methods in detail. It 
begins  by  describing  the  methods  chosen  for  stool  and  nucleic  acid  extraction.  A 
review  of  the  published  PCR  methods  for  the  detection  of  the  five  main  viral 
pathogens is then given. This discusses the advantages and disadvantages of each 
method and outlines relevant evaluation data. The factors that affected which of these 
assays  were  selected  for  further  investigation  in  this  research  are  then  described, 
together with details of the eventual methods chosen and the adaptation of these to the 
routine setting.    83 
3.3. Laboratory Methods 
3.3.1. Sample Preparation Methods 
Sample preparation in the form of stool extraction followed by nucleic acid 
extraction is a core part of all PCR based tests carried out on stool. Stool extraction is 
carried  out  in  order  to  remove  any  sample  debris  that  may  inhibit  nucleic  acid 
extraction  and  other  laboratory  equipment.  The  nucleic  acid  extraction  method  is 
carried  out  in  order  to  remove  PCR  inhibitors  and,  in  some  cases,  to  concentrate 
nucleic acid (Atmar and Estes, 2001). Concentrating the nucleic acid in a sample aids 
the sensitivity of the PCR test, as more nucleic acid can be added to a PCR reaction. A 
number of methods are available for each of the stool and nucleic acid extraction 
steps, the choice of which is independent of the PCR method chosen. 
3.3.1.1. Stool Extraction Protocol 
Faecal extraction consists of three main steps. First the stool is added to some 
form of liquid medium to make a 10-20% solution, which is then centrifuged in order 
to pellet cell debris. The supernatant is then removed and can be used for nucleic acid 
extraction. Various solutions and centrifugation speeds have been described in the 
literature (Schaffer et al, 1985; Logan et al, 2006; Lennette, Balows, Hausler and 
Sahdow,  1985  (Fourth  Edition)).  Solutions  described  include  distilled  water, 
phosphate buffered saline (PBS), viral transport medium (VTM), Hanks medium and 
specially designed medium from commercial companies, although no studies exist 
that focus on comparing the utility of these methods. The method implemented in this 
research uses PBS to make the 10-20% solution, which is then centrifuged at 3,000 
rpm for 30 minutes. Examples of its use can be found in the literature (Lennette et al, 
1985) and its effectiveness was already established in the laboratory as part of the 
existing EM protocol. Details of the exact implementation are outlined in section 3.4. 
3.3.1.2. Nucleic Acid Extraction Method 
Nucleic  acid  extraction  is  necessary  to  purify  and  concentrate  nucleic  acid 
(DNA and RNA) from stool samples and to remove any factors that may inhibit PCR. 
There  are  numerous  in-house  and  commercial  methods  available  for  nucleic  acid 
extraction.  
An in-house method commonly used for the extraction of nucleic acid from 
stool samples is the “Boom” method (Boom et al, 1990). This method uses guanidium   84 
thiocyanate to lyse the stool samples. Acid phenol-chloroform-isoamyl alcohol is then 
used to extract nucleic acid from the lysed faecal samples and the nucleic acid is then 
purified  by  silica  binding.  This  protocol  has  been  shown  to  successfully  extract 
ssRNA, dsRNA and DNA from stool samples (Rasool et al, 2002). Other published 
in-house methods used for the extraction of nucleic acids from stool samples include 
(Atmar and Estes, 2001); exclusion chromatography (using spin columns containing 
sephadex G200); heat release (heating stool samples for 5 minutes at 95-99
oC); and 
antibody capture (virus-specific antibodies, bound
 to a 96-well plate, bind virus from 
clinical samples and viral RNA and/or DNA is released
 from the capsid after washing 
and heating). These methods differ in their ability to purify nucleic acids and are 
variously suited to particular sample types, viruses and nucleic acid types.  
In general, in-house extraction procedures are inexpensive and are therefore 
suited to use in the research setting. Their primary aim is to remove inhibitors from 
the sample and then efficiently extract nucleic acid. Of less importance are their ease 
of use and the number of samples that can be extracted at any one time. As a result, 
these methods tend not  to be high throughput,  can be difficult to standardise  and 
require prolonged hands-on time, which increases the risk of error and contamination. 
These factors combined mean that such methods were not considered for use in the 
research described in this thesis. 
Numerous commercial companies offer methods for nucleic acid extraction 
(Fiebelkorn et al, 2002; Loens et al, 2007; Jongerius et al, 2000; Chiu et al, 2006).  
Most of these are based on either silica-gel-membrane or magnetic-particle extraction 
technology.  Purification  using  silica-gel–membrane  technology  uses  the  “Boom” 
method described above and numerous kits are available that can extract RNA or 
DNA,  or  can  perform  total  nucleic  acid  extraction  from  numerous  sample  types. 
Magnetic particle systems can also be used to extract both RNA and DNA. Samples 
are first lysed and then the target RNA or DNA (or both) is bound to the magnetic 
particles. The nucleic acid is then washed before elution.  
Although more expensive than in-house techniques, commercial methods are 
easy to use, standardised, and as a result offer improved Quality Control (QC). All of 
the necessary components are delivered in a single kit, including reagents that have 
been pre-optimised for the process. In comparison to in-house methods such systems 
can result in fewer errors, are more consistent, and reduce the risk of contamination. 
They are often available in a manual format that is suited to processing small numbers   85 
of  samples.  However,  a  number  of  companies  also  offer  automated  extraction 
platforms  that  allow  rapid,  reliable  and  high  throughput  extraction  (between  8-96 
samples in 1-4 hrs). As a result these are ideal for use in the routine diagnostic setting 
and were considered suitable for use in this research. 
 At the time of the research the Qiagen Biorobot 9604 with the Qiagen Blood 
kit was already in use for the nucleic acid extraction of samples for other molecular 
tests at the laboratory. Since this system was also found to meet the requirements of 
the proposed new service for viral IID it was also used in this research. Implementing 
an alternative additional system was not considered as this could be expensive and 
may not be of use for the other molecular assays that test for alternative sample or 
virus  types.  The  Qiagen system  utilises  silica-gel-membrane  extraction technology 
(based  on  the  Boom  method)  and  can  process  up  to  96  samples  and  controls  in 
approximately 2hrs. Following initial set-up the process is fully automated, which aids 
ease of use. This kit has been shown to offer sensitive extraction of both RNA and 
DNA from numerous sample types including faecal samples, blood, urine, vesicle 
fluid, genital swabs, respiratory samples (throat swabs, nasopharyngeal aspirates etc), 
CSF, tissue and blood spots (Qiagen, 2001). Moreover, PCR methods that use this 
extraction system have been shown to be sensitive via numerous External Quality 
Control (EQC) schemes including those provided by Quality Control for Molecular 
Diagnostics  (QCMD),  the  National  External  Quality  Assurance  Scheme  (NEQAS) 
and the United Kingdom Clinical Virology Network (UKCVN).  
As an indication of the Qiagen platform’s ability to sensitively extract RNA 
and DNA the results of three EQC panels tested at the WOSSVC are presented here 
(Table  4,  Table  5  and  Table  6).  Results  are  shown  for  PCR  tests  on  CSF,  RSV, 
Human metapneumovirus (hMpV) and HSV positive samples (since no EQA panel is 
currently available for viral causes of IID). Although the panels are concerned with 
the PCR systems as a whole, the sensitivity of such systems is dependent on effective 
nucleic acid extraction and in each case was found to be high. This, together with its 
ability to extract both DNA and RNA from stool samples, and its high throughput, 
rapidity and ease of use made this automated extraction system highly suitable for the 
proposed molecular diagnostic service for viral gastroenteritis. Details of the exact 
extraction protocol are outlined in section 3.4.   86 
Table 4: Results of a NEQAS EQA panel for molecular detection in CSF (2004). 
Sample 
Number 
Expected 
Result 
WOSSVC 
Result 
% Of NEQAS Participants With Correct Result 
(N=123) 
1  Enterovirus  Enterovirus   98% 
2  HSV-1  HSV-1  100% 
3  HSV-2  HSV-2  97% 
4  VZV  VZV  98% 
5  HSV-1  HSV-1  90% 
6  Negative  Negative  100% 
 
Table 5: Results of a QCMD EQA panel for molecular detection in respiratory samples 
(2005). 
Sample 
Number 
Target 
Concentration  
(Genome Equi/Ml) 
Expected 
Result 
WOSSVC 
Result 
% Of QCMD 
Participants  
With Correct Result 
(N=16) 
1  10E-3  RSV  RSV  87% 
2  10E-5  RSV  RSV  69% 
3  10E-6  RSV  RSV  56% 
4  -  Negative  Negative  100% 
5  10E-3  hMPV  hMPV  93% 
6  10E-4  hMPV  hMPV  86% 
7  10E-2  hMPV  hMPV  93% 
 
Table 6: Results of a QCMD EQA panel for HSV-1 and 2 samples (2004). 
Sample 
Number 
Target Concentration 
(Genome Equi/Ml) 
Expected 
Results 
WOSSVC 
Results 
% Of QCMD Participants 
With Correct Result 
(N=143) 
1  -  Negative  Negative  95% 
2  7.5x10
6  HSV-2  HSV-2  98% 
3  2x10
3  HSV-1  HSV-1  62% 
4  2x10
3  HSV-1  HSV-1  64% 
5  2x10
7  HSV-1  HSV-1  97% 
6  -  Negative  Negative  95% 
7  1.2x10
6  VZV  VZV  93% 
8  2.5x10
3  HSV-2  HSV-2  92% 
9  7.5x10
2  HSV-2  HSV-2  77% 
10  2x10
4  HSV-1  HSV-1  93% 
11  7.5x10
3  HSV-2  HSV-2  93% 
12  6.7x10
3  HSV-1  HSV-1  83% 
3.3.2. PCR Methods 
There are numerous PCR methods available in the literature that can be used 
for the detection of adenovirus, astrovirus, norovirus, rotavirus and sapovirus. The 
majority of these are conventional single round and nested gel-based PCR methods,   87 
although the number of real-time PCR methods using SYBR green or dual-labelled 
probe-based technology has increased in recent years. The following section provides 
a review of the published PCR protocols for each viral pathogen that were considered 
for use in the new outbreak and sporadic service. For each pathogen the areas of the 
genome targeted by the PCR assays are outlined, alongside data on the variability of 
each target region. In addition, the findings from relevant studies comparing the PCR 
methods  to  other  diagnostic  methods  (molecular  and  non-molecular)  are  given. 
Following  the  review,  the  methods  chosen  to  be  adapted  for  use  in  each  of  the 
proposed services are described, alongside the reasons for each choice and details of 
any adaptations necessary for use in the routine diagnostic laboratory setting.  
3.3.2.1. PCR Methods Considered For The Outbreak Service 
RT-PCR Assays For The Detection Of Norovirus 
There have been numerous RT-PCR assays published for norovirus detection 
and  a  number  of  targets  have  been  described.  Early  versions  were  gel-based  and 
tended to target the RNA dependent RNA polymerase (RdRp) part of the genome, as 
this region was initially thought to be the most functionally conserved region between 
noroviruses (Kojima et al, 2002). PCR assays that target this region have remained 
popular. However, significant variation can still be found in this region, which can 
hamper the detection of a number of norovirus strains and genotypes (Katayama et al, 
2002). On the other hand, the advantage of this variability is that the RT-PCR product 
from this region can further analysed in order to identify types and subtypes. 
In some of the earliest work in this area, Ando et al developed two broadly 
reactive RT-PCR assays that targeted the RdRp region, were shown to be specific and 
could  detect  and  differentiate  between  norovirus  strains  from  genogroup  1  and  2 
(Ando et al, 1995). Green et al developed a RT-PCR that used primers Ni and E3 to 
amplify a 113bp region of the norovirus RdRp (Green et al, 1995). This RT-PCR was 
compared to EM on 132 samples from outbreaks and sporadic cases of gastroenteritis 
that  had  occurred  in  the  UK  between  1992-1994.  Of  the  101  samples  that  tested 
positive for norovirus using EM, the PCR detected 93 as positive. Of the 31 samples 
that tested negative for norovirus using EM, the PCR detected 5 as positive. Based on 
the results of this study the authors judged that this PCR method offered a sensitive 
alternative to EM. The assay was also shown to be specific by cross testing with other 
pathogens including sapovirus. In the years following it became commonly used by   88 
testing centres throughout Europe and was used as the frontline test by the Health 
Protection Agency (HPA) in London (Vinje et al, 2003).  
Numerous other methods that target the RdRp region have been published for 
the detection of norovirus in clinical samples, shellfish, water and other environmental 
material (Green et al, 1995; Ando et al, 1995; Green et al, 1995; Guyader et al, 1996; 
Hafliger et al, 1997; Lees et al, 1995; Wyn Jones et al, 2000; Myrmel et al, 1999; 
Green et al, 1998). Nested and hemi-nested PCR formats have also been described, 
sometimes offering up to 1000 times more sensitivity than single round PCR assays 
(Green et al, 1998; Hafliger et al, 1997).  
However,  despite  the  large  number  of  tests  available  that  target  the  RdRp 
region, few studies have been published that directly compare these methods. In 2003, 
Vinje et al carried out an assessment of a number of conventional RT-PCR methods 
that targeted this region. The aim was to determine which were commonly used in 
European  laboratories,  and  if  possible,  determine  which  of  them  offered  the  best 
sensitivity. This study showed that the most commonly used methods were single 
round RT-PCR assays that utilised either the primers Ni and E3, JV12 and JV13, or 
mon 431-434, together with a nested assay that used the primers 32 and 33 for the first 
round RT-PCR, and primers 35 and 36 for the second nested step. Each assay was 
tested using a panel of 82 samples that tested positive for norovirus using EM and 
contained representatives from genogroups 1, 2 and 4. The end point detection limit of 
each  test  was  determined  using  a  number  of  dilution  series,of  multiple  norovirus 
genotypes. Overall, no one assay was found to be significantly superior to another. 
Looking at the data in more detail showed that the RT-PCR test that used primers Ni 
and E3 detected approximately 85% of the G1 types examined and 58% of the G2 
types. The assay that used JV12 and JV13 detected 100% of the G1 types examined 
and 75% of the G2 types. The nested method utilising the primer sets 32-33 and 35-36 
detected 85% of the G1 types examined and 85% of the G2 types, whereas the single 
round RT-PCR method using the primers mon 431-434 detected 85% of the G1 types 
examined and 69% of the G2 types. When these assays were compared on dilution 
series  a  wide  variation  in  their  end  point  detection  limits  was found.    This  study 
highlights that even tests targeting the same region can vary significantly in their 
sensitivity. Of the methods compared, the authors concluded that the primers JV12 
and JV13 offered more universal detection and as a result recommended these primers 
to laboratories that had yet to implement RT-PCR. Subsequently, these primers have   89 
also been used successfully in a nested format (Medici et al, 2005) and have been 
used in a multiplex format in tests for  adenovirus and astrovirus (Rohayem et al, 
2004). 
A number of Nucleic Acid Sequence-Based Amplification (NASBA) assays 
have also been described that target the RdRp region. Comparisons with established 
RT-PCR methods have shown that these have comparable sensitivity (Moore et al, 
2004; Houde et al, 2004; Rutjes et al, 2006; Greene et al, 2003; Patterson et al, 2006). 
This technology can also be used to quantitate the amount of virus in a stool sample 
via the amplification of known standards. 
Real-time PCR is a relatively new technique and therefore few methods of this 
type have been described that target the RdRp region. Pang et al described a SYBR 
green method which, for G2 detection only, targeted the RdRp area (the G1 assay 
targeted  the  capsid  region)(Pang et  al,  2004).  Compared  to  conventional  RT-PCR 
using the primers JV12 and JV13, the real-time PCR was found to be more sensitive 
for  G2  types.  However,  specificity  was  reduced  as  cross-reactions  were  observed 
between the G1 and G2 assay reducing its value as a typing assay. In another study 
Simpson  et  al  used  the  primers  JV12  and  JV13  in  a  SYBR  green  format.  Their 
method was shown to be significantly more sensitive than EM (Simpson et al, 2004). 
Richards et  al  also  used  previously  published  primers  (mon  431-434)  in  a  SYBR 
green  real-time  format  (Richards  et  al,  2004).  Here,  although  the  assay  was  not 
directly compared to any others it was shown to be sensitive.  
As an alternative approach, a number of norovirus RT-PCR assays have been 
published that target the capsid area. Yamazaki et al, for example, described an assay 
that targeted the capsid region (Yamazaki et al, 1996). This assay was compared to 
EM and was shown to be more sensitive. Vinje et al described a broadly reactive RT-
PCR  that  targeted  the  capsid  VP1  region.  This  was  used  for  both  diagnosis  and 
epidemiological study but was not compared to an alternative method (Vinje et al, 
2004). However, compared to the RdRp region, the capsid contains significantly more 
variation  as  it  includes  the  highly  variable  regions  that  determine  antigenic 
determinants, cell attachment and entry (Katayama et al, 2002). These areas come 
under  immune  pressure,  which  in  turn  promotes  the  emergence  of  new  norovirus 
phenotypes  (Nilsson  et  al,  2003).  The  variable  nature  of  the  capsid  region  thus 
increases the risk of false negative reactions due to nucleotide changes in the primer 
regions. Careful design is needed to ensure detection of a wide range of types and   90 
continued test monitoring is needed to maintain test sensitivity. The variable nature of 
the capsid region has also hampered the development of real-time probe-based RT-
PCR methods, as these methods require a greater area of nucleotide conservation than 
conventional PCR methods. Some examples do exist, however. Pang et al described a 
real-time  RT-PCR  method  that  targeted  the  capsid  region  in  order  to  detect  G1 
noroviruses (Pang et al, 2004). However, although it could detect all of the G1 types 
tested, the detection limit was found to be approximately 3 logs less sensitive than 
conventional  RT-PCR  using  primers  JV12  and  JV13.  As  described  above,  cross 
reactions between G1 and G2 types were also seen.  
In  2002,  Katayama  et  al  published  a  similarity  study  of  18  norovirus 
sequences  that  showed  for  the  first  time  that  the  most  conserved  region  of  the 
norovirus genome is the ORF1-ORF2 junction (Katayama et al, 2002). As a result, 
most of the recently published tests have targeted this region rather than the RdRp or 
capsid region, with the aim of detecting a wide range of norovirus types and subtypes. 
This finding, moreover, has significantly aided the development of real-time PCR 
methods since these require greater regions of conservation to allow probe as well as 
primer binding. 
One of the first assays to be published that targeted the ORF1-ORF2 junction 
was  described  by  Kojima  et  al  (Kojima et  al,  2002).  This  assay  was  a  gel-based 
multiplex assay that utilised two primer sets for the detection and differentiation of 
genogroup 1 and genogroup 2 noroviruses. It was compared to two other RT-PCR 
methods that targeted the RdRp and the capsid regions respectively, using 35 samples 
that tested positive for norovirus using EM. The new assay developed by Kojima et al 
was shown to be specific and detected all 35 samples as positive whereas the other 
assays detected 28 and 27 as positive. The new test was also shown to detect a wide 
range of norovirus strains, and the PCR product could be used for epidemiological 
studies using sequence analysis. 
Kageyama  et  al  described  the  first  real-time  RT-PCR  assay  to  target  this 
region (Kageyama et al, 2003). Aligning the sequence data provided by Katayama’s 
original study with a further 70 partial ORF1-ORF2 sequences led to the development 
of two probe-based real-time RT-PCR methods for the separate detection of norovirus 
types G1 and G2. The assays were compared to two conventional RT-PCR methods, 
one  targeting  the  capsid region  and  one  the  RdRp.  Of  the  81  samples  that  tested 
positive for norovirus using EM, the real-time  PCR methods together  detected 80   91 
whereas the two conventional RT-PCR methods detected 62 and 67, respectively. In 
addition,  the  real-time  RT-PCR  method  was  shown  to  be  specific  and  detected  a 
further 20 positive samples in a panel of 28 samples that had tested negative using 
EM. 
Houde et al compared this real-time PCR assay to both a NASBA test and a 
conventional RT-PCR that used the primers described by Ando et al (Ando et al, 
1995; Houde et al, 2006). All of the assays detected the same number of norovirus- 
positive clinical samples from a panel of G2 types. However, the real-time RT-PCR 
method was found to be more sensitive by at least 1-2 logs than either of the others 
when  the  endpoint  detection  limits  of  each  assay  were  assessed.  Jolkihumar  et  al 
further improved the sensitivity of this real-time RT-PCR method by up to 100 fold 
by removing the degeneracies from the forward G2 primer (Jolkihumar et al, 2005). A 
new  probe-based  G1  RT-PCR  was  also  developed  that  targeted  the  ORF1-ORF2 
junction  and  which  was  shown  to  more  sensitive  than  the  G1  real-time  assay 
developed by Kageyama and described above. Other studies have also published real-
time RT-PCR methods (including dual-labelled probe-based and ones based on MGB 
chemistries) that target the ORF1-ORF2 region (Pang et al, 2004; Schmid et al, 2004; 
Hoehne et al, 2006). In each case the assays were compared to conventional RT-PCR 
methods and were found to be more sensitive. 
3.3.2.2. Selection And Development Of The PCR Methods For Use In The 
Proposed Outbreak Service 
As described in Chapter 2, norovirus is highly variable “genomically” and, 
although one strain tends to dominate at any one time, there exists a wide range of 
types and subtypes (Katayama et al, 2002; Fankhauser et al, 2002; Green et al, 1995; 
Koopmans, 2000; Gallimore et al, 2004; Hale et al, 2000; Kageyama et al, 2004). 
Moreover,  individuals  with  norovirus  infection  have  been  shown  to  shed  virus  at 
levels below the detection limits of current tests, such as EM, soon after disease onset 
(Waters et al, 2000; Donelli et al, 1993).  
In terms of a diagnostic test, therefore, the priority is to select one that can 
detect a wide range of norovirus types and that has a low limit of detection. It is 
important, moreover, that the sensitivity remains stable over long periods of use with 
a minimum level of monitoring, which means that tests that target the most conserved 
area  of  the  genome  are  preferred.  Although,  as  shown,  it  is  possible  to  develop   92 
sensitive tests for norovirus that target other areas, the variable nature of these regions 
increases the risk of sensitivity drift over time and/or sudden loss of sensitivity due to 
the emergence of a new virus type or subtype. 
The first norovirus RT-PCR for use in the outbreak service was developed 
during  2000.  At  this  time  the  RdRp  region  was  widely  believed  to  be  most 
functionally conserved area amongst noroviruses. As a result tests that targeted this 
region were considered most appropriate for use in the proposed diagnostic service, 
since assays that targeted the ORF-1 and ORF-2 junction had yet to be published. 
Various single  round, nested and hemi-nested  RT-PCR methods have been 
published that target the RdRp region. Many of these have been shown to be specific 
and more sensitive than EM (Froggatt et al, 2004; Simpson et al, 2003; Ando et al, 
1995; Green et al, 1995 (i); Green et al, 1995 (ii)). However, although nested and 
hemi-nested RT-PCRs have been shown in some cases to offer high sensitivity the 
trade off is that the additional steps involved reduces test rapidity and ease of use 
(Green et al, 1998; Hafliger et al, 1997). The larger number of steps also results in 
more potential for error. Consequently, for the purposes of this work, single round 
RT-PCR assays were preferred as these are made up of fewer steps and as a result are 
likely  to  be  more  rapid  and  easier  to  use.  Numerous  single  round  RT-PCR  were 
published at the time this research began and some had already been shown to offer 
improved  sensitivity  in  comparison  to  EM  (Ando  et  al,  1995;  Green  et  al,  1995; 
Green et al, 1995). Of these, the RT-PCR described by Green et al was chosen to be 
adapted for the detection of norovirus in outbreak samples (Green et al, 1995). This is 
a conventional single round RT-PCR assay that had been shown to be specific and 
able to detect a broad range of norovirus types, and had been compared to EM on 
outbreak samples and found to be sensitive. A major contributing factor that led to the 
selection of this assay over the other candidates outlined above was that a gel-based 
version of the assay was used as the frontline test by the HPA in England (Vinje et al, 
2003). During its use there it had been shown to be able to detect the predominant 
strains  circulating  in  England  and  it  was  hypothesised  that  similar  types  may  be 
encountered in Scotland.  
Once this assay was selected the aim was to adapt this conventional gel-based 
RT-PCR  into  a  real-time  format,  in  order  to  increase  its  potential  for  rapid  turn-
around-times and, by association, high throughput. At the time no real-time RT-PCR 
assays for the detection of norovirus had been published (highlighting the novelty of   93 
this work). Rapidity is particularly important in a norovirus test that is to be used in 
the outbreak setting as rapid results may inform decisions on the infection control 
procedures to be used.  
In  order  to  convert  the  chosen  assay  into  a  real-time  format  SYBR  green 
technology was employed, which was the predominant real-time technology available 
at the time. This is an established means of converting conventional PCR tests into a 
real-time PCR format. SYBR green is a DNA chelating dye that is incorporated into 
DNA, fluoresces under ultra violet excitation and is measured at the end of each PCR 
cycle.  This  negates  the  need  for  post  amplification  analysis  (such  as  gel-based 
analysis) and can therefore reduce turn-around-times, improve ease of use and reduce 
the risk of contamination. However, SYBR green is non-specific and will bind to any 
DNA being produced during the PCR reaction including non-specific products and 
primer-dimers. With careful primer design and reagent optimisation such pitfalls can 
be limited but, to increase specificity, it is good practice to confirm positive results 
using melt curve analysis. The PCR product melting point is directly related to its 
sequence composition, length and concentration (Mackie et al, 2002). A small PCR 
product, for example, tends to result in a melting point that is consistently within a 
narrow temperature range, thus aiding interpretation of the results. As such, the PCR 
product produced by the chosen assay developed by Green et al (which was 113 bp in 
length) was highly suited to this technique. 
The real-time version of the assay was implemented on the Lightcycler™ RT-
PCR platform, which was one of only two PCR platforms available in the laboratory 
at the time of this initial development phase, the other being a conventional PCR 
block (the ABI 9700). The Lightcycler™ platform was a leading edge commercial 
platform at the time, as evidenced by its widespread use in the published real-time 
PCR assays (Schalasta et al, 2000; Ohyashiki et al, 2000; Kamihari et al, 2000; Espy 
et  al,  2000;  Kessler  et  al,  2000),  although  the  number  and  choice  of  real-time 
platforms available has since increased. 
The  Lightcycler™  platform  allows  the  testing  of  32  reactions  per  run, 
compared to a typical 48-96 in conventional PCR platforms. It is designed for small 
PCR  reaction  volumes  (<10ul),  which  are  placed  in  glass  capillaries  that  can  be 
rapidly heated and cooled. As a result, the PCR parameters are much shorter than in 
conventional PCR methods. Using this system, 40 cycles of PCR can be carried out in 
less than 40 minutes (whereas conventional PCR parameters take between 3-5 hours).   94 
It therefore has the potential for both high throughput and rapid testing, making it 
highly suitable for the proposed norovirus outbreak service. 
Other  adaptations  of  the  assay  described  by  Green  et  al  included  the 
replacement of the stated RT step with a previously published in-house method (Ellis 
et al, 1997). This method utilises random hexamers and is therefore a universal RT-
step, converting all RNA in the extracted sample to cDNA. This means that the cDNA 
produced is not specific to a particular test and may be used for all PCR assays. This 
has significant value in a routine diagnostic setting since, for example, samples of 
different types can be processed together and samples that are to be tested for multiple 
pathogens do not have to be repeatedly processed for each individual test (increasing 
the efficiency and reducing costs in both cases). Another advantage of this approach is 
that it reduces the potential for error since the RT step is standardised in the laboratory 
for all RT-PCR assays, which in turn aids quality control.  
For the PCR step itself, the primers (Ni and E3) were used as described in 
Green et al. Reagents that were optimised for use on the Lightcycler™ platform were 
employed in the form of a commercial mastermix. The SYBR green was added to this 
mastermix before use, as was Taq start antibody, which helps prevent non-specific 
Taq polymerase activity. Details of the exact protocol used in implementing the assay 
are provided in section 3.4.  
From  2003,  several  other  real-time  PCR  platforms  were  obtained  by  the 
laboratory, including the Rotorgene (Corbitt research™), Icycler (Biorad™) and ABI 
7500 (Applied Biosystems™). Each of these systems supports a number of different 
real-time  PCR  chemistries  including  SYBR  green,  dual-labelled  probes,  MGB, 
molecular  beacons  and  labelled  primers.  Compared  to  the  Lightcycler™  platform 
these offer improved throughput as they can process 72-96 samples in approximately 
1-2 hours.  
At the same time, it had recently been shown that the most conserved region of 
norovirus  was  in  fact  the  ORF1-ORF2  junction,  rather  than  the  RdRp  region 
(Katayama et al, 2002) and assays that target this region had begun to appear (Kojima 
et al, 2002; Kageyama et al, 2003). One was a real-time RT-PCR method (Kageyama 
et  al,  2003)  and  had  been  shown  to  detect  both  G1  and  G2  noroviruses,  which 
together are responsible for the majority of human cases of norovirus IID. The real-
time RT-PCR assay used dual-labelled probe-based technology and was shown to be 
more  sensitive  than  two  conventional  RT-PCR  assays.  Dual-labelled  probes  (also   95 
known as Taqman™ probes) are oligonucleotides that contain a fluorescent dye on the 
5' base, and a quenching dye located on the 3' base. They are designed to hybridise to 
an internal region of a PCR product. During PCR, when the polymerase replicates a 
template on which the probe is bound, the 5' exonuclease activity of the polymerase 
cleaves  the  probe.  This  separates  the  fluorescent  and  quenching  dyes,  allowing 
detection of the signal from the reporter dye. Fluorescence increases in each cycle, 
proportional to the rate of probe cleavage. Compared to SYBR green based assays, the 
advantage of this technique is that the incorporation of a probe means it can be more 
specific, and therefore a melt curve step is not required. From a diagnostic standpoint, 
the removal of the need for a melt curve step reduces the duration of the test and 
further reduces the potential for human error.  
The assay described by Kageyama et al was therefore chosen for investigation 
as a further possible development of the routine norovirus outbreak service in 2003. 
The  primers,  probes  and  PCR  parameters  (i.e.  the  concentration  and  annealing 
temperatures)  were  used  as  described.  However,  the  published  method  used  two 
separate dual-labelled probe-based real-time assays to detect G1 and G2 noroviruses, 
whereas here the two assays were multiplexed with the aim of reducing turn-around-
times and test costs. The multiplexed test was implemented on the ABI 7500 platform 
as this offered the maximum capacity of 96 sample reactions. Reagents that were 
optimised  for  use  on  the  platform  were  employed  in  the  form  of  a  commercial 
mastermix. With this kit the RT step, PCR and detection all take place in a single 
tube. This was a further improvement on the previous test, reducing the number of 
steps  involved.  Details  of  the  exact  protocol  used  in  implementing  the  assay  are 
provided in section 3.4. 
3.3.2.3. PCR Methods Considered For The Sporadic Service 
PCR Assays For The Detection Of Adenovirus 
Numerous  adenovirus  PCR  tests  are  available  in  the  literature.  The  vast 
majority target the hexon region of the adenovirus genome. The hexon is a product of 
L3 and is the major component of the adenovirus capsid. Although there are also 7 
hyper variable regions that determine the subgenera and serotypes, it also contains 
regions that are conserved throughout most adenovius serotypes (Crawford-Miksza 
and Schnurr, 1996). The combination of conserved and variable regions means that, 
with careful PCR design, the hexon region can be used both for diagnosis and can be   96 
used for epidemiological purposes. Conventional single round and nested PCR assays 
have been described that target this region (Allard et al, 1990; Morris et al, 1996; 
Echavarria et al, 1999; Na et al, 2002; Lee et al, 2005; Formiga-Cruz et al, 2005). 
Furthermore, the conserved regions have also proven to be useful targets for dual-
labelled probe-based real-time PCR methods (Heim et al, 2003; Claas et al, 2005).  
Allard et al provided an example of a single round PCR method that, using a 
low annealing temperature, could detect all known adenovirus serotypes (Allard et al, 
1990). This assay was shown to be more sensitive than a latex agglutination method 
and a group F specific PCR. However, later studies found this assay to be insensitive 
for the detection of group B adenoviruses and serotype 11 (Morris et al, 1996). 
A  number  of  other  single  round  PCR  methods  exist  that  target  the  hexon 
region and detect all adenovirus serotypes (Echavarria et al, 1999; Na et al, 2002; Lee 
et al, 2005). For example, Hierholzer et al developed a single round PCR that detected 
all adenovirus serotypes by targeting a 162bp region of the P2 domain within the 3’ 
region of the hexon (Hierholzer et al, 1993). Freymuth et al compared this assay to 
immunoflourescence on 277 nasopharyngeal aspirates (NPA) samples and showed a 
significant increase in detection of adenovirus (in 30 samples vs 4) (Freymuth et al, 
1997). Cooper et al described a single round PCR method that targeted a 140bp region 
of the hexon region using primers ADJC1 and ADJC2 (Cooper et al, 1999). This PCR 
was compared to tissue culture on 59 eye swabs. The PCR detected adenovirus in 51 
eye swabs whereas using culture it was detected in 40. A later study multiplexed this 
assay with in-house PCR methods for HSV and Chlamydia trachomatis (Elnifro et al, 
2000 (i)). Compared to tissue culture the PCR detected adenovirus in 48 of 49 eye 
swabs whereas tissue culture detected 26 samples as positive. In a subsequent study 
this  assay  was  also  shown  to  provide  typing  information  after  restriction  enzyme 
digestion (Elnifro et al, 2000 (ii)).  
Single  round  multiplex  PCR  assays  have  also  been  described  that  allow 
detection of all adenovirus serotypes. Pring-Akerblom et al provided an example of 
such  an  assay  where  each  adenovirus  subgroup  could  be  determined  by  its  PCR 
product size (Pring-Akerblom et al, 1999). A number of PCR methods have also been 
published  that  are  in  a  nested  format  (Takeuchi et  al,  1999;  Avellon  et  al,  2001; 
Inagara et al, 1996) or detect a particular serotype, serotypes or subgroup (Cooper et 
al, 1996; Houng et al, 2002; Fujimoto et al, 2000; Echavarria et al, 1999). The nested   97 
assays were found to offer high sensitivity and have been used to detect adenovirus in 
water sources (Lee et al, 2005; Formiga-Cruz et al, 2005). 
In recent years a number of dual-labelled probe-based real-time PCR methods 
have also been described that target the hexon region. A number of these have been 
designed  to  target  only  a  particular  sub-genera  or  serotype  of  adenovirus.  For 
example, Logan et al described a dual-labelled probe-based assay that detected group 
F adenoviruses (Logan et al, 2006; Jiang et al, 2005). Other such assays include one 
for  the  detection  of  group  C  adenoviruses  (Garnell  et  al,  2002),  one  for  type  4 
adenovirus (Houng et al, 2002) and one for all non group F adenoviruses (Faux et al, 
2004). Others have been described that detect all adenovirus serotypes via the hexon 
region. Ebner et al decribed a 2 reaction adenovirus real-time PCR that utilised 5 
probes and 8 primers and was designed to detect and differentiate between adenovirus 
subgenera A, C, F and B, D, E (Ebner et al, 2005). However, it should be noted that 
the group F adenoviruses were detected by both assays. Heim et al also developed a 
real-time dual-labelled probe-based PCR assay that targeted the hexon region and was 
able  to  detect  all  adenovirus  serotypes  (Heim et  al,  2003).  This,  unlike  the  assay 
published by Ebner, utilised a single set of primers and one probe. The new assay was 
compared to the nested PCR described by Allard et al (Allard et al, 1992) and was 
shown to be more sensitive. Claas et al, meanwhile, described a MGB assay that 
targeted  the  hexon  region  and  could  detect  all  adenovirus  serotypes  (Claas  et  al, 
2005). 
Although  the  hexon  region  is  targeted  in  most  of  the  PCR  assays  for  the 
detection of adenovirus, alternative targets have also been used. The E1 region is one 
example.  As  described  in  Chapter  2,  the  E1a/b  region  of  adenoviruses  is  a 
transcription unit that encodes two proteins which play a major role in the adenovirus 
infection cycle (Shenk and Flint, 1991; Shenk, 2001). However, although moderately 
high levels of E1 sequence identity have been observed between members of the same 
subgroup, with similarity scores of approximately 50-60%, significant variation has 
been found between adenoviruses from different subgroups with similarity scores of 
less than 30% (Avvakumov et al, 2002). As a result it can be difficult to design assays 
that  detect  all  adenovirus  subgroups  and  serotypes  based  on  targeting  this  region. 
Allard et al described a group F specific PCR that targeted this region (Allard et al, 
1990).  The  PCR  products  for  the  group  F  PCR  were  2187  bp  and  838  bp  for 
adenovirus 40 and 41 respectively. This assay was compared to a universal PCR that   98 
targeted  the  hexon  region  of  the  adenovirus  genome  (308  bp)  and  to  a  latex 
agglutination  assay  on  60  stool  samples  taken  from  children  with  gastroenteritis. 
Although  both  PCR  assays  were  found  to  be  more  sensitive  than  the  latex 
agglutination assay, the group F specific assay also detected a number of non group F 
adenovirus types indicating low specificity. This assay was also found to be 10 times 
less sensitive than the PCR assay that targeted the hexon region. In 1992, the group F 
PCR assay was adapted to a two-step nested assay, which resulted in an improvement 
in sensitivity that made it comparable to the PCR assay which targeted the hexon 
region (Allard et al, 1992). Roussell et al also developed a group F specific PCR that 
targeted  the  E1b  region.  This  assay  successfully  detected  adenovirus  type  41  in 
samples that had previously tested positive using EM. However, it was not compared 
in detail to any other diagnostic method (Rousell et al, 1993). 
A few published assays have targeted the adenovirus pIX gene. The pIX gene 
is  encoded  by  the  adenovirus  intermediate  region.  The  pIX  gene  is  the  minor 
structural component of the capsid and serves to cement the hexon in place (Akalu et 
al,  1998).  Members  of  different  adenovirus  genera  show  wide  variation  in  the 
sequence of the pIX region,  especially in the  C terminal part.  As a result careful 
design of the PCR parameters (e.g. primers, annealing temperatures etc) is warranted 
if all adenovirus serotypes are to be detected. Akalu et al developed a PCR test that 
targeted  this  region.  However,  assessment  showed  that  the  PCR  failed  to  detect 
adenoviruses from groups A, D and E. 
Finally, there are some examples of PCR assays that target the fiber gene. The 
adenovirus fiber is coded for by the late protein L5. The fiber is present on the capsid 
surface and determines tissue tropism (Stone et al, 2003). The fiber has a role in 
haemagluttination  and  the  formation  of  neutralisation  antibody.  As  a  result 
considerable fiber sequence variation can be found between serotypes. Consequently, 
it has proven difficult to design primers that detect all adenovirus serotypes, with the 
published assays described using separate PCR tests to detect each adenovirus type 
(Xu et al, 2000) or detecting groups B and C only (Adhikary et al, 2001; Bruzzone et 
al, 2000). 
RT-PCR Assays For The Detection Of Astrovirus 
There  are  numerous  astrovirus  RT-PCR  assays  published  in  the  literature. 
Single round and nested conventional RT-PCR assays and real-time RT-PCR assays   99 
exist for the detection of astrovirus (Cubitt et al, 1999, Akhter et al, 1995; Major et al, 
1992; Jonassen et al, 1993; Jonassen et al, 1995; Noel et al, 1995; Zhang et al, 2006; 
Le Cann et al, 2004; Royeula et al, 2006). In general, these assays target either the 3’ 
terminus NCR region or the capsid region.  
Sequence alignments of all known astrovirus serotypes (1-8) have shown the 
88 bp 3’ end of the astrovirus genome to be highly conserved (Monceyron et al, 1997; 
Belliot et al, 1997; Wang et al, 2002). This makes it a highly effective target for 
diagnostic PCR assays but less useful for epidemiological study. Numerous diagnostic 
RT-PCR methods have been developed that target this small but conserved region 
(Cubitt et al, 1999, Akhter et al, 1995; Major et al, 1992). Jonassen et al, for example, 
developed an RT-PCR assay targeting this region, which produced a PCR product of 
77 bp (Jonassen et al, 1993; Jonassen et al, 1995). This assay was assessed on 38 
samples that tested positive for astrovirus using EM and was shown to detect all but 2 
of the panel. However, it was also shown to be non specific. Cubitt et al used a similar 
RT-PCR method to investigate an outbreak of astrovirus in a BMT ward. Compared 
to EM and EIA, the RT-PCR was shown to be more sensitive, detecting positive cases 
earlier than the other methods and showing that those infected were shedding virus for 
longer periods.  
In recent years, the 3’NCR region has also proved to be a good target for real-
time PCR (Zhang et al, 2006; Le Cann et al, 2004; Royeula et al, 2006). Le Cann et al 
described  a  dual-labelled  probe-based  assay  that  was  used  to  detect  astrovirus  in 
sewage. Although not assessed on clinical samples or samples of known subtypes it 
was shown theoretically to detect all 8 serotypes. Zhang et al, meanwhile, used a 
SYBR green based assay to quantify the level of astrovirus in several patient groups 
in order to examine whether there was a correlation between viral load and disease 
severity (no relationship could be found). Royeula et al also developed a real-time 
PCR based on using SYBR green that was shown to be more sensitive than both an 
EIA and a conventional PCR. 
An alternative PCR target for the detection of astrovirus is the capsid region of 
the genome. However, as with other RNA viruses the capsid region contains areas of 
high variability (Belliot et al, 1997; Wang et al, 2001). Wang et al described 4 sub-
regions in the capsid, each with differing levels of variability. The terminal N and the 
C regions were relatively conserved (56-86%) between astrovirus serotypes making 
them suitable targets for diagnostic purposes,  whereas the two regions in-between   100 
contained  significant  levels  of  variation.  These  in-between  areas  are  thought  to 
contain the regions that determine antigenicity and cell attachment and entry and are 
therefore useful for epidemiological study. Researchers have taken advantage of these 
characteristics to design RT-PCR assays that can detect all astrovirus serotypes, and 
can also provide a PCR product that can be sequenced for epidemiological study (Yan 
et al, 2003; Royahem et al, 2004). Noel et al described two RT-PCR methods that 
targeted the capsid region, one using primers mon 244-245 and one using mon 269-
270 (Noel et al, 1995). Both offered universal detection, and typing of the product by 
sequence analysis. Of the two sets of primers, mon 269-270 was found to result in the 
most sensitive test. These primers have been used in numerous other studies since 
(Mustafa et al, 1998; McIver et al, 2000; Simpson et al, 2004; Medina et al, 2000). 
McIver et al compared this RT-PCR to EM on clinical samples and found it to detect 
astrovirus in the same number of cases as EM. Medina et al showed that it was more 
sensitive then EIA on 251 samples from children with acute gastroenteritis, detecting 
an extra 12 positive samples. These primers have also been used to target the capsid 
region  in  a  SYBR  green  format  and  the  resulting  assay  was  shown  to  be  more 
sensitive than EM (Simpson et al, 2004). As of yet, however, no probe-based real-
time PCR assay has been published that targets this region. This is likely to be due to 
the variable nature of the region. 
RT-PCR Assays For The Detection Of Rotavirus 
Most of the published RT-PCR assays for the detection of rotavirus target the 
following parts of the genome: the VP7, VP4, NSP3, VP6 and NSP2 regions. 
One  of  the  first  RT-PCR  assays  described  for  the  detection  of  rotavirus 
targeted the VP7 gene (Gouvea et al, 1990). The product VP7 is the major constituent 
of the rotavirus outer capsid and is the target of type-specific antibodies (Jayaram et 
al, 2004). The advantage of targeting this region with PCR is that it contains at least 6 
discrete regions that determine the rotavirus subgenera. Therefore, with careful primer 
design, it can be used for the simultaneous detection and subtyping of rotavirus from 
clinical samples. However, careful monitoring is needed to maintain the sensitivity of 
such  an  assay  to  ensure  that  changes  in  the  primer  binding  sites  which  result  in 
reduced sensitivity do not occur.  
In the assay described by Gouvea et al the primers Beg9 and End9 were used 
as a first round PCR to detect the 5’ and 3’ end of gene segment 9, giving a RT-PCR   101 
product of 1062 bp. Following this, a nested step was used that employed primers 
specific for the main rotavirus G types. 
Several  studies  have  since  utilised  this  nested  method  for  diagnosis  and 
epidemiology (Pang et al, 1999; Ushijima et al, 1994). Pang et al, for example, found 
it to offer increased diagnostic sensitivity when compared to an EIA test on samples 
from children with IID (Pang et al, 1999). Ushijima et al used this method to show the 
presence of rotavirus in various clinical specimens (such as CSF, serum and throat 
swabs) in patients with acute rotavirus infection.  
Other methods that target the VP7 region have also been described. Xu et al 
described a single round RT-PCR that amplified the full length of gene segment 9. 
This assay was found to be significantly more sensitive than a hybridisation assay and 
a  standard  electropherotype  method  when  compared  on  stool  samples  (Xu  et  al, 
1990). 
The rotavirus VP4 protein has also been used as a target for PCR. This is a 
viral haemaglutinin and plays a major role in cell attachment, entry and penetration 
(Estes, 2001; Gorziglia et al, 1990). It is a product of gene segment 4 and contains the 
variable regions that are used to determine the rotavirus P type. Like the VP7 region, 
with  careful  primer  design,  assays  that  target  this  region  can  be  used  for  both 
diagnosis and epidemiological study. Numerous methods have been described that 
target this region for the detection of rotavirus. Gentsch et al described a nested assay 
that could be used to detect and type rotaviruses (Gentsch et al, 1992). Masendycz et 
al  also  described  a  nested  RT-PCR  that  could  be  used  for  the  same  purpose 
(Masendycz  et  al,  1997).  This  was  compared  to  an  EIA  method  and  a  cDNA 
hybridisation probe on 102 clinical samples. Overall, the nested RT-PCR assay was 
found to be the most sensitive, with the hybridisation probe second followed by the 
EIA. Rasool et al adapted the assay described by Gentsch et al to a single round RT-
PCR that was shown to detect all human rotaviruses (Gentsch et al, 1992; Rasool et 
al, 2002). Following this, Min et al described a SYBR green based real-time RT-PCR 
method  that  utilised  the  primers  reported  by  Rasool  et  al  for  the  same  purpose, 
although here again this was not compared to any other method (Min et al, 2006). 
An alternative genome target for the detection of rotavirus is the VP6 region. 
The VP6 is the major constituent of the intermediate layer of the rotavirus. It has an 
important structural and immunological role (Greenberg et al, 1983; Pothier et al, 
1987). Sequence analysis has shown that the VP6 is relatively conserved between   102 
human rotaviruses. As a result it is a potentially good target for the detection of a wide 
range of rotaviruses, although in practice few assays of this type have been developed 
to date. Kang et al described a real-time SYBR green based assay that targeted a 379 
bp region of VP6 (Kang et al, 2004). This quantitative assay was not compared to any 
other diagnostic methods but was used to investigate the relationship between the 
severity of the rotavirus illness and the amount of rotavirus detected in the stool (they 
found  that  low  viral  loads  were  often  found  in  less  severe  and  asymptomatic 
infections). 
Other  areas  of  the  rotavirus  genome  have  also  been  considered  for  PCR 
targeting including the NSP2 and the NSP3 regions. The role of NSP2 is currently 
unclear  although  it  has  been  suggested  to  have  a  role  in  RNA  replication  and 
packaging  (Gombold  et  al,  1985).  Sequence  analysis  has  shown  that  the  first  75 
nucleotides of the 5’ end and the last 28 nucleotides of the 3’ end are conserved in all 
rotaviruses (Patton et al, 1993). Xu et al described a one step RT-PCR that targeted 
the 3’ and 5’ end of the NSP2. The assay detected all group A rotaviruses (Xu et al, 
1990). It was compared to PAGE and a hybridisation assay and was shown to be 
significantly more sensitive than either method (between 5000-100,000 times). The 
large PCR product also contained restriction enzyme sites, which favours cloning and 
sequencing. 
Little is also known about the role of NSP3, although some have suggested a 
role in protein synthesis or viral replication (Poncet et al, 1996). The NSP3 protein is 
coded for by rotavirus gene segment 7. It contains areas of sequence variability that 
can  be  used  to  divide  rotaviruses  into  3  evolutionary  groups  (SaII,  Wa  and  S2). 
However, there is also a region of approximately 80 nucleotides in the 3 UTR that is 
highly conserved in all rotavirus strains (Rao et al, 1995). Pang et al described a 
probe-based real-time RT-PCR assay that targeted this highly conserved area (Pang et 
al, 2004). This assay was compared to both EM and the nested RT-PCR that targets 
the VP7 (Goveau et al, 1990) on 623 samples from children with gastroenteritis. The 
assays were also compared on a dilution series of a sample that tested positive for 
rotavirus using EM. Overall, the real-time RT-PCR detected 123 samples as positive, 
whereas the conventional nested RT-PCR detected 113 and EM detected 79. On the 
dilution series the real-time RT-PCR was shown to have a detection limit that was 2 
logs greater than the nested assay.   103 
RT- PCR Assays For The Detection Of Sapovirus 
In comparison to the number of PCR methods published for the other viral 
causes of IID there are considerably fewer available for the detection of sapovirus. 
Amongst those published, most target the RdRp or capsid regions or the polymerase-
capsid junction. 
Early examples in particular targeted the RdRp region, since early studies had 
shown that this area was more conserved than the capsid region (Berke et al, 1997; 
Liu et al, 1995; Matson et al, 1995). One of the first RT-PCR assays described for the 
detection of sapoviruses was described by Jiang et al (Jiang et al, 1999). This RT-
PCR detected both norovirus and sapovirus using the primers p289-290. Sapovirus 
was distinguished from norovirus based on the PCR product size (the norovirus PCR 
product was 312 bp whereas sapovirus was 331 bp). Later studies highlighted that 
these primers also detected rotavirus via a cross reaction with gene segment 1 (Lindert 
et al, 2004). Robinson et al also published a single round RT-PCR assay that targeted 
this region. It was used to examine the epidemiology of sapoviruses in South West 
England but was not compared to any other method (Robinson et al, 2002). Vinje et al 
compared a single round assay that targeted the RdRp (using primers JV33 and SR80) 
with two other RT-PCR assays that also targeted the RdRp (Ando et al, 1995; Noel et 
al, 1997). The assay was designed using a sequence alignment of the known sapovirus 
sequences, which represented the three recognised genogroups (Vinje et al, 2000). 
The three assays were then compared using 31 stool samples that had tested positive 
for  sapovirus  using  EM.  The  assay  using  the  primers  JV33-SR80  detected 
considerably more samples as positive than the other assays. Since then these primers 
have  also  been  used  in  a  real-time  SYBR  green  based  assay  by  Simpson  et  al 
(Simpson et al, 2004). This method was shown to be more sensitive than EM on 
samples from children with IID, both hospitalised and managed in the community. 
However, it should be noted that significant variation can still be found within the 
RdRp (Oka et al, 2006). As a result designing an assay that can detect all sapovirus 
types and subtypes remains difficult and requires careful primer design. 
The capsid has been targeted by a small number of sapovirus RT-PCR assays 
(Okada et al, 2006; Okada et al, 2002; Vinje et al, 2000). Like noroviruses, the capsid 
region of the sapovirus contains some areas of high genetic variability, which are 
likely to be the determinants of antigenicity, cell attachment and entry. Thus, although   104 
the capsid region can be used for diagnosis, the variable nature of the capsid region 
tends to make it more suitable for epidemiological studies (Gallimore et al, 2006). For 
example, Okada et al described a nested RT-PCR multiplex assay that targeted the 
capsid and gave genotype data without the need for sequencing (Okada et al, 2002). 
In recent  years, RT-PCR assays have been described that target the RdRp-
Capsid  junction.  This  work  is  based  on  growing  awareness  that  this  is  the  most 
conserved region of the sapovirus genome, rather than the RdRp region. This was 
highlighted  by  the  similarity  study  carried  out  by  Oka  et  al  described  earlier  in 
Chapter 2 (Oka et al, 2006). Okada et al developed a nested RT-PCR that could be 
used to detect and type all sapovirus  genogroups (Okada et al, 2006). This assay 
consisted of universal primers and primer sets for each sapovirus genogroup but was 
not compared to any other assay. A small number of dual-labelled probe-based RT-
PCR assays have also been developed which also target this region. Oka et al carried 
out a similarity study of a number of sapovirus types from all genogroups to develop a 
real-time  probe-based  RT-PCR  able  to  detect  all  5  sapovirus  genogroups  using  4 
primers and 2 MGB probes (Oka et al, 2006). This assay was compared to another 
real-time  RT-PCR  assay  developed  by  Chen et  al  (Chen  et  al,  2006), which  also 
targeted  the  RdRp-Capsid  junction.  Both  assays  were  shown  to  offer  similar 
sensitivity (an improvement over conventional RT-PCR), with the exception that the 
assay described by Chen et al was unable to detect the newly discovered genogroup 
G5. 
3.3.2.4. Selection And Adaptation Of The PCR Assays For Use In The 
Proposed Service For Sporadic Cases Of IID 
As with the norovirus outbreak service described above, the research relating 
to the sporadic service took place in two stages. The first development phase took 
place between 2000 and 2002.  
As outlined earlier, at this time there were two PCR platforms available in the 
laboratory;  the  Lightcycler
TM,  which  is  real-time;  and  the  ABI  9700,  which  is  a 
conventional PCR block. However, based on the fact that norovirus had been found to 
be the cause of most outbreaks of  IID, together with the high level of disruption 
caused by outbreaks of gastroenteritis in closed settings such as hospitals, the decision 
was taken to prioritise use of the Lightcycler
TM for the proposed norovirus outbreak 
service.  This  meant  that,  initially,  the  development  of  new  tests  for  the  sporadic   105 
service focused on conventional PCR methods that could be implemented on the ABI 
9700. This platform allows the processing of 96 samples and controls per run. On it, 
the PCR step of an assay takes approximately 3-5hrs to run, depending on the exact 
nature of the reaction. Post amplification analysis is then required to complete the test, 
which is carried out within the laboratory using agarose gel analysis (an established 
means of observing PCR results). 
As with the outbreak service, the selection of sensitive assays able to detect all 
or the majority of the known subtypes of each pathogen was again a priority, as was 
the use of single round assays in order to minimise the number of steps involved. 
Here, moreover, in order to further reduce the number of steps in the overall testing 
process (and thus the associated costs) the ambition was to develop a multiplex assay 
that could test for all four pathogens simultaneously. Since an RT step is, in theory, 
only required to test for three out of the four pathogens (not adenovirus, which is a 
DNA  virus)  this  would  mean  applying  an  unnecessary  RT  step  in  the  case  of 
adenovirus, as it is not possible to add both cDNA and DNA to a multiplex PCR 
simultaneously. However, there are several examples in the literature  of tests that 
employ this approach (Yan et al, 2004; O’Neill et al, 2002), which is possible since 
DNA  may  still  be  present  in  the  reverse  transcribed  template.  Moreover,  in 
comparison  to  four  separate  tests  a  multiplex  assay  was  felt  to  have  significant 
benefits in terms of the lower material and staffing costs, and reduced turn-around-
times (the latter was also important in providing an improvement on the existing EM 
service).  It  did,  however,  mean  that  in  order  to  aid  result  interpretation  it  was 
important to choose assays for each pathogen with different PCR product lengths.  
With these factors in mind the first adenovirus PCR selected for investigation 
was the single round PCR described by Cooper et al (Cooper et al, 1999; Elnifro et al, 
2000; Elnifro et al, 2000 (ii)). This PCR assay targeted the adenovirus hexon region 
and was selected since it was shown in more than one study to be both sensitive and 
able  to  detect  all  adenovirus  serotypes.  Also,  its  PCR  product  was  small  (140bp) 
which favoured multiplexing with one or more of the other non-norovirus assays. 
For astrovirus, the RT-PCR described by Noel et al using primers mon 269-
270  (Noel  et  al,  1995)  was  chosen.  This  assay  targeted  the  capsid  region  of  the 
astrovirus genome, detected all known astrovirus serotypes, and was chosen because it 
had been tested in several research studies and shown to be more sensitive than both 
EM and EIA without the need for a nested step (Mustafa et al, 1998; McIver et al,   106 
2000; Simpson et al, 2004; Medina et al, 2000). In addition, the size of the PCR 
product was favourable to multiplexing as it was different to that of the assay chosen 
for adenovirus (449bp vs 140bp). This was crucial since although the 3’NCR region 
of astrovirus is generally held to be less variable than the capsid region the RT-PCR 
product of assays that target the 3’NCR are similar in length to that of the adenovirus 
PCR (<100bp). 
The RT-PCR assessed for rotavirus was a single round version of the assay 
that used the primers con2 and con3 to target the VP4 region of the rotavirus genome 
(Gentsch et al, 1992; Rasool et al, 2002). This was chosen because it was a single 
round assay and was shown to detect all rotavirus types. Many of the other assays 
available were nested RT-PCR assays that may have offered increased sensitivity but 
involved a greater number of steps. Of the assays that were single round RT-PCR 
assays, moreover, a further benefit of this one was that the PCR product was smaller 
than many of the other published assays (220 bp), which makes the PCR reaction 
more efficient. The PCR product length was also different to that of the tests chosen 
for the other pathogens.  
The initial test selected for sapovirus was the assay described by Vinje et al 
(Vinje et al, 2000). This assay targeted the RdRp region of the sapovirus genome, 
which  was  thought  to  be  the  most  conserved  region  at  the  time  of  the  initial 
developments. The assay was chosen since it was a single round RT-PCR and had 
been shown to be sensitive and capable of detecting all of the recognised genogroups 
of sapovirus at the time. The size of the predicted RT-PCR product was 349 bp, which 
was different to that of the other PCR assays. 
For  each  of  the  selected  assays  the  primers  were  used  as  described  in  the 
original  paper,  which  also  specified  the  annealing  temperature  used.  This  was 
different  in  each  case.  However,  for  a  multiplex  assay  a  single  temperature  is 
required. It was therefore decided to employ the median temperature of all four tests 
in the first iteration of the new multiplex assay. A reverse transcriptase step was also 
applied as part of the sample preparation in all cases to samples for all four pathogens, 
despite the fact that adenovirus is a DNA virus. In theory a reverse transcriptase step 
was required in tests for only three of the four pathogens (i.e. all except adenovirus). 
The step was carried out using the laboratory-standard method described earlier for 
norovirus detection. Details of the exact protocols used in implementing the assay are 
provided in section 3.4.    107 
In 2003, when the other real-time platforms became available in the laboratory 
the possibility of implementing real-time PCR for all tests in the sporadic service was 
introduced,  although  in  fact  the  developments  did  not  take  place  until  2004  (for 
reasons described in Chapter 4). Here the decision was taken to move straight to dual-
labelled probed-based technology, rather than SYBR green based assays, in line with 
the  ongoing  developments  in  tests  for  the  outbreak  service  and  for  the  reasons 
described earlier. Due to the relatively recent nature of this technology, however, the 
choice of available assays was limited. 
For  adenovirus,  the  real-time  dual-labelled  probe-based  assay  described  by 
Heim et al was examined (Heim et al, 2003). This targeted the hexon region of the 
virus and was chosen since it could detect all adenovirus serotypes and used just one 
set of primers and probes. Other published assays used multiple primers and probes, 
which would increase test costs and complexity with little potential gain in sensitivity. 
For astrovirus the real-time RT-PCR chosen was that published by Le Cann et al (Le 
Cann et al, 2004). This assay targeted the 3’NCR region of the genome and had been 
shown  theoretically  to  detect  all  astrovirus  serotypes.  It  was  also  the  only  dual-
labelled  probe-based  assay  published  for  astrovirus  at  this  point.  For  rotavirus 
detection the dual-labelled probe-based assay published by Pang et al was examined 
(Pang et al, 2004). This targeted the NSP3 region and was again the only assay of this 
type published at the time. It had been shown to detect all rotavirus types and in tests 
was more sensitive than a nested RT-PCR (Gouvea et al, 1990) and EM.  
At the time of development, no dual-labelled probe-based real-time PCR assay 
was  available  for  the  detection  of  sapovirus  in  the  literature  (the  first  assay  was 
published  in  2006).  As  a  result  an  in-house  assay  was  developed.  Analysis  of 
available sapovirus sequences detailed in the BLAST (Basic Local Alignment Search 
Tool) database identified small conserved regions of the capsid and RdRp areas (300-
500 bp). Attempts using the software package Beacon Designer (Premier Biosoft) to 
design a dual-labelled probe-based assay that targeted the submitted sequence from 
the RdRp were unsuccessful, as no test could be designed to meet the recommended 
guidelines (Qiagen, 2004). However, a suitable test that targeted the capsid region was 
created.   108 
The real-time PCR amplicon was then tested for secondary structure, and for 
specificity. Secondary structure prediction was carried out using Michael Zukers’ m-
fold server
2. The predicted secondary structure for the sapovirus amplicon is shown in 
Figure 11. The software predicted that there was little secondary structure of note (as 
measured by the low dG), which suggests it would have little effect on test sensitivity. 
The  amplicon  was  then  resubmitted  to  BLAST  to  determine  which  sapovirus 
genotypes and types it would theoretically be able to detect. This process showed that 
the assay  was only  complimentary to sapovirus G1 types (Table 7). However, no 
cross-reactions to other viruses or organisms were predicted suggesting the test would 
be specific. Data from the HPA and other studies suggested that sapovirus G1 types 
were  the  most  predominant  strains  pre-2004  (Okada  et  al,  2002;  Gallimore  et  al, 
2006).  Thus,  although  this  test  would  be  unlikely  to  detect  non  G1  types,  it  was 
decided to assess it in comparison to the gel-based RT-PCR described above with the 
intention of replacing it either when a new assay was published or improved software 
design programs were available in the laboratory to allow the development of a more 
sensitive assay capable of detecting more types.  
Where  assays  were  selected  from  the  literature  the  primers,  probes  and 
annealing temperatures were used exactly as described. The in-house sapovirus real-
time  PCR  test  used  standard  dual-labelled  probe-based  PCR  conditions.  All  RNA 
real-time  PCR  assays  utilised  a  commercial  one  step  real-time  RT-PCR  kit  from 
Invitrogen. This kit, also used in the norovirus dual-labelled probe-based RT-PCR 
allows the RT step, PCR and detection all to take place in a single tube, removing the 
need for a separate RT step. This again increases the efficiency of the process and 
reduces the potential for error. Such kits, however, only became economically viable 
around  this  time.  The  adenovirus  assay  utilises  a  commercial  DNA  mastermix 
(Invitrogen). Details of the exact protocol are described in section 3.4.  
                                                 
2 (http://www.bioinfo.rpi.edu/~zukerm/rna/)   109 
Figure 11: Predicted structure of the sapovirus real-time PCR amplicon. 
 
 
   110 
Table 7: Alignment of primers and probe in real-time PCR developed for sapovirus. 
Prototype Strain  Genogroup  Forward Primer  Probe  Reverse Primer 
Real-time assay    GCTGTTSCYACTGGTGCA  CCAATCSAATGTCCCTGAGGCAATACGSAA  TGCTTGGAARGACAGGATGCC 
Leeds/00/UK 
(DQ158098) 
1.4  GCTGTTGCCACTGGTGCA  CCAATCCAATGTCCCTGAGGCAATACGCAA  TGCTTGGAACGACAGGATGCC 
Sapporo/82/JP 
(U65427) 
1.1  GCTGTTGCCACTGGTGCA  CCAATCCAATGTCCCTGAGGCAATACGCAA  TGCTTGGAATGACAGGATGCC 
Stockholm/97/SE 
(AF104182) 
1.3  GCTGTCGCTACTGGGTCA  CCAATCAAATGTCCCTGATGCAATACGCAA  TGCTTGGAACGATAGAATGCC 
Houston/90/US 
(U95644) 
1.2  GCTGTTGCTACTGGTTCC  CCAATCAAATGTCCCTGAAGCGGTACCAGA  TGCTTGGAATGACAGAATGCC 
Mex340/90 
(AF435812) 
2.2  GCTATGGCGACAGGAGCA  CACGAGCAACGTACCAAATTGCATCCGGGA  ACCCTGGACTACACGGCAAGC 
Lyon598/97/FR 
(AJ271056) 
2.1  GCAATGGCCACAGGGGCA  AACCAGCAATGTGCCCAACTGCATCCGGGA  ACCATGGACCACCCGGCAAGC 
Bristol/98/UK 
(AJ249939) 
2.1  GCAATGGCCACAGGGGCA  GACCAGCAATGTGCCCAACTGCATCCGGGA  ACCATGGACCACCCGGCAAGC 
*Primers could not find a match for representatives of sapovirus genogroups G3 (AF182760), G4 (AF435814) and G5 (AY289803).   111 
3.4. Technical Description Of Laboratory Methods 
3.4.1. Sample Preparation Methods 
3.4.1.1. Faecal Extraction 
Faecal  samples  were  processed  by  making  a  10%  solution  in  Phosphate 
Buffered Saline (PBS). Samples were then centrifuged at 3,000 rpm for 30 minutes. 
Sample supernatants were then transferred to labelled specimen tubes before nucleic 
acid extraction.  
3.4.1.2. Nucleic Acid Extraction  
The nucleic acid extraction procedure was carried out on the Qiagen 96 DNA 
blood biorobot 9604 (Qiagen, Crawley, West Sussex, UK). Briefly, 40ul of protease 
(140mg/ml), 220ul of specimen and 240ul of buffer AL (Guanidium chloride) was 
added to each well and incubated at 56°C for 10 minutes. 250 µl of ethanol (96-100%) 
was then added to each well. 670ul of the sample lysate was then added to the vacuum 
manifold and 310ul of buffer AW1 (Wash Buffer) was added. AW1 was removed by 
vacuuming for 7 minutes. 1100ul of AW2 (Wash Buffer) were then added to each 
specimen and removed by vacuuming for 2 minutes. This step was then repeated. The 
extraction plate was then placed on the S block and centrifuged for 10 min at 6,000 
rpm to dry the membrane. 200ul Buffer AE (10mM Tris-Cl; 0.5mM EDTA; ph9) was 
then added to each well incubation at room temperature for 1 minute. The extraction 
plate was then placed upon a collection tube plate and centrifuged at 6,000 rpm for 3 
min to elute the nucleic acid.  
3.4.2. PCR Methods 
3.4.2.1. Reverse Transcriptase Step (Gel-Based RT-PCR) 
Where the PCR assay involved an RNA target, after nucleic acid extraction the 
following reverse transcription step was employed for all conventional and SYBR 
green based real-time PCR (Ellis et al, 1997). Briefly, 22.2ul of RNA was added to a 
reaction mixture (17.8ul) containing 20mM Tris (pH 8.4), 50mM KCI (Invitrogen, 
Paisley,  UK),  7.5mM  MgCL2  (Invitrogen,  Paisley,  UK),  1.5mM  dNTPs  (Roche, 
Lewes, UK), 20ng of pd(N)6, 1.6U RNA guard (Amersham Pharmacia Biotech, US) 
and  200U  of  Malony  murine  leukaemia  virus  reverse  transcriptase  (Invitrogen,   112 
Paisley, UK). The RT step was carried out under the following cycling conditions: 10 
minutes at 25
oC, 45 minutes at 37
oC, 5 mins at 99
oC. Samples were then centrifuged 
to ensure that the sample was thoroughly mixed. 
3.4.2.2. PCR Methods For The Outbreak Service  
Real-Time SYBR Green Based Assay  
In the first PCR method investigated in 2000 amplification was performed in a 
10ul  mixture,  containing  5ul  of  5mM  Mg
2+  universal  LightCycler™  mastermix 
(BioGene,  Cambs,  United  Kingdom),  5pM  of  each  primer  Ni  and  E3  (Table  8), 
Sybergreen and 2.5ul of cDNA template. The PCR parameters were used as in the 
original publication (Green et al, 1995). First a pre-amplification step of 94
oC for 45 
seconds was carried out. This was followed by 40 cycles of: 94
oC for 1 sec, 43
oC for 5 
seconds and 74
oC for 1 sec. The amplification product was then melted by raising the 
temperature from 70 to 94
oC.  
Dual-Labelled Probe-Based Real-Time PCR For Norovirus 
In the new assay developed for norovirus in 2003, amplification of norovirus 
was carried out in a 50ul reaction volume using the Invitrogen superscript III one step 
q-RT-PCR system (Invitrogen, Paisley, UK) containing 10ul of extracted nucleic acid, 
0.05uM of each probe PROBE RING 1a, PROBE RING 1b and PROBE RING 2, and 
0.5uM  of  each  primer  COG1F,  COG  1R,  COG  2F,  COG  2R  (Table  9).  Reverse 
transcription was performed for 30 min at 50
oC. Using an ABI 7500 SDS platform, 
platinum taq polymerase was activated at 95
oC for 2 min followed by 40 cycles of: 
95
oC for 30 seconds and 56
oC for 60 seconds.  
3.4.2.3. PCR Methods For The Sporadic Service (Adenovirus, Astrovirus, 
Rotavirus And Sapovirus) 
The following section details the implementation of the gel-based multiplex 
assay  developed  and  assessed  in  2000,  and  the  real-time  assays  subsequently 
investigated  in  2004.  Note  that  in  the  case  of  the  real-time  assays  for  astrovirus, 
rotavirus and sapovirus the PCR conditions (i.e. cycling times etc.) were the same in 
each case, with the result that these tests could all be run on the same plate.  
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Gel-Based  Multiplex  Assay  For  Adenovirus,  Astrovirus,  Rotavirus  And 
Sapovirus 
In  the  test  assessed  in  2000  10ul  of  cDNA  was  added  to  a  50ul  reaction 
containing 10xPCR buffer (100mM tris-HCI, 15mM MgCl2, 500mM KCL), 0.2mM 
of each dNTP, and 0.2mM of each primer (Table 8). A mixture of 2U of Taq DNA 
polymerase, 0.028uM TaqStart antibody (Clontech Laboratories, Paolo Alto, USA), 
and 4xTaqStart antibody dilution buffer (Clontech Laboratories, Paolo Alto, USA) 
was incubated at room temperature for 10 minutes before being added to the final 
reaction mixture. PCR conditions were as follows: 94
oC for 3 mins; 40 cycles of 94
oC 
for 30 seconds, 47
oC for 40 seconds, 72
oC for 30 seconds; with a final extension step 
of  72
oC  for  7  min.  Products  were  then  subjected  to  agarose  gel  electrophoresis. 
Positive bands were expected at 140bp for adenovirus, 220bp for rotavirus, 449bp for 
astrovirus and 320bp for sapovirus. 
Dual-Labelled Probe-Based Real-Time PCR For Adenovirus 
Amplification of adenovirus was carried out in a 50ul reaction volume using 
Invitrogen platinum Taq DNA (Invitrogen, Paisley, UK) containing 10ul of extracted 
sample, 0.05uM of ADENO probe and 0.5uM of each primer ADENO 1 and ADENO 
2 (Table 9). Using an ABI 7500 SDS platform, platinum taq polymerase was activated 
at 95
oC for 2 min, followed by 40 cycles of: 95
oC for 30 seconds and 60
oC for 60 
seconds. 
Dual-Labelled Probe-Based Real-Time PCR For Astrovirus 
Amplification of astrovirus was carried out in a 50ul reaction volume using the 
Invitrogen  superscript  III  one  step  q-RT-PCR  system  (Invitrogen,  Paisley,  UK) 
containing 10ul of extracted nucleic acid, 0.05uM of ASTRO probe, and 0.5uM of 
each primer ASTRO 1 and ASTRO 2 (Table 9). Reverse transcription was performed 
for 30 min at 50
oC. Using an ABI 7500 SDS platform, platinum taq DNA polymerase 
was activated at 95
oC for 2 min, followed by 40 cycles of: 95
oC for 30 seconds and 
60
oC for 60 seconds. 
Dual-Labelled Probe-Based Real-Time PCR For Rotavirus 
Amplification of rotavirus was carried out in a 50ul reaction volume using the 
Invitrogen  superscript  III  one  step  q-RT-PCR  system  (Invitrogen,  Paisley,  UK) 
containing 10ul of extracted nucleic acid, 0.05uM of ROTA probe, and 0.5uM of each 
primer ROTA 1 and ROTA 2 (   114 
Table 4). Reverse transcription was performed for 30 min at 50
oC. Using an 
ABI 7500 SDS platform, platinum taq polymerase was activated at 95
oC for 2 min, 
followed by 40 cycles of: 95
oC for 30 seconds and 60
oC for 60 seconds. 
Dual-Labelled Probe-Based Real-Time PCR For Sapovirus 
Amplification of sapovirus was carried out in a 50ul reaction volume using the 
Invitrogen  superscript  III  one  step  q-RT-PCR  system  (Invitrogen,  Paisley,  UK) 
containing 10ul of extracted nucleic acid, 0.05uM of probe SAPO probe, and 0.5uM 
of each primer SAPO 1 and SAPO 2 (Table 9). Reverse transcription was performed 
for 30 min at 50
oC. Using an ABI 7500 SDS platform, platinum taq polymerase was 
activated at 95
oC for 2 min, followed by 40 cycles of: 95
oC for 30 seconds and 60
oC 
for 60 seconds.   115 
Table 8: Oligonucleotide primers for PCR tests in the outbreak and sporadic service (2000-2003). 
Virus  Service  Primers  Sequence  Amplicon 
size 
Nucleotide 
position 
Norovirus (SYBR 
green assay) 
Outbreak and sporadic service  Ni 
 
E3 
GAA TTC CAT CGC CCA CTG GCT 
 
ATC TCA TCA TCA CCA TA 
 
113bp  4495-4608 
bp
a 
Rotavirus  Con1 
Con2 
TTGCCACCAATTCAAAATAC 
ATTTCGGACCATTTATAACC 
220bp  676-896 
bp
b 
Astrovirus  Mon269 
Mon270 
TCAGATGCATTGTCATTGGT 
CAACTCAGGAAACAGGGTGT 
449bp  212-676 
bp
c 
Adenovirus  ADRJC1 
ADRJC2 
GACATGACTTTCGAGGTCGATCCCATGGA 
CCGGCTGAGAAGGGTGTGCGCAGGTA 
140bp  2840-2980 
bp
d 
Sapovirus 
Sporadic service and outbreak samples that test negative 
for norovirus 
Jv66 
Sr80 
GTGTANATCCARTCATCACC 
TGGGCATTCTACACAAAACCC 
320bp  XX 
 a Based on alignment with AB220921 (Norovirus Hu/ Chiba/complete genome) 
 b Based on alignement with AB222786 (Human rotavirus VP4 complete sequence)
 
 c Based on alignement with AB000288 (Human astrovirus serotype 1 capsid gene) 
 d Based on alignment with X51783 (adenovirus type 41 hexon region) 
   116 
Table 9: Oligonucleotide primers and probes for real-time PCR tests in the outbreak and sporadic service (2004-2006). 
Virus  Service  Primers  Probe  Nucleotide 
position 
Norovirus  Outbreak 
and 
sporadic 
service 
COG1F- CGYTGGATGCGNTTYCATGA 
COG1R- CTTAGACGCCATCATCATTYAC 
COG2F- 
CARGARBCNATGTTYAGRTGGATGAG 
COG2R- TCGACGCCATCTTCATTCACA 
PROBE RING 1A- VIC-AGATYGCGATCYCCTGTCCA-
BHQ-1 
PROBE RING 1B- CY5-AGATCGCGGTCTCCTGTCCA-
BHQ-1 
PROBE RING 2- FAM-TGGGAGGGCGATCGCAATCT-
BHQ-1 
For G1  
(5291-5375)
a 
 
For G2  
(5003-5100)
b 
Rotavirus  ROTA 1-ACCATCTACACATGACCCTC 
ROTA 2-GGTCACATAACGCCCC 
ROTA PROBE FAM-
ATGAGCACAATAGTTAAAAGCTAACACTGTCAA-BHQ-1 
 
987-1083
c 
Astrovirus  ASTRO 1-CCGAGTAGGATCGAGGGT 
ASTRO 2-
GCTTCTGATTAAATCAATTTTAA 
ASTRO PROBE FAM-
CTTTTCTGTCTCTGTTTAGATTATTTTAATCACC-BHQ-1 
236-312
d 
Adenovirus  ADF-GCCACGGTGGGGTTTCTAAACTT 
ADR-GCCCCAGTGGTCTTACATGCACATC 
ADPRO-FAM TGCACCAGACCCGGGCTCAGGACTCCGA-
BHQ1 
17363-17495
e 
Sapovirus 
Sporadic/ 
service and 
outbreak 
samples 
that test 
negative for 
norovirus 
SAPO 1-GCTGTTSCYACTGGTGCA 
SAPO 2-GGCATCCTGTCRTTCCAAGCA 
SAPO PROBE FAM-
CCAATCSAATGTCCCTGAGGCAATACGSAA-BHQ-1 
139-233
f 
a Based on the alignment of M87661 
b Based on the alignment ofAF145896 
c Based on the alignment of DQ490535.1 
d Based on the alignment of AJ620757.1 
e Based on the alignment of DQ923122.2 
f Based on the alignment of AB327277.1   117 
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Assessment Of The PCR Protocols And 
Subsequent Development  
4.1. Overview 
This chapter outlines a series of studies relating to the evaluation of the PCR 
protocols described in the previous chapter. The chapter is made up of three parts: the 
first  outlines  the  experimental  assessment  of  the  test  developed  for  norovirus  in 
outbreaks  of  IID;  the  second  outlines  the  evaluation  of  the  selected  tests  for 
adenovirus, astrovirus, rotavirus and sapovirus for the investigation of sporadic IID; 
and  the  third  part  describes  the  results  of  a  number  of  adaptations  to  the  tests 
eventually implemented, which aimed to reduce the turn-around-time and cost of each 
of these tests without affecting their sensitivity. Evaluation in each case consists of an 
experimental  comparison  of  the  sensitivity  of  the  PCR  with  that  of  alternative 
techniques (such as EM and EIA) available at the time of the research. The chapter 
concludes by summarising the results of the experiments and their implications for the 
laboratory diagnostic service. 
4.2. Introduction 
Chapter  3  outlined  the  PCR  methods  that  were  chosen  and  adapted  for 
investigation as the potential replacements for EM in the laboratory diagnostic service 
for IID. This chapter describes a series of experiments relating to their assessment 
and,  where  found  suitable,  their  subsequent  evolution  once  implemented  into  the 
routine diagnostic service.  
In  the  first  part  of  the  chapter  the  experimental  evaluation  of  the  tests 
developed for norovirus in outbreaks of IID is described. Initially for this service, the 
norovirus RT-PCR method described by Green et al (Green et al, 1995) was chosen 
and adapted to a SYBR green based real-time PCR method, which was implemented 
on the Lightcycler
TM platform. The first experiment in this series thus compares this 
Lightcycler™ RT-PCR to the existing EM test on a panel of untested stool samples 
taken from outbreaks and sporadic cases of gastroenteritis.  
The Lightcycler™ RT-PCR is subsequently compared to a number of other 
methods  that  emerged  during  the  period  of  study  (2000-2006)  including  a   119 
conventional  gel-based  RT-PCR,  two  commercial  EIAs  and  an  alternative  dual-
labelled probe-based real-time RT-PCR.  
The conventional RT-PCR method was recommended in 2003 by a European 
collaboration that compared a number of commonly used RT-PCR methods, including 
the original method described by Green et al (Vinje et al, 2003). Of the many methods 
assessed, the conventional RT-PCR assay using primers JV12 and JV13 was found to 
be most sensitive and was recommended to laboratories yet to set up a PCR service 
for norovirus. This assay and the Lightcycler™ RT-PCR are compared using dilution 
series of typed norovirus-positive samples and a panel of untested stool samples taken 
from outbreaks and sporadic cases of IID.  
The EIA methods were compared to the Lightcycler™ RT-PCR based on the 
manufacturer’s claim that these are a sensitive, high throughput, rapid and easy to use 
alternative to EM and RT-PCR. The methods are compared using panels of untested 
samples from both outbreaks and sporadic cases of IID.  
The final study outlined in this section is a comparison of the Lightcycler™ 
RT-PCR  with  the  dual-labelled  probe-based  real-time  RT-PCR  (Kageyama  et  al, 
2003)  selected  and  adapted  (as  described  in  Chapter  3)  once  the  appropriate 
technology  became  available  in  the  laboratory.  These  methods  are  compared  on 
panels of outbreak and  sporadic samples, and dilution series of norovirus-positive 
samples.  
The second part of this chapter outlines the data relating to the evaluation of 
the PCR methods for sporadic cases of IID. The initial aim was to replace EM with a 
multiplex gel-based PCR for adenovirus, astrovirus, rotavirus and sapovirus alongside 
the norovirus assay developed for the outbreak service. The initial experiment outlines 
the results of the attempts made to adapt the four conventional gel-based PCR assays 
chosen in Chapter 3 into a multiplex RT-PCR assay. The sensitivity of the multiplex 
RT-PCR  assay  with  respect  to  each  pathogen  is  compared  to  the  individual  PCR 
assays on both dilution series of samples and panels of samples known to be positive 
for one of the four pathogens.  
Based on the results of this experiment adaptations to the multiplex assay are 
described.  The  resultant  assays  are  compared  to  antigen  detection  methods  for 
astrovirus and rotavirus using a panel of clinical samples from sporadic cases of IID 
in children. Such methods have been shown to have sensitivity comparable or better 
than EM and are commonly used in routine microbiology laboratories (Anand et al,   120 
2001; Eing et al, 2001; Kelkar et al, 2004; Giordano et al, 2005; Rabenau et al, 1998; 
Cubitt et al, 1999).  
Finally, the gel-based PCR assays developed are compared to the dual-labelled 
probe-based real-time PCR methods chosen and adapted as described in Chapter 3, 
using panels of untested clinical samples from sporadic cases of IID and a number of 
dilution series of typed positive samples.  
Based on these series of experiments the eventual tests implemented for the 
outbreak  and  sporadic  services  are  described.  The  third  part  of  this  chapter  then 
outlines experiments carried out in an attempt to reduce the turn-around-times and 
cost of these tests without affecting their sensitivity. The first examines the effect of 
reducing  the  length  of  the  PCR  cycling  times  on  test  sensitivity  and  rapidity. 
Following this is a study examining whether real-time PCR tests for DNA pathogens 
can be carried out using the parameters employed for RNA pathogens without a loss 
in  test  sensitivity  (and  hence  can  be  carried  out  simultaneously).  Further  studies 
include  an  examination  of  whether  pooled  positive  controls  (i.e.  a  single  control 
containing all 5 viral causes of IID) can be used in order to reduce the cost of PCR 
testing by allowing more clinical samples to be processed at any one time. The use of 
primer and probe pools (vials containing aliquoted volumes of both optimised primer 
and probe) is also examined to determine whether these can provide easier and more 
rapid test set up. The final experiment examines whether reducing the PCR reaction 
volumes affects the sensitivity of the PCR assays.  
4.3. Assessment Of The PCR Protocols For Use In The Proposed 
Outbreak Service  
4.3.1. Real-Time Lightcycler™ RT-PCR (SYBR Green) Vs EM 
The  aim  of  this  first  experiment  was  to  compare  the  novel  Lightcycler™ 
SYBR green real-time assay for norovirus described in Chapter 3 to the existing EM 
method  employed  in  the  laboratory.  The  specificity  of  the  Lightcycler™  RT-PCR 
assay  was  first  assessed  using  a  panel  made  up  of  recognised  enteric  and  other 
pathogens.  It  was  then  compared  to  EM  using  a  panel  of  untested  samples  from 
outbreaks and sporadic cases of IID. As with all the experiments in this series the 
panel consisted of all samples submitted to the laboratory during a fixed period of 
time in order to provide a realistic cross-section of samples with which to test the two   121 
methods. Samples from sporadic cases of IID were included since the test developed 
for the outbreak service was also to be used to test for norovirus in the proposed 
sporadic service. 
4.3.1.1. Methods 
Sample Panels 
Specificity Panel 
The specificity panel consisted of a total of 12 stool samples and 7 nucleic 
acid  extracts  containing  variously:  bacterial  and  parasitical  causes  of  IID;  non-
norovirus  viral  pathogens  known  to  cause  IID;  and  other  pathogens  that  can  be 
detected in stool that are unrelated to IID. The bacterial and parasitical stool samples 
included: Salmonella enteridis, Campylobacter jejuni, Giardia lambdia, E-coli 0157 
and Cryptosporidium parvum. These samples were provided by Monklands District 
General Hospital. The stool samples containing non-norovirus causes of IID included: 
astrovirus types 1 and 3; sapovirus (Sapporo/82/JP); rotavirus types G1 and G2; and 
adenovirus types 41 and 40. Nucleic acid extracts of other pathogens unrelated to IID 
included:  enterovirus;  CMV;  HSV-1  and  2;  EBV;  Nessieria  gonnorhoeae  and 
Chlamydia trachomatis. With the exception of the sapovirus sample, provided by Dr 
Koopmans  (Bilthoven,  Netherlands),  the  remaining  samples  were  clinical  samples 
stored  as  part  of  the  WOSSVC  collection.  All  samples  were  extracted  using  the 
nucleic acid extraction protocol described in Chapter 3. 
Clinical Samples 
The comparison of the Lightcycler™ RT-PCR with EM was carried out using 
samples from 9 suspected outbreaks of viral gastroenteritis (consisting of a total of 85 
samples) together with a further 90 samples from sporadic cases of IID. As in all the 
experiments,  and  the  laboratory  diagnostic  service  itself,  the  information  used  to 
determine  whether  a  sample  was  from  an  outbreak  or  sporadic  case  of  IID  was 
derived from the specimen request forms. The samples used in this experiment were 
all  those  submitted  to  the  laboratory  diagnostic  service  between  October  and 
December 2000. As with all other clinical samples employed in this research, details 
of the date of illness onset and its duration are not known since the clinician did not 
provide these. The conditions of transport were also not recorded. This, in fact, is true 
for the majority of samples submitted to the laboratory. Thus, although these factors 
affect the performance of the tests examined, the samples employed in the research   122 
are representative of those expected in the ‘live’ service. Negative PCR controls (in 
the form of VTM) were included in each run to control for test contamination.  
Laboratory Methods 
The Lightcycler™ RT-PCR assay was implemented as described in Chapter 3, 
incorporating  stool  extraction  (section  3.4.1.1),  nucleic  acid  extraction  (section 
3.4.1.2)  and  the  RT  and  PCR  steps  (sections  3.4.2.1  and  3.4.2.2).  As  part  of  the 
assessment process samples that tested positive for norovirus were then re-processed 
starting  from  stool  extraction  and  the  interpretation  of  the  results  confirmed  by 
running the PCR product on an agarose gel.  
The existing EM protocol employed uses the same stool extraction technique. 
Following this 2-5ml of the supernatant is spun at 100,000 rpm for 30 minutes. The 
supernatant is then removed and the pellet air dried for at least 10 minutes before 
being re-suspended. A  drop of the virus suspension is then mixed with a drop of 
negative stain in a 50mm sterile Petri dish and placed on the ‘matt’ surface of an EM 
specimen grid. Grids are then examined at an instrument magnification of 60K. Each 
grid is examined for a period of at least 15 minutes.  
4.3.1.2. Results 
  The LightCycler™ RT-PCR did not detect any of the specificity panel 
as positive, suggesting it was specific. Meanwhile the results for the clinical samples 
showed  that,  overall,  29  tested  positive  for  norovirus  using  the  EM  technique 
compared to 47 using the LightCycler™ RT-PCR (Table 10). 
 Table 10: Comparison of LightCycler™ RT-PCR and EM. 
Sample Type  Number of Samples  EM Positive  LightCycler™ Positive 
Outbreak 1  5  3  5 
Outbreak 2  5  0  0 
Outbreak 3  6  4  4 
Outbreak 4  6  0  0 
Outbreak 5  6  1  3 
Outbreak 6  7  0  0 
Outbreak 7  5  0  1 
Outbreak 8  41  3  6 
Outbreak 9  4  2  3 
Total Outbreak   85  13  22 
Sporadic   90  16  25 
Total samples  175  29  47 
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The  table  shows  that  the  Lightcycler™  RT-PCR  consistently  detected 
norovirus  in  more  samples  than  the  EM  test,  in  samples  from  both  suspected 
outbreaks of norovirus (from various sources) and sporadic cases of IID. 
Examining  the  results  in  more  detail,  all  samples  that  tested  positive  for 
norovirus using EM also tested positive using the Lightcycler™ RT-PCR. Moreover, 
all negative controls tested negative using the LightCycler™ RT-PCR. Examination 
of the melting curves of the samples that tested positive using the LightCycler™ RT-
PCR showed melting point temperatures of between 81-83
oC (see Figure 12 for an 
example) for all but two samples, which were outwith this range (80.3
oC and 80.4
oC). 
In order to corroborate the results, all Lightcycler™ RT-PCR positive results were re-
investigated, by repeating the test from extraction and running the PCR products on a 
gel.  A  band  of  113bp  in  length  was  observed  for  all  47  samples,  confirming  the 
original results.  
Figure 12: Example of Lightcycler™ RT-PCR SYBR green melt curves (norovirus-
positive results). 
 
At the WOSSVC, an outbreak is confirmed as being caused by a particular 
pathogen if at least two of the submitted samples from a particular location are found 
to be positive for that pathogen. On the other hand, for an outbreak to be classified as 
negative at least six samples from the same outbreak have to be submitted and found 
to be negative for the pathogen in question.  In either case, more than one sample is 
required before a classification is made in order to reduce the risk of false diagnoses.  
Based on these criteria four of the nine outbreaks investigated were confirmed 
using EM compared to five using the Lightcycler™ RT-PCR assay (Table 10). Both 
tests  in  addition  detected  a  single  norovirus  positive  in  samples  from  one  other 
outbreak, which meant the outbreak could not definitely be attributed to norovirus.    124 
4.3.1.3. Study Conclusions 
The results of this study showed that the Lightcycler™ RT-PCR assay was 
specific and more sensitive than the existing EM protocol, detecting more outbreaks 
and individual cases of norovirus (Miller, Gunson and Carman, 2002). The increased 
sensitivity of the Lightcycler™ RT-PCR in comparison to EM confirmed the findings 
of  earlier  work  (Buesa  et  al,  1996)  and  was  subsequently  substantiated  further 
(Rabenau et al, 2003; Simpson et al, 2003). However, a possible disadvantage found 
was the varied melting temperature observed for the positive samples in this study 
(80-83
oC).  This  highlights  a  potential  difficulty  in  defining  a  strict  melting 
temperature range for result interpretation, as norovirus RdRp variation may result in 
a PCR product with a melting temperature outwith the accepted range and thus a false 
negative result. Since this research was carried out other studies using SYBR green 
based  RT-PCR  assays  have  also  highlighted  melting  temperature  variation  as  a 
problem and have related this to norovirus type (Richards et al, 2004). Here, however, 
all samples with a melting temperature range of 80-83
oC were confirmed when re-
tested  using  agarose  gel  analysis  to  interpret  the  results,  indicating  this  is  an 
acceptable range to employ. Thus, the increased sensitivity of the Lightcycler™ RT-
PCR assay combined with its increased sample capacity meant the decision was taken 
to implement it as the frontline test for outbreak samples in January 2001. EM was 
retained for testing all samples from sporadic cases of IID and as the secondary test 
for outbreak samples that tested negative for norovirus using the new PCR assay. 
4.3.2. Real-Time  Lightcycler™  RT-PCR  (SYBR  Green)  Vs  A 
Recommended Conventional Gel-Based RT-PCR  
Following  implementation  of  the  Lightcycler™  assay  as  part  of  the  new 
laboratory diagnostic service the primers it employs, Ni and E3, were independently 
assessed as part of a European collaboration study designed to identify which of the 
commonly  used  RT-PCR  methods  offered  the  most  sensitive  and  wide  ranging 
detection of norovirus types (Vinje et al, 2003). This study found that the primers Ni 
and E3 were unable to detect some G1 and G2 types, and that of all the RT-PCR 
assays examined, the most sensitive assay used the primers JV12 and JV13. As a 
result these were recommended to other laboratories interested in setting up a RT-
PCR assay for norovirus (Vinje et al, 2003).    125 
In order to investigate these findings, the Lightcycler™ RT-PCR assay was 
compared to the recommended gel-based RT-PCR. First, the specificity of the gel-
based RT-PCR was assessed using the same panel employed earlier in assessing the 
Lightcycler™ RT-PCR. Subsequently, the two assays were compared using a dilution 
series  of  a  G1  and  G2  norovirus  sample.  Finally,  the  two  PCR  methods  were 
compared using clinical samples from both the sporadic and outbreak setting.  
4.3.2.1. Methods 
Sample Panels 
Specificity Panel 
The specificity panel described in section 4.3.1.1 for the assessment of the 
Lightcycler™ assay was also employed in this experiment. 
Clinical Samples 
The gel-based RT-PCR was compared to the LightCycler™ RT-PCR method 
using 81 faecal samples collected from 46 sporadic cases and 7 outbreaks (containing 
a total of 35 samples) of suspected viral gastroenteritis. All samples were submitted to 
the WOSSVC during January to February 2002. Negative PCR controls (in the form 
of VTM) were included in each PCR run to control for test contamination. Both RT-
PCR methods were also compared using a 10 fold dilution series of a G1 (White 
Rose) sample and a G2 (Lordsdale/93/UK X86557) norovirus-positive sample. The 
G1 sample was provided by Dr Marion Koopmans whereas the G2 sample was from 
the WOSSVC collection. 
4.3.2.2. Laboratory Methods 
The Lightcycler™ assay was used as previously described (section 4.3.1.1). 
The  gel-based  RT-PCR  employed  the  same  stool,  nucleic  acid  extraction  and  RT 
methods (sections 3.4.1.1, 3.4.1.2 and 3.4.2.1). Following this, 10ul of cDNA was 
added to a 50ul reaction containing 10xPCR buffer (100mM tris-HCI, 15mM MgCl2, 
500mM  KCL),  0.2mM  of  each  dNTP,  0.2mM  of  primers  JV12Y  and  JV13I 
(Koopmans et al, 2003). A mixture of 2U of Taq DNA polymerase, 0.028uM TaqStart 
antibody (Clontech Laboratories, Paolo Alto, USA) and 4xTaqStart antibody dilution 
buffer (Clontech Laboratories, Paolo Alto, USA) was incubated at room temperature 
for 10 minutes before being added to the final reaction mixture. PCR was carried out 
under  the  following  conditions:  94
oC  for  3  mins,  followed  by  40  cycles  of  the   126 
following: 94
oC for 1 min, 37
oC for 1 min, 74
oC for 1 min. This is followed by a final 
extension  step  of  72
oC  for  7  mins.  Products  were  then  subjected  to  agarose  gel 
electrophoresis. Positive bands were expected at 324bp. 
4.3.2.3. Results 
The gel-based RT-PCR was shown to be specific as it did not detect any of the 
specificity panel as positive. Results from testing the sample panel showed that, in 
total,  the  gel-based  RT-PCR  detected  more  norovirus-positive  samples  than  the 
LightCycler™ RT-PCR (28 vs 19), as shown in Table 11.  
6  of  the  7  of  the  suspected  outbreaks  were  diagnosed  as  being  caused  by 
norovirus using both methods. One outbreak contained 1 positive sample that was 
detected by both methods. Based on the criteria outlined above this outbreak could not 
be confirmed as being caused by norovirus. No additional outbreaks were diagnosed 
using the gel-based RT-PCR assay although the overall sample percentage positive 
rate was greater using the gel-based RT-PCR method (approximately 69% vs 49%). 
All negative controls tested negative using both assays. 
Table 11: Comparison of LightCycler™ RT-PCR and recommended gel-based RT-PCR. 
Sample Type  Number of Samples  Lightcycler™ Positive  Gel-based Positive 
Outbreak 1  13  4  6 
Outbreak 2  3  2  3 
Outbreak 3  3  1  1 
Outbreak 4  4  3  3 
Outbreak 5  4  2  3 
Outbreak 6  5  2  4 
Outbreak 7  3  2  3 
Total Outbreaks  35  16  23 
Sporadic   46  3  5 
Total  81  19  28 
 
The  increased  sensitivity  of  the  conventional  gel-based  RT-PCR  was 
confirmed using the dilution series. Using a G2 norovirus sample the conventional 
RT-PCR was shown to be more sensitive than the Lightcycler™ RT-PCR assay with a 
detection  limit  of  10
-4  compared  to  10
-3  (Table  12).  However,  similar  end  point 
detection limits were observed when testing the dilution series of the G1 (White rose) 
positive sample (Table 13).   127 
Table 12: Comparison of LightCycler™ RT-PCR and recommended gel-based RT-PCR 
on a dilution series of a norovirus-positive sample (Lordsdale/93/UK (X86557). 
Dilution of G2 Sample  LightCycler™ Result  Gel-based Result 
10
-1  +  +  
10
-2  +  + 
10
-3  +  + 
10
-4  -  + 
10
-5  -  - 
 
Table 13: Comparison of LightCycler™ RT-PCR and recommended gel-based RT-PCR 
on a dilution series of a norovirus-positive sample (G1 - White Rose). 
Dilution of G1 Sample  LightCycler™ Result  Gel-based Result 
10
-1  +  +  
10
-2  +  +  
10
-3  +  +  
10
-4  -  - 
 
4.3.2.4. Study Conclusions 
This study demonstrated that of the two methods examined the gel-based RT-
PCR method recommended by Vinje et al (Vinje et al, 2003) offered more sensitive 
diagnosis of individual cases of norovirus in outbreaks and sporadic cases of viral 
gastroenteritis (Gunson, Miller and Carman, 2003(i)). The increased sensitivity of the 
gel-based RT-PCR was confirmed using the dilution series of a G2 positive sample, 
but not using a G1 dilution panel. However, the real-time LightCycler™ RT-PCR 
assay did confirm an equal number of outbreaks and had the advantage of providing 
fewer  and  shorter  steps.  For  example,  the  Lightcycler™  RT-PCR  includes  the 
following steps: stool extraction, nucleic acid extraction, a reverse transcriptase step 
and then PCR (a total of 4 steps). The gel-based RT-PCR consists of all of these plus 
a gel-based analysis step, which can take approximately 1-3 hours depending on the 
number of samples under scrutiny. Moreover, the PCR step in the Lightcycler
TM test 
is  considerably  shorter  (approximately  45  mins  versus  2-4  hours  in  the  gel-based 
assay). As discussed earlier the fewer the steps in a test the less potential for human 
error and the faster the process. This together with the fact that it did not miss any 
outbreaks meant that the LightCycler™ RT-PCR remained the assay of choice for the 
investigation of outbreaks of IID at the WOSSVC.   128 
4.3.3. Real-Time  Lightcycler™  RT-PCR  Vs  First  And  Second 
Generation Commercial EIA Methods 
During  the  period  of  study  a  number  of  commercial  EIA  tests  became 
available for the diagnosis of norovirus. The manufacturers of these assays claim they 
are a rapid, high throughput and sensitive alternative for laboratories with no access to 
EM  or  RT-PCR  techniques.  However,  few  data  exist  comparing  these  antigen 
detection methods to RT-PCR methods. In this study, first and second-generation EIA 
assays were compared with the LightCycler™ RT-PCR on samples from outbreaks 
and  sporadic  cases  of  IID.  The  first  generation  EIA  (IDEIA,  DAKO  Cytomation, 
Cambridgeshire, UK) uses polyclonal antibodies to detect and differentiate between 
G1 and G2 norovirus strains. In 2003, it was replaced by a second generation EIA. 
This second generation EIA (IDEIA NLV, Dako Ltd, Ely, Cambridgeshire, UK) uses 
a  cocktail  of  genotype-specific  monoclonal  antibodies  to  detect  and  differentiate 
between the antigens of G1 and G2 norovirus strains.  
4.3.3.1. Methods 
Sample Panels 
Comparison Of First Generation EIA With Lightcycler™ RT-PCR 
The two assays were compared using 35 faecal samples from 7 outbreaks of 
gastroenteritis and 46 from sporadic cases of  gastroenteritis sent to the WOSSVC 
during  October  to  November  2002.  Each  sample  was  tested  within  3  days  of 
collection from the patient in line with the EIA manufacturer’s requirements. Samples 
for which the two tests produced different results were re-tested using the gel-based 
RT-PCR assessed in the previous experiment in order to corroborate the results. The 
specificity of both assays was assessed using 7 VTM vials.  
Comparison Of Second Generation EIA With Lightcycler™ RT-PCR 
The  two  assays  were  compared  using  42  faecal  samples  from  6  suspected 
outbreaks of gastroenteritis and 28 from sporadic cases of gastroenteritis sent to the 
WOSSVC during March to April 2003 (Gunson, Miller and Carman, 2003 (ii)). Each 
sample was tested within 3 days of collection from the patient in line with the EIA 
manufacturer’s  requirements.    Samples  for  which  the  two tests  produced  different 
results  were  re-tested  using  the  gel-based  RT-PCR  assessed  in  the  previous   129 
experiment in order to  corroborate the results.  The specificity of both  assays was 
assessed using 7 VTM vials.  
4.3.3.2. Laboratory Methods 
The Lightcycler™ RT-PCR and gel-based RT-PCR were used as described in 
the previous sections. 
First Generation Commercial EIA For Norovirus   
The reagents were reconstituted according to the manufacturer’s instructions 
(DAKO  Cytomation,  Cambridgeshire,  UK).  Briefly,  approximately  0.1g  of  faecal 
specimens  was  added  to  1ml  of  sample  diluent  and  mixed  thoroughly.  For  the 
genogroup  1  assay,  the  appropriate  number  of  microtitre  wells  for  samples  and 
controls was selected from the kit. 100ul of G1 cut off  control was added to the 
appropriate well. 100ul of the negative control was added to two wells. 100ul of the 
samples to be tested were added to the appropriate wells. 100ul of G1 conjugate was 
then added to each well and the plate was incubated at 20-30
oC for 120 minutes. The 
wells  were  then  washed  5  times  using  working  strength  wash  buffer.  100ul  of 
substrate was then added to the wells. This was then incubated at 20-30
oC for 30 
minutes. 100ul of stopping solution was then added to the well. The colour change 
was then measured photometrically at 450nm with 600nm reference. According to the 
manufacturer, negative controls must have a mean absorbance value of under 0.15 
A450 units. Positive controls must have a cut off value of more than 0.18 A450 units. 
Samples with A450 units above the positive control threshold are considered positive. 
Any  sample  with  an  A450  value  of  within  0.010  of  the  cut  off  control  should  be 
considered  equivocal  and  retested,  or  interpreted  alongside  clinical  and 
epidemiological data.  
For the  genogroup 2 assay the appropriate number of microtitre wells was 
removed from the kit. 100ul of G2 cut off control was added to the appropriate well. 
100ul of the negative control was added to two wells. 100ul of the samples to be 
tested were added to the appropriate wells. 100ul of G2 conjugate was then added to 
each well and the plate was incubated at 20-30
oC for 120 minutes. The wells were 
then washed 5 times using working strength wash buffer. 100ul of substrate was then 
added to the wells. This was then incubated  at 20-30
oC for 30 minutes. 100ul of 
stopping solution was then added to the well. The colour change was then measured 
photometrically at 450nm with 600nm reference. Negative controls must have an A450   130 
value of less than 0.15. Positive controls must have a cut off value of more than 0.18 
A450 units. Samples with A450 units above the positive control threshold are considered 
positive. Any sample with an A450 value of within 0.010 of the cut off control should 
be  considered  equivocal  and  retested,  or  interpreted  together  with  clinical  and 
epidemiological data.  
Second Generation Commercial EIA For Norovirus  
The EIA for norovirus was carried out as per the manufacturer’s instructions 
(DAKO  Cytomation,  Cambridgeshire,  UK).  Briefly,  approximately  0.1g  of  faecal 
specimens  was  added  to  1ml  of  sample  diluent  and  mixed  thoroughly.  For  the 
genogroup 1 assay, the appropriate number of microtitre wells was selected from the 
kit.  100ul  of  G1  cut  off  control  was  added  to  the  appropriate  well.  100ul  of  the 
negative control was added to two wells. 100ul of the samples to be tested were added 
to the appropriate wells. 100ul of G1 conjugate was then added to each well and the 
plate was incubated at 20-30
oC for 120 minutes. The wells were then washed 5 times 
using working strength wash buffer. 100ul of substrate was then added to the wells. 
This was then incubated at 20-30
oC for 30 minutes. 100ul of stopping solution was 
then  added  to  the  well. The  colour  change  was then  measured  photometrically  at 
450nm with 600nm reference. Negative controls must have a mean A450 value of less 
than 0.15. Positive controls must have a cut off value of over 0.18 A450 units. Samples 
with  A450  units  above  the  positive  control  threshold  are  considered  positive.  Any 
sample with an A450 value of within 0.010 of the cut off control should be considered 
equivocal and retested, or interpreted alongside clinical and epidemiological data.  
For the genogroup 2 assay the appropriate number of microtitre wells were 
selected. 100ul of G2 cut off control was added to the appropriate well. 100ul of the 
negative control was added to two wells. 100ul of the samples to be tested were added 
to the appropriate wells. 100ul of G2 conjugate was then added to each well and the 
plate was incubated at 20-30
oC for 120 minutes. The wells were then washed 5 times 
using working strength wash buffer. 100ul of substrate was then added to the wells. 
This was then incubated at 20-30
oC for 30 minutes. 100ul of stopping solution was 
then  added  to  the  well. The  colour  change  was then  measured  photometrically  at 
450nm with 600nm reference. Negative controls must have an A450 value of under 
0.15.  Positive  controls  must  have  a  cut  off  value  of  more  than  0.18  A450  units. 
Samples  with  A450  units  above  the  positive  control  are  considered  positive.  Any   131 
sample with an A450 value of within 0.010 of the cut off control should be considered 
equivocal, and retested or interpreted together with clinical and epidemiological data.  
4.3.3.3. Results 
Comparison Of First Generation EIA With Lightcycler™ RT-PCR 
In total, the Lightcycler™ assay detected norovirus in more samples than the 
EIA (18 versus 6), as shown in Table 14. All of the Lightcycler™ positives were 
confirmed using the gel-based RT-PCR, compared to 5 of the 7 EIA positives. A total 
of 4 norovirus-positives were detected by both assays  
Table 14: Comparison of LightCycler™ PCR and first generation EIA. 
Sample Type  Number of Samples  LightCycler™ Positive  EIA Positive 
Outbreak 1  13  4  2 
Outbreak 2  3  2  0 
Outbreak 3  3  1  1 
Outbreak 4  4  3  0 
Outbreak 5  4  1  0 
Outbreak 6  5  2  0 
Outbreak 7  3  2  1 
Total Outbreak  35  15  4 
Sporadic  46  3  2 
Total  88  18  6 
 
The  EIA  detected  norovirus-positive  samples  in  3  of  the  7  suspected 
outbreaks.  However,  in  2  of  these  outbreaks  only  1  sample  tested  positive.  As 
discussed earlier, the WOSSVC criteria state that a norovirus outbreak must contain at 
least 2 positive samples in order to be confirmed as positive, as the presence of 1 
positive sample could be due to a sporadic case of norovirus. Using this criterion here, 
only 1 outbreak could be confirmed as being caused by norovirus. The LightCycler™ 
RT-PCR, in comparison, confirmed norovirus as the cause in 5 outbreaks.  
Amongst  the  sporadic  cases  of  IID  the  LightCycler™  RT-PCR  detected 
norovirus in 3 samples. All 3 results were confirmed using the gel-based RT-PCR. In 
contrast, the EIA test detected norovirus in 2 sporadic samples, neither of which could 
be confirmed using the gel-based RT-PCR. In terms of specificity the EIA detected 
one of the VTM samples as positive. Testing with the gel-based RT-PCR, however, 
confirmed  that  the  VTM  sample  was  norovirus-negative.  Meanwhile  all  negative 
controls tested negative using the Lightcycler™ assay.    132 
Comparison Of Second Generation EIA With Lightcycler™ RT-PCR 
In total, the LightCycler™ RT-PCR detected norovirus in more samples than 
the EIA (26 versus 9), as shown in Table 15. All of the Lightcycler™ positive results 
were confirmed using the gel-based RT-PCR. A total of 8 samples tested positive for 
norovirus using both  assays. The EIA detected norovirus in 2 samples that tested 
negative using the LightCycler™ RT-PCR assay. However, neither of these positive 
results could be confirmed using the second RT-PCR. One sample was classified as 
equivocal using EIA but tested positive for norovirus suing the Lightcycler™ RT-
PCR. 
In total 6 suspected outbreaks of viral gastroenteritis were investigated. Using 
the WOSSVC criteria, the EIA technique diagnosed norovirus as the cause of 1 of the 
6 outbreaks (outbreak 6), whereas the LightCycler™ RT-PCR established norovirus 
as the cause in all outbreaks. 
Amongst  the  sporadic  cases  of  IID  the  LightCycler™  RT-PCR  detected 
norovirus in 5 samples. All 5 results were confirmed using the gel-based RT-PCR. In 
contrast, the EIA test detected norovirus in 3 sporadic samples, only one of which 
could be confirmed using the gel-based RT-PCR. In terms of specificity all negative 
controls tested negative using the Lightcycler™ assay and the EIA.  
Table 15: Comparison of Lightcycler™ PCR and EIA  
Sample Type  Number of Samples   Lightcycler™ Positive  EIA Positive 
Outbreak 1  5  2  0 
Outbreak 2  6  4  1 
Outbreak 3  8  4  1 
Outbreak 4  11  3  0 
Outbreak 5  6  4  1 
Outbreak 6  6  4  3 
Total Outbreak  42  21  6 
Sporadic  28  5  3 
Total  70  26  9 
4.3.3.4. Study Conclusions 
These  results  show  that  both  the  first  and  second  generation  EIA  were 
inadequate for norovirus detection. The LightCycler™ RT-PCR detected norovirus in 
more  samples  and  confirmed  more  norovirus  outbreaks  than  either  EIA.  In  both 
comparisons all of the extra cases of norovirus detected by the LightCycler™ RT-
PCR were  confirmed using the alternative  (more sensitive)  gel-based RT-PCR.  In 
contrast both EIAs produced positive results that could not be confirmed using the   133 
gel-based RT-PCR. It is possible that these samples tested negative using the gel-
based  method  due  to  primer  mismatches  or  inhibition.  However,  given  that  these 
samples also tested negative using the Lightcycler™ assay, the EIA results may also 
have  been  false  positives  and  therefore  the  specificity  of  these  assays  should  be 
questioned. The fact that in the first study a VTM negative control tested positive for 
norovirus using the EIA points toward this conclusion.  
As these EIA tests are relatively new, there are few comparisons with PCR 
available in the literature. Richards et al compared the first generation (polyclonal 
based) EIA with a RT-PCR assay on patient samples taken from outbreaks of IID 
(Richards et al, 2003). Overall they found the EIA to be less sensitive and specific 
than  the  RT-PCR  method.  These  results  confirmed  those  of  the  above  study. 
However,  Richards  et  al  concluded  their  report  by  stating  that  EIA  is  a  suitable 
alternative  to  EM  as  an  initial  screening  tool  before  testing  all  samples  found  to 
negative using PCR or EM. This, however, is likely to result in longer turn-around-
times since a significant proportion of samples are likely to test negative using EIA 
and thus require a second phase of testing. Moreover, the lower specificity of the EIA 
found in this research may result in the false diagnosis of norovirus outbreaks leading 
to  unnecessary  implementation  of  costly  infection  control  procedures.  It  is  worth 
noting that the first generation EIA was withdrawn from the market in 2003.  
A  recent  study  by  Burton-MacLeod  further  substantiated  the  results  of  the 
above  study  examining  the  second  generation  (monoclonal  based)  EIA.  In  the 
reported study the EIA was assessed on a panel of known types of norovirus and other 
causes of viral IID (Burton-MacLeod et al, 2004). They found the EIA could not 
detect all G2 strains and had an overall sensitivity of 39% (albeit with a specificity of 
100%). They concluded that the Dako assay could not be used as a frontline test for 
norovirus.  Other  recent  studies  have  also  found  the  Dako  assay  to  have  lower 
sensitivity and specificity than RT-PCR tests (Wilhelmi et al, 2007; Castriciano et al, 
2007; Dimitriadis, Bruggink and Marshall, 2006; Dimitriadis and Marshall, 2005). 
For example, Wilhemli et al assessed the EIA using 117 samples that tested positive 
for norovirus using RT-PCR. They found the EIA to have a sensitivity of 76.9% and a 
specificity of 85%. Similar results were obtained by Castriciano et al and Dimitraidis 
et al.   134 
Based on the findings of this research the EIA method was not implemented in 
the  WOSSVC  and  the  Lightcycler
TM  RT-PCR  remained  the  frontline  assay  for 
outbreaks of norovirus. 
4.3.4. Real-Time  Lightcycler™  RT-PCR  Vs  Dual-Labelled  Probe-
Based Real-Time PCR 
As discussed earlier, in 2003 the WOSSVC obtained a number of real time 
PCR platforms that could support other real time chemistries including dual-labelled 
probes.  Compared  to  the  Lightcycler™  platform,  these  platforms  offer  greater 
throughput (72-96 vs 32 per run) and potentially, therefore, more rapid turn-around-
times. Dual-labelled probe-based real-time PCR methods may also offer improved 
specificity in comparison to a SYBR green based approach due to the incorporation of 
an additional probe complimentary to the target sequence. As a result such assays do 
not  require  a  melting  curve  step,  which  aids  rapidity  and  offers  easier  result 
interpretation not reliant on melting temperature. 
The aim of this experiment, therefore, was to compare the Lightcycler™ RT-
PCR to the dual-labelled probe-based RT-PCR selected and adapted as described in 
Chapter 3. First the specificity of the new assay was tested using the panel employed 
earlier  in  assessing  the  Lightcycler™  assay.  The  sensitivity  of  the  two  real-time 
assays was then compared using clinical samples from outbreaks and sporadic cases 
of IID and dilution series of both a G1 and G2 positive sample.  
Resource  constraits  meant  that  corroboratory  testing  using  an  alternative 
method was not carried out at the time. However, all samples for which the two tests 
produced different results were re-tested using an alternative nested RT-PCR in 2007 
(Gallimore et al, 2007). The assay described by Gallimore et al was selected since it 
targets parts of both the RdRp and the ORF-2 regions. This extra testing was carried 
out in order to confirm the initial results obtained in 2004 and to ensure that the 
correct service decisions were made regarding the routine diagnostic service.  
4.3.4.1. Methods 
Sample Panels 
Specificity Panel 
The specificity panel described in section 4.3.1.1 for this original assessment 
of the assay was again employed in this experiment.    135 
Clinical Samples 
The dual-labelled probe-based real-time RT-PCR and the LightCycler™ RT-
PCR were compared using 217 faecal samples collected from 6 suspected outbreaks 
of IID (n=64 samples), and 153 community managed cases of acute gastroenteritis. 
All  samples  were  submitted  to  the  WOSSVC  during  October  to  December  2003. 
Finally,  each  method  was  compared  using  a  dilution  series  of  a  known  G1 
(Birmingham  (AJ277612))  sample  and  a  known  G2  (Lordsdale/93/UK  (X86557)) 
sample. The G1 sample was provided by Dr M Koopmans whereas the G2 sample 
was part of the WOSSVC sample collection. 
Laboratory Methods 
The LightCycler™ RT-PCR assay was implemented as described earlier. The 
dual-labelled probe-based assay was implemented as described in section 3.4.2.2 of 
Chapter 3. 
Nested RT-PCR For Norovirus 
 Extracted RNA (12.5ul) was amplified using a combined one step RT-PCR 
kit (Qiagen, Crawley, UK) using primers G2FBN and G2SKR (25 pmoles/reaction) 
under  the  following  conditions.  The  RT  step  was  carried  at  50
oC  for  30  minutes 
followed by the first round PCR step at 95
oC for 15 minutes. This was followed by 35 
cycles of: 95
oC for 40 seconds; 45
oC for 40 seconds and 72
oC for 1 min. 2ul of first 
round  product  was  then  transferred  to  a  48  ul  second  round  reaction  (Qiagen) 
containing primers G2FBN2 and G2SKR (50 pmoles/ reaction) and subjected to 40 
cycles  of:  94
oC  for  40  seconds;  45
oC  for  25  seconds  and  72
oC  for  1  minute  30 
seconds. This was followed by a hold step 72
oC for 10 min. Products were visualised 
using agarose gel electrophoresis. A PCR product of 357bp was expected if norovirus 
was successfully amplified from the sample. 
4.3.4.2. Results 
The dual-labelled probe-based RT-PCR was shown to be specific since it did 
not detect any of the specificity panel as positive. When compared on the sample 
panel  the  new  real-time  assay  detected  norovirus  in  more  samples  than  the 
LightCycler™ RT-PCR in total (41 vs 13) as shown in Table 16. All extra positives 
detected  by  the  dual-labelled  probe-based  assay  were  confirmed  as  containing 
norovirus by re-testing with the nested RT-PCR.    136 
Using  the  standard  WOSSVC  criteria,  the  probe-based  method  diagnosed 
norovirus to be the cause of 4 outbreaks (outbreaks 1, 3, 4 and 5). In comparison, the 
LightCycler™  RT-PCR  diagnosed  norovirus  as  the  cause  of  only  one  outbreak 
(outbreak  3).  In  both  tests  a  single  positive  sample  was  detected  in  one  other 
suspected  outbreak  (in  outbreak  2  using  the  dual-labelled  probe-based  assay  and 
outbreak 4 using the LightCycler™ RT-PCR), neither of which could be confirmed as 
being caused by norovirus due to the lack of multiple positive samples. All of the 
samples  from  one  outbreak  tested  negative  for  norovirus  using  both  methods 
(outbreak 6).  
Table 16: Comparison of dual-labelled probe-based PCR and LightCycler™ RT-PCR.  
Sample  
Type 
Number of Samples  Dual-labelled Probe-based  
Positives 
Lightcycler™  
Positives 
Outbreak 1  21  3  0 
Outbreak 2  5  1  0 
Outbreak 3  7  7  6 
Outbreak 4  5  2  1 
Outbreak 5  13  13  0 
Outbreak 6  13  0  0 
Total Outbreak  64  26  7 
Sporadic  153  15  6 
Total  217  41  13 
 
Amongst  the  sporadic  cases,  the  dual-labelled  probe-based  assay  detected 
norovirus in more samples (15 vs 6).  
Finally, the greater sensitivity of the dual-labelled probe-based RT-PCR was 
confirmed using the dilution panels of a G1 and G2 positive sample (made up of 10 
fold dilutions). The results are shown in Table 17 and Table 18. The dual-labelled 
probe-based assay was found to have a lower detection limit for both norovirus type 
G1 (10
-5 vs 10
-2) and G2 (10
-6 vs 10
-4).  
Table 17: Comparison of dual-labelled probe-based RT-PCR and LightCycler™ RT-PCR 
on a dilution series of a norovirus positive sample (G1-Birmingham AJ277612). 
Dilution of G1 Sample  LightCycler™ Result  Dual-labelled Probe-based Result (Ct) 
10
-1  +  + (23.2) 
10
-2  +  + (27.0) 
10
-3  -  + (30.2) 
10
-4  -  + (33.4) 
10
-5  -  + (36.2) 
10
-6  -  -   137 
Table 18: Comparison of dual-labelled probe-based RT-PCR and LightCycler™ RT-PCR 
on a dilution series of a norovirus positive sample (G1-Lordsdale/93/UK X86557). 
Dilution of G2 Sample  LightCycler™ Result  Dual-labelled Probe-based Result (Ct) 
10
-1  +  + (20.1) 
10
-2  +  + (23.4) 
10
-3  +  + (27.1) 
10
-4  +  + (30.2) 
10
-5  -  + (33.6) 
10
-6  -  + (37.0) 
10
-7  -  - 
4.3.4.3. Study Conclusions 
Overall, the results showed that the adapted version of the dual-labelled probe-
based test described by Kageyama et al was specific and consistently more sensitive 
than the Lightcycler™ assay (Gunson and Carman, 2005). This was confirmed by 
repeat testing of the discrepant results using an alternative PCR assay in 2007. The 
dual-labelled probe-based PCR also had the potential for increased throughput since it 
could test more samples per run than achievable on the Lightcycler™ method. As 
mentioned above the Lightcycler™ assay consisted of four steps (stool extraction, 
nucleic acid extraction, RT, and PCR) whereas the dual-labelled probe-based assay 
consists of just three steps (the RT and PCR steps are combined). Based on these 
results it was used to replace the Lightcycler™ assay as the frontline test for norovirus 
in outbreaks of IID in January 2004. 
4.4. Assessment Of The PCR Protocols For Use In The Proposed 
Sporadic Service 
4.4.1. Gel-based  Multiplex  RT-PCR  For  Adenovirus,  Astrovirus, 
Rotavirus And Sapovirus Vs Individual PCR Assays For Each  
The aim of the first experiment in this series was to compare the sensitivity of 
the novel multiplex assay described in Chapter 3 with that of the individual assays 
from  which  it  was  developed,  to  ensure  the  multiplex  RT-PCR  was  at  least  as 
sensitive. Of particular interest were the results for adenovirus, to determine if the 
addition of an RT step affected the sensitivity of the test.  The final multiplex was 
then  assessed  for  specificity  using  a  panel  of  samples  containing  recognised 
gastrointestinal pathogens.   138 
4.4.1.1. Methods 
Sample Panels 
Clinical Samples 
Both methods were initially compared using 10-fold dilution series of four 
different samples, each known (via testing by EM) to be positive for one of the four 
viral pathogens of interest. Testing with a dilution series is an important first step in 
the assessment of multiplex assays prior to the assessment using clinical samples, in 
order to determine if there are any cross-reactions between the primers that reduce test 
sensitivity. The clinical panel in this case consisted of 74 samples from sporadic cases 
of  IID  containing  20  that  tested  positive  for  adenovirus  (using  the  EIA  method 
Adenoscreen (Microgen) at the Royal Hospital for Sick Children (RHSC) in Glasgow, 
10 samples that tested positive for astrovirus using EM at the WOSSVC, 20 rotavirus-
positive  samples  tested  using  an  EIA  method  (Microgen),  at  the  RHSC  and  24 
sapovirus-positive samples containing representatives of both G1 and G2 sapoviruses 
(provided by Dr M Koopmans, Bilthoven, Netherlands).  
Specificity Panel 
The specificity panel described in section 4.3.1.1 was also employed in this 
experiment, with the addition of 7 norovirus types for cross-testing purposes. The 7 
norovirus types consisted of 5 G1 types (Birmingham AJ277612), White Rose, Malta, 
Musgrove and Mikkelo) and 2 G2 types (Lordsdale/93/UK X86557 and Leeds/90/UK 
AJ277603) and were sourced from Dr M Koopmans, Bilthoven, Netherlands and the 
G2 types were part of the WOSSVC sample collection. 
4.4.1.2. Laboratory Methods 
All  samples  were  processed  using  the  faecal  extraction  and  nucleic  acid 
extraction  protocols  outlined  in  Chapter  3  (section  3.4.1.1  and  3.4.1.2).  Where 
employed, the reverse transcriptase step was the standard laboratory method described 
in  Chapter  3  (section  3.4.2.1).  The  multiplex  RT-PCR  for  adenovirus,  astrovirus, 
rotavirus and sapovirus is also described in Chapter 3 (section 3.4.2.3). 
Individual PCR For Adenovirus 
10ul  of  cDNA  was  added  to  a  50ul  reaction  containing  10xPCR  buffer 
(100mM  tris-HCI,  15mM  MgCl2,  and  500mM  KCL),  0.2mM  of  each  dNTP  and 
0.2mM of primers ADJC1 and ADJC2 for adenovirus (Cooper et al, 1999). A mixture   139 
of 2U of Taq DNA polymerase, 0.028uM TaqStart antibody (Clontech Laboratories, 
Paolo Alto, USA) and 4xTaqStart antibody dilution buffer (Clontech Laboratories, 
Paolo Alto, USA) was incubated at room temperature for 10 minutes before being 
added  to  the  final  reaction  mixture.  The  PCR  conditions  were  94
oC  for  3  mins, 
followed by 40 cycles of: 94
oC for 30 secs, 47
oC for 40 secs, 72
oC for 30 secs; with a 
final extension step of 72
oC for 7 mins. Products were then subjected to agarose gel 
electrophoresis. Positive bands were expected at 140bp for adenovirus. 
Individual RT-PCR For Astrovirus 
10ul  of  cDNA  was  added  to  a  50ul  reaction  containing  10xPCR  buffer 
(100mM tris-HCI, 15mM MgCl2, 500mM KCL), 0.2mM of each dNTP and 0.2mM 
of primers mon269 and mon270 for astrovirus (Noel et al, 1995). A mixture of 2U of 
Taq DNA polymerase, 0.028uM of TaqStart antibody (Clontech Laboratories, Paolo 
Alto, USA) and 4xTaqStart antibody dilution buffer (Clontech Laboratories, Paolo 
Alto, USA) was incubated at room temperature for 10 minutes before being added to 
the final reaction mixture. PCR conditions were 94
oC for 3 mins, 40 cycles of: 94
oC 
for 1min, 50
oC for 1 mins, 72
oC for 1 min; with a final extension step of 72
oC for 7 
mins.  Products  were  then  subjected  to  agarose  gel  electrophoresis.  Positive  bands 
were expected at 449bp for adenovirus. 
Individual RT-PCR For Rotavirus 
10ul  of  cDNA  was  added  to  a  50ul  reaction  containing  10xPCR  buffer 
(100mM tris-HCI, 15mM MgCl2, 500mM KCL), 0.2mM of each dNTP, 0.2mM of 
each primer con1 and con2 (Gentsch et al, 1992; Rasool et al, 2002). A mixture of 2U 
of  Taq  DNA  polymerase,  0.028uM  TaqStart  antibody™  (Clontech  Laboratories, 
Paolo Alto, USA) and 4xTaqStart antibody dilution buffer (Clontech Laboratories, 
Paolo Alto, USA) was incubated at room temperature for 10 minutes before being 
added to the final reaction mixture. PCR conditions were 94
oC for 5 mins, 40 cycles 
of: 94
oC for 30 secs, 42
oC for 1 minute, 72
oC for 1 minute 30 secs; with a final step of 
72
oC for 7 mins. Products were then subjected to agarose gel electrophoresis. Positive 
bands were expected at 220bp for rotavirus. 
Individual RT-PCR For Sapovirus 
10ul  of  cDNA  was  added  to  a  50ul  reaction  containing  10xPCR  buffer 
(100mM tris-HCI, 15mM MgCl2, 500mM KCL), 0.2mM of each dNTP, 0.2mM of   140 
primers JV66 and SR80 for sapovirus (Vinje et al, 2000). A mixture of 2U of Taq 
DNA polymerase, 0.028uM TaqStart antibody (Clontech Laboratories, Paolo Alto, 
USA), and 4xTaqStart antibody dilution buffer (Clontech Laboratories, Paolo Alto, 
USA) was incubated at room temperature for 10 minutes before being added to the 
final reaction mixture. PCR conditions were 94
oC for 3 mins, 40 cycles of: 94
oC for 1 
min, 37
oC for 1 min 30 secs, 74
oC for 1 minute; with a final extension step of 72
oC 
for 7 min. Products were then subjected to agarose gel electrophoresis. Positive bands 
were expected at 349bp for sapovirus. 
4.4.1.3. Results  
Results for the dilution series (Table 19) showed significant reductions in the 
end point detection limits for astrovirus, rotavirus and sapovirus the multiplex version 
of  the  assay.  In  fact,  the  multiplex  assay  failed  to  detect  rotavirus  at  any  of  the 
concentrations tested. 
Assuming  that  these  decreases  in  sensitivity  were  due  to  cross-reactions 
between the primers for each pathogen, each set of primers was removed in turn from 
the multiplex assay in order to investigate the source(s) of the problem. All other 
constituents and parameters in the multiplex assay remained the same. 
Removing the adenovirus PCR assay from the multiplex RT-PCR assay did 
not improve the end point detection limit of the astrovirus, rotavirus or sapovirus RT-
PCR  tests  (Table  20).  Similarly,  removing  the  astrovirus  RT-PCR  and  did  not 
improve  the  rotavirus  and  sapovirus  RT-PCR  (Table  21).  However,  removing  the 
rotavirus  RT-PCR  resulted  in  the  remaining  multiplex  RT-PCR  assay  producing 
similar levels of sensitivity to the corresponding individual PCR assays (Table 22).  
Table 19: Comparison of multiplex PCR for adenovirus, astrovirus, rotavirus and 
sapovirus with singleton assays on dilution series. 
Adenovirus  Astrovirus  Rotavirus  Sapovirus  Dilution 
Multi 
Result 
Single 
Result 
Multi 
Result 
Single 
Result 
Multi 
Result 
Single 
Result 
Multi 
Result 
Single 
Result 
10
-1  +  +  +  +  -  +  +  + 
10
-2  +  +  -  +  -  +  +  + 
10
-3  +  +  -  -  -  +  -  + 
10
-4  +  +  -  -  -  -  -  - 
10
-5  -  -  -  -  -  -  -  - 
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Table 20: Comparison of multiplex PCR for astrovirus, rotavirus and sapovirus with 
singleton assays on dilution series. 
Astrovirus  Rotavirus  Sapovirus  Dilution 
Multi 
Result 
Single 
Result 
Multi 
Result 
Single 
Result 
Multi 
Result 
Single 
Result 
10
-1  +  +  -  +  +  + 
10
-2  -  +  -  +  +  + 
10
-3  -  -  -  +  -  + 
10
-4  -  -  -  -  -  - 
10
-5  -  -  -  -  -  - 
 
Table 21: Comparison of multiplex PCR for adenovirus, rotavirus and sapovirus with 
singleton assays on dilution series. 
Adenovirus  Rotavirus  Sapovirus  Dilution 
Multi 
Result 
Single 
Result 
Multi 
Result 
Single 
Result 
Multi 
Result 
Single 
Result 
10
-1  +  +  -  +  +  + 
10
-2  +  +  -  +  +  + 
10
-3  +  +  -  +  -  + 
10
-4  +  +  -  -  -  - 
10
-5  -  -  -  -  -  - 
 
Table 22: Comparison of multiplex PCR for adenovirus, astrovirus and sapovirus with 
singleton assays on dilution series. 
Adenovirus  Astrovirus  Sapovirus  Dilution 
Multi 
Result 
Single  
Result 
Multi  
Result  
Single  
Result  
Multi  
Result  
Single  
Result  
10
-1  +  +  +  +  +  + 
10
-2  +  +  +  +  +  + 
10
-3  +  +  -  -  +  + 
10
-4  +  +  -  -  -  - 
10
-5  -  -  -  -  -  - 
 
When  tested  using  the  74  clinical  samples,  moreover,  this  version  of  the 
multiplex assay detected all cases of adenovirus, astrovirus and sapovirus in the panel. 
In addition, it did not detect any samples in the specificity panel as positive and hence 
was shown to be specific. 
In all versions of the multiplex assay the inclusion of an RT step was shown to 
have no effect on the sensitivity of the adenovirus detection. The data also showed 
that changing the original annealing temperature as part of the multiplexing process 
had little effect on the individual assays’ sensitivity.  
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4.4.1.4. Study Conclusions 
The results from this experiment showed that it was not possible to multiplex 
all four assays without seriously affecting their sensitivity. Instead, the four chosen 
PCR assays were reduced to two tests: a single RT-PCR assay for rotavirus and a 
novel  multiplex  assay  for  the  detection  of  adenovirus,  astrovirus  and  sapovirus. 
Although not as efficient as a single four-way test, this still represents a saving in the 
cost and rapidity of testing in comparison to four separate tests since fewer steps will 
be  carried  out,  less  reagents  will  be  used  and  less  technician  time  is  required. 
However, on balance it was felt that the benefits of a dual PCR test solution were not 
enough to warrant the replacement of the EM service for sporadic IID at this stage. 
4.4.2. Developed Gel-Based PCR Methods Vs EIA Methods  
As described earlier, EIA methods are popular assays in laboratories without 
access to EM or PCR. Studies have shown these to be similar in sensitivity to EM 
(Giordano et al, 2005; Rabenau et al, 1998; Putzker et al, 2000) although few studies 
exist comparing them to PCR methods. The advantage of such methods is that they 
are considered simple to implement, easy to use and are rapid and high throughput. 
The  aim  of  this  second  study,  therefore,  was  to  measure  the  sensitivity  of 
commercial EIA methods in comparison to the RT-PCR assay for rotavirus and the 
multiplex RT-PCR for adenovirus, astrovirus and sapovirus developed in the previous 
experiment. Should the EIA methods prove as sensitive as the PCR assays, or more 
so, this and the relative ease of their implementation in comparison to a dual PCR 
solution would mean these were potential candidates as the replacement for EM in the 
sporadic service.  
The multiplex RT-PCR assay was compared to an EIA for astrovirus, whilst 
the rotavirus RT-PCR was compared to both an ICG and an EIA for the detection of 
rotavirus.  EIA  methods  for  the  detection  of  adenovirus  and  sapovirus  were  not 
included  in  the  comparison  since  an  adenovirus  EIA  was  not  available  in  the 
laboratory during the period of study and a commercial sapovirus EIA had yet to be 
developed. Similarly, an ICG test for astrovirus was not available in the laboratory 
during this time. Both types of test were assessed using faecal samples taken from 
children with clinically diagnosed IID. 
Subsequently, in 2007, all samples for which the two tests produced different 
results were re-tested using the dual-labelled probe-based real-time RT-PCR assays   143 
described  in  section  3.4.2.3  of  Chapter  3  once  these  became  available.  These  are 
useful methods for confirmation since they target alternative regions of the rotavirus 
and  astrovirus  genome  (Pang  et  al,  2004;  Le  Cann  et  al,  2004)  to  the  gel-based 
methods.  This  extra  testing  was  carried  out  in  order  to  confirm  the  initial  results 
obtained in 2004 and to ensure that the correct service decisions were made regarding 
the routine diagnostic service.  
4.4.2.1. Methods 
Sample Panels 
Comparison Of Rotavirus RT-PCR With Commercial EIA And ICG 
The single gel-based RT-PCR assay was compared with a commercial ICG 
and  EIA  on  107  faecal  samples  collected  from  children  under  5  years  old  with 
sporadic  IID.  All  samples  were  from  patients  clinically  diagnosed  as  having 
gastroenteritis  (as  shown  on  the  specimen  request  forms)  and  were  submitted  to 
Monklands District General Hospital (MDGH), Lanarkshire between February and 
April 2002. All samples had initially been tested at MDGH using an ICG test for 
rotavirus  (Rotascreen  Dipstick,  Microgen  Bio  Products).  Samples  were  then 
immediately  sent  to  the  WOSSVC  and  tested  using  both  the  RT-PCR  and  a 
commonly used EIA (Rotascreen II EIA, Microgen Bio Products). All samples were 
tested within 7 days of collection from the patient in line with the EIA manufacturer’s 
requirements. Negative (VTM) PCR controls were included in each PCR run.  
Comparison Of Multiplex RT-PCR With Commercial EIA For Astrovirus 
In total, 48 faecal samples were used to compare the EIA with the multiplex 
RT-PCR for astrovirus, adenovirus and sapovirus. All samples had originally been 
sent to Monklands District General Hospital (MDGH), Lanarkshire in February to 
April 2002, from children under 5  years old with clinically diagnosed community 
managed gastroenteritis. All samples had tested negative for rotavirus (using ICG) 
and for other microbiological pathogens at the MDGH. They had also tested negative 
at the WOSSVC for adenovirus, rotavirus and sapovirus using the singleton gel-based 
RT-PCR assays described earlier and norovirus using the Lightcycler™ RT-PCR test. 
All samples were tested within 7 days of collection from the patient in line with the 
EIA manufacturer’s requirements. Negative (VTM) PCR controls were included in 
each PCR run to control for test contamination.    144 
4.4.2.2. Laboratory Methods 
All samples to be tested using both the rotavirus RT-PCR and the multiplex 
RT-PCR  were  processed  using  the  faecal  extraction  and  nucleic  acid  extraction 
protocols outlined previously in Chapter 3 (Section 3.4.1.1 and 3.3.1.2). The rotavirus 
RT-PCR is described previously (section 4.4.1.1) and the multiplex developed in the 
previous experiment is described below. The real-time PCR methods for rotavirus and 
astrovirus are also described in Chapter 3 (section 3.4.2.3). 
Multiplex RT-PCR For Adenovirus, Astrovirus And Sapovirus 
10ul  of  cDNA  was  added  to  a  50ul  reaction  containing  10xPCR  buffer 
(100mM tris-HCI, 15mM MgCl2, 500mM KCL), 0.2mM of each dNTP, 0.2mM of 
each set of primers for each of the different pathogens. A mixture of 2U of Taq DNA 
polymerase, 0.028uM TaqStart antibody (Clontech  Laboratories, Palo Alto, USA), 
and 4xTaqStart antibody dilution buffer (Clontech Laboratories, Palo Alto, USA) was 
incubated at room temperature for 10 minutes before being added to the final reaction 
mixture. PCR conditions were 94
oC for 3 mins, 40 cycles of: 94
oC for 30 secs, 47
oC 
for 40 secs, 72
oC for 30 secs; with a final extension step of 72
oC for 7 min. Products 
were then subjected to agarose gel electrophoresis. Positive bands were expected at 
140bp for adenovirus, 449bp for astrovirus and 349bp for sapovirus. 
Commercial EIA Assay for Rotavirus (Microgen) 
The commercial antigen detection assay used for rotavirus was the Rotascreen 
II  EIA  test  supplied  by  Microgen  Bio-Products,  Camberley,  Surrey,  UK.  Before 
carrying  out  the  EIA  test  all  reagents  were  made  up  as  per  the  manufacturer’s 
instructions.  The  commercial  EIA  was  then  carried  out  according  to  its 
manufacturer’s  instructions  (Microgen  Bio-Products,  Camberley,  Surrey,  UK). 
Briefly, approximately 0.1g of faecal specimens was added to 1ml of sample diluent 
and mixed thoroughly. The appropriate number of microtitre wells for samples and 
controls was selected from the kit. 50ul of positive control was then added to the 
appropriate  positive  control  well.  50ul  of  negative  control  was  added  to  the 
appropriate  negative  control  well.  50ul  of  the  sample/s  were  then  added  to  the 
appropriate wells. 50ul of conjugate was then added to each well. The plate was then 
incubated at room temperature for 30mins. The wells were then washed three times 
using the wash buffer. 100ul of substrate was then added to all wells before a second 
incubation  step  at  room  temperature  for  20mins.  100ul  of  stop  solution  was  then   145 
added  to  each  well.  The  wells  were  read  at  absorbance  450nm.  According  to  the 
manufacturer’s instructions, the positive control must have an absorbance value of 
more than 0.6 A450 units. The negative control must have an absorbance value of less 
than 0.15A450 units. Samples are regarded as positive if the A450 value is greater than 
the A450 value of the negative control plus 0.1 absorbance units. It is recommended 
that faecal samples giving absorbance values within 10% of the cut off should be 
retested.  
Commercial EIA For Astrovirus 
The  EIA  used  for  astrovirus  used  an  amplified  IDEIA  test  (DAKO 
Cytomation,  Cambridgeshire,  UK)  and  was  carried  out  in  accordance  with  the 
manufacturer’s instructions. Approximately 0.1g of faecal specimens were added to 
1ml of sample diluent and mixed thoroughly. The appropriate number of microtitre 
wells was selected from the kit. 100ul of positive control was added to the appropriate 
positive control well. 100ul of negative control was added to the appropriate negative 
controlwell.  100ul  of  clinical  sample  was  added to  the  appropriate  well.  100ul  of 
conjugate was then added to all wells. Wells were incubated at 25
oC for 60 minutes 
and then washed five times using wash buffer. 100ul of substrate was then added to 
each  well  and  incubated  at  25
oC  for  10  minutes.  100ul  of  stopping  solution  was 
added.  Wells  were  read  photometrically  at  450nm.  According  to  manufacturers 
instructions  the  positive control  must  have  an  absorbance  value  of  more  than  0.5 
absorbance units. Negative controls should have absorbance values of less than 0.15 
absorbance units. Cut off values are calculated by adding 0.1 absorbance units to the 
negative control value. Positive samples must have absorbance units above the cut off 
value. A result within 0.1 absorbance units of the cut off value should be interpreted 
cautiously taking into account the clinical and epidemiological data.   
4.4.2.3. Results 
Comparison Of Rotavirus RT-PCR With EIA And ICG 
The RT-PCR assay detected rotavirus in 58 samples whereas the ICG detected 
it in 29 and the EIA in 28 (Table 23-Table 25). Rotavirus was detected in the same 17 
samples  by  both  antigen  detection  methods.  These,  plus  all  other  EIA  and  ICG 
positive  results  were  confirmed  using  the  RT-PCR.  All  negative  controls  tested 
negative using the RT-PCR assay and the EIA and ICG methods. In 2007, all of the   146 
RT-PCR positive results were confirmed as positive using the dual-labelled probe-
based RT-PCR. 
Table 23: Comparison of RT-PCR and EIA for the detection of rotavirus. 
  RT-PCR 
EIA  Positive  Negative 
Positive  28  0 
Negative  30  49 
 
Table 24: Comparison of RT-PCR and ICG for the detection of rotavirus. 
  RT-PCR 
ICG  Positive  Negative 
Positive  29  0 
Negative  29  49 
 
Table 25: Comparison of ICG and EIA for the detection of rotavirus. 
  EIA 
ICG  Positive  Negative 
Positive  17  12 
Negative  11  67 
 
Comparison Of Multiplex RT-PCR With Commercial EIA For Astrovirus 
Using  the  multiplex  RT-PCR,  initial  testing  of  the  sample  panel  provided 
results  with  numerous  non-specific  bands  that  could  not  be  read  with  confidence 
(Figure 13). At this stage it was not clear if this were due to human error or a more 
serious problem with the robustness of the multiplex RT-PCR. Repeat testing rectified 
the problem so that the results could be examined.  
Following  repeat  testing  the  multiplex  RT-PCR  detected  astrovirus  in  18 
samples compared to 8 that tested positive using the EIA (Table 26). Astrovirus was 
detected by both tests in 7 cases. The other sample that tested positive for astrovirus 
using  the  EIA  tested  negative  using  the  multiplex  RT-PCR.  29  samples  tested 
negative for astrovirus using both assays. No other viral causes of IID were detected 
in  these  samples  using  the  multiplex  RT-PCR,  confirming  the  findings  of  the 
singleton assays and the Lightcycler™ RT-PCR. All extra RT-PCR positive results 
were confirmed as positive using the dual-labelled probe-based RT-PCR. The sample 
that tested positive for astrovirus using the EIA assay but negative using the multiplex 
RT-PCR was also found to be negative using the dual-labelled probe-based assay.   147 
Figure 13: Example Of Non-Specific Banding Patterns Observed With The Multiplex RT-
PCR. 
 
 
Table 26: Comparison of RT-PCR And EIA For The Detection Of Astrovirus. 
  RT-PCR 
EIA  Positive  Negative 
Positive  7  1 
Negative  11  29 
4.4.2.4. Study Conclusions 
The results showed that both the rotavirus and the multiplex RT-PCR methods 
were more sensitive than either of the antigen detection methods examined (Gunson et 
al, 2003(iii); Gunson et al, 2003(iv)). Both detected the relevant pathogen in more 
samples than the antigen detection methods (The improved sensitivity of these assays 
was confirmed by re-testing the extra positive samples using real-time PCR in 2007). 
These  results  are  similar  to  those  found  for  the  assessment  of  the  norovirus  EIA 
methods in the previous section.  
The  poorer  sensitivity  of  the  EIA  methods  meant  these  were  rejected  as 
replacements for the existing EM-based service for sporadic cases of IID. However, 
the numerous steps involved in a dual PCR solution together with concerns over the 
robustness  of  the  multiplex  RT-PCR  (since  repeat  testing  was  required  in  this 
experiment to establish clear result bands) meant that, at this stage, the decision was 
also  taken  not  to  proceed  with  the  implementation  of  the  gel-based  assays  as  the 
frontline tests for sporadic cases of IID. EM remained the test employed in routine   148 
service until 2004, when dual-labelled probe-based technology was introduced. This 
is described in the following section. 
4.4.3. Developed Gel-Based PCR Methods Vs Dual-Labelled Probe-
Based Real-Time PCR Methods 
As mentioned earlier, in 2003 the WOSSVC implemented a number of PCR 
platforms that could support real-time chemistries such as dual-labelled probes.  
This  introduced  the  possibility  of  implementing  real-time  PCR  tests  for 
adenovirus, astrovirus, rotavirus and sapovirus in the diagnostic service for sporadic 
cases of IID, a two test gel-based PCR solution having previously been rejected on the 
basis of involving too many steps. Commercial antigen detection methods had also 
been rejected due to their limited sensitivity.  
The aim of the third experiment in this series, therefore, was to assess the 
sensitivity of the real-time assays for adenovirus, astrovirus, rotavirus and sapovirus 
selected and developed as described in Chapter 3 in comparison to the two gel-based 
PCR tests. The assays were compared using a number of dilution series and a panel of 
322 stool samples taken from children with clinically diagnosed sporadic IID. The 
dual-labelled  probe-based  assays  were  also  assessed  using  the  sample  specificity 
panel described earlier. 
In 2007, all samples for which the two test types of produced different results 
were  re-tested  using  a  number  of  gel-based  PCR  methods.  These  methods  were 
chosen because they targeted alternative regions of the viral genome to that targeted 
by the real-time PCR methods. In addition some of these were nested protocols - a 
type  of  assay  that,  although  rejected  for  routine  use  due  to  the  numerous  steps 
involved, has been shown to be sensitive. Although confirmatory testing had no effect 
on the service decisions made at the time, it provided reassurance that the correct 
decisions were taken. 
 All discrepant adenovirus results were tested using the assay described by Xu 
et al (Xu et al, 1990). This is a universal adenovirus test that targets an alternative part 
of the hexon region to the others under examination. For astrovirus discrepant results, 
a hemi nested RT-PCR was used that targets the capsid region (Gallimore et al, 2005). 
The assay uses the same primers (mon 269 and mon 270) as described by Noel et al in 
the first round and uses an adapted mon 269 as the internal primer in the second 
nested step. This assay had already been shown to be more sensitive than the single   149 
round  RT-PCR  described  by  Noel  et  al.  For  rotavirus,  all  discrepant  results  were 
tested using the nested RT-PCR described by DiStefano et al (Distefano et al, 2005). 
This assay targets the VP7 region of the rotavirus genome. Finally for all sapovirus 
discrepant results, the universal nested RT-PCR described by Okada at al was used 
(Okada et al, 2006). This assay targeted both the RdRp and Capsid region.  
4.4.3.1. Methods 
Sample Panels 
Specificity Panel 
The same specificity panel as used in section 4.4.1.1 was used to assess the 
specificity of the dual-labelled probe-based real-time PCR methods.  
Dilution Series 
In order to establish end point detection limits of each test 8 separate dilution 
series  were  tested.  The  following  pathogens  were  represented  (each  in  a  separate 
dilution series): rotavirus types G1 and G2; adenovirus types 40 and 41; astrovirus 
types 1 and 3 and sapovirus types G1 (Sapporo/82/JP U65427) and G2 (Bristol/98/UK 
AJ249939). 
Clinical Samples  
A total of 322 faecal specimens were collected from children (aged less than 5 
years)  with  clinically  diagnosed  gastroenteritis.  All  samples  were  submitted  to 
Monklands  General  District  Hospital  (MDGH),  Lanarkshire  by  GPs  in  the 
Lanarkshire  area  between  December  2000  and  March  2001.  Samples  were 
subsequently sent to the WOSSVC for PCR testing. The first phase of the study tested 
all samples using the developed gel-based RT-PCR for rotavirus, the Lightcycler
TM 
RT-PCR for norovirus, and the gel-based multiplex RT-PCR assay for adenovirus, 
astrovirus, and sapovirus. Samples were then stored at –70
oC. Subsequently (in 2004) 
all  samples  were  tested  using  the  dual-labelled  probe-based  real-time  PCR  for 
adenovirus, astrovirus, rotavirus and sapovirus described in Chapter 3. Following this 
second testing, samples were stored at –70
oC before confirmatory testing in 2007. 
4.4.3.2. Laboratory Methods 
All samples to be tested using the gel-based and real-time PCR methods were 
processed using the faecal extraction and nucleic acid extraction procedures outlined 
previously. The gel-based RT-PCR technique for the detection of rotavirus and the   150 
multiplex RT-PCR assay for astrovirus, adenovirus and sapovirus are described in the 
previous  experiment.  The  dual-labelled  probe-based  methods  for  adenovirus, 
astrovirus, rotavirus and sapovirus are described in Chapter 3 (section 3.4.2.3).  
Confirmation PCR Methods 
PCR For Adenovirus 
Extracted DNA (25ul) was amplified using a 25ul volume of the Qiagen PCR 
master  mix  (Qiagen,  Crawley,  UK)  using  primers  AD1  and  AD2  (both  at  50 
pmoles/µl per reaction). The plate was incubated in the Applied  Biosystems PCR 
machine using the programme 94
oC for 4 min, 40 cycles of: 94
oC for 1 min, 54
oC for 
45 sec and 72
oC for 2 min; followed by a hold step of 72
oC for 10 min. Products were 
visualised using agarose gel electrophoresis. For the hexon assay a PCR product of 
482bp was expected if adenovirus was successfully amplified from the sample.  
Nested RT-PCR For Astrovirus 
Extracted RNA (12.5ul) was amplified using a combined one step RT-PCR kit 
(Qiagen, Crawley, UK) using primers Mon 269 and Mon 270 (25 pmoles/ reaction). 
The  plate  was  incubated  in  the  Applied  Biosystems  PCR  machine  using  the 
programme 50
oC for 30 min, 95
oC for 15 min and 35 cycles of: 95
oC for 40 sec, 45
oC 
for 40 sec and 72
oC for 1 min. 2ul of first round product was transferred to a 48 ul 
second  round  reaction  (Qiagen)  containing  primers  mon269N  (an  adapted  primer 
internal to mon 269) and mon270 (50 pmoles/reaction). This was then subjected to 40 
cycles of: 94
oC for 40 sec, 45
oC for 25 sec and 72
oC for 1 min 30 sec. This was 
followed by a hold step 72
oC for 10 min. Products were visualised using agarose gel 
electrophoresis. A PCR product of 424bp was expected if astrovirus was successfully 
amplified from the sample. 
Nested RT-PCR For Rotavirus 
Extracted RNA (12.5.ul) was amplified using a combined one step RT-PCR 
kit (Qiagen, Crawley, UK) and the published forward and reverse primers (25 pmoles/ 
reaction). The plate was incubated in the Applied Biosystems PCR machine using the 
programme 50
oC for 30 min, 95
oC for 15 min and 35 cycles of: 95
oC for 40 sec and 
45
oC for 40 sec. This was followed by 72
oC for 1 min. 2ul of first round product was 
then transferred to a 48 ul second round reaction (Qiagen) containing the published 
internal primers (50 pmoles/reaction) and subjected to 40 cycles of: 94
oC for 40 sec, 
45
oC for 25 sec and 72
oC for 1 min 30 sec. This was followed by a hold step of 72
oC   151 
for  10  min.  Products  were  visualised  using  agarose  gel  electrophoresis.  A  PCR 
product  of  365bp  was  expected  if  rotavirus  was  successfully  amplified  from  the 
sample. 
Nested RT-PCR For Sapovirus 
Extracted RNA (12.5.ul) was amplified using a combined one step RT-PCR 
kit (Qiagen, Crawley, UK) using primers F13/14 and R13/14 (25 pmoles/reaction). 
The plate was incubated in the Applied Biosystems PCR machine using 50
oC for 30 
min, 95
oC for 15 min and 25 cycles of: 95
oC for 40 sec, 45
oC for 40 sec and 72
oC for 
1 min. 2ul of first round product was then transferred to a 48 ul second round reaction 
(Qiagen) containing primers F22 and R2 (50 pmoles/reaction) and subjected to 40 
cycles of: 94
oC for 40 sec, 45
oC for 25 sec and 72
oC for 1 min 30 sec. This was 
followed by a hold step of 72
oC for 10 min. Products were visualised using agarose 
gel  electrophoresis.  A  PCR  product  of  420bp  was  expected  if  sapovirus  was 
successfully amplified from the sample. 
4.4.3.3. Results 
None of the real-time assays detected any of the specificity panel as positive 
indicating that they were specific. 
For each of the dilution series tested the real-time PCR methods were shown 
to have a lower limit of detection than the conventional gel-based (Table 27-Table 
30).  For  both  rotavirus  types  the  real-time  RT-PCR  assay  was  shown  to  be 
approximately 3 log more sensitive. The improvement was by a factor of 1-2 log for 
the real-time RT-PCR for astrovirus types 1 and 3, and for the adenovirus real-time 
PCR it was 1 log. The sapovirus real-time RT-PCR was more sensitive on the G1.1 
dilution  series  by  approximately  2  log  (Gunson,  Collins  and  Carman,  2006(i)). 
However, it failed to detect any of the G2.1 dilutions. This was as anticipated based 
on the developmental data reported in Chapter 3, where sequence alignment showed 
the test was unlikely to detected G2 types. 
Results  from  testing  the  sample  panel  showed  that  the  gel-based  RT-PCR 
assays detected one or  more pathogens in 209 (65.0%) of the 322 faecal samples 
investigated (Table 31). All of these positive results were also detected using the real-
time dual-labelled probe-based methods. In addition, a further 36 viral pathogens were 
detected using the real-time methods. In total therefore, the real-time PCR methods 
detected  viral  pathogens  in  245  samples  (76.1%).  A  viral  pathogen  could  not  be   152 
detected in 77 faecal specimens using these methods. Greater numbers of positive 
detections were observed for all of the individual real-time PCR tests in comparison to 
the  conventional  gel-based  PCR  assays.  The  greatest  increase  in  detections  was 
observed for the rotavirus, adenovirus and astrovirus tests. A smaller number of extra 
positive  detections  was  observed  for  the  dual-labelled  probe-based  assay  for 
sapovirus. In 2007, upon re-testing with the gel-based confirmatory assays, all the 
extra real-time PCR results were confirmed as positive. 
Table 27: Comparison of real-time PCR for adenovirus with multiplex RT-PCR assay on 
an adenovirus dilution series. 
Reat-Time PCR Result  Multiplex RT-PCR Result  Dilution 
Ad40  Ad41  Ad40  Ad41 
10
-1  +   +   +  + 
10
-2  +   +   +  + 
10
-3  +   +   +  + 
10
-4  +   +   +  + 
10
-5  +   +   +  - 
10
-6  +   -  -  - 
10
-7  -  -  -  - 
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Table 28: Comparison of real-time RT-PCR for astrovirus with multiplex RT-PCR assay 
on an astrovirus dilution series. 
Reat-Time RT-PCR Result  Multiplex RT-PCR Result  Dilution 
Astrovirus  
Type 1 
Astrovirus  
Type 3 
Astrovirus  
Type 1 
Astrovirus  
Type 3 
10
-1  +   +   +  + 
10
-2  +   +   +  + 
10
-3  +   +   +  + 
10
-4  +  +   +  - 
10
-5  +   +   -  - 
10
-6  +   -  -  - 
10
-7  +   -  -  - 
10
-8  -  -  -  - 
Table 29: Comparison of real-time RT-PCR for rotavirus with gel-based RT-PCR on a 
rotavirus dilution series. 
Reat-Time RT-PCR Result  Gel-Based RT-PCR Result  Dilution 
Rotavirus G1  Rotavirus G2  Rotavirus G1  Rotavirus G2 
10
-1  +   +   +  + 
10
-2  +   +   +  + 
10
-3  +   +   +  + 
10
-4  +   +   -  + 
10
-5  +   +   -  - 
10
-6  +   +   -  - 
10
-7  -  +   -  - 
10
-8  -  -  -  - 
 
Table 30: Comparison of real-time RT-PCR for sapovirus with multiplex RT-PCR assay 
on a sapovirus dilution series. 
Reat-Time RT-PCR Result  Multiplex RT-PCR Assay Result  Dilution 
Sapovirus G1.1  Sapovirus G2.1  Sapovirus G1.1  Sapovirus G2.1 
10
-1  +   -  +  + 
10
-2  +   -  +  + 
10
-3  +   -  +  - 
10
-4  +   -  -  - 
10
-5  +   -  -  - 
10
-6  -  -  -  - 
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Table 31: Comparison of real-time PCR and gel-based PCR detection rates for 
adenovirus, astrovirus, rotavirus and sapovirus. 
Aetiological IID (s)  Gel-Based PCR  Reat-Time PCR 
Rotavirus       81  (25.2%)      95  (30%) 
Astrovirus       70  (21.7%)      82  (25.5%) 
Adenovirus       30  (9.3%)      38  (11.8%) 
Sapovirus       11  (3.4%)      13  (4.0%) 
Rotavirus and astrovirus         8  (2.5%)        8  (2.5%) 
Adenovirus and astrovirus         2  (0.6%)        2  (0.6%) 
Adenovirus and rotavirus         5  (1.5%)        5  (1.5%) 
Sapovirus and rotavirus         1  (0.3%)        1  (0.3%) 
Astrovirus, adenovirus and rotavirus         1  (0.3%)        1  (0.3%) 
Total viral pathogens detected    209   (65.0%)    245  (76.1%) 
Total negative    113  (35.0%)      77  (23.9%) 
Total samples  322  322 
4.4.3.4. Study Conclusions 
The  dual-labelled  probe-based  real-time  PCR  methods  were  shown  to  be 
specific and more sensitive than their conventional gel-based counterparts. The real-
time PCR methods detected more viral pathogens in more samples in the sample panel 
and had a lower end point detection limit in most of the series tested. The increased 
detection rate was confirmed by re-testing with gel-based methods in 2007. 
The only test where real-time PCR was not found to be an improvement was 
the dual-labelled probe-based RT-PCR for sapovirus, which failed to detect the G2.1 
type. This confirms the development data presented in Chapter 3, which showed that 
the primers and probe developed were specific to G1 sapoviruses only and would fail 
to detect sapoviruses from the other genogroups. However, despite this the real-time 
PCR assay detected more cases of sapovirus in the sample panel than the gel-based 
RT-PCR, which detects sapoviruses from several genogroups (G1-3). This suggests 
that G1 types were more common in this panel and that the new dual-labelled probe-
based assay was still useful.  
The 2-test gel-based solution incorporates more steps than using 4 separate 
dual-labelled probe-based methods. For example, to test one sample using both the 
rotavirus  RT-PCR  and  the  multiplex  RT-PCR  would  require  7  separate  steps 
(including  universal  steps  for  stool  extraction,  nucleic  acid  extraction  and  reverse 
transcriptase, together with the PCR steps and  agarose-gel  analysis steps for  each 
assay). To test a single sample using all real-time PCR methods, on the other hand, 
would require 6 separate steps (including universal steps for stool extraction, nucleic   155 
acid extraction, and four separate RT-PCR steps for each of the 4 assays). Moreover, 
in the gel-based methods the RT and PCR steps together can take 4-5 hours, compared 
to 1-1.5 hours using the real-time methods. The agarose gel analysis step in addition 
can take 2-3 hours, depending on the number of samples under scrutiny 
The  improved  sensitivity  of  the  real-time  PCR  methods,  coupled  with  the 
reduced  duration  and  number  of  steps  involved,  resulted  in  these  assays  being 
implemented as the frontline tests for the detection of adenovirus, astrovirus, rotavirus 
and sapovirus sporadic cases of IID in November 2004 (and as the secondary tests for 
outbreaks  of  IID  that  were  negative  for  norovirus).  These  methods  replaced  EM, 
which was retained solely for examining outbreaks classified as negative for all 5 
main viral pathogens using the real-time PCR methods.  
4.5. Experiments  Aimed  At Improving the Efficiency and Cost Of 
Reat-Time PCR In The Routine Diagnostic Setting 
Based on the research described, from 2004 dual-labelled probe-based real-
time PCR methods have been employed at the WOSSVC as the frontline tests for both 
sporadic cases and outbreaks of IID. In this third section, a number of experiments 
aimed  at  reducing  the  turn-around-time  of  these  real-time  PCR  methods  and 
increasing sample throughput are described. Some of these methods are also aimed at 
reducing the cost of carrying out a real-time PCR test. The experiments described 
examined  the  effect  on  test  sensitivity  of  variously  reducing  the  length  of  PCR 
parameters; carrying out DNA PCR under RT-PCR conditions; using pooled positive 
controls; using primer/probe pools and reducing the overall volume of PCR reagents. 
4.5.1. Reducing The PCR Cycling Times 
Most probe-based real-time PCR assays consist of the following steps: a Taq 
DNA polymerase activation step of 95
oC for 2-15 minutes (depending on the exact 
Taq DNA polymerase used) and 40-50 cycles of the following steps: a denaturation 
step  of  95
oC  for  15-30  seconds,  and  an  annealing/extension  step  of  60
oC  for  60 
seconds. If the target is RNA then a reverse transcriptase step of 50
oC for 30 minutes 
is required prior to these steps. Based on these parameters the overall turn-around-
time of most real-time PCR assays ranges from 2-2.5 hours (excluding extraction). 
Any  technique  that  can  be  used  to  reduce  this  duration  without  affecting  the 
sensitivity of the test represents a saving, both in terms of the result turn-around-times   156 
and the economic cost of the test (since shorter duration means more efficient use of 
laboratory equipment, allowing more testing within the working day). The aim of this 
first experiment, therefore, was to examine whether the PCR cycling times in the 
implemented tests could be reduced without affecting their sensitivity.  
The  dual-labelled  probe-based  real-time  PCR  methods  for  astrovirus, 
adenovirus,  norovirus,  rotavirus  and  sapovirus  were  compared  using  normal  and 
reduced  PCR  cycling  conditions.  As  a  first  approximation  the  cycling  times  were 
reduced by 50%. The reduced PCR parameters consisted of the following: the RT step 
(where in use) was reduced from 30 minutes to 15 minutes; the denaturation step from 
15  seconds  to  8  seconds;  and  the  annealing/extension  step  was  altered  from  60 
seconds to 30 seconds. The Taq DNA polymerase activation step was not changed as 
it was felt that this would result in sub-optimal Taq DNA polymerase activity and was 
most likely to reduce sensitivity. 
4.5.1.1. Methods 
The effect of employing different cycling time parameters was assessed using 
(10 fold) dilution panels of adenovirus, astrovirus, norovirus, rotavirus and sapovirus 
positive  samples.  The  cycle  thresholds  of  each  dilution  and  the  end  point  were 
recorded and compared. 
4.5.1.2. Results And Study Conclusions 
The results of this study (Table 32) showed that reducing the duration of the 
reverse transcription, the denaturing and annealing/extension steps by 50% reduced 
the  reaction  run  time  of  the  assay  significantly  without  any  concurrent  loss  in 
sensitivity. Overall the reaction run time was reduced to approximately 60 minutes 
from 100 minutes for DNA real-time PCR, and to 75 minutes from 120 minutes for 
RNA  real-time  PCR.  As  a  result,  the  reduced  PCR  cycling  time  parameters  were 
introduced into the routine service in January 2005.   157 
Table 32: Comparison of real-time PCR sensitivity with normal and reduced PCR cycling parameters. 
Adenovirus Ct Value  Astrovirus Ct Value  Norovirus Ct Value  Rotavirus Ct Value  Sapovirus Ct Value 
Dilution 
Normal 
Parameters 
Reduced 
Parameters 
Normal 
Parameters 
Reduced 
Parameters 
Normal 
Parameters 
Reduced 
Parameters 
Normal 
Parameters 
Reduced 
Parameters 
Normal 
Parameters 
Reduced 
Parameters  
10
-1  25.1  25.7  27.1  27.5  22.8  21.9  26.1  25.5  21.7  21.4 
10
-2  30.6  29  30.8  30.4  26.3  25.9  28.8  27.5  25.1  24.9 
10
-3  33.4  33.6  34.2  34.1  29.8  30.0  32.7  30.4  28.9  29.0 
10
-4  -  -  -  -  34.8  33.7  -  -  32.8  33.0 
10
-5  -  -  -  -  -  -  -  -  36.2  37.2 
10
-6  -  -  -  -  -  -  -  -  -  - 
TRT 
(mins)   100  60  120  75  120  75  120  75  120  75 
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4.5.2. Simultaneous RNA and DNA Testing 
Where purchased from the same supplier, the kits for most DNA and RNA 
real-time PCR tests contain the same reagents (Taq DNA polymerase, buffers etc.), 
which has the advantage that the same temperature(s) can be used to activate the 
enzymes contained in them. Thus, where the PCR parameters are also the same across 
tests,  multiple  assays  can  be  processed  simultaneously  on  the  same  plate.  This 
increases the efficiency of platform use and helps reduce sample turn-around-times.  
In the service for sporadic cases of  IID, the RNA assays implemented for 
astrovirus, rotavirus and sapovirus employed the same kit and PCR parameters, and as 
a result were routinely processed on the same plate to ensure the platform was always 
used  to  its  maximum  capacity.  (The  norovirus  RNA  assay  employed  a  different 
annealing temperature and as a result was always carried out separately.) 
The second experiment in this series sought to examine whether the real-time 
DNA assay for adenovirus could also be carried out on the same plate as these RNA 
assays. The adenovirus assay also employed the same reagents and PCR conditions as 
the tests for astrovirus, rotavirus and sapovirus - with the exception that there was no 
RT step. The RT step in this case involved an extra temperature hold of 15 minutes at 
50
oC (reduced from 30 minutes following the results of the previous experiment). The 
aim of this experiment, therefore, was to examine whether the adenovirus assay could 
be implemented using these (RNA) conditions without affecting its sensitivity, and 
thus could be carried out at the same time as the RNA assays.  
4.5.2.1. Methods 
A  dilution  series  of  an  adenovirus-positive  control  was  tested  using  the 
adenovirus PCR under both DNA and RNA conditions (see section 3.4.2.3 in Chapter 
3). The endpoint Ct value was recorded and compared.  
4.5.2.2. Results And Study Conclusions 
The results of this study (Table 33) showed that the adenovirus assay did not 
suffer any loss in performance when executed using the RNA cycling conditions. As a 
result, from January 2005, where otherwise the platform would be operating at less 
than maximum capacity, the adenovirus test was run simultaneously with those for 
astrovirus, rotavirus and sapovirus under RNA conditions.    159 
Table 33: Comparison of adenovirus real-time PCR under DNA and RNA testing 
conditions. 
Dilution  Adenovirus PCR Ct  
(Under DNA Conditions) 
Adenovirus PCR Ct  
(Under RNA Conditions) 
10
-1  19.8  20.0 
10
-2  23.5  23.7 
10
-3  26.5  26.7 
10
-4  29.9  29.6 
10
-5  33.0  33.3 
10
-6  36.7  36.8 
4.6. Use Of Pooled Positive Controls 
Positive and negative controls are an essential part of any diagnostic service. A 
positive control i.e. a sample known to be positive for the pathogen of interest (and in 
the case of real-time PCR tests, with a known Ct value) is included in the process 
from sample preparation onwards. In a stable system the test result for this control 
should always be consistent, providing reassurance in each run that the test is working 
properly.  This,  in  turn,  increases  the  confidence  in  the  negative  results  provided, 
indicating that they are not due to a loss in sensitivity of the assay. 
In  the  implemented  IID  service  a  positive  control  was  included  for  each 
pathogen that samples could potentially be tested for (6 in total including G1 and G2 
for norovirus). This meant, however, that 6 of the 96 wells in each nucleic extraction 
run were required for positive controls alone. Positive controls were also required on 
the PCR reaction plate(s) for each pathogen tested for on that particular plate.  
The aim of this experiment, therefore, was to examine whether all positive 
controls could be pooled into one tube, thereby freeing up both extraction wells and 
PCR  wells  for  actual  clinical  samples.  Since  extraction  costs  in  particular  are  a 
substantial component of the overall test cost this would, if successful, help reduce the 
cost of the service as well as improving sample throughput and thus turn-around-
times. 
4.6.1.1. Methods 
To make up the pooled control, 6 samples containing variously adenovirus, 
astrovirus, norovirus (G1 and G2), rotavirus and sapovirus were diluted to give a Ct of 
between 28-31. From this, the dilution that would give a Ct value approximately 1 log 
above this value was made. The 6 controls were then added together and the volume 
made up with VTM to make a 1:10 dilution of this (returning the Ct to between 28-  160 
31). Following this the pooled control was aliquoted into single use vials. In order to 
test its effectiveness, the pooled control was then repeatedly tested over a period of 
time using the relevant PCR assays (from sample preparation onwards) to check that 
the Ct value detected for each pathogen in the pooled control was stable over time. 
The control was tested on the day of manufacture, at week 4, week 8 and week 24, 
and when not in use was stored at –70
oC. 
4.6.1.2. Results And Study Conclusions 
Experimental data showed that pooling all positive controls into a single pool 
resulted in a stable control that could reliably be used to monitor a PCR reaction 
(Table  34).  As  a  result  pooled  controls  were  implemented  in  the  IID  service  in 
January 2005.  
Table 34: Effect of using pooled positive controls on test sensitivity. 
 
Adenovirus  
Result   
(Ct) 
Astrovirus  
Result  
(Ct) 
Norovirus  
G1 Result 
(Ct) 
Norovirus  
G2 Result 
(Ct) 
Rotavirus  
Result 
(Ct) 
Sapovirus  
Result 
(Ct) 
Day of Manufacture  29.2  31.2  29.7  31.2  28.2  29.5 
Week 4  29.4  31.8  29.9  31.0  28.6  29.4 
Week 8  29.1  30.9  28.9  31.2  28.9  29.9 
Week 24  30.0  31.4  29.5  31.9  28.3  29.3 
4.7. Use of Primer/Probe Pools 
All  PCR  methods  utilise  a  number  of  reagents,  which  have  to  be  added 
together before use. Although the real-time PCR methods implemented in the IID 
service utilised commercial RNA and DNA kits that have most PCR reagents added 
together in a ready-to-use mix (including buffer, dNTPs, Mg2+ and, in the case of 
DNA mastermixes, Taq Polymerase), the primers, probe and sometimes water still 
had to added separately in addition to the sample and, where appropriate, the RT-PCR 
enzyme. However, the greater the number of pipetting steps there are in a test the 
more likely it is that an error may occur.  
The aim of this experiment, therefore, was to examine whether the necessary 
primers, probes and water for a given assay could be added together in large quantities 
in  pre-prepared  batches  and  then  frozen,  stored  and  defrosted  as  required  without 
affecting the sensitivity of the test. Batch processing in this way has several potential 
advantages. First, preparing the mastermix, RT enzyme and primer/probe pools in   161 
large quantities ensures that the concentrations of each are the same between runs (i.e. 
it  facilitates  reproducibility).  It also reduces the number of steps required in  each 
individual  run  of  an  assay,  thereby  reducing  the  potential  for  human  error  and 
speeding up the process. The proposed batches were of 2-3 aliquots, each containing 
enough volume for 24 PCR reactions, and stored at –20
oC. 
4.7.1.1. Methods 
The use of primer/probe pools was tested using the dual-labelled probe-based 
assays for adenovirus (an example of a DNA test) and astrovirus (an example of an 
RNA test). First, for each, a positive control was tested using unpooled primers/probes 
(as  in  the  implemented  service)  to  establish  a  baseline  Ct  value  for  the  control. 
Following this, batches of the appropriate Mastermix (and RT enzyme in the case of 
astrovirus)  were  prepared  by  aliquoting  these  separately  into  24-reaction  volumes. 
The  relevant  primers,  probes  and  water  were  then  also  pooled  into  24-reaction 
aliquots.  
To test the effect of pooling on test sensitivity the positive control was then re-
tested using the pooled primers/probes to check the Ct value detected was the same as 
in the original test. The primer/probe pools were then stored at –20
oC and the process 
repeated at week 4, week 6 and week 8 to examine whether the performance of the 
primer/probe pools was affected by the storage and de-frosting process.  
4.7.1.2. Results And Study Conclusions 
Examination  of  the  Ct  values  for  the  astrovirus  and  adenovirus  controls 
showed no difference when tested at baseline, day of manufacture, 4, 6 and 8 weeks 
(Table 35). Use of primer/probe pools did not affect the sensitivity of either test and 
these were equally effective after storage and defrosting. Based on these results the 
use of primer/probe pools for all real-time PCR methods was implemented in January 
2005.    162 
Table 35: Effect of using primer/probe pools on test sensitivity. 
  Adenovirus Result 
(Ct value) 
Astrovirus Result 
(Ct value) 
Before Pooling  28.6  31.5 
Day of Manufacture  28.7  31.2 
Week 4  29.0  32.2 
Week 6  27.9  31.5 
Week 8  28.4  30.8 
4.7.2. Reducing The PCR Reagent Volume  
Most published real-time PCR reactions are carried out in 50ul volumes. This 
was also the case in the original implementation of the real-time tests used in the new 
IID service. Reducing this volume could significantly reduce the cost of the test, since 
more  tests  could  then  be  carried  out  per  commercial  kit.  The  aim  of  this  study, 
therefore, was to examine whether reducing the PCR reaction volume would affect 
test sensitivity.  
4.7.2.1. Method 
The possibility of reducing reagent volumes was examined using the dual-
labelled  probe-based  assay  for  adenovirus  (as  an  example  of  a  DNA  test)  and 
norovirus types G1 and G2 (an example of an RNA test). For each a positive control 
was  diluted  10  fold.  Each  dilution  series  was  then  tested  in  triplicate  using  PCR 
reaction volumes of 50ul, 25ul and 15ul. The endpoint detection limits of each test 
using the different volumes were then examined to look for any loss in sensitivity. 
4.7.2.2. Results And Study Conclusions 
The results of this experiment showed that reducing the PCR reaction volume 
had no significant effect on the endpoint detection limit of the real-time PCR methods 
examined (Table 36). As a result reaction volumes in the implemented tests were 
reduced from 50ul to 25ul in January 2005 and further to 15ul in January 2007 once it 
was  confirmed  in  routine  service  that  the  initial  reduction  in  volume  had  no 
detrimental effects.    163 
Table 36: End point detection limits of tests for adenovirus and norovirus using 
different PCR volumes. 
Adenovirus Result (Ct)  Norovirus G1 Result (Ct)  Norovirus G2 Result (Ct) 
Dilution 
50ul  25ul  15ul  50ul  25ul  15ul  50ul  25ul  15ul 
10-1  19.2  18.8  19.3  22.1  21.8  22.1  26.2  26.5  25.8 
10-2  22.5  21.8  22.0  25.7  25.4  26.0  29.8  30.0  29.5 
10-3  26.0  25.8  25.9  29.0  29.1  29.4  33.0  34.2  33.5 
10-4  29.3  28.5  29.1  32.4  33.0  33.2  36.2  37.2  38.3 
10-5  33.0  32.9  33.3  36.4  37.2  36.8  -  -  - 
10-6  37.0  36.2  37.6  -  -  -  -  -  - 
10-7  -  -  -  -  -  -  -  -  - 
4.8. Summary 
This chapter presented a series of studies that assessed the sensitivity of the 
PCR methods selected and described in Chapter 3 in relation to possible alternatives 
were adapted for routine diagnostic use. The experiments were split into three parts: 
those  concerned  with  the  development  of  the  norovirus  outbreak  service,  those 
relating  to  the  sporadic  service,  and  finally,  experiments  aimed  at  improving  the 
efficiency of the tests implemented in both services.  
Results from the first experiment relating to the outbreak service showed that 
the SYBR green based Lightcycler™ RT-PCR developed as described in Chapter 3 
was more sensitive than EM for the detection of norovirus, in both samples from 
outbreaks and sporadic cases of IID (Miller, Gunson and Carman, 2002). This method 
was implemented as the frontline test for outbreak samples in January 2001. It was 
subsequently compared to two commercial EIA methods for norovirus and was found 
to  be  both  more  sensitive  and  specific  than  either  (Gunson,  Miller  and  Carman, 
2003(ii)). The Lightcycler™ method was also compared to a recommended gel-based 
RT-PCR that was held to be the most sensitive of the methods available at that time. 
However, although the Lightcycler™ RT-PCR assay was in fact shown to be less 
sensitive it did not miss any outbreaks and, moreover, involved fewer steps (Gunson, 
Miller and Carman, 2003(i)). As a result the decision was taken to retain it as the 
frontline test for norovirus in the outbreak service at this stage. The final experiment 
in this series, carried out in 2003 once the technology became available, showed that 
the new dual-labelled probe-based test for norovirus was also more sensitive than the 
Lightcycler™ RT-PCR, which in this case missed both individual cases and outbreaks 
of norovirus (Gunson and Carman, 2005). The dual-labelled probe-based RT-PCR 
also had the potential to offer better throughput and rapidity. As a result this assay   164 
was implemented in 2004 and remains the frontline test for norovirus in the outbreak 
service at the time of writing.  
The  initial  experiments  relating  to  the  sporadic  service  focused  on 
multiplexing the individual tests chosen in Chapter 3 for use in a single multiplex 
assay capable of testing for adenovirus, astrovirus, rotavirus and sapovirus. The result 
was  two  gel-based  assays:  a  rotavirus  RT-PCR  and  a  multiplex  RT-PCR  for 
adenovirus, astrovirus and sapovirus. Rotavirus could not be included in the multiplex 
since this resulted in a loss in sensitivity in both rotavirus and astrovirus detection. In 
the  second  experiment  the  two  assays  developed  were  then  compared  to  antigen 
detection methods for astrovirus and rotavirus, and shown to be more sensitive than 
either (Gunson, Collins and Carman, 2006(i)). However, the number and duration of 
the  steps  required  to  carry  out  the  two  gel-based  assays,  plus  concerns  over  the 
appearance of non-specific products in the multiplex RT-PCR, meant that these were 
not implemented in the sporadic service at this stage. In the final experiment in this 
series, again carried out once the necessary technology was available, the two gel-
based RT-PCR methods were compared to individual dual-labelled probe-based real-
time PCR assays on dilution series and a panel of clinical samples. In each case the 
dual-labelled probe-based real-time PCR assay detected a lower dilution of pathogen, 
and detected more clinical samples as positive than the relevant gel-based RT-PCR 
assay. The dual-labelled probe-based RT-PCR approach also involved fewer steps and 
had the potential to offer better throughput and rapidity than the EM test still used in 
the routine service. As a result these assays were implemented alongside the norovirus 
RT-PCR in November 2004 in the service for sporadic cases of IID. 
Once  dual-labelled  probe-based  PCR  assays  were  implemented  in  both  the 
outbreak  and  sporadic  services  a  series  of  experiments  aimed  at  improving  the 
efficiency of these tests was carried out (Gunson, Collins and Carman, 2006(ii)). In 
the first experiment it was shown that reducing PCR cycling times had no effect on 
test sensitivity and improved rapidity. The second experiment showed that the DNA 
test for adenovirus could be carried out under the same conditions (i.e. on the same 
PCR plate) as any of the RNA tests for astrovirus, rotavirus or sapovirus without 
affecting  its  sensitivity  (the  norovirus  assay  involved  a  different  annealing 
temperature to any of the other tests and as a result was always kept separate). Further 
studies then showed that pooled positive controls, primer/probe pools and reduced   165 
reagent volumes could all be employed without affecting test performance. Use of 
these measures was therefore implemented in January 2005.   166 
 
 
 
 
Chapter 5    167 
Effects Of Introducing The PCR Protocols 
On The Laboratory Diagnostic Service 
5.1. Overview 
 This chapter examines the effects of implementing the PCR assays described 
in the previous chapter as the frontline tests for the investigation of outbreaks and 
sporadic cases of gastroenteritis on the laboratory diagnostic service offered by the 
WOSSVC.    
First, the test monitoring system introduced following implementation of the 
PCR assays is described. The impacts of the changes on the routine laboratory service 
is then examined through the analysis of the WOSSVC laboratory records from 1999-
2006, together with a Scotland-wide survey of laboratory testing protocols for cases of 
IID, which was first carried out in 2004 and updated in 2006. These data are examined 
to determine whether the implementation of the new assays provided any benefits to 
the  routine  laboratory  service  in  terms  of  key  measures  of  performance  including 
sample  throughput,  test  sensitivity  and  turn-around-times.  Data  on  each  of  these 
aspects are presented at key stages during the period of change (1999-2006) and the 
implications for the routine laboratory service are discussed.  
5.2. Introduction 
As a result of the research described in Chapter 4, several changes were made 
to the WOSSVC routine laboratory service (these are summarised in Table 37). This 
chapter examines the effects of these changes on the laboratory service, including the 
need to implement a test monitoring system, and discusses whether or not the changes 
have led to benefits in terms of improved sample throughput, test sensitivity and turn-
around-times.  
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Table 37: Summary of testing protocols for outbreaks and sporadic cases of IID in the 
WOSSVC between 1999-2006. 
Year  Outbreaks Of Gastroenteritis  Sporadic Cases Of Gastroenteritis In 
Children <10 Years And 
Immunocompromised Patients 
Pre-2001  EM on all stool samples. 
2001-
2003 
Lightcycler
TM real-time RT-PCR for 
norovirus introduced in January 2001. 
 
If test result negative, EM. 
EM on all stool samples. 
 
2004  Dual-labelled probe-based real-time RT-
PCR for norovirus introduced in January 
2004. 
 
If test result negative, EM. 
Dual-labelled probe-based real-time RT-PCR 
for rotavirus, astrovirus, adenovirus, norovirus 
and sapovirus introduced in November 2004. 
Once weekly batch testing used.   
2005  Primer/probe pools, reduced cycling times, 
pooled positive controls and reduced PCR 
reagent volumes introduced in January 2005.  
2006 
Primer/probe pools, reduced cycling 
conditions, pooled positive controls and 
reduced PCR reagent volumes 
introduced in January 2005. 
 
If negative, testing for rotavirus, 
astrovirus, adenovirus and sapovirus 
using dual-labelled probe-based real-
time RT-PCR. 
 
If test result negative for all of the above, 
EM. 
Frequency of testing increased to at least three 
times weekly from January 2006. 
5.3. PCR Test Monitoring 
Unlike commercial tests such as EIA, PCR assays developed in the laboratory 
do  not  have  their  own  quality  control  systems.  As  a  result,  following  routine 
implementation of such assays, it is important to monitor the tests carefully to detect 
any contamination, or sudden or long-term loss in sensitivity that could lead to false 
negative or positive results. 
The real-time PCR assays implemented in the new diagnostic service for viral 
causes of IID were monitored in a number of ways. Firstly, positive and negative 
controls were included in each PCR test. For each assay a single positive control was 
included to ensure that the entire testing protocol (including the extraction, reverse 
transcriptase  and PCR steps) was optimally sensitive.  Initially the positive control 
used in all the PCR assays described here was a sample that had tested positive for the 
pathogen in question using EM and had been diluted to the endpoint detection limit of 
the PCR test. For a run to be passed as valid the positive control had to be detected as 
positive. If the control was found to be negative then the run had to be repeated. 
Subsequently, from 2005, all dual-labelled probe-based real-time PCR assays utilised 
a single positive control containing all viral pathogens to be tested. For a run to be   169 
passed as valid the Ct value of the positive control had to fall within a pre-determined 
range (plus or minus three standard deviations from the pre-determined mean, which 
was determined by testing the control at least 20 times). Again, if the control did not 
fall within the pre-determined range then the run was repeated. The Ct of the positive 
control was monitored using Westgard rules, which are designed to detect inter-test 
variation and test drift (Niesters, 2002; Gray et al, 1995; Gray, 1999). 
All PCR runs also included negative controls, which took the form of a viral 
transport  medium  for  every  eight  extractions.  Negative  controls  were  included  to 
detect test contamination, which can result in a false positive result. For a PCR run to 
be passed as valid all negative controls had to test negative using the PCR assays.  If 
any of the negative controls tested positive then all samples and controls had to be re-
extracted and the test repeated. 
The real-time PCR assays were also monitored to check for the emergence of 
variant viruses containing nucleotide base changes in the areas of the genome targeted 
by the primers or probes in the test, and which may result in a loss in test sensitivity. 
This is a particular problem in the case of norovirus, rotavirus and sapovirus where 
new variants have been shown to emerge in the past (Lopman et al, 2004; Gallimore 
et al, 2006). For norovirus, the number of negative outbreaks occurring over time was 
measured. An increase in the number of negative outbreaks would suggest that the test 
had become insensitive and may need to be re-designed or replaced by an alternative 
test. For the remaining pathogens, this kind of assessment is more difficult and relied 
upon awareness of the latest developments in the literature.  
5.4. Data Collection 
5.4.1. WOSSVC Laboratory Data (1999-2006) 
All WOSSVC laboratory data for viral gastroenteritis testing from 1999-2006 
was  transferred  from  the  routine  laboratory  record  database  (Telepath)  and 
downloaded into an Excel™ spreadsheet for examination. The data collected for each 
sample included:  
o  the patient name and date of birth;  
o  the date the sample was received in the laboratory and the date the final 
result was reported (from which the turn-around time can be deduced);  
o  the sample origin (e.g. GP, hospital, laboratory or health board);    170 
o  whether the sample was from a recognised outbreak or was a sporadic case 
of gastroenteritis (this was determined via the clinical details outlined on 
the specimen request form);  
o  the test/s carried out and;  
o  the final result/s.  
Based on these data, the data for outbreak samples and sporadic samples were 
analysed separately and summary statistics for each year were calculated, including:  
o  the total number of samples tested;  
o  the total number of positive detections made;  
o  the total number of outbreaks confirmed as being caused by norovirus (or 
another pathogen) and the number of outbreaks classified as negative for 
all viral pathogens (outbreak samples only);  
o  the turn-around-times for each test/sample (the time taken in days from 
when the sample was received in the laboratory and the date the final result 
was reported); 
o  the distribution of Health Boards of origin and;  
o  the age distribution of the patients tested.  
These data were then cross-referenced with the changes in the routine service, 
described above and summarised in Error! Reference source not found., in order to 
determine the effects of the changes on each of these aspects.  
The total number of samples tested each year is used as an indicator of the 
usefulness of the tests in place, since increased use suggests that clinicians find the 
test useful. The sample  submission data was also compared with the turn-around-
times to examine whether changes in the numbers of samples submissions affected 
test rapidity. Ideally the assays should be able to process large or small numbers of 
samples with little effect on turn-around-times.  
The  total  number  of  positive  detections  achieved  for  each  virus  type  is  a 
measure of sensitivity, and was measured for both outbreak and sporadic samples 
each year. A sensitive test is more likely to provide an etiological diagnosis, which in 
turn will be useful in the clinical and public health setting as the result is more likely 
to  influence  patient  management  and  infection  control.  Measuring  the  number  of 
laboratory-confirmed  positive  and  negative  outbreaks  was  used  as  an  additional 
method of assessing test sensitivity. At WOSSVC, an outbreak is confirmed as being 
caused  by  a  particular  pathogen  if  at  least  two  of  the  submitted  samples  from  a   171 
particular  location  are  found  to  be  positive  for  that  pathogen  using  a  laboratory 
method (Richards et al, 2003; Duizer et al, 2007). On the other hand, for an outbreak 
to be classified as negative at least six samples from the same outbreak have to be 
submitted and found to be negative for the pathogen in question.  In either case, more 
than one sample is required before a classification is made in order to reduce the risk 
of  false  diagnoses.  Outbreak  samples  that  do  not  meet  either  set  of  criteria  e.g. 
because  there  are  too  few,  remain  unclassified.    Improvements  in  test  sensitivity 
should  result  in  increased  positive  outbreak  classifications  while  ensuring  that  the 
number of outbreaks classified as negative remains low.  
The effect of each new test or test amendment on test rapidity was measured 
by measuring the turn-around-times for outbreak and sporadic samples. Ideally turn-
around-times should be as short as possible so that the results can usefully influence 
patient  and  outbreak  management.  Test  rapidity  is  particularly  important  in  the 
outbreak setting. 
The sample submission data broken down by health board was examined to 
determine whether the number of health boards using the WOSSVC service increased 
in response to service developments (again, an indication that users are finding the 
service useful).  
The  age  of  the  patients  from  which  samples  were  submitted  was  also 
examined to determine whether submission patterns had changed in line with the new 
test developments. 
5.4.2. Survey Of Laboratory Methods And Reporting Protocols 
In March 2004, as part of a study examining the effect of laboratory protocols 
on national surveillance systems, a telephone survey was carried out in order to ask 
laboratories  to  outline  their  current  testing  and  reporting  protocols  for  viral 
gastroenteritis. In total, 22 laboratories were contacted representing all NHS boards in 
Scotland  except  Orkney,  Shetland,  the  Western  Isles,  Fife  and  the  Borders 
(laboratories from these health boards declined to take part). The questions that were 
asked are outlined in Table 38.  
The survey results were used in addition to the laboratory data to determine 
how  Scottish  microbiology  laboratories  used  the  WOSSVC  diagnostic  service  for 
viral IID. This included whether or not any laboratories used the sporadic service 
offered  by  the  WOSSVC  on  a  routine  basis  and  whether  the  WOSSVC  outbreak   172 
molecular service was used either as the frontline test for outbreaks of IID or as a 
confirmatory test. 
Information on the types of tests used by the laboratories for both sporadic 
cases and outbreaks of gastroenteritis was then updated in 2006 in order to determine 
whether changes in the WOSSVC diagnostic service had led to service developments 
in other laboratories. 
Table 38: Survey of laboratory testing protocols for sporadic cases and outbreaks of 
viral gastroenteritis.  
Questions 
Do you test for viral pathogens in sporadic cases of IID? 
What viral pathogens do you test for in sporadic cases? 
What age groups do you test in sporadic cases? 
What diagnostic tests do you use in sporadic cases? 
What viral pathogens do you test for in outbreaks of viral gastroenteritis? 
5.5. Results 
5.5.1. WOSSVC Laboratory Data 1999-2006 
5.5.1.1. Total Number Of Samples Tested  
Figure  14  shows  the  total  number  of  samples  tested  annually  for  IID  at 
WOSSVC in the period 1999-2006 (incorporating both sporadic and outbreak cases). 
Figure 15 shows the same data but with the figures broken down by the test type 
employed.   173 
Figure 14: Total number of IID samples tested (1999-2006). 
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From Figure 14 it can be seen that from 2001 the total number of samples 
tested for IID at the WOSSVC increased, with a sharp peak observed in 2002. This 
increase in sample numbers is likely to be due to the emergence of a new norovirus 
variant (see Chapter 2). The increase continued to be seen year on year. Examining 
this data by sample source (outbreak or sporadic) shows that this increase was largely 
driven by increases in the number of outbreak samples submitted, which from 2001 
made up the majority of the IID samples submitted to the WOSSVC. Samples from 
sporadic  cases  of  IID  were  similar  in  all  years  examined  except  2006  where  the 
number submitted more than doubled compared to previous years. This increase was 
also due to the emergence of a new norovirus variant (Gallimore et al, 2007).   174 
Figure 15: Total number of IID samples tested by test type (1999-2006).   
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Examining this same data by type of test carried out shows that the increase in 
submissions  of  outbreak  samples  coincided  with  the  implementation  of  the 
Lightcycler
TM  real-time  RT-PCR  for  norovirus  as  the  frontline  test  for  the 
investigation of samples of this type in 2001 (Figure 15). After its implementation the 
number of samples tested from outbreaks of gastroenteritis using the Lightcycler
TM 
real-time  PCR  assay  increased  in  each  year.  Moreover,  the  increase  in  the  total 
number  of  samples  tested  continued  after  the  implementation  of  the  dual-labelled 
probe-based real-time RT-PCR in 2004.  
The number of sporadic samples tested by EM remained similar in all years of 
its use (1999-2003). The molecular service for sporadic samples was implemented in 
2004. After its implementation, initially the numbers tested were similar to that tested 
by EM. However, in 2006 the number of samples tested from sporadic cases rose to 
over a thousand (N=1147). This was the largest number of submissions in all years of 
the study. Implementation of the new test for sporadic cases of IID also resulted in a 
further drop-off in the number of samples tested using EM, since use of this test was 
now limited to the investigation of PCR negative outbreaks of gastroenteritis.   175 
5.5.1.2. Total Number Of Positive Detections  
Figure 16 shows the norovirus detection rate in samples from outbreaks during 
the period 1999-2006. EM was the test used from 1999-2000, the Lightcycler
TM real-
time RT-PCR was employed from January 2001, and subsequently, the dual-labelled 
probe-based real-time PCR was introduced in late 2004. Figure 17 shows the total 
number of positive viral detections made from sporadic cases of IID between 1999-
2006. EM was the frontline test for sporadic cases between 1999 and late 2004 and 
dual-labelled probe-based real-time PCR assays replaced EM from November 2004 
onwards.  For  each  figure  the  percentages  shown  were  calculated  relative  to  the 
number of samples tested using this method in each year.  
Figure 16: Detection rates for norovirus in outbreak samples (1999-2006). 
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Figure 16 shows that using EM, norovirus was detected in between 10-12% of 
all  outbreak  samples  submitted.  The  results  obtained  when  the  Lightcycler
TM  and 
dual-labelled  probe-based  real-time  RT-PCR  were  introduced  demonstrate  a 
substantial improvement on this detection rate, with norovirus identified in between 
28% and 41% of the samples tested. A similar pattern of increased detection was   176 
observed for sporadic cases of IID after the implementation of the molecular service 
for samples of this type (Figure 17).  
Figure 17: Detection rate achieved in sporadic samples. 
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Between 1999 and October 2004 for example, when EM was the frontline test 
for sporadic cases of IID, adenovirus was detected in less than 2% of all samples 
tested.  When,  however,  the  dual-labelled  probe-based  real-time  PCR  service  was 
implemented in November 2004 the detection rate for adenovirus rose to 14-22%. 
Similarly,  after  the  implementation  of  the  molecular  service  the  detection  rate  for 
norovirus  in  sporadic  cases  of  gastroenteritis  increased  from  1-7.4%  to  12-24%. 
Increases  in  the  detection  rate  were  also  observed  for  astrovirus  and  sapovirus. 
Rotavirus was the only viral pathogen for which the implementation of PCR did not 
result in a significant improvement in the detection rate. For the years examined the 
detection rates achieved by EM ranged between 1-15% whereas those achieved by   177 
dual-labelled  probe-based  real-time  RT-PCR  were  0-12%.  Overall,  however,  the 
detection rate in the sporadic setting ranged between 48-52% in the years following 
implementation of the molecular tests. This is significantly higher than that achieved 
with EM, where the overall percentage positive rates varied from just 2-23%. 
5.5.1.3. Total Number Of Outbreaks Confirmed Caused By Norovirus  
Figure  18  shows  the  number  of  clinically  diagnosed  outbreaks  of 
gastroenteritis that were confirmed as being caused by norovirus during the period 
1999-2006, together with the number that met the criteria for a norovirus-negative 
outbreak i.e. could not be attributed to norovirus using the tests employed.   
Figure 18: Total number of outbreaks confirmed positive and negative for norovirus. 
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It can be seen from Figure 18 that the number of outbreaks confirmed as being 
caused  by  norovirus  increased  considerably  after  the  implementation  of  the 
Lightcycler
TM real-time RT-PCR in 2001. In 1999 and 2000 the numbers of outbreaks 
confirmed by EM as being caused by norovirus were 15 and 16 respectively.  After 
the  introduction  of  the  Lightcycler
TM  real-time  RT-PCR  in  2001  the  number  of 
norovirus-positive outbreaks detected quickly increased to 83. Moreover, in each of 
the following five years the number of outbreaks in which norovirus was confirmed as   178 
the cause followed an upward trend and exceeded the level detected previously by 
EM. Of note is 2002, in which an exceptionally high number of norovirus-positive 
outbreaks was detected (N=223).  This is likely to have been due to the emergence of 
a new norovirus variant, which in other countries was also associated with a large 
increase in cases and outbreaks of norovirus (Lopman et al, 2004). A large number of 
norovirus  outbreaks  was  also  detected  in  2006.  As  shown  earlier,  this  is  also 
associated  with  the  emergence  of  a  new  norovirus  G2.4  variant  (Gallimore  et  al, 
2007). 
Figure  18  also  shows  that  the  number  of  outbreaks  that  were  confirmed 
negative  for  norovirus  has  also  fallen  steadily  since  the  implementation  of  the 
Lightcycler
TM real-time RT-PCR in 2001. In 1999 and 2000 the number of norovirus-
negative  outbreaks  was  20  and  23  (representing  60%  and  55%  of  all  classified 
outbreaks tested by EM).  In 2001 and 2002, the proportion of classified outbreaks 
that tested negative for norovirus using the Lightcycler
TM real-time PCR fell to 21% 
and 27%, respectively. From 2003 and after the implementation of the dual-labelled 
probe-based real-time RT-PCR in 2004 the number of norovirus negative outbreaks 
fell to very low levels. In these years the total number of classified outbreaks that 
were  confirmed  negative  for  norovirus  using  PCR  was  between  just  4  and  8 
(representing between 2-8% of all classified outbreaks tested).  
5.5.1.4. Turn-Around-Times  
Figure  19  and  Figure  20  summarise  the  WOSSVC  turn-around-times  for 
outbreak and sporadic samples between 1999-2006.  
It is clear from these figures that the use of real-time RT-PCR has improved 
the turn-around-times of samples tested both in the outbreak and sporadic setting. For 
example, when EM was the frontline test for outbreaks of gastroenteritis in 1999 and 
2000,  50%  of  results  were  reported  between  5  to  7  days  after  arriving  in  the 
laboratory, whilst 90% were reported between 11 to 13 days after submission (Figure 
19). The implementation of the Lightcycler
TM real-time RT-PCR for norovirus from 
2001-2003 resulted in an considerable improvement in these turn-around-times, with 
50% of results available by day 5 after submission and 90% reported by day 8 in all 
years (Figure 20). The implementation of the dual-labelled probe-based real-time RT-
PCR in 2004 resulted in further improvements, with 50% of results reported just 3 
days after submission and 90% of sample results reported by day 6 during this year. A   179 
further  improvement  in  turn-around-times  was  then  again  observed  in  2005  when 
primer/probe pools, reduced PCR cycling times, and pooled positive controls were 
implemented. In this year 50% of results were reported by day 2 and 90% by day 5. 
This improvement was maintained in 2006. 
Examining  the  turn-around-times  for  sporadic  samples  shows  that  between 
1999 and 2004, use of EM resulted in 50% of samples being processed by days 5 to 9, 
but 90% was not achieved until days 11 to 23. This is longer than that achieved using 
EM for outbreak samples and was despite the fact that, overall, fewer samples were 
tested using EM during this period. In 2004, after the implementation of the molecular 
service, 50% of results were processed by day 3, whilst 90% were reported by day 13. 
However, these figures were achieved on a very small number of samples (n=119). In 
2005, when larger numbers of samples were tested, 50% of results were available by 
day 9 and 90% by day 23. This was slower than when EM testing was employed. In 
2006,  however,  the  numbers  of  samples  of  this  type  submitted  to  the  laboratory 
increased and as a result batch testing was increased to at least three times a week. As 
a result the turn-around-times improved substantially, with 50% of results available 
after day 3 and 90% by day 6.   180 
Figure 19: Turn-around-times achieved for outbreak samples (1999-2006). 
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Figure 20: Turn-around-times for samples from sporadic cases of IID (1999-2006). 
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5.5.1.5. Health Board Of Origin 
Figure 21 and Figure 22 show the total number of samples from outbreaks and 
sporadic cases of IID submitted for testing to the WOSSVC during the period 1999-
2006, broken down by health board of origin.  
Figure 21: Total outbreak samples by health board (1999-2006). 
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In total there are fifteen health boards in Scotland. Figure 21 shows that in 
1999 and 2000, when EM was the frontline test for outbreak samples, the WOSSVC 
received outbreak samples from six of these health boards: Aryshire and Arran (AA), 
Argyle and Clyde (AC); Dumfries and Galloway (DG); Forth Valley (FV); Greater 
Glasgow (GG); and Lanarkshire (LN). Lanarkshire and Argyle and Clyde were the 
biggest contributors during this time.    183 
Post-2001, when RT-PCR was introduced for norovirus testing in outbreaks, 
two other health boards also submitted substantial numbers of samples: Highlands and 
Islands (HI); and Grampian (GR). Results from the telephone survey (Section 5.5.2) 
show that the laboratories in these two health boards utilised the WOSSVC service as 
either a back up test to EIA or as the frontline test for the investigation of samples 
from  outbreaks.  Tayside  (TY)  and  the  Western  Isles  (WI)  also  submitted  small 
numbers of samples. Lothian (LO), Fife (FF), the Borders (BR) and Orkney (OR) and 
Shetland (SH) submitted no samples to the WOSSVC during the time period studied. 
This was because these health boards utilised the EM service available in East of 
Scotland Virology Centre in Lothian.  
Figure 22: Total number of sporadic samples by health board (1999-2006). 
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Examination of the samples submitted for sporadic testing shows that from 
1999-2004  samples  were  received  from  five  health  boards:  Argyle  and  Clyde, 
Dumfries and Galloway, Forth Valley, Greater Glasgow and Lanarkshire (Figure 22).    184 
From late 2004 when PCR was implemented as the frontline test additional samples 
were also sent from Grampian.  
In 2006 a large increase in sample submissions was observed from Greater 
Glasgow Health Board. Closer examination showed that the majority of these samples 
had been submitted by Bone Marrow Transplant (BMT) wards at the Royal Hospital 
for Sick Children and the Glasgow Royal Infirmary (Figure 23). Both of these wards 
submitted only a few samples between 1999-2005. However, in 2006 both wards sent 
over 300 samples (308 from the GRI unit and 350 from the RHSC). The reasons for 
this are discussed in section 5.6.2. 
Overall,  therefore,  the  number  of  IID  samples  submitted  for  testing  to  the 
WOSSVC  laboratory  has  increased  steadily  since  the  introduction  of  the  first 
molecular tests in 2001, partly as a result of more health boards using the service, and 
partly as a result of those who already do so increasing their usage. 
Figure 23: Number of sporadic samples submitted from the RHSC and GRI bone 
marrow transplant wards (1999-2006). 
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5.5.1.6. Age Of Patients  
Figure 24 and Figure 25 show the total number of samples from outbreaks and 
sporadic cases of IID submitted for testing to the WOSSVC during the period 1999-
2006, broken down by the age of the patient.    185 
Figure 24: Total outbreak samples by age group (1999-2006) 
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Examination  of  the  data  from  outbreak  samples  shows  that,  each  year, 
although samples were submitted from all age groups the majority were from the 65 
years and over age group (Figure 24). This is in line with the known epidemiology of 
norovirus outbreaks. The data also show that after the norovirus outbreak service was 
introduced in 2001, the large increases in sample submission rates outlined earlier 
have come predominantly from the 65 years and over age group.    186 
Figure 25: Total number of sporadic samples by age group (1999-2006). 
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Examining the samples submitted from sporadic cases of gastroenteritis shows 
that the majority of samples in each year were from the under 5 years age group. For 
the period of 1999-October 2004 this is in line with the coding protocol in place at the 
time since the service was only offered on a routine basis for children under 10 years 
of  age.  After  the  implementation  of  the  molecular  service  in  November  2004  no 
significant change was observed until 2006 when a large increase in submission was 
observed in the 16-64 year age group. This was largely due to the large increase in 
submissions from the adult BMT patients (outlined in section 5.5.1.5). 
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5.5.2. Survey Of Laboratory Testing Practice 
5.5.2.1. Testing Protocols For Outbreaks Of Viral IID 
In March 2004, three years after the implementation of Lightcycler
TM real-
time RT-PCR at the WOSSVC, 20 of the 22 laboratories surveyed (91%) were shown 
to utilise the WOSSVC service for investigating samples from outbreaks of suspected 
viral IID (Table 39). One laboratory (5%) utilised EM and carried out testing for the 
health boards Lothian, Fife, the Borders and Orkney. One other laboratory was found 
to have no protocol for outbreaks of IID (5%).  
Of the laboratories that utilised the WOSSVC outbreak service, 17 (85%) were 
found to use it as their frontline test. These were from the health boards Ayrshire and 
Arran,  Argyle  and  Clyde,  Dumfries  and  Galloway,  Highlands  and  Islands,  Forth 
Valley,  Greater  Glasgow  and  Lanarkshire.    Three  laboratories  (15%)  used  the 
molecular service as a back up to their own testing system. These laboratories carried 
out testing for Grampian and Tayside. In each case norovirus was first tested for using 
an EIA (DAKO Cytomation, Cambridgeshire, UK), which replaced EM during 2003. 
Each stated that samples from all EIA negative outbreaks that tested negative for 
norovirus by EIA were submitted to the WOSSVC for testing by PCR.  
In  2006,  laboratories  were  contacted  again  by  email  and  asked  to  outline 
whether their testing policies had changed. Several changes were outlined. In 2005, 
the virus laboratory at Aberdeen Royal Infirmary switched from EIA to real-time RT-
PCR for norovirus as the frontline test for outbreaks of gastroenteritis (the same dual-
labelled probe-based assay as used at the WOSSVC) as the frontline test for outbreaks 
of  gastroenteritis.    The  laboratories  at  Ninewells  Hospital,  Dundee,  Perth  Royal 
Infirmary,  Dumfries  Royal  Infirmary,  Edinburgh  Royal  Infirmary  and  Wishaw 
General all stated that they plan to implement this test in their own laboratory as their 
frontline test for outbreaks of gastroenteritis in 2007. 
5.5.2.2. Testing Protocols For Sporadic Viral IID 
The results of the questionnaire (Table 39) showed that in March 2004, 14 
(64%) of the laboratories questioned had their own testing protocol for investigating 
sporadic viral IID. The eight laboratories with no testing protocol (36%) included 
Nuffield  Hospital  (Greater  Glasgow  Health  Board),  Oban  (Argyle  and  Clyde), 
Glasgow Royal Infirmary (Greater Glasgow), Hairmyres Hospital (Lanarkshire), the   188 
Western  Infirmary  (Greater  Glasgow),  the  Southern  General  Hospital  (Greater 
Glasgow), Vale of Leven Hospital (Argyle and Clyde), and Dumfries Royal Infirmary 
(Dumfries  and  Galloway).  No  laboratory  used  the  WOSSVC  service  for  sporadic 
cases of IID. 
With regards to the pathogens tested for in the sporadic setting, it was found 
that 10 laboratories tested for rotavirus only (71%). The remaining four laboratories 
tested for rotavirus as well as other non-rotavirus viral pathogens (26%): two of which 
(13%)  tested  for  norovirus,  adenovirus  and  rotavirus  and  two  of  which  tested  for 
adenovirus and rotavirus (13%). No laboratories tested for sapovirus or astrovirus.  
 Of the 14 laboratories with a testing policy, 9 (64%) tested only children (i.e. 
those aged under 5 years) for viral causes of IID whilst two (13%) tested both children 
and elderly patients (65yrs and over).  None of the laboratories tested samples from 
the adult population. Three laboratories (21%) did not state their testing policy with 
regards to the age group tested.  
Overall  13  laboratories  used  antigen  detection  methods  (93%)  for  testing 
sporadic  samples  of  IID.    Four  laboratories  used  EIA  (26%),  three  used  Latex 
agglutination (20%), and six used ICG (40%).  PAGE was utilised in one laboratory 
(7%). None of the laboratories were using molecular tests for the investigation of 
sporadic IID. 
The laboratories were contacted again in 2006 and asked whether the testing 
service had changed. All laboratories stated that the testing protocol for sporadic cases 
of IID remained the same as in 2004.   189 
Table 39: Responses to the questionnaire on laboratory testing practice. 
Outbreak IID  Sporadic IID 
Laboratory  NHS board  What viral pathogens  
tested for? 
Test for viral  
pathogens? 
What viral pathogens  
tested for? 
Age group 
tested? 
Tests 
used? 
Aberdeen Royal Infirmary  Grampian  Dako EIA for norovirus
a. If 
negative, norovirus at WOSSVC
b  Yes  Rotavirus, adenovirus  Not stated  EIA 
Falkirk District Royal Infirmary  Forth Valley  Norovirus at WOSSVC  Yes  Rotavirus  <5yrs, >65yrs  ICG 
Inverclyde Hospital  Argyle & Clyde  Norovirus at WOSSVC  Yes  Rotavirus  <5yrs, >65 yrs  ICG 
Wishaw Hospital  Lanarkshire  Norovirus at WOSSVC
c  Yes  Rotavirus  <5yrs  ICG 
Raigmore Infirmary  Highl&s & Isl&s  Norovirus at WOSSVC  Yes  Rotavirus  <5yrs  Latex 
Stirling Royal Infirmary  Forth Valley  Norovirus at WOSSVC  Yes  Rotavirus  <5yrs  ICG 
Ninewells Hospital, Dundee  Tayside  Dako EIA for norovirus
a. If 
negative, norovirus at WOSSVC
c  Yes  Rotavirus, adenovirus, 
norovirus 
Not stated 
 
EIA 
Perth Royal Infirmary  Tayside  Dako EIA for norovirus
a. If 
negative, norovirus at WOSSVC
c  Yes  Rotavirus, adenovirus, 
norovirus  Not stated  EIA 
Monklands District General 
Hospital  Lanarkshire  Norovirus at WOSSVC  Yes  Rotavirus  <5yrs  Latex 
Crosshouse Hospital  Ayrshire & Arran  Norovirus at WOSSVC  Yes  Rotavirus  <5yrs  Latex 
Nuffield Hospital  Greater Glasgow  None  No  -  -  - 
Edinburgh Royal Infirmary  Lothian  EM
c  Yes  Rotavirus  <5yrs  PAGE 
Royal Hospital for Sick Children, 
Glasgow  Greater Glasgow  Norovirus at WOSSVC  Yes  Rotavirus, adenovirus  <5yrs  EIA 
Oban Hospital  Argyle & Clyde  Norovirus at WOSSVC  No  -  -  - 
GRI  Greater Glasgow  Norovirus at WOSSVC  No  -  -  - 
Hairmyres Hospital  Lanarkshire  Norovirus at WOSSVC  No  -  -  - 
Western Infirmary  Greater Glasgow  Norovirus at WOSSVC  No  -  -  - 
Southern General Hospital  Greater Glasgow  Norovirus at WOSSVC  No  -  -  - 
Royal Alexandria Hospital  Argyle & Clyde  Norovirus at WOSSVC  Yes  Rotavirus  <5yrs  ICG 
Vale of Leven Hospital  Argyle & Clyde  Norovirus at WOSSVC  No  -  -  - 
Victoria Infirmary  Greater Glasgow  Norovirus at WOSSVC  Yes  Rotavirus  <5yrs  ICG 
Dumfries Royal Infirmary  Dumfries & Galloway  Norovirus at WOSSVC
c  No  -  -  - 
a EIA implemented in late 2003 in place of EM 
b Replaced by dual-labelled probe-based real-time PCR in 2005 (as used at WOSSVC)  
c Planned replacement by dual-labelled probe-based real-time PCR in 2007 (as used at WOSSVC)   190 
5.6. Discussion 
Since the introduction of molecular tests at WOSSVC for detection of viral 
pathogens  in  cases  of  gastroenteritis  the  number  of  samples  tested  by  the  routine 
diagnostic service has risen steadily, as have the detection rates for each of the main 
viral causes. Furthermore, this has been achieved at the same time as a substantial 
reduction  in  sample  turn-around-times.  The  reduced  turn-around-times  were 
maintained despite fluctuations in sample submissions. These improvements in the 
WOSSVC laboratory  service  have  been  observed  for  both  outbreaks  and  sporadic 
cases of gastroenteritis.  
5.6.1. Effects On The Diagnostic Service For Outbreaks Of IID 
The  improvements  outlined  above  have  been  most  telling  for  norovirus 
diagnosis in outbreak samples. Since the implementation of Lightcycler
TM real-time 
RT-PCR in 2001, followed by the dual-labelled probe-based real-time RT-PCR in 
2004, there has been a significant increase in the numbers of outbreak samples tested 
at the WOSSVC, with the number continuing to rise each year. The increase in the 
number of samples submitted is due to steadily increasing use by health boards who 
were already using the service pre-2001, together with an increase in the number of 
health boards utilising the service (from 6 to 9), both of which suggest that users find 
the  service  useful  (although  the  increases  in  sample  submissions  will  also  be  a 
reflection of outbreak activity). Laboratories were shown to use the service in two 
ways. The majority of those questioned in 2004 used the WOSSVC norovirus service 
as their frontline test for outbreak samples. A small number at this time (three) utilised 
the  service  as  a  back  up  to  their  own  frontline  norovirus  test  (EIA).  From  2007, 
moreover,  a  number  of  the  laboratories  questioned  plan  to  implement  the  dual-
labelled probe-based real-time RT-PCR for norovirus described in this thesis in their 
own laboratories. This further highlights the usefulness of this test.  
The  implementation  of  the  RT-PCR  assays  for  norovirus  in  samples  from 
outbreaks  has  led  to  significant  improvements  in  the  pathogen  detection  rate.  For 
example, in 1999 and 2000, less than 100 norovirus detections were made using EM.  
After 2001, the number of positive detections increased substantially. Increases in the 
number of outbreaks  classified as being caused by  norovirus were also seen  after 
2001. Although this increase in detection may be a result of a sudden increase in   191 
norovirus  activity  in  Scotland  in  2001  or  improved  submission  of  samples  by 
clinicians, it is more likely that this is due to the use of the real-time RT-PCR. The 
ability of the real-time RT-PCR assays to test larger numbers of samples compared to 
EM has no doubt contributed to the increase in the number of detections. However, it 
is the increased sensitivity of the RT-PCR assays that is most important. This can be 
seen when comparing the overall norovirus detection rates for EM and the real-time 
RT-PCR methods. For samples tested by EM, the detection rate was always below 
12%.  However,  from  2001-2006,  when  real-time  RT-PCR  was  implemented,  the 
detection rate for norovirus in outbreak samples rose to 28-41%. Interestingly, the 
dual-labelled probe-based real-time RT-PCR assay (introduced in 2004) resulted in a 
slightly greater detection rate than the Lightcycler
TM real-time RT-PCR assay (28-
41% vs 28-35%). This confirms the increased sensitivity of the dual-labelled probe-
based real-time RT-PCR assay outlined in Chapter 4. The improved sensitivity of the 
PCR  assays  in  comparison  to  EM  can  also  be  seen  when  examining  the  annual 
number of outbreaks classified as norovirus negative by the WOSSVC. Using EM, the 
majority of submitted outbreaks tested negative. However, after the implementation of 
RT-PCR the overall number and proportion of negative outbreaks fell. Two phases of 
reduction  were  observed.  The  first  was  seen  after  the  implementation  of  the 
Lightcycler
TM real-time RT-PCR in 2001. A further improvement was observed in 
2004 when the dual-labelled probe-based real-time RT-PCR was implemented, again 
highlighting the improved sensitivity of this assay compared to the Lightcycler
TM real-
time RT-PCR. The low and reducing number of negative outbreaks detected in all 
years since 2001 also suggests that the emergence of a new norovirus variant in 2002 
and again in 2006 has had no recognisable effect on either PCR’s sensitivity. 
Despite the increased sensitivity of both the RT-PCR assays, a fairly large 
proportion of the total outbreak samples submitted remained negative for norovirus 
and other viral pathogens. There are several possible explanations for this. Perhaps 
alternative nucleic extraction methods may have increased the detection rate achieved 
in this study. Only one method was used throughout this thesis and it had not been 
compared to other extraction methods (as it was already established for existing PCR 
methodology in the WOSSVC). Some of these may have been due to norovirus types 
that cannot be detected by the RT-PCR assays employed or those that are shed at 
levels below the detection limit of both RT-PCR assays. Vinje et al highlighted that 
the primers utilised by  the  Lightcycler
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some G1 and G2 types in the panels tested and, compared to other commonly used 
assays, failed to detect certain norovirus types at a lower limit of detection (Vinje et 
al, 2003). The dual-labelled probe-based real-time assay has also been shown to be 
less sensitive for some G1 and G2 noroviruses (Jolkihumar et al, 2005). Therefore, 
use of other tests may have improved detection further. In addition a number of the 
outbreak samples that tested negative for viral pathogens may have been caused by 
non-viral pathogens and thus were diagnosed accurately. 
Some of the samples may also have been negative due to the presence of PCR 
inhibitors. PCR inhibitors generally exert their effects through direct interaction with 
DNA/RNA or interference with DNA polymerases. The use of an internal control, a 
superior alternative to a positive control, would have provided the capability to detect 
these (Rosenstraus et al, 1998). An internal control is present in each PCR reaction to 
ensure it is working optimally. It is the ideal positive control as it can detect extraction 
failures, PCR inhibition, and technical errors relating to each individual sample (a 
positive control will detect general errors/failures that are assumed to be related to all 
samples at each stage rather than to the individual sample). Several internal control 
systems  are  described  in  the  literature  (Jenson  et  al,  2004;  Neisters  et  al,  2002; 
Maroufi et al, 2006). Most are separate PCR assays that are multiplexed with the 
diagnostic  assay,  although  some  are  used  as  separate  assays  altogether.  (More 
complicated versions also exist where the PCR primers for a particular pathogen also 
contain regions that are weakly complimentary to the internal control. Consequently, 
the primers bind to the internal control in the absence of the pathogen nucleic acid.) 
The  internal  control  target  usually  takes  the  form  of  a  non-human  virus,  an 
oligonucleotide or a plasmid, which is added manually to the sample, extraction or 
PCR mastermix (Tedder et al, 2006; Jenson et al, 2004; Neisters et al, 2002). Some 
systems also target parts of the human genome that should be present in all clinical 
samples (Muller et al, 2007; Whiley et al, 2004). 
Many of the newer automated nucleic acid extraction machines can be adapted 
to add the chosen internal control to all samples during the process of extraction. In 
most cases the internal control is usually added to the lysis buffer, which is then added 
to a “lysis plate” already containing the selected volume of clinical sample. For best 
control, clinical samples should be spiked with an internal control before extraction 
and  each  diagnostic  test  should  be  multiplexed  with  an  internal  control  assay. 
However, such a system increases the number of pipetting steps involved, prolongs   193 
hands-on time and can be difficult to standardise. An internal control was not included 
in this research due to concerns that it would significantly increase testing costs and 
would also increase technician hands-on time in order to spike samples and interpret 
results. However, it is something that is likely to be explored in the near future (see 
Chapter 6).   
A number of samples are also likely to have been sent from an outbreak site 
from patients and HCWs that do not have specific norovirus symptoms but are feeling 
“unwell”. Also, in the hospital and residential home setting, a large number of patients 
are  likely  to  suffer  from  enteric  illness  due  to  non-norovirus  causes  such  as 
incontinence,  reaction  to  medication  and  changes  in  diet  (Lopman  et  al,  2002).  
Enteric illness due to these causes is difficult to differentiate from norovirus illness 
and therefore these individuals are likely to have samples submitted for testing. A 
negative test result in such cases is entirely reasonable. A number of the RT-PCR 
negative samples may also be from outbreaks that have tested negative but could not 
be labelled as true negative outbreaks as they did not meet the minimum criteria of six 
submitted samples. 
One of the key objectives in introducing the new tests was the improvement of 
turn-around-times, since EM unlike PCR can be slow as it requires technical expertise 
and has been found unsuited to processing large numbers of samples (Utagawa et al, 
2002). As mentioned previously, a rapid result is more likely to be of use to clinicians 
and public health officials as it will affect patient and outbreak management. The data 
presented here shows that, in fact, this objective has been achieved. Although sample 
numbers have increased significantly since the introduction of RT-PCR for norovirus, 
these  have  been  processed  in  shorter  times  than  achieved  on  smaller  numbers  of 
samples using EM. It should be noted that the turn-around-times calculated included 
weekends, when the laboratory was closed. Also, the endpoint used in the calculation 
was the date the paper report was sent out, which means that the majority of results 
were actually generated the previous day, at least. As a result, the turn-around-times 
for the tests themselves are likely to be shorter than shown.   
For example, when EM was the frontline test for outbreaks, 90% of sample 
results were reported by day 13. In comparison, following implementation of the RT-
PCR assays the same proportion of a larger number of samples was processed in just 
5-8 days (depending on the RT-PCR test used). Furthermore the reductions in turn-  194 
around-times were maintained despite fluctuations in the sample numbers submitted. 
This shows both real-time PCR methods used for norovirus to be robust. 
Comparing the two RT-PCR assays in routine service, it was shown that the 
dual-labelled probe-based real-time assay resulted in better turn-around-times. Many 
factors contribute to this. Firstly, the dual-labelled probe-based real-time assay utilises 
a one step RT-PCR kit whereas the Lightcycler
TM real-time RT-PCR was a two-step 
assay (with separate reverse transcriptase and PCR steps). Fewer technical steps not 
only speeds up the process but also reduces the likelihood of error, which in turn 
results in fewer test repeats and thus reduced turn-around-times. The utilisation of 
such a kit in the Lightcycler
TM real-time RT-PCR assay would also have had this 
effect compared to the two-step process. However, during the Lightcycler
TM period of 
use an affordable kit of this type was not available. A second reason for the improved 
performance of the dual-labelled probe-based real-time assay is that it can process 96 
samples  and  controls  per  run,  whereas  the  Lightcycler
TM  real-time  RT-PCR  can 
process only 32 samples and controls. The dual-labelled probe-based real-time assay 
also offers simpler result interpretation in comparison to the Lightcycler
TM real-time 
RT-PCR assay (as outlined in Chapter 4). Again, easier interpretation reduces the 
number of repeat tests needed and thus helps reduce turn-around-times.  
A  further  improvement  in  turn-around-times  was  observed  after  the 
implementation  of  primer/probe  pools,  reduced  RT-PCR  cycling  parameters,  and 
pooled PCR positive controls in 2005. As outlined in Chapter 4, primer/probe pools 
are  aliquots  containing  pre-optimised  primer  and  probe.  These  are  stored  in  24-
reaction aliquots at –20
oC. The associated mastermix and enzyme are also stored in 
24-reaction aliquots at –20
oC. Depending upon the amount of tests to be carried out, 
the desired number of aliquots are defrosted and then added together with a minimum 
of pipetting, therefore increasing the ease and speed of the setup process and reducing 
the risk of errors. In addition to this, the use of reduced RT-PCR cycling parameters 
was shown in Chapter 4 to halve the time required to carry out each step of the RT-
PCR process compared to the manufacturer’s estimate (with the exception of the Taq 
activation phase which remains as the manufacturers describe). As a result DNA and 
RNA testing times are significantly reduced (by 30-40 minutes) and more test runs 
can be carried out in the laboratory each day. Pooled positive controls allow more 
samples to be processed per run, therefore improving throughput and rapidity. These   195 
amendments therefore contributed to the reduction in turn-around-times observed in 
2005 and 2006.  
5.6.2. Effects On The Diagnostic Service For Sporadic Cases Of IID 
Similar  improvements  to  those  described  above  for  the  norovirus  outbreak 
testing service were also observed for the testing of sporadic cases of gastroenteritis 
(although some caution should be applied in interpreting these results, since the time 
period involved since the introduction of these tests has been relatively short). The 
dual-labelled probe-based real-time PCR assays, which test for the five main causes of 
IID, were implemented in November 2004. In 2005 similar numbers of samples were 
tested as when EM was employed. However a large increase in sample submission 
was observed in 2006. Although this may be partly the result of increased disease 
activity in the community it is also likely to be due to increasing awareness of the 
utility of the service, especially in local BMT units (this is discussed further below). 
As with the norovirus outbreak service, the increased submission rates suggest users 
find the service useful. 
When compared to the norovirus outbreak diagnostic service, it was found that 
fewer health boards use the sporadic service on a routine basis. This may be partly 
due to the fact that the service is fairly recent in nature. However, it is more probably 
due  to  the  fact  that  most  laboratories  already  have  their  own  testing  protocol  for 
sporadic cases of gastroenteritis. This was indicated by the results of the laboratory 
survey, which highlighted that 64% of the laboratories questioned had an in-house 
testing service in place for sporadic gastroenteritis. In most cases laboratories tested 
for  rotavirus  only.  As  a  result  the  other  viral  causes  of  sporadic  IID  are  largely 
untested for, despite increasing evidence, confirmed by the results shown here, that 
these are common causes of illness. Examination of the health boards that did use the 
WOSSVC  molecular  service  in  each  year  suggests  the  service  is  mainly  used  by 
laboratories  with  no  testing  protocol  for  sporadic  gastroenteritis  of  their  own 
(although  this  was  not  explicitly  asked  in  the  questionnaire).  These  included  the 
following health boards: Argyle and Clyde, Dumfries and Galloway, Greater Glasgow 
and Lanarkshire.  
In 2006, most health boards submitted the same or slightly fewer sporadic 
samples  than  observed  in  2005.  The  substantial  increase  in  total  sample  numbers 
observed in 2006 originated primarily from Greater Glasgow health board. This was   196 
the result of a sharp increase in the number of samples being sent from the BMT ward 
at the Royal Hospital for Sick Children and the equivalent adult ward at Glasgow 
Royal Infirmary. Anecdotal evidence from clinicians working at these units suggests 
that they first became aware of the new test’s availability at WOSSVC in 2006 and 
would  have  made  use  of  the  service  had  they  been  aware  of  it  in  previous  years 
(Personal  communication,  Dr  Balfour,  RHSC).  Also  during  2006,  there  were 
occurrences of both outbreaks and sporadic cases of norovirus in each environment, 
affecting  multiple  patients  and  causing  long  term  shedding  in  a  number  of  those 
affected. Several patients with long term shedding suffered prolonged isolation and 
illness and may also have subsequently infected other patients. Patients, on the other 
hand, who were sent home to recover posed an infectious risk to family members and 
others (e.g. school pupils). Similar problems were also observed with occurrences of 
rotavirus, adenovirus, and astrovirus. One patient died as of a result of a disseminated 
adenovirus group F infection. Molecular methods are particularly useful in this setting 
as virus from immunocompromised patients is often shed at low levels, which other 
methods find difficult to detect. RT-PCR is more likely to detect those infected and 
can do so earlier than either EM or EIA (Cubitt et al, 1997). The increased sensitivity 
also decreases the likelihood of false negative results, which might otherwise lead to 
an infected patient remaining on the ward, causing further infections.  
As  a  result  of  these  issues,  both  wards  began  to  screen  all  patients  with 
diarrhoea  in  order  to  distinguish  viral  infection  from  other  causes  (e.g.  other 
pathogens or issues relating to the management of the transplant) and to isolate those 
with  infection  from  other  patients.  Increased  monitoring  of  infected  patients  also 
occurred in order to determine when shedding, and therefore the presumed infection 
or infectiousness, had stopped. Thus, in 2006, although the Royal Hospital for Sick 
Children already has an EIA-based service for investigating cases of gastroenteritis, 
the BMT ward chose largely to bypass this service in favour of the molecular test 
employed at WOSSVC - highlighting its usefulness. The awareness demonstrated by 
clinicians at these units of the problems caused by viral IID in BMT patients, together 
with their recently acquired awareness of the WOSSVC molecular service is likely to 
result in further use of the service in future years.  
Compared to the data obtained when using EM, the detection rates for most 
pathogens in sporadic samples showed significant increases when dual-labelled probe-
based real-time PCR was implemented. These increased detection rates have led to an   197 
increase in the overall detection rate. When EM was the frontline test the overall 
detection rate was between 2-23% whereas using the dual-labelled probe-based real-
time PCR the figure was between 48-52%. Again this shows the increased sensitivity 
of  the  real-time  PCR  assays  when  compared  to  EM  and  confirms  the  findings 
described in Chapter 4 and published in the literature. The most significant increases 
were observed for adenovirus and norovirus, which were the most common pathogens 
detected in the sporadic setting. Adenovirus has long been recognised as a common 
cause  of  sporadic  gastroenteritis.  However,  these  data  also  confirm  other  more 
recently  published  accounts  that  indicate  norovirus  is  also  a  common  cause  of 
gastroenteritis in the sporadic setting (Oh, Gaedicke, Schreier, 2003; Kirkwood and 
Bishop, 2001; Simpson et al, 2003; McIver et al, 2001; Subekti et al, 2002; Qiao et 
al, 1999; Phan et al, 2004; Bereciartu, Bok, Gomez, 2002; Sakai et al, 2001; Boga et 
al, 2004; Rodriguez-Baez et al, 2002; Phan et al, 2005; Buesa et al, 2002; de Wit et 
al, 2001; Bonn et al, 1999; Farkas et al, 2000; Pang et al, 2000; Froggatt et al, 2004; 
Chikhi-Brachet et al, 2002; Simpson et al, 2003; Fretz et al, 2005).  
Although the detection rates for astrovirus and sapovirus in sporadic samples 
remained small, increases were observed after the implementation of the dual-labelled 
probe-based real-time PCR assays in comparison to the EM test used previously. At 
the time of writing none of the laboratories questioned use either EM or a molecular 
method to test cases of sporadic gastroenteritis, which means that the WOSSVC is the 
only laboratory currently able to test for these pathogens.  
The benefits of dual-labelled probe-based real-time PCR assays in testing for 
adenovirus,  astrovirus,  norovirus  and  sapovirus  are  therefore  clear.  However,  the 
utility  of  the  assay  for  rotavirus  is  questionable based  on  the  evidence  shown,  as 
detection rates for this pathogen did not significantly improve compared to when EM 
was used (1-15% vs 0-12%). This lack of improvement in detection rate may be due 
to the fact that most of those seeking medical attention for rotavirus infection shed 
virus at levels that are equally detectable by both EM and RT-PCR (Kang et al, 2004). 
The low number of rotavirus detections overall compared to norovirus and adenovirus 
moreover, may be explained by the fact that some of the laboratories that use the 
service already screen sporadic samples for rotavirus before deciding whether or not 
to send them to the WOSSVC. The assay remains useful however, for those health 
boards that do not have a sporadic testing service, and is also likely to prove valuable 
for detecting rotavirus in the BMT setting.   198 
Samples from sporadic cases of IID that did not test positive for any viral 
pathogens are likely to result from a number of factors. Some are likely to contain 
PCR inhibitors and may therefore have been falsely classified as negative. Some are 
also likely to be from patients with intestinal illness due to other infectious causes 
(e.g. bacterial or parasitic infections, or other viral pathogens such as rotavirus C and 
enterovirus). Some cases may be due to viral infections that are not detected by the 
assays used (e.g. non-predominant noroviruses). For example, the sapovirus real-time 
RT-PCR assay is likely to miss any non-G1 sapoviruses. Perhaps using an alternative 
extraction protocol may also improve detection rates of all pathogens. Patients with 
non-infectious  causes  of  illness  may  also  contribute  to  the  proportion  of  sporadic 
samples that tested negative for viral pathogens.  
As with the diagnostic service for IID outbreaks, utilisation of the RT-PCR 
assays for sporadic cases of gastroenteritis has allowed more samples to be tested with 
reduced turn-around-times. When EM was the frontline test 50% of samples were 
reported by day 5-9, whilst 90% were reported by day 11-23. Initially, the results for 
the replacement RT-PCR assays were disappointing, with once-weekly batch testing 
leading to prolonged turn-around-times (with 90% of results not reported until day 23) 
since samples that needed repeat testing had to wait another week before this could 
take  place.  However,  as  the  sample  numbers  increased  testing  was  increased  in 
frequency  to  at  least  three  times  a  week.  As  a  result  turn-around-times  improved 
significantly, and in 2006 90% of samples were reported by day 6. 
5.7. Summary 
Chapter 5 examined real effects of implementing the developed PCR assays as 
the  frontline  tests  for  the  investigation  of  outbreaks  and  sporadic  cases  of 
gastroenteritis  on  the  laboratory  diagnostic  service  offered  by  the  WOSSVC.  The 
results showed that since the introduction of molecular tests in the laboratory for the 
detection of viral pathogens in cases of gastroenteritis the number of samples tested 
by the routine diagnostic service has risen steadily, as have the detection rates for each 
of the main viral causes. Furthermore, this has been achieved at the same time as a 
substantial  reduction  in  sample  turn-around-times.  The  reduced  turn-around-times 
were maintained despite fluctuations in sample submissions. These improvements in   199 
the WOSSVC laboratory service have been observed for both outbreaks and sporadic 
cases of gastroenteritis.  
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Chapter 6    201 
Discussion 
6.1. Summary Of Research 
The research in this thesis sought to advance knowledge in the field of public 
health by developing and assessing PCR methods for the detection of viral causes of 
IID in a routine diagnostic setting, an approach that distinguishes it from previous 
work in this area. 
As  described  in  Chapter  2,  outbreaks  and  sporadic  cases  of  Infectious 
Intestinal  Disease  (IID)  are  a  major  public  health  issue,  resulting  in  significant 
morbidity and sometimes mortality every year. Viral pathogens have been shown to 
be responsible for a significant proportion of the IID burden, particularly in sporadic 
cases in children and outbreaks in all age groups.  
Laboratory diagnosis of viral IID is important, as the aetiological causes of IID 
(bacteria,  parasites  or  viruses)  cannot  be  differentiated  based  on  clinical  or 
epidemiological data alone. Before this research began, Electron Microscopy or EM 
was the frontline method used at the West of Scotland Specialist Virology Centre 
(WOSSVC) for the diagnosis of viral causes of IID in samples from both outbreaks 
and sporadic cases of IID. However, although rapid on a small number of samples, 
this  test  has  limited  sensitivity  compared  to  other  emerging  techniques  and  is 
laborious,  requiring  highly  specialised  staff  and  expensive  equipment.  Alternative 
methods  of  detection  include  antigen  detection  methods.  These  offer  similar 
sensitivity to EM but in comparison have the potential for improved rapidity, ease of 
use and throughput. These methods, however, are not available for all the main viral 
causes of IID.  
In recent years, the molecular method Polymerase Chain Reaction (PCR) has 
been increasingly used in research on the main causes of viral IID. PCR assays are not 
currently offered by commercial companies but have been found to be more sensitive 
than either EM or antigen detection methods. However, conventional gel-based PCR 
methods can be expensive to implement and are technically complex, consisting of 
numerous steps. As a result, in the past these have not been considered suitable for use 
in the routine diagnostic setting, where the ideal test is one that is not only sensitive 
but also rapid, high throughput, and easy to use.    202 
Real-time PCR has the potential to overcome many of the pitfalls associated 
with gel-based methods. Using this technique, for example, all or the majority of the 
numerous steps associated with PCR can be carried out in a single step. The relatively 
recent nature of the technology, however, means that the choice of assays of this type 
is limited and, prior to this research, there were no examples of its use in a diagnostic 
setting.   
The  overall  aim  of  this  research  was  therefore  to  examine  whether  PCR 
methods could be adapted for use in the routine diagnostic setting and, in comparison 
to the EM-based service, bring significant benefits to the laboratory service in terms 
of increased detection rate and throughput, and reduced turn-around-times.  
Based on a review of the literature (see Chapter 2) the decision was taken to 
divide the proposed new service into two parts: a separate service for samples from 
outbreaks of gastroenteritis and one for those from sporadic cases of IID. For the 
outbreak  service,  a  norovirus  assay  was  chosen  as  the  frontline  test  for  sample 
investigation, based on an increasing number of reports showing norovirus to be the 
principle cause of outbreaks of IID. For the sporadic service, the decision was taken to 
employ this same norovirus assay together with PCR tests for adenovirus, astrovirus, 
rotavirus  and  sapovirus  to  investigate  sporadic  cases  of  gastroenteritis  in  children 
under 10 years of age and immunocompromised patients (the patient groups already 
tested using the EM-based service) since these viral pathogens have been shown to 
contribute significantly to IID in children and can cause severe and chronic infection 
in immunocompromised individuals of all age groups. In the case of the outbreak 
service,  moreover,  it  was  decided  that  samples  that  tested  negative  for  norovirus 
should be examined further using the tests for the other non-norovirus pathogens.  
Following  this,  the  PCR  and  associated  methods  for  use  in  the  proposed 
service were chosen and adapted as described in Chapter 3. In each case a review of 
the  available  methods  was  conducted  and  an  appropriate  test  selected  for  each 
pathogen based on a combination of clinical and laboratory requirements. In selecting 
an appropriate test evidence of its sensitivity and specificity was key (including the 
ability to detect a wide range of virus subtypes). However, other factors also played a 
important part. Based on the desire to use the test in a routine setting, for example, 
preference  was  given  to  single  round  assays  over  nested  techniques  in  order  to 
minimise test complexity and length (and hence the potential for error). Priority was 
also given to tests that targeted the most conserved regions of the virus, in order to   203 
minimise the risk of sensitivity drift over time and/or sudden loss of sensitivity due to 
the emergence of a new virus type or subtype, which is more likely when targeting 
more variable areas of the genome. 
With regards the outbreak service there were two phases of development. In 
2000, when the initial developments took place, there were no real-time PCR methods 
for the detection of norovirus available in the literature. The early work, therefore, 
sought  to  adapt  a  published  gel-based  method  (Green  et  al,  1995)  into  real-time 
format  in  order  to  increase  its  potential  for  rapid  turn-around-times,  and  by 
association,  high  throughput,  since  speed  is  particularly  important  in  an  outbreak 
setting where rapid results may inform decisions on the infection control procedures 
to be used. The novel real-time assay was developed using SYBR green technology, 
which  was  the  predominant  real-time  technology  available  at  the  time,  and  was 
implemented on the  Lightcycler™ RT-PCR platform, which was one of only two 
PCR platforms available in the laboratory, the other being a conventional PCR block 
(the ABI 9700).  
From  2003,  several  other  real-time  PCR  platforms  were  obtained  by  the 
laboratory, which can be used for other real-time PCR chemistries including dual-
labelled probes. Such chemistries use an additional probe, which specifically binds to 
the PCR product and fluoresces in direct relation to the amount of PCR product being 
produced. The use of a probe increases the specificity of the assay in comparison to 
SYBR  green  based  methods,  which  bind  to  all  dsDNA.  Compared  to  the 
Lightcycler™  platform,  these  platforms  also  offer  improved  throughput. 
Consequently, from this point on, the research focused on developing a real-time PCR 
assay  for  norovirus  that  used  dual-labelled  probe-based  technology.  The  assay 
described by Kageyama et al was chosen for investigation (Kageyama et al, 2003). 
The original publication used separate RT-PCR assays to detect G1 and G2 norovirus 
types. Here, as a further development the assays were multiplexed in an attempt to 
improve rapidity, throughput and reduce testing costs. 
As with the outbreak service, the research relating to the sporadic service also 
took place in two stages. The first development phase took place between 2000 and 
2002. The aim of the initial studies was to develop a novel gel-based multiplex RT-
PCR assay for adenovirus, astrovirus, rotavirus and sapovirus. The assays chosen to 
be  multiplexed  were  all  single  round  PCR  assays  selected  from  the  published 
literature (Gentsch et al, 1992; Rasool et al, 2002; Cooper et al, 1999; Vinje et al,   204 
2000; Noel et al, 1995). Multiplexing was attempted in order to reduce the number of 
steps  involved  in  the  testing  process  and  thus  improve  rapidity,  ease  of  use  and 
throughput (as well as reducing costs). Real-time PCR methods were not considered 
at this time since the decision had been taken to prioritise use of the only available 
real-time platform in the laboratory for use in the norovirus outbreak service.  
In 2003, when the other real-time platforms became available in the laboratory 
the possibility of implementing real-time PCR for all tests in the sporadic service was 
examined. Here the decision was taken to move straight to dual-labelled probed-based 
technology,  rather  than  SYBR  green  based  assays,  in  line  with  the  ongoing 
developments  in  tests  for  the  outbreak  service.  Where  possible  these  assays  were 
chosen from the literature (Pang et al, 2004; Le Cann et al, 2004; Heim et al, 2003). 
However, no such assay was available for sapovirus and thus a novel in-house method 
was  designed  (Gunson,  Collins  and  Carman,  2006(i)).  The  new  method  detected 
sapovirus G1 types only. However, although it was known that this test would miss 
non-G1  types,  data  from  the  HPA  and  other  studies  suggested  that  this  was 
reasonable, given that sapovirus G1 types were the most predominant strains pre-2004 
(Okada et al, 2002; Gallimore et al, 2006). 
Following selection and adaptation of the appropriate tests a series of studies 
was then carried out to assess the sensitivity of each assay in comparison to existing 
and possible alternative methods (see Chapter 4). Results from the first experiment 
relating to the outbreak service showed that the SYBR green based Lightcycler™ RT-
PCR assay developed as described in Chapter 3 was more sensitive than EM for the 
detection of norovirus, in both samples from outbreaks and sporadic cases of  IID 
(Miller,  Gunson  and  Carman,  2002).  This  was  the  first  real-time  RT-PCR  for 
norovirus to be published at the time and was implemented as the routine test for 
outbreak samples in the WOSSVC laboratory in January 2001. It was subsequently 
compared to two commercial EIA methods for norovirus and was found to be both 
more sensitive and specific than either (Gunson, Miller and Carman, 2003(ii)). This 
study was one of the first to show the relatively poor sensitivity and specificity of the 
EIA  methods,  findings  that  have  subsequently  been  confirmed  in  other  studies 
(Wilhelmi et al, 2007; Castriciano et al, 2007; Dimitriadis, Bruggink and Marshall, 
2006; Dimitriadis and Marshall, 2005). The Lightcycler™ method was also compared 
to a recommended gel-based RT-PCR that was held to be the most sensitive of the 
gel-based methods available at that time (Vinje et al, 2003). However, although the   205 
Lightcycler™ RT-PCR assay was indeed shown to be less sensitive it did not miss 
any outbreaks and, moreover, involved fewer and shorter steps than the gel-based 
assay (Gunson, Miller and Carman, 2003 (i)). As a result the decision was taken to 
retain it as the frontline test for norovirus in the outbreak service at this stage.  
The  final  experiment  in  this  series,  carried  out  in  2003  once  the  relevant 
technology became available, showed that the new multiplexed dual-labelled probe-
based assay for norovirus (based on the test published by Kageyama et al, 2003) was 
also more sensitive than the Lightcycler™ RT-PCR, which in this case missed both 
individual cases and outbreaks of norovirus. The dual-labelled probe-based RT-PCR 
also had the potential to offer better throughput and rapidity than the Lightcycler™ 
test.  As  a  result  it  was  implemented  in  2004  and  remains  the  frontline  test  for 
norovirus in the outbreak service at the time of writing.  
The initial experiment for the sporadic service focused on multiplexing the 
individual  assays  for  adenovirus,  astrovirus,  rotavirus  and  sapovirus  chosen  and 
adapted as described in Chapter 3. The results, however, showed that the rotavirus 
RT-PCR could not be successfully multiplexed as the primers interacted with and 
reduced the sensitivity of the astrovirus and sapovirus RT-PCR assays. Instead, the 
multiplexing process resulted in two RT-PCR assays: a rotavirus RT-PCR and a novel 
multiplex RT-PCR for adenovirus, astrovirus and sapovirus. 
The two assays developed were then compared to antigen detection methods 
for astrovirus and rotavirus, and shown to be more sensitive than either (Gunson et al, 
2003(iii), Gunson et al, 2003(iv)). However, the number of steps involved in carrying 
out  the  two  gel-based  assays  plus  concerns  over  the  appearance  of  non-specific 
products  in  the  multiplex  RT-PCR  meant  that  these  were  not  implemented  in  the 
sporadic service at this stage. 
In the final experiment in this series, again carried out once the technology 
became available, the two gel-based RT-PCR methods were compared to the dual-
labelled  probe-based  real-time  PCR  assays  selected  (or  developed  in  the  case  of 
sapovirus) as described in Chapter 3. The results showed that for each pathogen the 
real-time PCR assay detected a lower dilution of pathogen and identified more clinical 
samples as positive than the relevant gel-based assay (Gunson and Carman, 2005). 
The dual-labelled probe-based approach also involved fewer, shorter steps and had the 
potential to offer better throughput and rapidity than the EM test still in use in the 
routine service at this time. As a result these assays were implemented in the service   206 
for sporadic cases of IID in November 2004, alongside the dual-labelled probe-based 
norovirus RT-PCR. From this date EM was used solely to investigate outbreaks that 
tested negative for a viral pathogen using all of the PCR methods available. 
Following  implementation  of  the  dual-labelled  probe-based  real-time  PCR 
methods  in  the  routine  service  a  number  of  experiments  were  carried  out  that 
attempted to further modify these tests in order to reduce turn-around-times, improve 
throughput and reduce cost (see Chapter 4). In the first experiment it was shown that 
reducing PCR cycling times had no effect on test sensitivity and improved rapidity 
considerably (e.g. reducing turn-around-times from 100 minutes to 60 minutes). The 
second experiment showed that the test for adenovirus, a DNA test, could be carried 
out under the same conditions (i.e. on the same PCR plate) as any of the RNA tests for 
astrovirus, rotavirus or sapovirus without affecting its sensitivity, thus allowing more 
tests  to  be  carried  out  per  PCR  run.  (The  norovirus  assay  involved  a  different 
annealing  temperature  to  any  of  the  other  tests  and  as  a  result  was  always  kept 
separate).  Further  studies  then  showed  that  pooled  positive  controls,  primer/probe 
pools  and  reduced  reagent  volumes  could  all  be  employed  without  affecting  test 
performance,  thereby  improving  test  efficiency  (Gunson,  Collins  and  Carman, 
2006(ii)). Use of these measures was therefore implemented in January 2005.  
The effect of implementing the various changes on the WOSSVC laboratory 
diagnostic  service  for  IID  was  then  examined,  as  described  in  Chapter  5.  Sample 
submission data from the period 1999-2006 showed that since the introduction of 
molecular  tests  for  the  detection  of  viral  pathogens  in  cases  of  gastroenteritis  the 
number of samples tested by the routine diagnostic service has risen steadily. In 1999, 
when EM was the frontline test, a total of 887 IID samples from outbreaks and 668 
from  sporadic  cases  were  submitted  for  testing  at  the  WOSSVC.  In  the  years 
following  implementation  of  the  Lightcyler
TM  real-time  assay  for  norovirus  in  the 
outbreak service the number of outbreak samples tested rose to between 1112-4025 
(the latter figure a peak in activity due the emergence of a new worldwide variant of 
norovirus  in  2002).  The  rise  in  the  number  of  outbreak  samples  tested  continued 
following implementation of the dual-labelled probe-based assay in 2004, from 2033 
to 3189 in 2006. Similar patterns were observed in the submission rates for samples 
from sporadic cases of IID, although some caution should be applied in interpreting 
the results for this service since the time period involved since the introduction of the 
new tests has been relatively short. In 1999, a total of 668 samples from sporadic   207 
cases were tested, rising to 1153 in 2006 following introduction of real-time PCR tests 
to the sporadic service. The increased use of the service reflects greater use of the 
service  by  existing  users  (health  boards),  an  increasing  number  of  health  boards 
submitting  samples  to  the  laboratory  for  diagnosis,  and  an  increase  in  sample 
submission from immunocompromised patients and adult patients.  
In addition to increased submission rates, the detection rates in the routine 
service  have  risen  for  all  viral  pathogens  following  implementation  of  the  PCR 
methods, in both outbreaks and sporadic cases of gastroenteritis. For example, for 
samples submitted from outbreaks of IID the norovirus detection rate achieved by EM 
was always below 12%. However, from 2001-2003, when the Lightcycler™ RT-PCR 
was  the  frontline  test,  the  detection  rate  was  between  28-35%.  A  slight  further 
improvement in detection rate was observed after the implementation of the dual-
labelled  probe-based  real-time  RT-PCR  assay  in  2004,  with  a  detection  rate  of 
between 28-41%. The improved detection rate resulted in an increase in the number of 
outbreaks confirmed to be caused by norovirus, from a total of 15 and 16 in the years 
1999  and  2000  respectively,  compared  to  between  83-223  in  the  6  years  post-
implementation of the PCR-based service. Similar improvements were observed after 
the implementation of the PCR service for sporadic cases of IID. For example, in the 
years when EM was the frontline test the overall detection rate was between 2-23%, 
whereas  following  implementation  of  the  real-time  PCR  assays  the  figure  was 
between 48-52%.  
These  improvements,  moreover,  were  achieved  at  the  same  time  as  a 
substantial reduction in sample turn-around-times. For example, when EM was the 
frontline test for outbreaks of gastroenteritis in 1999 and 2000, 50% of results were 
reported  between  5  to  7  days  after  arriving  in  the  laboratory,  whilst  90%  were 
reported between 11 to 13 days after submission. Following implementation of the 
Lightcycler
TM real-time RT-PCR for norovirus in the period 2001-2003 a considerable 
improvement in these turn-around-times was observed, with 50% of results available 
by day 5 and 90% reported by day 8 in each of these years. The implementation of the 
dual-`labelled  probe-based  real-time  RT-PCR  in  2004  resulted  in  further 
improvements, with 50% of outbreak results reported just 3 days after submission and 
90% of sample results reported by day 6 during this year. These reduced turn-around-
times  were  maintained  despite  fluctuations  in  sample  submissions.  Finally,  the 
implementation  of  the  test  amendments,  e.g.  pooled  controls,  in  2005  saw  further   208 
reductions in outbreak sample turn-around-times. The final outcome was that at the 
time  of  writing  50%  of  outbreak  sample  results  are  reported  by  day  2  with  90% 
reported by day 5 (this was achieved in two consecutive  years) compared to best 
results of day 5 and day 11 respectively when EM was the frontline test for outbreaks.  
Similar improvements in turn-around-times were observed for samples from 
sporadic cases IID. For example, between 1999 and 2004, use of EM resulted in 50% 
of samples being processed by days 5 to 9, but 90% was not achieved until days 11 to 
23. At first, use of the new PCR-based service resulted in similar turn-around-times in 
2005 (50% of results were available by day 9 and 90% by day 23). In 2006, however, 
the numbers of samples of this type submitted to the laboratory increased and as a 
result batch testing was increased to at least three times a week. This, together with 
the test amendments outlined above led to a substantial improvement in turn-around-
times, with 50% of results available after day 3 and 90% by day 6. 
6.2. Main Findings 
In conclusion, the implementation of a molecular diagnostic service for viral 
causes of IID at the WOSSVC has enabled more stool samples to be tested in shorter 
periods of time, using more sensitive tests than any previously available.  
Whilst  it  is  possible  that  some  of  the  increases  in  sample  submission  and 
detection  rate  observed  for  the  PCR-based  service  were  due  to  increased  disease 
activity in the years examined, the size and consistency of the increases over a period 
of  several  years  suggests  this  was  not  the  determining  factor.  Moreover,  the 
possibility  that  PCR  techniques  may  be  over-sensitive  (discussed  in  Chapter  2)  - 
detecting asymptomatic IID or prolonged shedding following resolution of symptoms 
in a minority of cases - is less likely to apply in the routine diagnostic setting, where 
samples are only tested as a result of patients presenting with the symptoms of IID. In 
any case, the detection of prolonged or asymptomatic shedding in patients may still be 
of value in this context, since these patients may pose an infectious risk to others. This 
is particularly important in an outbreak setting where detecting those shedding virus 
in the absence of symptoms may aid infection control procedures (Gallimore et al, 
2004). 
Although  previous  research  has  shown  the  improved  sensitivity  of  PCR  in 
comparison to alternative methods such as EM and EIA, to date these studies have   209 
focused on use of the tests in a research setting, based on relatively small numbers of 
samples and carried out by highly specialised researchers. The research described in 
this  thesis,  in  contrast,  has  demonstrated  the  increased  sensitivity  of  PCR  in 
comparison to EM based on high volumes of samples in a routine diagnostic setting 
where the tests are often carried out by less specialised staff. 
Moreover, the research has also shown that such sensitivity can be achieved at 
the same time as reduced turn-around-times in comparison to EM. Studies showing 
the positive effect of real-time PCR methods on rapidity and throughput (and, by 
implication, ease of use) are largely absent from the published literature despite the 
fact that these factors can be very important, since they determine whether a test is 
suitable for a routine diagnostic setting and how clinically useful it will be (discussed 
in more detail in the following section).  
Diagnostic  laboratories  have  in  the  past  been  reluctant  to  implement  PCR 
assays as a result of many factors, most of them associated with negative perceptions 
or experiences of conventional gel-based PCR (see Chapter 2 for full details). The 
results shown here, however, have demonstrated that real-time PCR can overcome 
many of these difficulties. The real-time PCR methods introduced at WOSSVC have 
proven to be both robust and capable of high throughput, indicating relative ease of 
use. (In particular, the use of a specific labelled probe in the dual-labelled probe-based 
assays was found to aid ease of interpretation in comparison to a SYBR green based 
approach.) Moreover, several techniques for improving the efficiency of the real-time 
tests without affecting their sensitivity have been successfully demonstrated (Gunson, 
Collins and Carman, 2006(ii)). Such techniques are largely ignored in the scientific 
literature but are of high practical value in a diagnostic setting. 
One drawback of PCR remains, however, which is that the implementation of 
such methods still requires technical expertise in quality control (see Chapter 5). All 
PCR assays, and in particular real-time PCR assays, should be monitored carefully to 
detect  any  contamination,  or  sudden  or  long-term  loss  in  sensitivity.  Either  could 
result in false negative or positive results. However, to ease this problem there are 
now a number of useful guides available that describe monitoring systems such as 
those used here (described in Chapter 5), and which are relatively easy to implement 
and maintain (Gunson, Collins and Carman, 2005; Niesters, 2002; Gray et al, 1995; 
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In  addition  to  the  benefits  seen  within  the  laboratory  itself,  the  wider 
usefulness of the new molecular service for norovirus in outbreaks of IID is indicated 
by  the  fact  that  a  number  of  other  Scottish  Specialist  Virology  Centres  or  SVCs 
(Aberdeen,  Dundee  and  Edinburgh)  have  begun  to  use  the  WOSSVC  service  for 
norovirus outbreaks or  plan to do so in the near future, despite having their own 
testing capability. Moreover, since publications relating to the research carried out 
here,  which  were  among  the  first  to  show  the  practical  advantages  of  both  the 
Lightcycler™  and  dual-labelled  probe-based  real-time  RT-PCR  methods,  and  the 
reduced sensitivity and specificity of commercial EIA methods for norovirus (Miller, 
Gunson and Carman, 2002; Gunson, Miller and Carman, 2003) a number of virology 
laboratories have replaced or are about to replace EM or commercial EIA methods for 
the detection of viral pathogens in outbreak samples with the real-time PCR test for 
norovirus described here.  
In  the  sporadic  setting  the  real-time  PCR  tests  implemented  have  proven 
useful for laboratories with limited or no testing protocol of their own. They have also 
proven  useful  in  the  BMT  setting  for  the  detection  of  viral  IID  in 
immunocompromised patients, where the sensitivity of EM and EIA may not be good 
enough (Cubitt et al, 1999). At the time of writing no other laboratory in Scotland 
offers real-time PCR testing for viral causes of sporadic IID. The WOSSVC, in fact, 
provides the only service in Scotland that tests for all five main causes of viral IID.  
It is not only virology laboratories that can benefit from use of the PCR tests 
described here. The WOSSVC is currently involved in a pilot study to outsource real-
time PCR tests to microbiology laboratories affiliated to District General Hospitals 
(DGHs). The first phase of the study will examine the effect of implementing the 
WOSSVC  real-time  RT-PCR  for  norovirus  in  two  DGH  sites.  Each  site  will  be 
provided with a “kit” for the test containing the standard operating procedures, pre-
optimised primer/probe pools, and PCR controls and reagents. The WOSSVC will 
also offer full training to laboratory staff and a troubleshooting service. To facilitate 
the  implementation  of  the  test  the  laboratories  involved  have  obtained  automated 
extraction equipment and PCR platforms similar to those in use at the WOSSVC. 
Having a norovirus service on-site at the DGH will negate the need to send samples to 
the WOSSVC and therefore has the potential to improve the rapidity of sample results 
significantly. For clinicians, access to a sensitive and rapid service for norovirus will 
aid  patient  management  and  infection  control  decisions  (see  below  for  a  detailed   211 
discussion). In the laboratory, supported implementation of the test will provide useful 
experience of real-time PCR methodology, which in future could be used in other 
areas of their service. The plan is that, if successful, the project may be widened to 
include other sites and tests. 
Finally,  awareness  of  the  benefits  of  implementing  real-time  PCR, 
demonstrated in this research, has been used to improve other diagnostic services in 
the WOSSVC laboratory. Based on the successful experience of implementing real-
time PCR in the norovirus outbreak service, for example, in 2004 conventional RT-
PCR  assays  for  the  detection  of  viral  and  bacterial  respiratory  infections  were 
replaced in the laboratory with a number of real-time PCR methods (Gunson et al, 
2005). Since their implementation significant improvements have been observed in 
throughput, rapidity and overall detection rates. This service also benefited from the 
test  amendments  described  in  Chapter  4,  which  once  implemented  led  to  further 
improvements in rapidity, ease of use and cost. Similar real-time PCR systems have 
also been developed in the laboratory to test for viral pathogens in other sample types 
and/or patient groups (e.g. CSF samples and plasma from BMT patients). Plans for 
further use of this technology in the laboratory include extending its use to other areas 
of  microbiology  such  as  rapid  MRSA  screening  (Gilpin  et  al,  2007),  bacterial 
gastroenteritis (Wang and Mestaphai, 2007; Shannon et al, 2007) and bacterial sepsis 
(Stratidis, Bia and Edberg, 2007). 
6.3. Implications For Patient Management 
The  changes  in  the  WOSSVC  diagnostic  service  for  viral  causes  of  IID 
introduced in this research are likely to aid patient management on a number of fronts. 
More sensitive testing, for example, increases the likelihood of obtaining an accurate 
diagnosis,  which  enables clinicians to  confirm the initial clinical diagnosis and to 
exclude other, more serious causes of IID or non infectious causes of intestinal illness 
(Fine et al, 1998). A more rapid, accurate result also enables the clinician to correctly 
advise the patient on the likely duration of illness, its infectiousness and how they can 
reduce the likelihood of further spread to other members of the public (Guerrant et al, 
2001).  Patients,  for  example,  can  be  advised  on  the  sources  of  IID  (e.g.  soiled 
nappies)  and  informed  that  simple  procedures  such  as  frequent  hand  washing  can 
reduce the risk of infection.    212 
Accurate  management  based  on  a  laboratory  diagnosis  is  particularly 
important if the patient poses a public health hazard, since such patients may also 
require  follow  up  testing  before  returning  to  their  place  of  work.  This  applies  to 
patients working in the food industry or the National Health Service (Bresee et al, 
2002),  children  attending  nursery  school  or  elderly  residents  in  a  care  home.  The 
ability to swiftly advise a patient in such matters based on an accurate laboratory 
result will help prevent further infections, which in turn saves on further health care 
expenditure  related  to,  for  example,  GP/hospital visits  by  newly infected  patients. 
Furthermore, the ability to provide a result rapidly can help reduce the number of 
unnecessary tests that are carried out in the meantime, and in those with more serious 
illness may help prevent unnecessary hospitalisation or, if already hospitalised, may 
mean a reduction in the length of stay. All of these factors contribute to reducing 
unnecessary health care costs as well as improved care for the patient. 
Access to a more rapid and sensitive service also has benefits in reducing the 
prescription  of  unnecessary  treatments.  Although  not  generally  recommended  for 
treating IID, particularly in children and for patients managed in the primary care 
setting,  a  recent  study  in  Ireland  found  that  approximately  7.5%  of  patients  who 
consulted a GP for symptoms of IID received empirical therapy, which represented 
15% of all treatments prescribed (Acute Gastroenteritis in Ireland, North and South - 
A Telephone Study, 2003). This is despite the increasing evidence that shows viruses 
to cause much of the illness in all age groups (Phan et al, 2005; Bon et al, 1999; 
Bereciartu,  Bok  and  Gomez,  2002;  Qiao  et  al,  1999;  Oh,  Gaedicke  and  Schreier, 
2003; de Wit et al, 2001 (i); de Wit et al, 2001 (ii)) and the fact that antibiotics may, 
in some bacterial infections, result in more severe or prolonged symptoms (Armon et 
al, 2001). Those with travel associated IID, immunocompromised patients with IID 
and patients hospitalised due to IID are also likely to receive empirical anti-microbial 
treatment (Guerrant et al, 2001), despite data showing that viral pathogens can cause 
many of these cases (Keswick et al, 1982; Vollet et al, 1979; Bolivar et al, 1979; 
Steffen et al, 1999; Chapin et al, 2005). Consequently, access to a more rapid and 
sensitive viral diagnosis service can help encourage more judicious use of antibiotics, 
potentially reducing the number of patients receiving unnecessary treatment and/or 
reducing the duration of treatment (Armon et al, 2001). This will both reduce costs 
and help prevent the emergence of antimicrobial resistance (Holmberg et al, 1984; 
Cohen and Tauxe, 1986).    213 
For all of this to be effective, however, it is important that clinicians receive 
laboratory results as early as possible after the  onset of symptoms, and while the 
illness is still occurring. The sensitivity of the testing is key in providing an accurate 
diagnosis, but unless clinicians and public health managers receive test results within 
a clinically useful timeframe these are of little practical value either to them or to the 
patient.  
Previously, using the EM-based service the best turn-around-times achieved 
for  samples  from  cases  of  IID  were  50%  of  results  reported  by  day  5  and  90% 
reported by day 11 (the figures were the same for both outbreak and sporadic samples, 
although turn-around-times for the latter varied considerably more and could be as 
high as day 9 for 50% of results and day 23 for 90%). Based on these figures, it is 
likely that in a large proportion of cases the laboratory diagnosis was not received by 
clinicians until after resolution of the illness - too late to take steps to prevent the 
spread of the infection and/or unnecessary treatment/testing/hospitalisation. Following 
implementation of the new PCR-based service, on the other hand, turn-around-times 
for outbreak samples were reduced to days 2 and 5 respectively (50% and 90% of 
results reported), and days 3 and 6 for sporadic samples. Consequently, results from 
the  new  service  are  far  more  likely  to  be  of  value  to  clinicians  in  providing 
appropriate patient care. This increased utility is likely to have been a factor in the 
increased uptake of the service i.e. the increase in sample submission rates observed 
following introduction of the new tests.  
One of the main advantages of a rapid diagnostic result in any context is that it 
allows the appropriate treatment, (where available) to be started when the illness is 
occurring, the pathogen is present and when treatment is likely to be most useful. 
However, historically rapid and sensitive tests for the majority of viral pathogens have 
not been available and as a result anti-viral therapies have been mainly restricted to 
the  treatment  of  those  viral  pathogens  known  to  cause  chronic  infections  such  as 
HBV, HCV and HIV (Waugh et al, 2002; O’Shea, 2007; Sandrock and Kelly, 2007). 
In recent years, improvements in the rapidity and sensitivity of routine diagnostic tests 
for some viral pathogens have led to the emergence of new therapies. For example, 
the availability of rapid and sensitive tests for influenza such as DIF, bedside tests and 
real-time PCR have led to the development of new anti-influenza therapies. Examples 
include  oseltamivir,  a  neuraminidase  inhibitor  that  has  been  shown  to  be  most 
effective when given within 48 hours of disease onset (Waugh et al, 2002; Mitamura,   214 
2007). Similarly, the availability of rapid and sensitive tests has made the use of pre-
emptive therapies feasible for CMV, adenovirus and EBV-related disease in BMT 
patients  (Cochrane,  2006;  Baillie,  2006;  Okano  and  Gross,  2007;  Neofytos  et  al, 
2007).  
The  improvement  in  rapidity  offered  by  the  real-time  PCR  service 
implemented in this research can thus help create demand for the development of new 
anti-viral  agents  aimed  at  reducing  the  clinical  severity  of  IID,  the  duration  of 
infection or at preventing infection altogether (Estes et al, 2006) – particularly since 
data from the telephone survey suggest that other testing centres also intend to utilise 
or replicate the service. Such drugs could be used, for instance, to treat those with 
severe  disease  (to  reduce  severity  or  duration  of  symptoms)  or  could  be  used 
prophalatically  in  the  outbreak  setting  to  reduce  the  number  of  cases  and  further 
spread.  Recent  studies  using  nitrazoxanide,  a  thiolzolide  anti-infective  agent,  have 
shown  it  to  reduce  the  duration  of  symptoms  due  to  norovirus  and  rotavirus  in 
paediatric patients (Rossignol and Gohary, 2006; Rossignol et al, 2006). 
6.4. Implications For Infection Control 
The  new  molecular  service  for  IID  is  also  likely  to  be  beneficial  in  the 
outbreak setting as the increased rapidity and sensitivity of the service allows timely, 
focused  implementation  of  control  measures  that  are  recommended  by  published 
guidelines and the previous experience of infection control teams (MMWR weekly, 
2005).  Previously,  the  turn-around-times  of  the  EM-based  service  (where  the  best 
performance achieved for outbreak samples was 50% of results reported by day 5 and 
90% reported by day 11) were such that it was of limited use in this context, since 
results  would  often  be  obtained  too  late  to  inform  decisions  on  possible  control 
measures. As discussed in Chapter 2, the quicker infection control procedures can be 
implemented following the start of a norovirus outbreak the more likely it is that these 
will  be  effective.  One  estimate,  for  example,  is  that  control  procedures  must  be 
implemented within 3 days if they are to be successful (Lopman et al, 2003). The 
improved turn-around-times of the PCR-based service (50% of results reported by day 
2 and 90% by day 5), therefore, mean that the test results are now much more likely to 
be of value in this setting.   215 
Even where results were reported ‘in time’ to be of use, moreover, the poor 
detection  rate  of  the  EM-based  service  for  outbreaks  (a  total  of  15-16  outbreaks 
confirmed in the years 1999-2000 compared to between 83-223 in the 6 years post-
implementation of the PCR-based service) meant that false negative results were more 
likely and thus may have led to under-implementation of infection control procedures. 
Based on the new real-time PCR service, swift and confident knowledge of the 
actual cause of an outbreak can help persuade ward managers to implement expensive 
control procedures such as short-term ward closure. It can also help exclude other, 
potentially  more  serious,  causes  of  outbreaks  that  may  require  different  infection 
control measures. Once an outbreak of norovirus has been confirmed, moreover, the 
improved rapidity and sensitivity of the PCR tests described here can also aid ward 
management in other ways. Screening, for example, can be used to aid decisions on 
staff deployment and patient cohorting or isolation measures, by identifying those 
with symptomatic and asymptomatic infection (Gallimore et al, 2004).  
The rapid and sensitive testing provided by the PCR-based service may also 
allow new forms of infection control to be employed in future. A holding ward, for 
example,  could  be  used  to  temporarily  house  all  newly  admitted  patients  with 
symptoms  of  gastroenteritis.  A  rapid  test  could  then  be  carried  out  to  exclude 
norovirus  or  other  viral  infection  before  allowing  the  patient  to  be  transferred  to 
another ward. Norovirus-positive cases could remain in the holding ward until the risk 
of infection was past, thereby preventing spread to others within the hospital.  
In  future,  screening  could  also  be  considered  for  Health  Care  Workers 
(HCWs) before allowing them to return to work after a period of illness due to viral 
IID. Most current guidelines for norovirus infections suggest a worker  should not 
return to work until 48-72 hours after clinical symptoms have abated (Joint Working 
Group  from  NHS  Boards,  Local  Authorities  and  SCIEH,  2003).  A  further 
development of this would be to screen the returning HCWs to identify those with 
prolonged shedding, preventing these individuals from returning to work until the risk 
of infection had abated.  
The new PCR-based service could also be used in future to test environmental 
surfaces for viral contamination, thus measuring the effectiveness of infection control 
procedures  such  as  cleaning.  Several  studies  have  established  that  contaminated 
fomites can be responsible for prolonging or reseeding outbreaks in closed settings 
(Kussi, 2002; Evans, 2002), although the relationship between the presence of virus   216 
on  an  inanimate  surface  and  infectivity  has  yet  to  be  fully  proven.  Areas  at  risk 
include  much-handled  items  such  as  door  handles,  lockers,  taps,  soft  furnishings, 
floors, walls, soiled linen and commodes (Green, 1997; Gallimore et al, 2006). Whilst 
in theory most of these areas can be cleaned using already established procedures, in 
practice the cleaning is often poorly executed and/or external pressures to re-open a 
ward  can  prevent  the  proper  procedures  from  being  carried  out  (Christie,  2002; 
Cowden, 2002). The rapidity of the new PCR service, however, means that in future 
the effectiveness of the cleaning process could be tested using environmental swabs 
before a ward is re-opened, thereby encouraging strict adherence to procedure and 
reducing the risk of outbreaks recurring.  
6.5. Implications For Disease Surveillance 
At present the surveillance of viral  and other causes of  IID in Scotland is 
carried  out  by  Health  Protection  Scotland  (HPS),  formerly  known  as  the  Scottish 
Centre of Infection and Environmental Health (SCIEH). HPS collect data on cases of 
IID from three surveillance systems: the national surveillance scheme for laboratory 
confirmed infections, the national surveillance scheme for general outbreaks of IID, 
and  the  notifications  of  food  poisoning  system  (Wall  et  al,  1996).  Two  of  these 
systems  utilise  laboratory  data  (the  national  surveillance  scheme  for  laboratory 
confirmed infections and the national surveillance scheme for general outbreaks of 
IID) and are therefore likely to have been affected by the changes in the WOSSVC 
service described in this thesis.  
The  first  of  these  schemes,  the  national  surveillance  system  for  laboratory 
confirmed  infections,  is  a  voluntary  system  operated  by  HPS  that  aims  to  detect 
unusual outbreaks or new trends associated with a particular pathogen. It relies on 
clinical  microbiology  laboratories  in  Scotland  reporting  all  laboratory-confirmed 
infections to the HPS. In each case laboratories are asked to submit the following 
data:  patient  details  (surname  and  forename  or,  if  these  are  not  available,  the 
laboratory  number  can  be  submitted  instead),  organism  and  type,  the  age  of  the 
patient, NHS board of origin, and clinical details. The HPS provide a standard form 
requesting these data, although some laboratories send their own form to the HPS. 
The report is sent on a weekly basis to the HPS by post, email or fax. The data 
collected from these reports are then examined by health board and for the nation as a   217 
whole, and are compared to historical data in order to identify any outbreaks or new 
trends associated with a particular pathogen.  
The  data  collected  by  the  system  are  skewed  by  a  number  of  factors.  For 
example, not all cases of viral  IID occurring in the community are likely to seek 
medical attention (Wheeler et al, 1999; Wall et al, 1996; WHO 7
th report). Of those 
that  do,  most  are  likely  to  be  suffering  from  severe  infections  and  to  be  from 
particular at-risk patient groups (e.g. infants and the elderly). The GP/hospital sample 
submission rate is also important, as not all patients who present to GPs/hospitals 
have a sample submitted for laboratory investigation. Where a sample is submitted the 
testing  protocol  of  the  laboratory  is  very  important.  The  absence  of  a  test  for  a 
particular pathogen or the routine use of an insensitive diagnostic assay increases the 
chance of underestimating the presence of some pathogens in the community.  
Figure 26: Number of norovirus detections made at the WOSSVC vs total reported by 
the HPS surveillance system (1999-2006). 
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Comparing the number of norovirus detections made by the WOSSVC service 
to  that  collected  by  the  national  surveillance  scheme  for  laboratory  confirmed 
infections (Figure 26) suggests that the WOSSVC service is a major contributor to 
this surveillance system. In 2001 and 2002, in fact, when real-time PCR was first 
introduced in the laboratory, almost all reported cases were likely to have originated 
from the WOSSVC. In subsequent years, once other laboratories began to replace EM   218 
with  more  sensitive  tests  e.g.  EIA  (or  introduce  a  norovirus  testing  protocol),  the 
proportion of cases contributed by the WOSSVC initially fell but has since risen and 
continues to represent more than 50% of all reported cases. Thus the improvements 
observed in this research in terms of rapidity, detection rate and uptake of the service 
since the transition to real-time PCR are likely to substantially improve the quality of 
the HPS surveillance data. The increase in service sensitivity, together with the rise in 
the number of individuals tested from a greater range of health boards, allows a more 
accurate picture of the role of norovirus-related illness to be drawn, in different age 
groups, health board regions and in Scotland as a whole. The increased rapidity of the 
service, moreover, will help improve the timeliness of the surveillance data, creating a 
more  accurate  picture  of  when  cases  are  occurring.  Taken  together,  these 
improvements can aid the identification of unusual trends such as the large increases 
in  disease  activity  observed  as  a  result  of  the  emergence  of  a  new  worldwide 
norovirus variant in 2002 and again in 2006 (Lopman et al, 2004; Gallimore et al, 
2007).  
The  improved  timeliness  of  the  surveillance  data  will  also  increase  public 
health officials’ ability to investigate unusual outbreaks of norovirus whilst these are 
still  occurring  (and  thus  implement  suitable  control  measures).  Possible  examples 
include outbreaks of norovirus where the source is a pre-packaged food that is widely 
distributed e.g. through a supermarket chain, and which causes illness over a wide 
geographic area that can only be linked via a national surveillance scheme.  
For non-norovirus causes of IID the new PCR-based service in the laboratory 
is likely to have less impact on the data  collected by the national surveillance of 
laboratory confirmed infections, for a number of reasons. Between 2004 and 2006, for 
example, when real-time PCR for non-norovirus pathogens was first introduced in the 
laboratory,  the  rotavirus  and  adenovirus  detections  reported  by  the  WOSSVC 
contributed only a tiny proportion of the total number of cases reported to the HPS 
surveillance scheme (Figure 27). In the case of rotavirus, this can largely be attributed 
to the fact that many laboratories already screen for rotavirus (as shown in the results 
of the telephone survey described in Chapter 5) and report their cases to the HPS 
directly.  Samples  that  are  submitted  to  the  WOSSVC  tend  to  come  from  a  small 
number of laboratories with no rotavirus protocol of their own, or have already been 
screened for rotavirus pre-submission. In the case of adenovirus, meanwhile, cases 
reported to the HPS include detections from all types of adenovirus-related diseases   219 
(e.g. eye infections and respiratory infections) since the HPS system does not require 
respondents to distinguish between the different types. No  attempt is made in the 
system to distinguish between trends in adenovirus related to IID and those related to 
other diseases. Thus, although the WOSSVC is one of the few laboratories to test for 
adenovirus in samples from cases of IID (as shown in the results of the telephone 
survey  described  in  Chapter  5)  the  contribution  made  by  these  detections  to  the 
overall figures is tiny, and is too small to have a significant impact on the analysis of 
trends in adenovirus.  
Comparing the number of astrovirus and sapovirus detections reported by the 
WOSSVC since the introduction of real-time PCR for their detection in late 2004 with 
thenumber collected by the HPS surveillance system in the same period (Figure 28 
and Figure 29) confirms that the WOSSVC is the only laboratory currently able to test 
for these pathogens, as suggested by the telephone survey described in Chapter 5. (In 
fact,  in  some  cases  the  number  detected  by  the  WOSSVC  exceeded  the  number 
published by the HPS, either due to faulty reporting by the WOSSVC or failure to 
include all reported cases by the HPS.) Prior to this (between 1999-2003), EM was 
used to test for astrovirus and sapovirus in a number of laboratories including the 
WOSSVC, but was gradually phased out in other laboratories in favour of focusing on 
alternative tests (mostly EIA) for the detection of rotavirus. However, despite the fact 
that  the  WOSSVC  is  currently  the  only  laboratory  to  test  for  these  pathogens  in 
sporadic cases of IID, the number of samples submitted to this service and hence the 
rate of detections has been, to date, too low for the HPS to determine any useful 
epidemiological patterns - although the situation may improve as more samples from 
sporadic cases of IID are submitted to the WOSSVC service, of which there were 
some early indications in 2006.    220 
Figure 27: Number of rotavirus and adenovirus detections made at the WOSSVC vs 
total reported by the HPS surveillance system (1999-2006). 
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 Figure 28: Number of astrovirus detections made at the WOSSVC vs total reported by 
the HPS surveillance system (1999-2006). 
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Figure 29: Number of sapovirus detections made at the WOSSVC vs total reported by 
the HPS surveillance system (1999-2006). 
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The  national  surveillance  scheme  for  general  outbreaks  of  IID  is  another 
voluntary  system  operated  by  the  HPS  that  employs  laboratory  data.  It  aims 
specifically  to  provide  information  useful  for  formulating  infection  control  and 
prevention policies. Under this scheme, all preliminary reports of suspected ‘general 
outbreaks’ of IID from laboratories, Consultants in Public Health Medicine (CPHMs), 
Environmental Health Officers (EHOs) and other sources (for example, news reports, 
members of the public, hospitals etc.) are investigated. A general outbreak of IID is 
defined in this context as “affecting members of more than one private residence, or 
residents  of  an  institution”  and  is  considered  distinct  from  family  outbreaks. 
Following  the  report  of  a  suspected  outbreak  the  HPS  sends  out  a  standardised 
questionnaire  to  the  appropriate  lead  investigator.  The  data  requested  in  the 
questionnaire  include  the  causal  pathogen  (laboratory-confirmed,  suspected  or 
unknown), the vehicle of transmission and source, number of persons involved in the 
outbreak, number of cases confirmed using laboratory methods, and the NHS board of 
origin. Once complete, the form can be submitted by mail, fax or email.  
Unlike the national surveillance scheme for laboratory confirmed infections, in 
this system the recording and reporting of IID outbreak activity is not dependent on 
laboratory results. Outbreaks of gastroenteritis can be included in the final collected 
data  regardless  of  whether  or  not  any  patient  samples  have  been  submitted  to  a 
laboratory for testing. As a result, the new molecular services implemented at the   222 
WOSSVC as part of this research are likely to have less impact on the outbreak data 
collected  by  this  surveillance  system  than  on  the  previous  scheme  described. 
However, laboratory confirmation (or otherwise) of the viral cause of the outbreak 
remains  a  component  in  the  system  and  this  is  dependent  on  the  quality  of  the 
laboratory tests  employed. As a result, the increased sensitivity of the  PCR-based 
service for the detection of norovirus (the principle cause of outbreaks of IID) is likely 
to help increase the number of outbreaks proven to be caused by norovirus, thereby 
improving  the  quality  of  the  collected  data.  This  will  help  contribute  to  a  more 
accurate  measure  of  the  role,  epidemiology  and  public  health  effect  of  norovirus 
outbreaks in Scotland, which in turn will provide more accurate information on which 
to base infection control and prevention policies.  
The availability of a rapid, sensitive diagnostic service for norovirus such as 
that developed in this research could also be used as the basis for new surveillance 
systems for viral IID. One possible system would be to recruit a small number of GPs 
throughout Scotland to act as sentinel sites (Clothier et al, 2005). Each GP would be 
paid to submit all or a defined number of IID samples each week to their nearest 
Specialist Virology Centre (or a central facility) for testing. Results would then be 
returned  both  to  the  GPs  and  the  HPS.  Thus,  instead  of  relying  on  individual 
clinicians’  awareness  of  the  tests  available  for  IID  to  ensure  that  samples  are 
submitted for testing, surveillance of community acquired viral IID in Scotland would 
be  based  on  regular,  systematic  collection  of  data  from  a  representative  set  of 
geographic locations. While it is possible that such a system could be implemented 
based on tests other than PCR, the use of molecular methods means that the data are 
more likely to accurately represent the level of infection in the community and the 
times at which it occurs, thus increasing the likelihood of the necessary investment in 
the system. A similar PCR-based system is already in place for the surveillance of 
viral respiratory infections in Scotland
3. Other possible sentinel sites could include 
microbiological  laboratories,  schools  or  accident  and  emergency  departments 
(Takahashi et al, 2001).  
                                                 
3 http://www.hps.scot.nhs.uk/resp/influenzaseason.aspx#background   223 
6.6. Future Work 
There are a number of areas in which the molecular service for IID developed 
as described in this thesis would benefit from further research.  
Some  of  this  research  is  already  underway.  For  example,  as  mentioned  in 
Chapter  5,  the  current  WOSSVC  molecular  service  for  IID  does  not  include  an 
internal  control,  largely  because  of  concerns  relating  to  the  increased  cost  and 
complexity of using such a system at the time. Research is now underway, however, 
to investigate the use of an internal control system, based on the recent advent of 
specialised commercial kits for multiplex real-time PCR (see below). 
Research is currently underway at the WOSSVC on a laboratory-wide internal 
control system that uses murine cytomegalovirus (mCMV) for DNA tests and the 
plant virus brome mosaic virus (BMV) for RNA tests. The aim is to add these viruses 
to the sample lysis buffer, which will then be automatically added to each sample 
during the process of nucleic acid extraction. This method is intended to detect the 
presence of PCR inhibitors in the sample  and  will also aid the detection of post-
extraction  technical  errors.  It  will  not,  however,  detect  cases  where  the  original 
sample was not added to the bio-robot lysis plate. The main breakthrough that has 
favoured this development is the advent of new commercial kits specially designed 
for multiplex real-time PCR (in this case the Qiagen Quantitect multiplex kit). These 
kits contain synthetic factors that increase the concentration of primers at the target 
site  and  stabilise  the  bound  primers.  As  a  result,  the  process  of  multiplexing  an 
internal control PCR assay to the existing assays is made easier since these kits reduce 
the need for complex optimisation procedures, and reduce test competition and primer 
interaction.  
The availability of such kits also favours the implementation of multiplex real-
time PCR tests. This has led to the development of a novel dual-labelled probe-based 
multiplex RT-PCR for adenovirus, astrovirus, rotavirus and sapovirus (no such assay 
is currently available in the published literature) partly based on the results of the 
research described in this thesis. The multiplex test includes a new in-house astrovirus 
RT-PCR that targets the 3’ NCR region and can theoretically detect all serotypes of 
astrovirus, and a sapovirus real-time RT-PCR that can detect all 5 genotypes (Oka et 
al, 2006). The assays for adenovirus and rotavirus, however, are those outlined in this 
thesis. To date, the new multiplex assay has been shown to be as sensitive as the   224 
equivalent singleton assays using dilution series of typed samples. The inclusion of an 
RT  step,  moreover,  has  been  shown  to  have  no  effect  on  the  sensitivity  of  the 
adenovirus  PCR.  However,  the  sensitivity  of  the  multiplex  assay  is  still  to  be 
compared  with  that  of  the  current  service  on  clinical  samples.  If  found  to  have 
comparable  or  improved  sensitivity  the  test  is  planned  for  implementation  in  late 
2007, with the aim of further improving the efficiency of platform use within the 
laboratory, and further reducing turn-around-times and test costs.  
Another  extension  of  the  research  carried  out  here  that  is  currently  being 
pursued is the development of nucleotide sequencing protocols for viral causes of IID. 
Nucleotide  sequencing  is  a  powerful  technique,  allowing  the  determination  of  the 
precise order of the nucleotides in a DNA sequence (or RNA molecule following 
reverse transcription). The sequence can then be compared with a library of known 
sequences for epidemiological and clinical purposes. If implemented successfully, a 
sequencing service for the 5 main viral causes of IID will compliment the current 
molecular diagnostic service as it can be used to provide data on the circulating types, 
subtypes and variants of each pathogen, to investigate outbreak transmission routes 
and sources, and to link cases previously thought unrelated. A system of this type has 
already been published  that sequences the RdRp and ORF2 regions  of norovirus 
(Gallimore  et  al,  2007).  This  method  was  used  to  show  the  emergence  of  a  new 
variant of norovirus (G2 v4.4) in Scotland in January 2006. The new variant became 
the predominant strain by April of that year and, like the variant that emerged in 2002, 
was  associated  with  a  significant  increase  in  norovirus  detections,  outbreaks  and 
sample submissions. The new variant was also found in England and Wales, where it 
also resulted in an increase in disease activity (Gallimore et al, 2007). Following the 
early  success  of  this  system  the  possibility  of  offering  a  typing  service  for  every 
norovirus outbreak in Scotland is now being considered. The aim would be to use this 
facility to monitor the emergence of new variants and to investigate large outbreaks 
(potentially  identifying  their  sources  and  transmission  routes,  and  any  previously 
unrecognised links between outbreaks). A similar service for rotavirus is also possible 
if the new vaccination program is implemented in Scotland (see chapter 2). This could 
be used to monitor the types of rotavirus circulating in the community before and after 
introduction of the vaccine in order to help determine its effectiveness (Mazick et al,
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monitoring the PCR target sites used in the current tests, to ensure that variations do 
not occur which may result in reduced test sensitivity. 
Other  research  under  consideration  includes  a  comparison  of  alternative 
sample preparation methods to those employed here. All of the samples tested in the 
research described in this thesis were processed using the Qiagen Blood kit on the 
Biorobot 9604. However, in recent years several other kits and extraction platforms 
have been made available, including some specifically designed for the extraction of 
viral pathogens from stool (e.g. the Qiagen DNA stool mini kit) or for viruses in 
general (e.g. the Qiagen Virus kit), together with some kits that concentrate the eluted 
nucleic acid further than is achievable with the current system (e.g. the Nuclisens™ 
EasyMag kit). These kits and platforms have the potential to offer improved nucleic 
acid  extraction  compared  to  the  method  employed  in  this  research,  which  in  turn 
could lead to improved pathogen detection rates. In future, therefore, a comparison of 
these methods would be useful.   
 Similarly, the number of real-time PCR methods published for norovirus has 
increased significantly in recent years (Houde et al, 2006; Jolkihumar et al, 2005; 
Pang  et  al,  2004;  Schmid  et  al,  2004;  Hoehne  et  al,  2006;  Simpson  et  al,  2004; 
Richards  et  al,  2004),  although  detailed  sensitivity  comparisons  between  these 
methods remain rare. The dual-labelled probe-based RT-PCR assay investigated in the 
research  described  in  Chapter  4  and  subsequently  implemented  (Kageyama  et  al, 
2003) was one of the first of its type to be published. It is possible that one or more of 
the assays published subsequently may offer increased sensitivity in comparison. A 
comparative evaluation of the sensitivity of a number of these published real-time 
PCR assays, similar to the study carried out by Vinje et al for conventional PCR 
methods  (Vinje  et  al,  2003),  would  therefore  be  of  considerable  interest.  For  the 
sporadic service a comparison of the latest published methods for the detection of 
non-norovirus causes of IID would also be useful, although here the choice of real-
time  assays  remains  limited  to  a  small  number  of  SYBR  green  and  dual-labelled 
probe-based RT-PCR tests for astrovirus and sapovirus.  
6.7. Thesis Conclusion. 
The  thesis  expounded  in  this  research  is  that  the  implementation  of  the 
molecular method Polymerase Chain Reaction (PCR) for the diagnosis of the viral   226 
causes of outbreaks and sporadic cases of gastroenteritis can bring significant benefits 
to a routine laboratory service. The data presented here confirm that this is in fact the 
case. Since the introduction of the adapted molecular tests at the WOSSVC for the 
detection  of  viral  pathogens  in  outbreaks  and  sporadic  cases  of  gastroenteritis  the 
number  of  samples  tested  by  the  routine  diagnostic  service  has  risen  steadily. 
Moreover, the rate of positive detections has improved and this has been achieved at 
the  same  time  as  a  substantial  reduction  in  sample  turn-around-times.  This  is  a 
significant improvement over the previous EM-based service. 
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